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Abstract 
 
How novel phenotypes emerge in biological systems is a fundamental question of 
evolutionary biology that has been left poorly answered due primarily to the inherent 
complexity of establishing genotype-phenotype maps in complex biological systems. 
Thanks to the availability of comprehensive genomic and biochemical information 
about metabolic systems and efficient computational methods, mainly the 
experimentally validated method of flux balance analysis, I could systematically 
establish a quantitative framework to gain unprecedented insights into the causes and 
origins of phenotypic innovation in metabolic systems. My analyses revealed the 
power of recombination in bringing forth novel phenotypes in genome scale 
metabolisms. Because innovation and robustness are highly interrelated concepts, I 
also systematically analyzed the robustness of bacterial genomes to pervasive large-
scale gene deletions. My analyses revealed an organization of bacterial genomes that 
ensures substantially higher robustness to such destructive events than expected by 
chance. I followed these observations by rigorous analyses to identify the 
evolutionary mechanisms that can create such an organization. In this quantitative 
framework, I could also analyze constraints and contingencies in complex metabolic 
systems to show how predictable phenotypic innovation is. Furthermore, by 
establishing an exhaustive genotype-phenotype map in central carbon metabolism, 
within the framework of genotype networks, I have shown how phenotypic 
innovation is facilitated during evolution, and to what extent non-adaptive 
mechanisms such as exaptation can explain the origin of novel phenotypes in 
metabolic systems.  
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Zusammenfassung  
Ein grosses Teilgebiet der Evolutionsbiologie befasst sich mit der fundamentalen 
Frage der Entstehung neuartiger Phänotypen in biologischen Systemen. Das Erstellen 
von Genotyp-Phänotyp-Karten in biologischen Systemen ist sehr komplex und daher 
wurde die obige Frage bis jetzt nicht zufriedenstellend beantwortet. Dank der 
Verfügbarkeit umfassender genomischer und biochemischer Informationen über 
Stoffwechselsysteme und aufgrund effizienter Berechnungsmethoden wie der 
experimentell validierten „flux balance analysis“ (FBA), konnte ich dieser Frage 
quantitativ und systematisch nachgehen. Meine Analysen erlauben beispiellose 
Einblicke in die Ursachen und Ursprünge phänotypischer Innovationen in 
Stoffwechselsystemen. Sie demonstrieren zum Beispiel die Fähigkeit der 
Rekombination, neue metabolische Phänotypen hervorzubringen. Da Innovation und 
Robustheit in hohem Maße miteinander zusammenhängen, analysierte ich auch 
systematisch die Robustheit von bakteriellen Genomen gegenüber Deletionen eines 
oder mehrerer Gene, welche in der Genomevolution häufig vorkommen. Weiters 
konnte ich durch meine Analysen eine Organisation bakterieller Genome feststellen, 
welche eine wesentlich höhere Robustheit gegenüber solchen destruktiven 
Ereignissen aufweisen als der Zufall erwarten lässt. Mittels gründlicher Analysen 
identifizierte ich die evolutionären Mechanismen, welche eine solche Organisation 
zustande bringen. In diesem quantitativen Rahmen war es mir auch möglich, 
evolutionäre Einschränkungen („constraints“) und Kontingenzen in komplexen 
metabolischen Systemen zu analysieren und dadurch die Vorhersehbarkeit 
phänotypischer Innovation aufzuzeigen. Des weiterem habe ich im Rahmen von 
Genotyp-Netzwerken eine umfassende Genotyp-Phänotyp-Karte des zentralen 
Kohlenstoffmetabolismus erstellt. Dadurch konnte ich zeigen, wie phänotypische 
Innovation während der Evolution erleichtert wird und inwiefern nichtadaptive 
Mechanismen wie die Exaptation den Ursprung von neuen Phänotypen in 
metabolischen Systemen erklären können. 
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Chapter 1: Introduction 
1.1. Phenotypic innovation 
Theodosius Dobzhansky indeed did not exaggerate when he stated, “Nothing in 
biology makes sense except in the light of evolution”, because the theory of evolution 
by natural selection proposed by Charles Darwin powerfully unifies all of life’s 
marvelous diversity. Nevertheless, there is an important aspect of life that Darwin’s 
theory is unable to explain. Although his theory of evolution perfectly explains how 
already-existing variation spread by natural selection, it is completely silent on how 
new variants come into existence in the first place. The problem is that natural 
selection per se cannot innovate, because it is not a creative force; it merely selects 
what is already there [1]. Hugo de Vries, the Dutch geneticist who rediscovered 
Mendelian laws of heredity, beautifully expressed this problem when he said that 
“Natural selection may explain the survival of the fittest, but it cannot explain the 
arrival of the fittest”.  
How do the new variants that natural selection needs arise? In other words, how does 
nature innovate? A common sense answer would be that new variants arise randomly, 
by chance. However, Darwin was himself aware of the fact that chance alone can 
explain nothing, when at the beginning of the chapter on laws of variation in the 
Origin [2] he wrote that: 
“ I have hitherto sometimes spoken as if the variations … had been due to chance. 
This, of course, is a wholly incorrect expression, but it serves to acknowledge plainly 
our ignorance of the cause of each particular variation. “ 
More than 150 years after Darwin’s theory, we still do not have a systematic 
understanding of the origin of new variants, mostly because of the following two 
reasons:  
First, we have so far focused mostly on genotypes; that is we have focused our 
attention mostly on already-existing variation at the genotypic level and how it 
spreads. After rediscovery of the Mendelian laws of heredity, and after the 
introduction of the concept of the gene, the theory of evolution was extensively used 
in quantitative and mathematical studies to model the dynamics of genetic variation. 
This resulted in the emergence of a discipline called population genetics, which views 
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a population as a collective pool of genes instead of organisms. Nourished by the 
mathematical and statistical insights of great intellectuals like Sewall Wright, J. B. S. 
Haldane, and Ronald Fisher, population genetics became a mature field able to 
quantify how genetic variants spread. Advances in molecular biology, genome 
science and high throughput sequencing technologies permitted the application of 
evolutionary theory to genome evolution and paved the way for the birth of 
population genomics. However, even in population genomics the central theme 
remains intact; we can quantify at an unprecedented level how genetic variations 
spread, but despite all these technological advances, we still do not have a systematic 
understanding on how new variation emerges in the first place. 
Second, organismal phenotypes are highly complex, which renders the prediction of 
phenotypes from genotypes a very challenging task. Despite the efforts of thousands 
of biologists over many decades we still struggle to fully understand the phenotype of 
even the simplest organisms, because it is not easy to fully understand how genes 
help shape this phenotype. Population and quantitative genetics gradually included 
more complex phenotypes by allowing genes contribute in non-linear ways to a 
phenotype. They also study multivariate phenotypes that are represented as vectors 
not as a single scalar. Nevertheless, these representations cannot capture the entire 
complexity of phenotypes such as the fold of a protein. This phenotype, which 
includes the molecular motions of a protein’s amino acids, is so complex that we 
cannot compute it from information in the genotype. Moreover, most of the complex 
tasks inside a cell are performed by multiple proteins, which interact with each other 
in a coordinated way. In other words, underlying complex organismal phenotypes are 
networks of interacting molecules that form signaling, regulatory and metabolic 
networks. Hence, to predict a given phenotype we need to identify the underlying 
genotypic players and to understand how exactly they interact with each other. 
Systems biology has made significant progress in identifying these biological 
networks. For example, it has established interaction maps, which show who interacts 
with whom. However, merely listing the molecules and their interaction partners does 
not help us to understand complex phenotypes. We need to understand exactly how 
these molecular players interact with each other to form a whole phenotype. This has 
become possible to some extent through mathematical models that aim to describe 
how the concentrations and activities of molecules change over time. These models 
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need parameters, but these parameters are not fully known for all the processes, 
pathways and networks existing in a given organism. Moreover, the resulting 
mathematical equations are not simple to solve analytically.  
Therefore, in order to predict complex phenotypes from genotypes, we must be able 
to address these problems by choosing right modeling approaches. The models 
should be as simple as possible, and at the same time they must be able to capture the 
essential characteristics of the system, as Albert Einstein said “everything should be 
as simple as possible, but not simpler”. Population geneticists used simplified models 
to understand the evolution of genes and genotypes, and they mostly ignored the 
complexity of organismal phenotypes. These simplifications were crucial for 
population geneticists to understand natural selection in action. However, to 
understand the origin of novel phenotypes and innovability, we cannot ignore the 
complexity of organismal phenotypes, but we must embrace it. In other words, we 
must gain sufficient knowledge on how genotypes are mapped to their corresponding 
phenotypes. Thus, to approach the problem of innovation, we need to focus on 
biological systems for which the relationship between genotype and phenotype is 
well understood, and we must choose the right computational approaches to tackle 
their inherent complexity.  
Although it is inevitably difficult, let me define phenotypic innovation more precisely 
with the help of some examples. Consider the phenotypic differences between a 
complex organism and that of the simplest life forms. Each of these differences can 
be considered as an adaptive solution that emerged as a response to a particular 
challenge faced by an organism during its evolutionary history. For example, 
photosynthesis can be seen as an innovative response to convert light energy to 
chemical energy in order to fuel various essential cellular activities. Likewise, the 
requirement for moving from one place to another has led to the emergence of 
innovative responses as diverse as whale’s tail fluke and the bacterial flagellum. In 
general, we can define phenotypic innovation as “a new feature that endows its 
bearer with qualitatively new, often game-changing abilities [3]”. The phenotypic 
changes during major transformations in the history of life are magnificent examples 
of innovation. They include the emergence of plants with flowers, animals with hard 
skeleton, birds and insects with wings, multicellularity, organisms living in groups, 
teeth to digest hard foodstuffs, vascular systems of plants and nervous systems in 
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animals and etc. [3]. Another broad class of examples, which will be the focus of my 
thesis, are the metabolic innovations that emerge when an organism acquires the 
ability to use alternative sources of energy or produce novel chemical substances.   
1.2. Metabolic systems and innovation 
To systematically study phenotypic innovation in my Ph.D. research, I have focused 
exclusively on metabolic systems. I did so for three major reasons: First, metabolism 
is one of the most fundamental biological systems required for sustaining life. 
Second, metabolism is the source of many well-documented innovations, and 
especially in prokaryotic organisms. Third, we have efficient and experimentally 
validated computational methods that can systematically establish genotype-
phenotype maps in metabolic systems. 
Metabolism and replication are the two fundamental requirements for sustaining life. 
A minimal life form requires a metabolism, a network of chemical reactions that 
extracts energy and creates molecular building blocks of life. The reactions in this 
network are accelerated (i.e. catalyzed) by enzymes, which are encoded by metabolic 
genes. Broadly speaking, a metabolism encompasses two complementary kinds of 
chemical transformations. The first extracts energy from energy-rich molecules such 
as glucose, and the second uses the extracted energy to transform nutrient molecules 
to molecular building blocks such as amino acids in proteins, DNA nucleotides, RNA 
nucleotides and lipids. In addition, metabolism manages body’s waste, for example 
by converting toxic molecules to harmless ones.  
Besides its fundamental roles in life, metabolism is the source of countless well-
documented innovations. Especially, bacterial species are astonishing metabolic 
innovators. They can metabolize a bewildering variety of natural, synthetic, and even 
toxic molecules. These novel abilities help bacterial species to survive in unusual 
environments and let them explore or invade new habitats. For example, microbes 
have been reported to thrive on toxic industrial substances such as polychlorinated 
biphenyls [4], chlorobenzenes [5], organic solvents, and synthetic pesticides like 
pentachlorophenol [6,7]. One study on microbial isolates from pristine soils showed 
that some microbes not only are not killed by several antibiotics including 
ciprofloxacin, a fully synthetic compound, but also are able to use those antibiotics as 
food [8].  
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Another way by which microbes innovate is by synthesizing novel compounds. For 
example, halophilic bacteria can survive on saturating salt concentrations of 30% by 
synthesizing compatible solutes such as ectoine or glycine betaine, which are able to 
stabilize proteins and neutralize the high osmotic pressure caused by high salt 
concentrations [9–11]. Another example is the synthesis of light-harvesting 
chlorophyll pigments, which was a key innovation step in the evolution of 
photosynthesis [12,13].  
Although metabolic innovation is mostly documented in the prokaryotic world, we 
can also find metabolic innovations in higher animals. A typical one is the urea cycle 
in land living organisms. Ammonia, which is a toxic product of animal metabolism is 
converted to less toxic compounds in the urea cycle. Importantly, the urea cycle 
exemplifies the combinatorial nature of innovation: The individual reactions are not 
necessarily new, but it is their combination that is new. The urea cycle is formed by 
combining a set of four reactions involved in arginine biosynthesis with arginase, a 
reaction involved in arginase degradation [14]. These reactions are not new, as they 
all exist in both prokaryotes and eukaryotes, but their novel combination allows the 
conversion of ammonia to urea. 
Plants are also particularly ”talented“ metabolic innovators. They can produce an 
amazing diversity of chemical compounds known as secondary metabolites [15]. 
These compounds confer a wide variety of selective advantages. For example, floral 
scent pigments increase fertilization rates by attracting insect pollinators [16,17]. 
Toxic secondary metabolites can play defensive roles by repelling pathogens and 
herbivores [18,19]. Specific chemical compounds found in fruits can prevent 
spoilage, and finally, specific metabolites can help plants grow in harsh conditions 
such as high salt concentrations or arid environments [20,21].   
Fortunately, thanks to the efforts of many experimental labs over decades, we have 
accumulated systematic knowledge about the biochemical reactions of metabolism in 
many different species from bacteria to human. Moreover, technological advances 
permitting genome sequencing of many different species have provided us with an 
unprecedented opportunity to reconstruct genome-scale metabolic networks from 
genomic data [22,23]. Comprehensive information about thousands of reactions with 
their corresponding enzymes, enzyme-coding genes, and gene-reaction association 
rules are stored in biological databases such as KEGG (Kyoto Encyclopedia of Genes 
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and Genomes) [24–26], BIGG (Biochemical and Genetic and Genomic database) 
[27], and SEED (a database and infrastructure for comparative genomics) [28].  
The final reason that makes metabolism an ideal system for studying innovation is the 
availability of efficient, well established and experimentally validated computational 
methods for predicting metabolic phenotype from metabolic genotype. I discuss these 
computational approaches in more detail in the following section. 
1.3. Computational modeling of metabolic systems  
a) Kinetic modeling 
Classical biochemical studies were based on small-scale analyses of metabolic 
systems including a handful of reactions or a linear sequence of reactions [29], and 
modeling the behavior of such small systems was based on kinetic models using 
ordinary differential equations [30]. In order for these equations to accurately predict 
the concentrations of metabolites over time, they need precise experimentally 
determined parameters. For example, in the following Michaelis-Menten equation of 
enzyme kinetics [31]  
![!]!" = !!"# [!]!!![!]     (1) 
The concentration of product ([P]) over time is described by the concentration of a 
substrate ([S]) and two parameters that are required to be determined experimentally 
as precisely as possible. These are 𝑉!"# , the maximum catalytic rate achievable by 
the enzyme at saturating substrate concentration, and 𝐾! (the Michaelis constant), 
which is the substrate concentration at which the reaction rate is half of 𝑉!"#. 
Moreover, in such kinetic models, all regulatory information, including allosteric 
interactions, which are defined as regulation of enzyme activity by effector molecules 
outside of the enzyme’s active site, should be considered. These kind of kinetic 
models are not easily scalable for analyzing genome-scale metabolic networks 
including thousands of reactions and enzymes, for which most parameters and 
regulatory interactions are unknown. Therefore, alternative modeling approaches, 
which sacrifice precision in order to scale up to large-scale systems, are required.   
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b) Constraint-based modeling 
To circumvent the need for experimentally measured kinetic parameters and the lack 
of sufficient knowledge about the underlying regulatory interactions, a coarse grained 
approach based on constraint-based modeling called flux balance analysis (FBA) is 
often used to model genome-scale metabolic systems. FBA is based on a steady state 
assumption, that is, the concentrations of metabolites in the cell are stationary and do 
not change over time. Moreover, FBA only requires stoichiometric information about 
reactions. Thus, it is completely independent of kinetic parameters. Finally, in this 
method, regulatory information about enzymatic reactions is completely neglected. 
Nevertheless, FBA is able to predict system level qualitative phenotypes accurately, 
because its predictions are consistent with experimental studies [32]. For example, 
FBA is able to accurately predict whether a given metabolism is able to produce all 
essential biomass precursors from a given nutrient or not, even though it may not 
provide accurate predictions for the flux of all individual reactions. 
FBA predicts the metabolic flux of each reaction based on the stoichiometric 
coefficients of the metabolites participating in the reactions of a given metabolic 
network. Stoichiometric coefficients are stored in a stoichiometric matrix S, which is 
of dimension m×n, where m and n, respectively, denote the number of metabolites 
and the number of reactions in a metabolic network. The flux through each reaction 
is constrained based on the assumption that metabolite concentrations do not change, 
i.e., 𝑆𝑣 = 0, where v is the vector of metabolic fluxes vi through reaction i. The 
solutions of the equation 𝑆𝑣 = 0, that is, the nullspace of matrix S, comprises all flux 
vectors that are allowable in steady state.  
Thus, there may be infinitely many solutions within the null space that can satisfy the 
steady state assumption. Therefore, the null space has to be constrained by additional 
physicochemical information regarding the maximum and minimum possible flux 
through each reaction. FBA relies on an optimization procedure called linear 
programming to identify those flux vector(s) among the allowable ones that 
maximize an objective function Z such as ATP production rate or biomass 
production rate that is, the rate at which metabolic compounds are converted into 
biomass constituents. This task can be formulated as finding a flux vector v* with the 
property 
	 8	
v*=maxv Z(v)= maxv { cTv | Sv=0, a≤v≤ 𝑏},  (2) 
where the vector c contains a set of scalar coefficients representing the maximization 
criterion, and each entry ai and bi of vectors 𝑎 and 𝑏, respectively, indicate the 
minimally and maximally possible flux through reaction i. It is important to note that 
in our applications, the vector c is a binary vector, whose elements are all zero except 
the element corresponding to the biomass reaction. Therefore, v* maximizes the 
biomass growth flux, that is, the rate at which a metabolic network can produce 
biomass [33].  
An alternative constraint-based approach with widespread applications in metabolic 
engineering is Elementary Flux Mode Analysis (EFMA) [34]. Similar to FBA, 
EFMA also solves 𝑆𝑣 = 0 subjected to the imposed constraints. However, in EFMA 
the aim is not to calculate a specific flux vector to optimize an objective function. 
Instead, the goal is to identify all possible flux vectors (or flux modes) belonging to 
the nullspace, which satisfy the following “elementary flux mode” property. The set 
of non-zero indices in a flux vector (i.e. a mode) are called the support of the flux 
mode. A flux mode (e) is called elementary (EFM), if its support is not a superset of 
the support of any other feasible flux mode (v) (supp e ⊅ supp v ). An EFM is 
thus a minimal and unique set of reactions with non-zero flux in steady state [35]. If 
any of the reactions with non-zero flux is deleted, the EFM is not able to remain 
functional in steady state anymore [36]. In other words, EFMs are non-decomposable 
steady-state pathways through a network. The most important advantage of EFMs is 
that any steady state flux vector can be represented as a non-negative weighted sum 
of EFMs. 
The full metabolic capabilities of a metabolic network can be expressed by its set of 
elementary flux modes [37]. EFMA is employed in the first steps of metabolic 
engineering to check the feasibility of production of a given metabolite from a given 
substrate [35]. Production is possible, if there is at least one EFM that connects the 
substrate and the product of interest. Moreover, EFMA is further employed in the 
optimization step of metabolic engineering projects by identifying the target 
reactions that do not participate in the desired EFMs and whose elimination can 
improve the production yield of desired metabolites [38,39]. Experimental studies 
have confirmed the power of EFMA in the construction of minimal metabolic 
networks with optimal production efficiency [40–44].  
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Exhaustive enumeration of all possible EFMs is possible only for small metabolic 
systems, but for larger systems, the calculation of EFMs represents a major 
algorithmic challenge, which limits EFMA’s applicability [35]. Several methods 
have been introduced to tackle the computational complexity of EFMA [45–50]. The 
common core of all these algorithms is the same. They generate EFMs by pairwise 
combination of existing EFMs, followed by verification of the generated EFMs to 
ensure that they have not been identified before. The verification step is the major 
bottleneck of these algorithms. To make this step computationally more efficient, 
several algorithmic improvements have been introduced, including the application of 
binary representation [51], matrix rank [52], bit pattern trees [53], distributed 
memory parallelization [54], and efficient sampling-based approaches [55,56].         
Because in my studies I analyze millions of large-scale metabolic networks, the 
computational efficiency is very important to make my studies feasible. Therefore, 
FBA, which is parameter-free and efficient, is the method of my choice in this 
dissertation. It allows me to systematically analyze many different metabolic systems 
required for studying metabolic innovation. I use FBA to predict qualitatively 
whether a given metabolic network is viable in a given environment, and I consider a 
metabolic network viable if it can produce all essential biomass precursors. 
c) C13 based metabolic flux analysis 
FBA determines the reaction fluxes based on the assumption that cellular metabolism 
maximizes a specific objective function. However, this optimization principle may 
not reflect biological reality, because cellular metabolism seems to display 
suboptimal performance in some biological systems [57,58]. Thus, to obtain more 
realistic estimates of metabolic fluxes, it can be desirable to quantify intracellular 
steady state fluxes within a predefined metabolic network under in vivo conditions.  
This approach uses experimental information from isotope tracer experiments to infer 
intracellular flux distributions. Specifically, C13-labeled substrates are fed to a 
growing cell population until the isotope label is distributed through the metabolic 
network [59]. As a function of the particular distribution of metabolic fluxes in an 
organism, specific labeling patterns occur in metabolic intermediates [60,61] . Data 
based on C13 labeling are obtained by analytical methods such as NMR [62–64] or 
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mass spectrometry [65–67]. To infer intracellular fluxes from C13 labeling patterns, 
one of the following two complementary procedures is used. 
In the first procedure, C13-labeled based data and extracellular fluxes are integrated 
into a computational model. The goal is to fit flux of metabolic reactions to 
experimental data. The fluxes are fitted iteratively to measured data until the 
difference between observed and simulated isotope spectra is minimized [61]. The 
second procedure relies on direct interpretation of selected labeling patterns. In this 
approach, a flux ratio is derived that quantifies the relative contribution of converging 
pathways to the formation of particular metabolites from a given NMR or mass 
spectrometry pattern [66,68].  
Due to the complexity of flux inference procedures and the experimental difficulty 
associated with carbon labeling experiments, this approach cannot be applied to 
studying genome-scale metabolic systems. Instead, it is only applicable for small 
metabolic systems with 50 to 100 reactions, such as central carbon metabolism [66]. 
Nevertheless, C13 metabolic flux analysis has played a major role in biotechnology 
and metabolic engineering to produce molecules with industrially important 
capabilities, such as the amino acids lysine and glutamate [69,70]. Moreover, it has 
been used to study the metabolism of microorganisms engineered for secondary 
metabolite production, such as penicillin production in Penicillium chrysogenum 
[71].   
d) Metabolic control analysis 
One aspect of metabolic systems that is not quantifiable by the approaches I 
described thus far is how cells regulate and control their fluxes. Our knowledge of 
metabolic systems remains incomplete until we completely uncover all the details of 
metabolism’s regulation. Identifying the mechanisms controlling flux through a 
particular pathway and quantifying the extent of the pathway’s control require 
alternative computational approaches. Gaining insight into these control mechanisms 
is particularly important for metabolic engineering purposes; for example, how to 
optimally manipulate fluxes to maximize the production of a given metabolite. These 
quantifications can be achieved to some extent through a computational method 
called Metabolic Control Analysis (MCA), which defines a quantitative link between 
pathway fluxes and the activity of a pathway’s constituent enzymes [72]. 
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MCA quantifies how variables such as reaction fluxes or metabolite concentrations 
depend on network parameters. In this mathematical framework, network dependent 
properties are encapsulated in control coefficients and MCA describes how these 
coefficients depend on local properties called elasticities. MCA is fundamentally a 
first order sensitivity analysis in the vicinity of a fixed point that is the steady state of 
a metabolic system.  The relative steady state change in a system variable such as 
pathway flux (J) or metabolite concentration (Sc) in response to a relative change in a 
parameter (P) such as enzyme activity or the steady state flux of the ith reaction (vi) is 
quantified by control coefficients. The two main control coefficients are the flux and 
concentration coefficients. The flux control coefficients 𝐶!!!  are defined as: 𝐶!!! = !"!" !! !!!!! !!! = !"#$ !!"#$ !!        (3) 
And the concentration coefficients 𝐶!!!"  are defined as follows: 𝐶!!!" = !"#!" !!" !!!!! !!! = !"#$ !"!"#$ !!         (4) 
The control coefficients of different reactions are not independent of each other, 
because metabolic fluxes are system properties. Thus, their control is shared by all 
reactions in the system. For a metabolic pathway this is formulated as the summation 
theorem [73,74]: 
 C!!! = 1!                (5) 
 C!!!" = 0!                (6) 
It implies that when a given reaction changes its control of flux, the change is 
compensated by changes in the control of the flux by all other reactions.  
The local response of a chemical reaction to changes in its environment, such as 
changes in substrate or product concentrations, is measured by elasticity coefficients (𝜀!"! ). The relationship between elasticity and control coefficients in a metabolic 
pathway is expressed by the connectivity theorem, which highlights the close 
relationship between the kinetic properties of individual reactions and the systems 
properties of a pathway [73,75]: 
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C!!ε!"!! = 0                                  (7) C!!"!ε!!!! = 0,   n ≠ m                (8) C!!"!ε!"!!! = −1,   n = m             (9) 
Equation 7 (i.e., the connectivity theorem for flux-control coefficients) implies that 
for a common metabolite Sc, the sum of the products of the flux-control coefficient of 
all steps affected by Sc and its elasticity coefficients towards Sc, is zero. For the 
concentration-control coefficients, the analogous equations 8 and 9 apply. Equation 8 
applies to the case in which the reference metabolite (𝑆𝑐!) is different from the 
perturbed metabolite (𝑆𝑐!). Equation 9 applies to the case in which the reference 
metabolite is the same as the perturbed metabolite. The connectivity theorems 
describe how perturbations on metabolites of a pathway propagate through the chain 
of enzymes. The local (kinetic) properties of each enzyme effectively propagate the 
perturbations to and from its immediate neighbors. 
Finally, by combining the summation theorem with the connectivity theorem, we can 
obtain closed expressions that relate control coefficients to elasticity coefficients. 
Based on explicit expressions for control coefficients we can quantify the control 
mechanisms of a metabolic system. For example, we can determine whether the flux 
through a given metabolic pathway is controlled predominantly by one single 
reaction (traditionally referred to as a rate limiting step) or whether the control is 
distributed among all the reactions in the pathway. This invaluable information can 
be applied to identify the regulatory mechanisms in metabolic pathways and can help 
to optimally engineer metabolic pathways for the production of metabolites of 
industrial or medical importance [76–78]. 
In my analyses, my aim is not to discover the regulatory mechanisms in metabolic 
systems, and I am not concerned about the properties of individual reactions in 
metabolism. Therefore, I do not utilize MCA in my studies. I use FBA, which 
neglects the regulatory mechanisms in metabolic systems. However, for the 
qualitative phenotypes that I am concerned with, namely the viability or inviability on 
a given set of carbon sources, this simplification is not too unrealistic, especially if 
we consider the fact that regulatory constraints can easily be broken in evolution, 
even on the short time scales of laboratory evolution experiments [79–81].  
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e) Markov-Chain Monte Carlo Sampling  
Systematic understanding of phenotypic innovation is only achievable through 
systematic genotype-phenotype maps, where thousands and millions of genotypes 
with their corresponding phenotypes are analyzed. Therefore, for most of the research 
described here, my analyses requires going beyond any known biological system and 
analyzing thousands and millions of potential metabolisms with new combination of 
reactions. To this end, I utilize the concepts of a reaction universe and a metabolic 
genotype space in my analyses. The reaction universe comprises all N reactions 
known to exist in some prokaryotic species. If we represent a given potential 
metabolism (i.e. a metabolic genotype) as a binary vector whose length is identical to 
the number of reactions in the reaction universe (N), the total number of possible 
genotypes is 2N. These comprise the metabolic genotype space.  
In part of my studies, where I focus on central carbon metabolism, the reaction 
universe only has 51 internal reactions [23,82], which allows establishing an 
exhaustive genotype-phenotype map. Having access to such a map, I was able to 
study innovation in the framework of genotype networks [83,84]. All genotypes with 
the same phenotype are arranged in a genotype network, where two genotypes are 
connected by an edge if they differ from each other by the smallest genotypic 
difference, which corresponds to a single reaction in metabolic systems. This 
representation allows us to utilize the concepts and methods developed in graph and 
network theory [85] to facilitate analysis of the evolution of metabolic systems.   
Unfortunately, for genome-scale metabolic systems such an exhaustive approach is 
not possible because the reaction universe contains more than 5000 reactions. Thus, 
the genotype space is astronomically large (25000 genotypes). Therefore, analyzing 
genotype-phenotype relationship in genome-scale metabolic systems is possible only 
through sampling approaches. In other words, I needed to sample thousands of 
genotypes with a given phenotype from this vast genotype space. To this end, I used 
the Markov Chain Monte Carlo (MCMC) method [86], a widely used approach for 
sampling from large and high dimensional spaces, that have also been applied to 
study metabolic systems [87,88]. In each step of the MCMC algorithm, a genotype is 
generated from a previous genotype using a probabilistic transition rule. At each 
transition, a small modification to the current genotype is proposed, and the modified 
genotype is accepted as the next genotype if the phenotype does not change, 
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otherwise the modification proposal is rejected (Figure 1). Therefore, this algorithm 
generates a sequence of genotypes with the same phenotype. To sample metabolic 
genotypes, the modification that I introduce at each transition step is a reaction swap 
that adds a randomly chosen reaction from the reaction universe to the current 
genotype, and deletes a randomly chosen reaction from the current genotype. The 
MCMC algorithm is thus a random walk in the subspace of the genotype space 
containing all genotypes with the same phenotype. It requires an initial genotype and 
in most of my analysis I used the genotype of a well-studied organism like E. coli. 
Previous studies have shown that in order to ensure that the sampled genotypes are 
not biased by the initial genotype, at least 3000 MCMC steps are needed before 
saving the first chosen genotype [87,88]. Moreover, due to strong autocorrelations 
between successive genotypes, it is advisable to only save every 1000th genotype in 
the sample. Thus, to sample 1000 genotypes, running an MCMC algorithm with 106 
steps (successful reaction swaps) will be needed.  
 
Figure 1: MCMC Sampling of random viable genotypes. Genotypes are represented as arrays of 
black and white boxes, each of which correspond to a given reaction in the reaction universe. Black 
boxes indicate that the corresponding reaction is present in a genotype, and white boxes show the 
absence of the corresponding reaction. The input of the MCMC algorithm is an initial genotype (a 
known genotype like that of E. coli). The initial genotype is subjected to 10,000 steps of phenotype-
preserving reaction swaps (gray rectangles), in which a randomly chosen present reaction is removed 
(indicated by a red arrow) and a randomly chosen absent reaction is added (indicated by a black 
arrow). Then the phenotype of the new genotype is computed by FBA to ascertain viability. If the new 
genotype is viable, the reaction swap is accepted and the new genotype becomes the input of the next 
reaction swap, otherwise the reaction swap is not accepted. The viable output of the 10,000-th reaction 
swap, which is a viable random genotype, is the output of the MCMC algorithm.   
 
 
 
 
Input: 
If viable
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1.4. Prokaryotic recombination 
As I briefly mentioned in section 1.2, innovation in metabolic systems has a 
combinatorial nature, that is, new combinations of already existing reactions can lead 
to the emergence of novel phenotypes. As an example, the ability to digest the 
synthetic pesticide pentachlorophenol by Sphingomonas chlorophenolica is caused by 
the formation of a new metabolic pathway comprising four reactions catalyzed by 
enzymes that process natural chlorinated chemicals and by an enzyme involved in 
tyrosine metabolism [7]. Similarly, Arthrobacter aurescens can thrive on the man-
made pesticide atrazine as a sole carbon and nitrogen source by assembling six 
reactions that exist in other organisms into a new pathway [89].  
Recombination as a pervasive genetic force, which helps to form new combinations 
of already existing components might therefore be a strong genetic force behind 
phenotypic innovations. There is compelling evidence attesting to the power of 
recombination in the origin of novel phenotypes based on DNA shuffling, a widely 
used experimental technique to engineer novel biological systems [90]. This 
technique generates recombinant DNA molecules consisting of multiple recombinant 
fragments of several parental DNA molecules [91]. For example, in an experiment to 
create antibiotic resistant cephalosporinases, DNA shuffling yielded a 270 fold 
increase in resistance to moxalactam, as compared to an only 8 fold increase in 
resistance by mutagenesis [92]. Moreover, for improving production of the antibiotic 
tylosin in the bacterium Streptomyces fradiae, genome-scale recombination through 
DNA shuffling is 20 times more effective than random mutagenesis [93].  
Although prokaryotes are haploid and lack the meiotic recombination of eukaryotes, 
they can still recombine genetic material. Prokaryotic recombination is not rare and 
can occur much more frequently than point mutations [94–99]. Deep sequencing of 
bacterial populations and metagenomic sequencing have shown that homologous 
recombination in bacteria leads to pervasive genetic mosaicism in different bacterial 
and archaeal species of diverse extremophiles, mesophiles, terrestrial and aquatic 
bacteria, and pathogenic and non-pathogenic microbes [94–98,100–107]. Although 
the rate of homologous recombination decreases exponentially with genomic 
sequence divergence, it can still be substantial even for a nucleotide divergence of 
10% or greater [100,103].  
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The most prominent mechanism for adding genes to prokaryotic genomes is 
horizontal gene transfer. It leads to addition of new reactions to metabolic networks 
when enzyme-coding genes are transferred. The mechanisms of horizontal gene 
transfer include bacterial conjugation via transferrable plasmids, transduction of DNA 
mediated by viruses, and transformation (i.e., the uptake of naked DNA from the 
environment) [108].  Horizontal gene transfer can change the organization of 
genomes on relatively short evolutionary time scales and its rate strongly declines 
with sequence divergence [108–117]. Importantly, there is ample empirical evidence 
attesting to the fact that horizontal gene transfer can affect DNA regions of various 
length, from fragment of genes, to multiple adjacent genes and mega-base scale 
extrachromosomal elements [118–126].  
In sum, because of the theoretically high potential of recombination as a genetic force 
behind phenotypic innovation, and because of the pervasiveness of recombination in 
prokaryotes, I aimed to quantify the importance of recombination in metabolic 
innovation as one of the major goals of my dissertation. 
1.5. Deletional robustness 
It has been shown that many genes newly added to a genome via horizontal gene 
transfer reside in the genome only for short amounts of time [110,127]. For example, 
fewer than 15 percent of newly acquired genes in the E. coli genome may be retained 
in the long run [128,129]. The reason is that bacterial genomes are constantly 
subjected to DNA deletions on the length scales of few nucleotides to long segments 
of DNA comprising multiple genes [130–134]. Importantly, in bacterial genomes, 
deletions occur more frequently than insertions [130–135]. In other words, there is a 
general bias towards DNA deletion in bacterial genomes [130–135].  
Moreover, recent comparative genomic studies have shown that large scale gene loss 
events are not a peculiarity of bacterial genomes with extremely reduced genomes 
such as obligate pathogens [136] or endosymbionts [137], but a dominant mode of 
evolution in bacterial genomes [138,139]. These observations are further confirmed 
by experimental evolution studies, which have shown that extensive gene loss by 
large-scale deletions tend to occur on short evolutionary time-scales [133,140,141]. 
There is evidence especially from bacterial pathogens that gene loss has not always 
been deleterious, but have also been associated with adaptive gains in pathogenicity 
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[142]. For example, the loss of allergen gene 1 (ALL1), which encodes a small 
cytoplasmic protein that is involved in capsule formation in Cryptococcus 
neoformans [143], of the cadA gene in Shigella, which encodes a Lysine 
decarboxylase catalyzing a reaction producing an enterotoxin inhibitor called 
cadaverine [144], of arabinose operon genes in Burkholderia [145] and of the mucA 
gene, encoding inhibitors of alginate biosynthetic genes in Pseudomonas aeroginosa	
[146], confer adaptive advantages during infection. 
In the presence of pervasive gene loss events, in order for horizontal gene transfer to 
be an effective genetic force behind phenotypic innovations, bacterial genomes must 
ensure phenotypic robustness against the deleterious effects of such DNA deletions. 
Robustness is like a prerequisite for innovation; without being able to preserve 
current phenotypes, gaining novel phenotypes may be useless. Previous studies have 
shown that robustness promotes innovation in many different biological systems 
[147–151]. Without studying robustness, my analyses of innovation would remain 
incomplete. Thus, studying robustness to gene and reaction deletions in bacterial 
metabolic systems forms an integral part of this dissertation. 
1.6. Bacterial genome organization 
To study the robustness of bacterial genomes to large-scale gene deletions, it is 
necessary to study the organization of genes in bacterial genomes closely.  
Comparative genomic analyses of prokaryotic and eukaryotic genomes have revealed 
striking differences in their genomic organization. In eukaryotes, the genome evolves 
predominantly through gene duplication. Chromosomes have very distinctive regions 
such as centromeres and telomeres and their transcription units usually include one 
single gene. In contrast, in prokaryotes, genomes expand mostly through horizontal 
gene transfer (HGT) rather than by duplication, chromosomes are relatively uniform, 
and genes are typically cotranscribed in operons [152].  
Gene expression has strongly influenced the local organization of genes in bacterial 
genomes. For example, in operons enzyme-coding genes tend to be colocalized and 
co-transcribed in polycistronic units [153,154]. Moreover, the order of metabolic 
genes in the chromosome reflects the order of the corresponding enzymes in 
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metabolic pathways [155], and many operons code for complete metabolic pathways 
[156].  
A fundamental question is why operons exist in prokaryotic genomes? According to 
the regulatory model of operon evolution, functional neighbors are adaptively 
brought together in the chromosome to ensure efficient gene regulation. However, 
this model raises two important questions. First, how do genes become closely linked 
before the emergence of co-regulation? Second, why are neighboring genes 
frequently functionally related? To address these questions, Lawrence and Roth 
proposed an alternative model called “the selfish operon hypothesis” [157], which 
claims that clustering of functionally related genes in operons is the result of selection 
on genes, not on organisms, to increase their own fitness through horizontal gene 
transfer. In other words, clustering of functionally related genes increases the 
probability of successful transfer, because HGT adds a complete functional module to 
a pre-existing network. Indeed, enzymes encoded in HGT-acquired operons have 
been shown to form metabolic pathways that are well integrated into the recipient 
metabolic network [110]. However, other studies provide evidence against the selfish 
operon hypothesis [158,159]. For example, operons indeed frequently contain 
essential genes, not just genes with peripheral metabolic functions [158]. Moreover, 
HGT-acquired genes have the same chance to be in operons as “native” genes, and 
thus there is no strong association between operons and horizontal gene transfer 
[159]. 
Above the operon level, there seem to be selective advantages in preserving the 
contiguity of pairs of operons [160]. Moreover, the conserved ordering of multiple 
operons in different genomes, which is called an uber-operon, has frequently been 
observed [161].  There might be regulatory advantages for contiguity between related 
operons. For example, operon pairs oriented in opposite directions, can share 
bidirectional regulatory regions, and thus allow the coregulation of the two operons 
[162,163]. Such operons show correlated expression levels and are more conserved 
than operons oriented in the same direction [164]. In addition, there might be other 
still unknown regulation-independent selective advantages associated with conserved 
operon ordering. 
In addition to gene expression, DNA replication can also exert a global effect on 
bacterial genome organization. Because cell division is not necessarily coupled with 
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DNA replication, in some cases the ratio (R) between the time required to replicate 
the chromosome and the time between two successive cell divisions, can exceed one. 
Consequently cells can experience multiple replication rounds that cause a 
replication-induced gene dosage effect [152]. In other words, genes that are closer to 
the replication origin will be on average 2R times more abundant in the cell than the 
genes close to the terminus [165]. This replication-associated gene dosage effect 
systematically affects the organization of genes in bacterial genomes, because highly 
expressed genes such as RNAP, rDNA, and the genes encoding ribosomal proteins 
tend to be clustered near the origin of replication [166]. Moreover, because of the 
asymmetric replication of DNA (i.e. the leading strand replicates continuously, 
whereas the lagging strand replicates semi-continuously), sequence composition and 
gene content on the two DNA strands can differ considerably from each other 
[152,167]. It has been shown that the driver of this strand bias is not gene expression, 
but the essentiality of genes [168,169]. Last but not least, it has also been shown that 
in bacterial genomes essential genes are not uniformly distributed in the genome, but 
they are preferentially clustered in particular regions of the genome [170,171].  
In sum, in this section I described organizational principles of bacterial genomes 
because they can help us understand the phenotypic robustness to large-scale gene 
deletion that I discussed in section 1.5. As I mentioned before, studying phenotypic 
innovation is incomplete without studying phenotypic robustness. In the next sections 
I will focus on other aspects of phenotypic innovation.  
1.7. Phenotypic constraints in biological systems 
Another important aspect of phenotypic innovation is the extent of its predictability. 
If there is absolutely no constraint on phenotypic innovation, all possible novel 
phenotypes can potentially emerge, and thus phenotypic innovation becomes an 
unpredictable process. In contrast, if the emergence of novel phenotypes is subjected 
to various constraints, phenotypic innovation may be a predictable phenomenon. In 
this case, identifying the potential causes of phenotypic constraints can help us 
understand the rules governing the emergence of novel phenotypes.  
As a general definition, an evolutionary constraint is a bias or limitation in the 
emergence of phenotypic variation in a given biological system [172]. Absolute 
constraints occur when some phenotypes cannot be produced, and relative constraints 
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exist when some phenotypes are more likely to arise than others. Are biological 
systems able to produce every conceivable kind of phenotypic variation? According 
to ample real-world examples of phenotypic constraints, it is more likely that both 
absolute and relative answers to this question are negative.  
Ample evidence from organismal and anatomical levels down to the molecular level 
attests to the pervasiveness of phenotypic constraints in biological systems. Examples 
of absolute constraints in organismal level include the absence of photosynthesis in 
higher animals, the absence of birds that can give birth to live young instead of to 
eggs, and the absence of palm trees in cold climates [172,173]. Anatomical examples 
include the general lack of teeth in the lower jaw of frogs, the maximally five digits 
(fingers and toes) of tetrapod limbs and constrained variation in segment number, 
orientation and identity in the fruit fly Drosophila melanogaster [174]. Last but not 
least, molecular examples of phenotypic constraints include the absence of D-isomers 
in the 20 amino acids found in natural proteins [31].  
There are four major causes of phenotypic constraints that are not mutually exclusive. 
They include physicochemical, selective, genetic, and developmental constraints. The 
first major case is physicochemical constraints including the limited number of 
protein folds caused by the packing requirements of hydrophobic amino-acids [175]. 
Another case in this category is the necessity to have a circulatory system in 
organisms above a given size to ensure efficient delivery of nutrients to all body parts 
[173]. The second major cause is selective constraints, which are imposed by natural 
selection, for example by eliminating the phenotypes with lower fitness. Third, 
genetic constraints occur when any one genotype and its variants can produce only a 
tiny fraction of all possible phenotypes. For example, while mutations in the fly 
Drosophila subobscura cause the emergence of a wide range of wing shapes and eye 
morphology, in Drosophila melanogaster mutations do not have the same broad 
phenotypic effects [172]. Fourth, the developmental processes that produce a 
phenotype from information encoded in a genotype can impose further constraints on 
phenotypic variation. For example, the number of digits in salamanders and frogs is 
constrained during development [176,177]. 
These anecdotal examples can inform us about the existence of phenotypic 
constraints in biological systems. However, in order to quantify the extent of 
phenotypic variation in a given biological system, we need to study thousands or 
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millions of genotypes with their corresponding phenotypes. The genotype-phenotype 
map that I establish in metabolic systems based on flux balance analysis and Markov 
Chain Monte Carlo sampling algorithms can thus be an invaluable resource to 
systematically analyze the pervasiveness of phenotypic constraints and their 
underlying causes.    
1.8. Historical contingency 
A concept closely related to phenotypic constrain is historical contingency. If the 
origin of a novel phenotype depends on the history of a population, for example, on 
pre-existing genotypes or phenotypes, we consider that an example of historical 
contingency [178,179]. Historical contingency can occur especially because of the 
interactions between different mutations; for example, when the beneficial effect of a 
mutation does not manifest itself unless it occurs with another mutation, we can speak 
of contingent mutation effects [180,181]. As a prominent example of historical 
contingency, experimental evolution of Escherichia coli in Lenski lab has shown that 
the emergence of E. coli strains with the ability to utilize citrate as a novel metabolic 
phenotype is strongly dependent on the occurrence of potentiating mutations after 
20,000 generations [182]. In other words, this long-term evolutionary experiment has 
shown that the emergence of novel citrate utilization phenotypes is strongly 
contingent on the genetic history of a population [182].  
In the framework of genotype networks, historical contingency can be systematically 
quantified. Of special importance in this context is the concept of connectivity in 
genotype networks. If a genotype network, which is comprised of genotypes with the 
same phenotype, forms a single connected component in genotype space, where 
every pair of genotypes is reachable from each other through a phenotype-preserving 
mutational path, historical contingency will not play a major role in the phenotypic 
outcome of genotypic changes in the system. In contrast, if a genotype network is 
fragmented into several independent connected components, the evolutionary fate of 
a system may strongly depend on the initial genotypes and the mutational history of 
the system. Moreover, fragmentation of genotype space can potentially restrict the 
accessibility of novel phenotypes.   
Previous studies on genotype networks in RNA molecules have shown that RNA 
genotype networks are highly fragmented, therefore historical contingency can play a 
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major role in the evolution of RNA secondary structure phenotypes [183,184]. The 
situation is even more extreme in gene regulatory networks, where genotype 
networks can be fragmented into 108 distinct connected components [185].  However, 
the role of historical contingency in metabolic systems is not well studied. 
Understanding its extent was therefore one of my research goals. 
1.9. Exaptation  
There are two broad candidates for the origin of novel phenotypes or traits. First, such 
traits can originate as adaptations that help an organism survive or reproduce. Second, 
they can also have non-adaptive origins as pre-adaptations or exaptations [186,187]. 
Exaptation occurs when a trait, which served initially an old function, evolves to 
serve a new function. In other words, the function of a trait shifts during its 
evolutionary history. The original idea of exaptation can be attributed to Darwin, 
where in Origin he said that “an organ originally constructed for one purpose… may 
be converted to one for a widely different purpose“ [2].  
Multiple lines of evidence from the organismal down to the molecular scale later 
confirmed the importance of exaptations as potential sources of evolutionary 
innovations [188–190]. The classical example of exaptation is feathers, which are 
made of keratins and originally served as thermoregulation and waterproofing, but 
were later ”exapted“ for flight [186]. Another anatomical example is lungs in ancient 
extant fishes that underwent exaptation to become gas bladder in present-day fishes 
[191]. Exaptation may have also played an important role in human evolution [192]. 
Molecular examples of exaptation include crystallins, which originally were 
metabolic enzymes and later became light-refracting proteins in eye lenses [193]. 
Gene regulation is another potential source of exaptation. The same gene or set of 
genes can serve different functions by changing their patterns of regulations [188]. 
Moreover, metabolic networks, by possessing an inherent flexibility in utilizing a 
wide variety of substrates as sources of energy, show high capacity for exaptation to 
new environments [194]. 
Despite the widespread examples of exaptations in life, it is not clear to what extent 
exaptation can contribute to evolutionary innovations. In other words, a systematic 
quantification of the potential of a biological system for exaptation is required. Large-
scale quantitative genotype-phenotype maps in metabolic systems can provide us 
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with an unprecedented opportunity to approach this problem. A previous study 
quantified exaptation in genome-scale metabolic networks based on sampling 
methods [194]. As the last objective of my dissertation, here, I complemented that 
study using the exhaustive genotype-phenotype map of central carbon metabolism.  
1.10. Thesis outline 
I present the results of my research in 6 chapters. The first one is chapter 2, where I 
describe my quantitative analyses on the role of recombination for phenotypic 
innovation in genome-scale metabolic networks. My observations reveal the power of 
recombination in originating metabolic innovations. I systematically characterize 
genotypic and phenotypic features of recombining parental metabolisms that can 
enhance the emergence of innovative offspring. Moreover, my results highlight the 
importance of a specific class of reactions called super-essential reactions in 
metabolic innovations. 
In chapter 3, I focus on the phenotypic robustness that is a prerequisite for 
phenotypic innovation. I show that bacterial genomes have evolved a genomic 
organization that provides a substantially higher robustness to large-scale metabolic 
gene deletions. I follow these observations with systematic analyses of the 
evolutionary forces that can create such a genomic organization. I show that essential 
genes are significantly clustered in bacterial genome, and I provide empirical 
evidence implying that this gene clustering might be an adaptive response to the 
pervasive gene loss events that bacterial genomes are exposed to.   
In chapter 4, using recombining parental metabolic networks with specific 
phenotypes, I comprehensively quantify the extent of phenotypic constraints and 
contingencies in complex metabolic systems. My results reveal that the emergence of 
novel phenotypes in metabolic systems is not absolutely but only relatively 
constrained by and contingent on parental phenotypes or genotypes. Moreover, I 
suggest biochemical causes behind such phenotypic constraints and contingencies. 
In chapter 5, 6 and 7, I exclusively focus on central carbon metabolism and 
construct an exhaustive genotype-phenotype map comprising 1015 genotypic variants. 
In chapter 5, by analyzing the connectivity of genotype networks, I show that 
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historical contingency does not play a substantial role in the evolution of metabolic 
properties in central carbon metabolism. In chapter 6, I describe how the 
organization of genotypes in the genotype space facilitates the emergence of novel 
phenotypes in central carbon metabolism. Finally, the analyses of chapter 7 reveal a 
high potential for exaptation as a non-adaptive origin of evolutionary innovations in 
central carbon metabolism. 
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2.1. Abstract 
Recombination is an important source of metabolic innovation, especially in 
prokaryotes, which have evolved the ability to survive on many different sources of 
chemical elements and energy. Metabolic systems have a well-understood genotype-
phenotype relationship, which permits a quantitative and biochemically principled 
understanding of how recombination creates novel phenotypes. Here we investigate 
the power of recombination to create genome-scale metabolic reaction networks that 
enable an organism to survive in new chemical environments. To this end, we use 
flux balance analysis, an experimentally validated computational method that can 
predict metabolic phenotypes from metabolic genotypes. We show that 
recombination is much more likely to create novel metabolic abilities than random 
changes in chemical reactions of a metabolic network. We also find that phenotypic 
innovation is more likely when recombination occurs between parents that are 
genetically closely related, phenotypically highly diverse, and viable on few rather 
than many carbon sources. Survival on a new carbon source preferentially involves 
reactions that are superessential, that is, essential in many metabolic networks. We 
validate our observations with data from 61 reconstructed prokaryotic metabolic 
networks. Our systematic and quantitative analysis of metabolic systems helps 
understand how recombination creates innovation. 
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2.2. Introduction 
Organisms that reproduce sexually and recombine their DNA bear high evolutionary 
costs, among them the disruption of well-adapted phenotypes caused by 
recombination. Nonetheless, recombination is common in nature. This paradox has 
spurred many efforts to resolve it [1–3].  
From a genetic perspective, the major benefit and costs of recombination are similar 
in kind, because recombination can create well-adapted phenotypes just as it can 
destroy them. Recombination has the ability to join beneficial mutations from two 
organisms or molecules [4,5], and thus speed up adaptive evolution [6]. In recent 
years, experimental evidence obtained through DNA shuffling experiments has made 
clear how great this benefit of recombination can be in creating proteins with novel 
phenotypes [7]. Many experimental studies have confirmed the power of 
recombination in generating genes, pathways, and genomes with novel features [8–
11].  
Because recombination can involve large-scale genotypic change, its power to disrupt 
existing well adapted phenotypes may also be large. However, recent directed 
evolution experiments and computational studies based on model transcriptional gene 
regulatory circuits and lattice proteins, suggest that random mutations can be more 
likely to disrupt existing phenotypes than recombination [12–14]. 
To understand the relative costs and benefits of recombination, one needs to 
understand how genotypic change causes phenotypic change, but this is difficult even 
for well-studied systems like proteins. For example, measuring the phenotypic effects 
of genetic changes engineered into proteins is laborious, and our ability to predict 
altered protein functions from altered amino acid sequences computationally is very 
limited. However, in one class of biological systems, the complex and genetically 
encoded chemical reaction network of metabolism, we understand genotype-
phenotype relationships better [15–18]. The reason is that computational tools such as 
flux balance analysis (FBA) provide a means to predict metabolic phenotypes – the 
ability of an organism to survive on specific nutrients – from information about 
metabolic genotypes, i.e., the collection of chemical reactions that a metabolic 
reaction network is able to catalyze [19]. What is more, FBA-based qualitative 
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predictions of metabolic phenotypes are in good agreement with experimental data 
[20]. We here use FBA to quantify and understand the disruptive and creative effects 
of recombination on the biochemistry of metabolic systems. We will focus especially 
on metabolic innovation, the ability of recombination to create metabolic networks 
that are able to survive on new sources of carbon and energy. In doing so, we 
represent metabolic genotypes not as DNA sequences but as sets of metabolic 
reactions that can be altered through recombination, a common approach in metabolic 
systems biology [15–18,21–25].          
Metabolism is an ideal system to study innovation, especially for microorganisms, 
because the prokaryotic world is rife with examples of metabolic innovations. For 
instance, microorganisms have acquired the capability to extract energy from a 
bewildering variety of non-natural and even toxic substances [26–29].  Microbial 
isolates from pristine soils not only have acquired resistance to a wide range of 
antibiotics, but they can even use some of these molecules as food [30]. Halophilic 
bacteria can tolerate high salt concentration by synthesizing novel molecules such as 
ectoine or glycine betaine [31].  
In eukaryotes, recombination occurs during meiosis and is thus linked to 
reproduction. It involves parents that are usually genetically similar and belong to the 
same population and species. In contrast, prokaryotic recombination is not usually 
linked to reproduction. It occurs via horizontal gene transfer [32], whose incidence is 
large and greater than that of point mutations [33–35]. It changes the organization and 
gene content of genomes on short evolutionary time scales [32,36,37], and can 
involve very distantly related organisms [38,39]. Although horizontal gene transfer 
adds genes from a donor to a recipient, incorporating such genes into the recipient 
genome relies on DNA rearrangements that can also delete resident genes [40]. More 
generally, the majority of newly acquired genes obtained via horizontal gene transfer 
reside in the genome only for short amounts of time [41],  and prokaryotic genomes 
show a bias towards DNA deletions [42]. Motivated by these observations, we here 
model prokaryotic recombination as a process where the transfer of biochemical 
reactions from a donor to a recipient is accompanied by concurrent deletion of 
reactions from the recipient. 
Our work builds on an approach that we developed previously to study typical 
properties of a metabolic network with a given phenotype – the ability to survive on a 
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given set of carbon and energy sources. These are properties that are independent of 
any one organism such as E. coli [18,23–25,43,44]. The method explores a vast space 
of possible metabolic genotypes to create a random sample of metabolic networks 
that are viable on specific carbon sources such as glucose. We here use this approach 
to create pairs of ”parental” metabolic networks with well-defined genotypes and 
phenotypes. We ask how likely it is that recombination between these parents (i) 
disrupts their metabolic phenotypes, and (ii) creates novel, innovative metabolic 
networks that can survive on at least one novel sources of carbon and energy, among 
50 different such sources we consider. We validate our observations with data from 
61 prokaryotic genome-scale metabolic networks. 
Our observations show that recombination creates more metabolic innovations than 
an equivalent amount of random change in a metabolic network’s reaction 
complement – our model’s representation of random mutation. At the same time 
recombination is no more disruptive than random change. Importantly, the innovative 
power of recombination increases with the phenotypic diversity of the parents. In 
contrast, it decreases with their genotypic diversity and with their phenotypic 
complexity (the number of carbon sources on which they are viable). Moreover, we 
find that a class of metabolic reactions that we refer to as superessential plays an 
important role in metabolic innovation [45].  
 
2.3. Results 
(a) Recombination causes more metabolic innovations than random change 
To quantify the power of recombination in creating novel phenotypes in metabolic 
systems, we created 1000 donor-recipient pairs of random viable metabolic networks 
with a fixed metabolic genotypic distance of D=100 reactions. (Genomic data shows 
that bacteria at this or greater metabolic divergence often recombine successfully: see 
electronic supplementary material text S4, and figure S4). For each of these pairs, we 
generated 1000 recombinant offspring by recombining a given number n of reactions 
(See Methods). We quantified the incidence of metabolic innovation as the fraction 
(finnov) of offspring retaining viability on glucose that also gain viability on at least 
one additional carbon source. Moreover, we compared recombination’s effects on 
innovation with those of an equivalent amount of random change (“mutation”, 
Methods). That is, we computed the fraction of innovative offspring (finnov) for 
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metabolic networks with a number of random reaction deletions or additions 
equivalent to that caused by recombination.  
 
Figure 1: Cost-benefit relationship of recombination as compared with random reaction change 
(“mutation”). (a) Mean (bars) and standard deviation (vertical lines) of the fraction of innovative 
offspring (finnov) among all offspring retaining viability on glucose that are generated by recombination 
(red) and random reaction change (black) , as a function of the number of reaction changes (n, x-axis). 
(b) Recombinational robustness (red), that is, the fraction of recombinant offspring retaining viablity 
on glucose, and mutational robustness, that is, the fraction of mutant offspring that can retain viability 
on glucose, as a function of the number of reaction changes (n, x-axis). Boxes span the 25-th to 75-th 
percentile, and whiskers indicate maxima and minima. 
Figure 1a shows the mean and standard deviation of finnov as a function of n. Two 
patterns are germane. First, the fraction of innovative offspring (finnov) is consistently 
greater for recombination (figure 1a, red) than for random change (black). For 
example, for recombination events involving n=10 reactions, 5 percent of the viable 
recombinant offspring could gain viability on at least one novel carbon source on 
average. In contrast, for random change involving n=10 reactions, this fraction is 
more than 4 times smaller, consistently below 1.3 percent. Second, finnov increases 
with the number of reactions exchanged through recombination. Our observations are 
robust to an alternative approach to generating metabolic network pairs with a fixed 
D=100, and to the choice of an alternative primary carbon source (See methods and 
electronic supplementary material, figures S3a, S3b, and S3c). In sum, recombination 
produces a higher incidence of innovation. The diversity of metabolic innovations it 
produces is similar to those produced by random change (electronic supplementary 
figure S5).  
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Next we quantified the cost of recombination, i.e., its power in disrupting existing 
phenotypes. To this end, we measured recombinational robustness, the fraction of a 
parental pair’s recombinant offspring that retains viability on glucose. Figure 1b (red) 
shows the recombinational robustness of the 1000 donor-recipient pairs as a function 
of the number n of exchanged reactions. We also wanted to compare this 
recombinational robustness with our model’s equivalent of mutational robustness, 
i.e., robustness to a comparable amount of random additions and deletions of 
reactions from a metabolic network. Figure 1b shows that recombinational robustness 
is not lower than robustness to random reaction change, regardless of the number (n) 
of altered reactions. Again, an alternative approach to generating metabolic network 
pairs with a fixed D=100, or an alternative primary carbon source yields similar 
observations (See methods and electronic supplementary material, figures S3d, S3e, 
and S3f). We also note that innovative offspring grow even faster than parental 
metabolic networks on the carbon source where their parents were viable (electronic 
supplementary material, figure S6). Therefore, recombination can cause more 
innovation than random change, but it does not incur higher costs.  
(b) Superessential reactions play an important role in metabolic innovation 
To understand the specific reaction changes associated with metabolic innovation, we 
next analyzed all 8171 recombinant offspring with metabolic innovations that our 
analysis had identified. In most of them, only one of the multiple reactions added in a 
recombination event was responsible for gaining viability on a novel carbon source. 
For example, among three recombinant offspring that had independently gained 
viability on acetate, all three had gained the phosphoglycerate kinase reaction. 
Likewise, the five recombinant offspring that had independently gained viability on 
pyruvate achieved this gain through addition of the ribulose 5-phosphate 3-epimerase 
reaction in the pentose phosphate pathway. More generally in 98.91 percent of 
innovative offspring, a single reaction accounted for the innovation. An example of 
the 89 (1.09 percent) instances where multiple reaction additions are responsible for 
an innovation is the newly acquired viability on the carbon source trehalose. It was 
caused by simultaneous addition of reactions catalyzed by trehalose 6-phosphate 
phosphorylase and 2-dehydro-3-deoxy-phosphogluconate aldolase. 
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The reactions that cause viability on new carbon sources come from a relatively small 
subset of the “universe” of 5906 reactions (see Methods). Specifically, only 19 
reactions among the 5906 reactions are responsible for gaining viability on new 
carbon sources in the majority (53%, 4430) of the 8171 innovative offspring. The 
remaining 47% of innovations are caused by only 147 other reactions. What is more, 
these reactions tend to share a property that we refer to as their superessentiality [45]. 
The superessentiality index (ISE) of a metabolic reaction denotes the fraction of 
metabolic networks in which this reaction is essential for viability on carbon source C 
[45]. It can be computed from randomly sampled metabolic networks viable on that 
carbon source. The greater a reaction’s superessentiality index (ISE) the larger is also 
the number of bacterial genomes encoding this reaction [45]. Reactions with ISE >0.5 
are essential for viability in the majority of metabolic networks where they occur.  
Reactions that cause viability on a new carbon source tend to have a higher 
superessentiality index than those, which rarely or never cause viability on new 
carbon sources (Figure S7a). Examples include the ribulose-5-phosphate 3-epimerase 
reaction, which causes viability on new carbon sources in 731 innovative offspring, 
and has a superessentiality index of ISE=0.9714. They also include ribose-5-
phosphate isomerase (ISE=0.9530), which causes metabolic innovation in 677 
offspring. More generally, we observed (i) a significant correlation between the 
superessentiality index and the number of innovations a reaction causes (figure S7b), 
and (ii) that the fraction of innovative offspring (finnov) of metabolic network pairs 
increases with fsuper, i.e., with the fraction of reactions with ISE >0.5 (electronic 
supplementary material, figure S7c; Pearson’s r=0.18, P<10-8).  
 (c) Genotypically more similar parental metabolic networks are more likely to 
generate metabolically innovative offspring 
Thus far we examined the effects of recombination on metabolic innovation and 
robustness among parental metabolic networks with a fixed genotypic distance D. 
This distance, however, could have an influence on the effect of recombination. For 
example, recombination among more distant parents could lead to a smaller incidence 
of metabolic innovation, because fewer reactions “imported” from a distant metabolic 
network may integrate productively into the resident metabolic network. To find out 
whether this is the case, we varied the distance among recombining parents between 
	 49	
D=100 and D=1500. We did not examine greater distances, because according to 
available data on the rate of successful recombination among prokaryotic species, this 
rate becomes negligible at such large distances (electronic supplementary material, 
text S4). However, as a reference point for including parents with the maximal 
genotype distance (Dmax), we analyzed random metabolic changes, where new 
reactions are added not from another parental metabolic network but from the 
(maximally diverse) reaction universe. Specifically, for each value of D, we created 
1000 random pairs of parental metabolic networks, and from each pair we formed 
1000 recombinant offspring by recombining a fixed number n of randomly chosen 
reactions (see Methods). 
 
 
Figure 2: Effect of parental genotypic and phenotypic features on the incidence of innovative 
offspring. The vertical axes show mean (bar) and standard deviation (vertical line) of the fraction of 
innovative offspring (finnov), generated by recombination between parental metabolic networks with (a) 
genotypic distance (D), (c) phenotypic distance (ΔP), and (e) phenotypic complexity (||P||), where D, 
ΔP, and ||p|| are color-coded according to their corresponding legend. The horizontal axis shows the 
number of recombined reactions (n). In panels (b), (d), and (f) , the vertical axes show the fraction of 
reactions with superessentiality index exceeding 0.5 (fsuper, x-axis) among reactions that can potentially 
be transferred from the parental donor to the recipient metabolic network. The horizontal axes show in 
(b) genotypic distance (D), (d) phenotypic distance (ΔP), and (f) phenotypic complexity (||P||). Boxes 
span the 25-th to 75-th percentile, and whiskers indicate maxima and minima. 
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Figure 2a shows that for any given number n of recombining reactions, the fraction of 
innovative offspring (finnov) decreases with increasing parental genotype distance. In 
other words, the more distant two recombining parents are, the smaller the likelihood 
that their offspring can survive on novel carbon sources. Although this relationship 
could be the result of an increasing fraction of inviable offspring when distantly 
related parents recombine, electronic supplementary material, figure S8 shows that 
this is not the case. These observations still hold if we require parental metabolic 
networks to be viable on acetate instead of glucose (electronic supplementary 
material, figures S9a and S9b).  
We also examined how the fraction of reactions with ISE >0.5 (fsuper) that can 
potentially be transferred from donor to the recipient metabolic network changes with 
genotypic distance. Both the median and the variance of fsuper decreases with 
increasing D (Figures 2b, and electronic supplementary material, figure S9c). This 
observation further supports the importance of highly superessential reactions for 
metabolic innovation.   
Moreover, we showed that parental metabolic networks with higher phenotypic 
diversity have greater potential to create innovative offspring (electronic 
supplementary material, texts S5 and S6, and figures 2c, 2d, S10, and S11). In 
addition, we also found that parental metabolic networks with more reactions (higher 
genotypic complexity), and those viable on fewer carbon sources (lower phenotypic 
complexity) are more likely to generate innovative offspring (electronic 
supplementary material, texts S7 and S8, and figures 2e, 2f, S12, S13, and S14). 
(d) Recombination in prokaryotic metabolic networks has similar innovation 
potential as in randomly sampled metabolic networks  
While sampling viable metabolic networks from a metabolic genotype space 
permitted us to control parameters such as phenotypic and genotypic diversity, this 
analysis also has limitations. For example, it neglects the potential influence of gene 
linkage on metabolic innovation by recombination, because it is based on the 
exchange of biochemical reactions rather than genes. We thus wanted to validate our 
observations with genome-scale metabolic networks of prokaryotic organisms. To 
this end, we used genome-scale metabolic networks from 61 bacterial species from 
the BiGG database [50], which differ in both their genotypes and phenotypes, i.e., 
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their viability on 137 different carbon sources (See Methods). We first determined the 
innovation potential of each of the 3660 possible pairs that can be formed from these 
metabolic networks, by asking whether the union of a pair’s reaction sets confers 
viability on a carbon source on which neither member of the pair is viable. This was 
the case for 1126 pairs (30.77%).  
 
 
 
 
 
Figure 3: Recombination between 
prokaryotic metabolic networks shows the 
same innovation potential as in randomly 
sampled metabolic networks. (a) Robustness 
to recombination, i.e., the fraction of 
recombinant offspring retaining viability on at 
least one parental carbon source, and (b) Mean 
(bar), and standard error (vertical line) of the 
number of innovative offspring among 1000 
recombinant offspring (y-axis), as a function 
of the number of recombined reactions (x-
axis). Offspring were generated by i) linkage-
based recombination between prokaryotic 
metabolic networks (black), and ii) free 
recombination between prokaryotic metabolic 
networks (gray). (c) The vertical axis shows 
the mean (bar) and standard deviation (vertical 
line) of the fraction of innovative offspring 
(finnov) generated by linkage-based 
recombination between prokaryotic parental 
metabolic networks with i) high genotypic 
distance (D>40), low phenotypic distance 
(ΔP<30), and high phenotypic complexity 
(||P||>60) (blue, N=96 parental pairs), ii) low 
genotypic distance (D<30), low phenotypic 
distance (ΔP<30), and high phenotypic 
complexity (||P||>60) (green, N=106 parental 
pairs), iii) high genotypic distance (D>40), 
high phenotypic distance (ΔP>40), and low 
phenotypic complexity (||P||<40) (yellow, 
N=12 parental pairs), and iv) low genotypic 
distance (D<30), high phenotypic distance 
(ΔP>40), and low phenotypic complexity 
(||P||<40) (red, N=64 parental pairs). 
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For each of these 1126 metabolic network pairs, we generated 1000 recombinant 
offspring through a procedure we refer to as “linkage-based” recombination, which 
maps reactions onto genes, and recombines random stretches of DNA whose length is 
chosen such that a given number of n reactions is altered in the offspring’s metabolic 
network (see Methods). For the purpose of comparison, we also used a 
complementary “free recombination” procedure, which disregards linkage and creates 
recombinant offspring by altering a given number n of reactions in the recipient, just 
as we had done for randomly sampled viable networks. When analyzing robustness to 
recombination, we found that linkage-based recombination is much more likely to 
preserve viability than free recombination (Figures 3a, and electronic supplementary 
material, figure S15a). In other words, the linear organization of metabolic genes in 
the genome facilitates robustness to recombination.  
The fraction of innovative offspring is somewhat lower under linkage-based 
recombination (electronic supplementary material, figure S15b). However, a higher 
overall fraction of viable offspring (figure 3a) results in substantially higher total 
number of innovative offspring under linkage-based recombination than free 
recombination, (especially for higher numbers of recombined reactions (n), (figure 
3b)). Therefore, higher robustness to recombination in prokaryotic metabolic 
networks results in a higher potential for metabolic innovation. 
In a majority of the 1126 prokaryotic metabolic network pairs where metabolic 
innovation is possible (854 of 1126, or 75.84%), the addition of a single reaction 
from donor to the recipient was sufficient to gain viability on a new carbon source, 
just as we had observed for randomly sampled metabolic networks. Also, only a 
small fraction (106) of the 3404 reactions that occurred in these 61 metabolic 
networks caused metabolic innovation. And just as in randomly sampled metabolic 
networks, reactions that cause innovation are more often essential (higher ISE [45]) 
than those that do not cause innovation (electronic supplementary material, figure 
S15c). In addition, the fraction of innovative offspring (finnov) increases with the 
fraction of reactions with superessentiality index ISE  larger than 0.5 (electronic 
supplementary material, figure S15d; Pearson’s r=0.13, P<10-5).  
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Finally, we showed that parental prokaryotic metabolic networks with low genotypic 
distance, high phenotypic distance and low phenotypic complexity are more likely to 
generate innovative offspring (figure 3c, and electronic supplementary material, text 
S9, and figures S16 and S17a), just as they did in randomly sampled viable metabolic 
networks. Moreover, genotypic distance, phenotypic complexity, and phenotypic 
diversity do not strongly influence recombinational robustness, just as they did not 
for randomly sampled metabolic networks (electronic supplementary material, text 
S9, and figures S16, S17b, and S17c). 
In sum, our observations show that recombination in prokaryotic metabolic networks 
resembles those in randomly sampled metabolic networks in its innovation potential, 
and in the mechanisms by which it causes metabolic innovation.  
 
2.4. Discussion 
Recombination is a major force behind many innovations in biological systems [12–
14,53,54]. Here we studied its innovation potential in metabolic systems, where 
innovations enable organisms to survive on novel sources of energy and chemical 
elements. To do so, we computationally recombined biochemical reactions among 
thousands of metabolic network pairs that are viable on specific carbon sources. We 
sampled most of these from a vast space of such networks with a Markov Chain 
Monte Carlo technique, but also validated our observations by analyzing 61 
prokaryotic metabolic networks.  
We found that recombination provides greater benefit – a greater number of new 
metabolic abilities – at no greater cost in terms of viability loss than an equivalent 
amount of random mutation, modeled as random alterations in a metabolic network’s 
complement of chemical reactions. Metabolic innovation is more likely when 
recombination occurs between parents that are genetically closely related, 
phenotypically highly diverse, and viable on few rather than many carbon sources. 
Survival on a new carbon source preferentially involves reactions that are highly 
super-essential, that is, they are required in most metabolic networks viable on this 
carbon source.   
One well-studied facilitator of evolutionary adaptation and innovation is the 
robustness of a biological system to genetic change [55,56]. Robustness can facilitate 
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a population’s exploration of a genotype space, and thus accelerate the origin of novel 
phenotypes [57]. Our observations support this positive role of robustness. 
Specifically, the frequently higher robustness of prokaryotic metabolic networks 
under linkage-based recombination results in a higher total number of innovative 
offspring (Figures 3a and 3b). Moreover, larger metabolic networks are more robust 
to recombination, and they are more likely to create metabolic innovations (electronic 
supplementary material, figure S14). We also showed, however, that robustness is not 
the only factor affecting innovation by recombination. For example, parental 
genotypic distance, phenotypic diversity and complexity impact innovation without 
influencing robustness, so they modulate the incidence of innovation independent of 
robustness. The ability to study these factors in isolation is a key advantage of our 
computational approach. 
Systemic properties like robustness and parental diversity are not the only factors 
influencing innovation by recombination. One property of individual reactions – 
superessentiality – is at least as important. Multiple reactions may be transferred in a 
recombination event, but in the vast majority of such events, only the addition of a 
single reaction causes innovation, and this reaction is often highly superessential. 
What is more, reaction superessentiality can help explain multiple systemic patterns 
in our data, e.g., that phenotypically diverse parents have greater innovation potential 
(see electronic supplementary material, text S10, and figure S18). That being said, 
exceptions to the importance of superessentiality exist, where innovations are caused 
by reactions that are rarely essential. An extreme example is adenyl cyclase, which 
catalyses the conversion of ATP to 3’,5’-cyclic AMP and diphosphate. It is not 
essential for viability on any of the 10000 randomly sampled metabolic networks (I-
SE=0), yet it is responsible for metabolic innovation in 10 out of 8171 innovative 
offspring. Relatedly, we found 3 examples of reactions that were blocked (i.e. 
inactive, with zero flux) in the donor metabolic network that caused innovation after 
being added to a recipient metabolic network. However, the innovation potential of 
such inactive reactions is small compared to active or highly superessential reactions 
(electronic supplementary material, figure S2). 
Our approach of using randomly sampled viable metabolic networks has several 
advantages, most notably that we can arrive at general conclusions that go beyond 
any one organism, and that we can control important quantities such as parental 
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genotypic diversity. However, it also has several limitations. First, our computational 
analysis is based on FBA, which neglects regulatory constraints that can arise through 
suboptimal enzyme expression. However, as we discussed in more detail in online 
supplementary material, text S1d, this limitation is not likely to affect our main 
observations. 
Second, our approach ignores the linkage of related metabolic genes on 
chromosomes, for example in operons [58]. Although on long evolutionary time 
scales operons often break up and reform [59,60], functionally related genes tend to 
be linked. Randomly sampled metabolic networks may contain combinations of 
reactions that are not found in any known organism, so that we cannot meaningfully 
assign linkage patterns to them. Third, our specification of a metabolic genotype 
represents this genotype on the level of the reaction rather than that of a gene and 
considers only the presence or absence of metabolic reactions. Although widely used 
[15–18,21–25], this representation neglects potentially important information, among 
them myriad mechanistic details of DNA recombination. Perhaps even more 
importantly, it also neglects that some reactions are catalyzed by multiple enzymes 
[61], and that some enzymes catalyze multiple reactions [62–64].  
We were able to mitigate the last two limitations by comparing our observations with 
those obtained from 61 curated prokaryotic metabolic networks, where gene-reaction 
maps and linkage information is available for metabolic genes. The incidence of 
metabolic innovation among hundreds of pairs of these prokaryotic metabolic 
networks shows the same patterns as our randomly sampled viable metabolic 
networks. In addition, these metabolic networks revealed an additional intriguing 
pattern, their increased metabolic robustness to recombination. Essential genes in 
general are known to be clustered in prokaryotic genomes [65,66], which may 
increase a genome’s robustness to large-scale gene deletions. However, the 
evolutionary forces shaping the organization of metabolic genes are not well known, 
and call for further research. 
Recombination and DNA mutations, such as point mutations and gene duplications, 
play complementary roles in creating metabolic innovation. In an evolving 
population, recombination cannot be effective unless mutation has created diversity 
beforehand. Mutations introduce novel parts (enzymes, reactions), and recombination 
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creates novel combinations of these parts (metabolic pathways). Our results 
demonstrate the power of this combinatorial principle for metabolic innovation. One 
source of this power is that recombination shuffles system parts that have been “pre-
tested” in evolution, because they form part of a viable metabolic network. This is 
also why superessential reactions are important for innovation, and why robustness 
facilitates innovation. 
 
2.5. Methods 
(a) Genome-scale metabolic networks and their phenotypic representations 
A metabolism is a network of enzyme-catalyzed biochemical reactions. Each such 
metabolic network contains a subset of the “reaction universe” of all biochemical 
reactions that take place in the biosphere. We have curated a representation of this 
universe, which comprises 5906 reactions and is based on current metabolic 
knowledge (for more details, see electronic supplementary material text S1a and S1b) 
[18,46–49]. We represent an organism’s metabolic genotype as a binary vector of 
length 5906. Each entry of this vector corresponds to a given reaction in the universe, 
and is equal to one if the corresponding reaction is present in the network, and zero 
otherwise. Thus, each genotype can be thought of as a single member of a vast space 
of all possible metabolic networks, which contains 25906 distinct genotypes. We 
define the phenotype of a given metabolic genotype based on its viability on 50 
distinct minimal environments that differ only in the carbon source (electronic 
supplementary material text S1c). We consider a genotype viable on a given carbon 
source, if it can produce all the essential biomass precursors from the given carbon 
source, and we use Flux Balance Analysis (FBA, See electronic supplementary 
material text S1d) to determine viability [19].  
(b) Generation of random metabolic networks 
We here employ a previously described in silico process which relies on Markov 
Chain Monte Carlo (MCMC) random walks to generate metabolic networks 
comprising random sets of reactions that are viable on a given carbon source 
(electronic supplementary material text S1e) [18,23]. This procedure can produce 
metabolic networks that are sampled uniformly from the set of all metabolic networks 
viable on a given carbon source.  
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(c) Generation of parental metabolic network pairs 
Our analyses required us to recombine pairs of “parental” metabolic networks with 
particular features, such as (i) their genotypic distance (D), defined as the number of 
reactions differing between the parents, (ii) their phenotypic complexity (||P||), that 
is, the number of carbon sources on which they are viable, (iii) their phenotypic 
distance (ΔP), that is, the number of carbon sources on which only one but not the 
other member of a parental pair is viable, and (iv) their genotypic complexity (||G||, 
or metabolic network size), defined as the number of reactions in each metabolic 
network. We used simultaneous genotype-converging MCMC random walks to 
generate pairs of metabolic networks with the features described above (See 
electronic supplementary material texts S1f, and S2). 
(d) Modeling recombination and mutation in metabolic networks 
To implement recombination for each parental metabolic network pair, we generated 
1000 recombinant offspring by (i) adding to the recipient metabolic network a given 
number n/2 of randomly chosen reactions that were present in the donor and absent in 
the recipient, followed by (ii) deleting n/2 reactions randomly chosen from the 
recipient. Thus, the total number of reactions changed by a recombination event in 
the recipient is equal to n (for more details, see electronic supplementary material 
texts S1g, S3, and figures S1, S2 and S3). We then quantify the incidence of 
metabolic innovation as the fraction (finnov) of offspring retaining viability on parental 
carbon sources that also gain viability on at least one additional carbon source. 
To implement an amount of random change – our model’s equivalent of “mutation”– 
in a metabolic network comparable to the same amount of recombinational change 
for a given n, we created a network’s “mutational” offspring by adding n/2 randomly 
chosen reactions from the reaction universe, and deleting n/2 randomly chosen 
reactions from the network. Note that the n/2 reactions added to recombinant 
offspring are chosen randomly from another viable network (the donor), whereas in 
mutation they are taken from the whole reaction universe.  
To validate our model’s results, we also analyzed the metabolic networks of 61 
prokaryotes obtained from the BIGG database [50], using the R package Sybil [51]. 
In these networks, we incorporated information about the linkage of the genes 
encoding metabolic reactions. To this end, we used the gene-reaction association 
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rules defined in the BiGG database for each organism (in MAT files, grRules) [50], 
and ordered the genes in each organism based on their genomic position, as obtained 
from the RefSeq microbial genome database [52] (for more details see electronic 
supplementary material text S1h).  
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2.7. Supplementary Information 
Text S1: Supplementary Methods  
(a) Genome-scale metabolic networks and their phenotypic representations 
The set of genomically encoded biochemical reactions proceeding inside a given 
organism constitutes an organism’s metabolic genotype [1–3]. This genotype enables 
an organism to extract energy and produce small biomass building blocks, such as 
amino acids, from extracellular nutrients. Reconstruction of this genotype from 
genomic and biochemical information has been successful for multiple organisms [4–
7].  
Each metabolic network contains a subset of the “reaction universe” of all 
biochemical reactions that take place in the biosphere (See Text S1b). We have 
curated a representation of this universe, which comprises 5906 reactions and is 
based on current metabolic knowledge [8–12]. We represent an organism’s metabolic 
genotype as a binary vector of length 5906. Each entry of this vector corresponds to a 
given reaction in the reaction universe, and is equal to one if the corresponding 
reaction is present in the metabolic network, and zero otherwise. Thus, each genotype 
can be thought of as a single member of a vast space of all possible metabolic 
networks, which contains 25906 distinct genotypes. We define the phenotype of a 
given metabolic genotype based on its viability on 50 distinct minimal environments 
that differ only in the carbon source (See Text S1c). We consider that a genotype is 
viable on a given carbon source, if it can produce all the essential biomass precursors 
from the given carbon source, and we use Flux Balance Analysis (FBA, See Text 
S1d) to determine viability [12–14]. We represent the phenotype of a given metabolic 
genotype as a binary vector of length 50. Each entry of this vector corresponds to a 
given carbon source, and it is equal to one if the genotype is viable on this carbon 
source, and zero otherwise.  
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(b) Reaction universe  
The reaction universe is a set of metabolic reactions known to occur in some 
organism. For the construction of this universe, we used data from the LIGAND 
database [9,15]of the Kyoto Encyclopedia of Genes and Genomes [11,16]. Briefly, 
the LIGAND database, which is comprised of the REACTION and the COMPOUND 
databases, provides information on reactions, associated stoichiometric information, 
chemical compounds involved, and the Enzyme Classification (E.C.) identifier of 
each reaction. We used the REACTION and the COMPOUND databases to construct 
our universe of reactions, and excluded (i) all reactions involving polymer 
metabolites of unspecified numbers of monomers, or general polymerization 
reactions with uncertain stoichiometry, (ii) reactions involving glycans, due to their 
complex structure, (iii) reactions with unbalanced stoichiometry, and, (iv) reactions 
involving complex metabolites without chemical information about their structure 
[8]. The published E. coli metabolic model (iAF1260) consists of 1397 non-transport 
reactions [12]. We merged all reactions in the E. coli model with the reactions in the 
KEGG dataset, and retained only the unique (non-duplicate) reactions. This resulted 
in a universe of reactions consisting of 682 transport, 5906 non-transport reactions 
and 5030 metabolites. 
(c) Chemical environments 
We consider 50 minimal growth environments, each of which included oxygen, 
ammonium, inorganic phosphate, sulfate, sodium, potassium, cobalt, iron (Fe2+ and 
Fe3+), protons, water, molybdate, copper, calcium, chloride, magnesium, 
manganese, zinc, and a specific carbon source Importantly, to represent different 
chemical environments, we vary the carbon source while keeping all other nutrients 
constant. We consider a metabolic network viable on a given carbon source, if it can 
synthesize all essential biochemical precursors when this carbon source is provided 
as the sole carbon source in a minimal medium.  
We used 50 carbon sources for our analysis of randomly sampled metabolic 
networks, including the following 27 glycolytic carbon sources: D-Glucose, D-
Glucose 6-phosphate, Trehalose, Maltose, Lactose, D-Fructose 6-phosphate, D-
Fructose, D-Mannose, D-Mannitol, D-Glucose 1-phosphate, D-Sorbitol, Maltotriose, 
D-Allose, D-Ribose, D-Xylose, D-Gluconate, 5-dehydro-D-Gluconate, L-Rhamnose, 
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L-Fucose, L-Arabinose, L-Lyxose, D-Galactose, Melibiose, D-Galactonate, N-
Acetyl-D-glucosamine, N-Acetyl-D-mannosamine, N-Acetylneuraminate.  
In addition, we used the following 23 gluconeogenic carbon sources: Pyruvate, L-
Alanine, L-Lactate, D-Alanine, D-Malate, Acetate, L-Serine, L-Malate, D-Serine, 
Glycine, Glycolate, L-Aspartate, Succinate, Fumarate, 2-Oxoglutarate, D-
Galacturonate, D-Galactarate, D-Glucarate, L-Galactonate, D-Glucoronate. 
And we used 3 nucleoside carbon sources: Adenosine, Deoxyadenosine, Inosine. 
For the analysis of prokaryotic metabolic networks in the BiGG database, we used the 
following 137 carbon sources: 
Acetaldehyde, Acetate, Acetoacetate, Adenine, Adenosine, Allantoin, Bicarbonate, 
Biotin, Butyrate (n-C4:0), Carbonic acid, Choline, Citrate, Cyanate, Cytidine, 
Cytosine, D-Alanine, D-Fructose, D-Galactarate, D-Galactonate, D-Galactose, D-
Galacturonate, D-Glucarate, D-Gluconate, D-Glucosamine, D-Glucose, D-Glucose 6-
phosphate, D-Glucuronate, D-Glyceraldehyde, D-Lactate, D-Mannitol, D-Mannose, 
D-Mannose 6-phosphate, D-Methionine, D-Ribose, D-Serine, D-Sorbitol, D-Xylose, 
Deoxyadenosine, Deoxycytidine, Deoxyguanosine, Deoxyinosine, Deoxyuridine, 
Dihydroxyacetone, Dimethyl sulfide, Dimethyl sulfoxide, Ethanol, Folate, Formate, 
Fumarate, Galactitol, Gamma-butyrobetaine, Glycerol, Glycerol 3-phosphate, 
Glycine, Glycine betaine, Glycolate, Guanine, Guanosine, Hexadecanoate (n-C16:0), 
Hypoxanthine, Indole, Inosine, L-Alanine, L-Arabinose, L-Arginine, L-Asparagine, 
L-Aspartate, L-Carnitine, L-Cysteine, L-Fucose, L-Fucose 1-phosphate , L-
Glutamate, L-Glutamine, L-Histidine, L-Idonate, L-Isoleucine, L-Lactate, L-Leucine, 
L-Lysine, L-Malate, L-Methionine, L-Phenylalanine, L-Proline, L-Rhamnose, L-
Serine, L-Threonine, L-Tryptophan, L-Tyrosine, L-Valine, L-tartrate, Lactose, 
Maltohexaose, Maltopentaose, Maltose, Maltotetraose, Maltotriose, Melibiose, Meso-
2,6 Diaminoheptanedioate, Methanol, N-Acetyl-D-glucosamine, N-Acetyl-D-
mannosamine, N, Acetylneuraminate NMN, Nicotinamide adenine dinucleotide, 
Octadecanoate (n-C18:0), Ornithine, Phenylpropanoate, Pimelate, Protoheme, 
Putrescine, Pyruvate, Riboflavin, Spermidine, Succinate, Sucrose, Taurine, 
Tetradecanoate (n-C14:0),Thiamin, Thymidine,Trehalose, Trimethylamine, 
Trimethylamine N-oxide, Uracil, Urea, Uridine, Xanthine, Xanthosine, AMP, (R)-
Pantothenate, S)-Propane-1,2-diol, 1,5-Diaminopentane, 2-Dehydro-3-deoxy-D-
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gluconate, 2-Oxoglutarate, 3-(3-hydroxy-phenyl)propionate, 3-hydroxycinnamic acid. 
(d) Flux balance analysis  
Flux balance analysis (FBA) is a computational method that is widely used for the 
quantitative analysis and modeling of metabolic networks [13]. Based on the 
stoichiometric coefficients of the metabolites participating in the reactions of a given 
metabolic network, FBA predicts the metabolic flux through each reaction. 
Stoichiometric coefficients are stored in a stoichiometric matrix S, which is of 
dimension m×n, where m and n, respectively, denote the number of metabolites and 
the number of reactions in a metabolic network. FBA constrains the flux through 
each reaction based on the assumption that a metabolic network is in a steady state 
where metabolite concentrations do not change, i.e., 𝑆𝑣 = 0, where v is the vector of 
metabolic fluxes vi through reaction i. The solutions of the equation 𝑆𝑣 = 0, that is, 
the nullspace of matrix S, comprises all flux vectors that are allowable in steady 
state. The null space is further constrained by physicochemical information regarding 
the maximum and minimum possible flux through each reaction. FBA relies on an 
optimization procedure called linear programming to identify those flux vector(s) 
among the allowable ones that maximize an objective function Z. This task can be 
formulated as finding a flux vector v* with the property 
v*=maxv Z(v)= maxv { cTv | Sv=0, a≤v≤ 𝑏}, 
where the vector c contains a set of scalar coefficients representing the maximization 
criterion, and each entry ai and bi of vectors 𝑎 and 𝑏, respectively, indicates the 
minimally and maximally possible flux through reaction i. The vector c represents 
the proportions of each small biomass molecule in a cell’s biomass. Therefore v* 
maximizes the biomass growth flux, that is, the rate at which a metabolic network 
can produce biomass [14]. Here we use FBA to predict qualitatively whether a given 
metabolic network is viable in a given environment, and we consider a metabolic 
network viable if it can produce all essential biomass precursors. In a free-living 
bacterium like E. coli, there are approximately 60 such molecules including 20 
amino acids, DNA, and RNA precursors, lipids and cofactors. We used the biomass 
composition of the E. coli metabolic model iAF1260 to define the vector c [12]. 
Moreover, we used the packages CPLEX (11.0, ILOG; http://www.ilog.com/) and 
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CLP (1.4, Coin-OR; https://projects/coin-or.org/Clp) to solve the linear programming 
problem of FBA.  
The major limitation of FBA is that it neglects regulatory constraints that can arise 
through suboptimal expression or regulation of enzymes. Newly horizontally 
transferred genes cannot easily establish regulatory interactions with their host genes, 
and it may thus take considerable adaptive evolution until they become expressed at a 
maximal or optimal level [17]. Such regulatory constraints would be especially 
important if we focused on quantitative predictions of biomass growth [18]. 
However, we use FBA solely for qualitative prediction of viability. This focus on 
qualitative phenotypes is biologically sensible. The reason is that many organisms 
grow slowly in their native environment [19–21], implying that regulation for 
maximal biomass production is far from universal. Moreover, we note that regulatory 
constraints can easily be broken in evolution, even on the short time scales of 
laboratory evolution experiments [18,22,23].  
(e) Generation of random metabolic networks 
We here employ a previously described in silico process which relies on Markov 
Chain Monte Carlo (MCMC) random walks to generate metabolic networks that 
comprise random sets of metabolic reactions that are viable on a given carbon source 
[8,24]. This procedure can produce metabolic networks that are sampled uniformly 
from the set of all metabolic networks viable on a given carbon source [8,24]. Briefly, 
in each step of such a random walk we perform a reaction swap, which is defined as 
altering a metabolic network by adding a randomly chosen reaction from the reaction 
universe, and then deleting a reaction randomly chosen from the set of reactions 
present in the metabolic network. If the reaction swap disrupts the metabolic 
network’s viability on the given carbon source (as determined by FBA) we reject it, 
and perform another reaction swapping until we find a reaction swap that does not 
disrupt viability. This procedure also ensures that the total number of reactions 
remains constant. For the MCMC method to produce random samples of metabolic 
networks, it is essential to carry out enough reaction swaps to “erase” the random 
walker’s similarity to the initial metabolic network. Previously, it has been shown 
that 3 × 103 reaction swaps are sufficient for this purpose [8,24]. Each of our random 
walks starts from E. coli’s metabolic network and performs 104 reaction swaps before 
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storing the final metabolic network for further analysis. We used 104 independent 
random walks conducted in this way to create 104 random metabolic networks viable 
on glucose. We used the same procedure to generate 104 random metabolic networks 
viable on acetate. 
(f) Generation of parental metabolic network pairs 
Our analyses required us to recombine pairs of “parental” metabolic networks with 
particular features, such as (i) their genotypic distance (D), defined as the number of 
reactions differing between the parents, (ii) their phenotypic complexity (||P||), that 
is, the number of carbon sources on which they are viable, (iii) their phenotypic 
distance (ΔP), that is, the number of carbon sources on which only one but not the 
other member of a parental pair is viable, and (iv) their genotypic complexity (||G||, 
or metabolic network size), defined as the number of reactions in each metabolic 
network pair.  
To identify parental metabolic networks with a given ΔP and ||P|| we first selected, 
among all 10!2  possible random metabolic network pairs that can be formed from 
104 MCMC-sampled metabolic networks, those pairs that are viable on exactly ||P|| 
carbon sources and that have a given ΔP. We then randomly chose from them a set of 
1000 pairs for further analysis.  
Less straightforward than identifying parental metabolic networks with a given ΔP 
and ||P|| is to identify those with a given genotypic distance (D), because the random 
metabolic networks generated by MCMC sampling generally have genotypic 
distances sufficiently large (D≈2000) to be biologically unrealistic for modeling 
frequently recombining prokaryotic genomes. To create less diverse metabolic 
network pairs, we took two different MCMC random walk approaches that yielded 
similar results. The first revolves around a reaction-swapping random walk starting 
with a pair of randomly chosen metabolic networks from our sample of 104 sampled 
metabolic networks. In each step of this random walk, we subjected each parental 
metabolic network to a reaction swap, and we accepted each reaction swap if it (i) 
preserved the original phenotype, and (ii) did not increase the genotypic distance of 
the two metabolic networks after the swap, otherwise we rejected the reaction swap. 
We continued this procedure until the genotypic distance between the metabolic 
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networks became equal to a desired distance D. This approach is very time-
consuming. The second approach is much faster and uses a more biologically inspired 
mechanism to generate metabolic networks (see Text S2 [24,25]), but it also suffers 
from a technical limitation (Text S2), which is why we report mostly on the first 
approach.  
Finally, to generate parental metabolic networks with a given number of reactions 
||G|| we started from a random viable metabolic network generated by MCMC 
sampling, as described in the Text S1e. All such metabolic networks have the same 
number of reactions as E. coli (2079). We then applied a sequence of reaction 
deletions that preserved viability on glucose (or acetate, depending on analysis) until 
we reached the desired ||G||. Then, we sampled pairs of metabolic networks with a 
given D, ΔP and ||P|| among the metabolic networks with ||G|| reactions in the 
manner described above. 
(g) Modeling recombination and mutation in metabolic networks 
Prokaryotic genomes undergo recombination via horizontal gene transfer [26], whose 
incidence is large and greater than that of point mutations [27–29]. It changes the 
organization and gene content of genomes on short evolutionary time scales 
[26,30,31], and can involve very distantly related organisms [32,33]. Various 
mechanisms of horizontal gene transfer add genes unidirectionally from a donor to a 
recipient, but incorporating such genes into the recipient genome relies on 
recombination [26]. The genomes of many prokaryotes frequently undergo 
homologous recombination, that is, a reciprocal exchange of DNA segments between 
DNA sequences [34]. Because such recombination can also delete genes, and because 
of a general deletion bias in prokaryotic genomes [35], prokaryotic recombination 
involves gene loss as well as gene gain. What is more, the majority of newly acquired 
genes obtained via horizontal gene transfer reside in the genome only for short 
amounts of time [36]. Motivated by these observations, we here model prokaryotic 
recombination as a process where the transfer of reactions from a donor to a recipient 
metabolic network is compensated by deletion of other reactions from the recipient.  
To model recombination for each parental metabolic network pair, we generated 1000 
recombinant offspring by (i) adding to the recipient metabolic network a given 
number n/2 of randomly chosen reactions that were present in the donor and absent in 
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the recipient, followed by (ii) deleting n/2 reactions randomly chosen from the 
recipient. Thus, the total number of reactions changed by a recombination event in 
the recipient is equal to n. For reasons of computational feasibility, we analyzed only 
recombinant pairs where the probability that a recombination event preserves 
viability exceeded 10-3. Text S3 and figure S1 show that this is the case for values of 
n up to 60, which is why we chose n=60 as the highest amount of reaction changes 
during a recombination event. Empirical observations also suggest that this number of 
reactions would not be unrealistically large, because horizontal gene transfer can 
affect long DNA regions[44]. Transferred material that is integrated into the host 
genome by recombination can constitute stretches of non-coding DNA, fragments of 
genes [37,38], entire genes [39], multiple adjacent genes [40,41], operons, 
transposable chromosomal elements, plasmids, as well as other naturally occurring 
extrachromosomal elements [42]. The length of contiguous transferred stretches may 
range from a few nucleotides [43] to more than 3 Mbp [44], i.e., some two thirds of 
the length of the E. coli genome, which encodes more than 1300 reactions. In 
addition, some megabase-scale horizontally transferred genes can become 
incorporated into a chromosome in the form of hundreds of smaller fragments [45]. 
To implement an amount of random mutational metabolic change that is comparable 
to the same amount of recombinational change, for a given number of altered 
reactions (n) we created a “mutational” offspring of a metabolic network by adding 
n/2 randomly chosen reactions from the reaction universe, and deleting n/2 randomly 
chosen reactions among the set of reactions present in the metabolic network. Note 
the key difference between mutation and recombination: In recombination the n/2 
reactions that are added to the recombinant offspring are chosen randomly from 
another viable metabolic network (the donor), whereas in mutation they are taken 
from the whole reaction universe.  
(h) Genomic recombination in prokaryotic metabolic networks from the BiGG 
database 
We validated our observations based on randomly sampled viable metabolic networks 
by considering the genome-scale metabolic networks of 61 bacterial species available 
at the BiGG database [46], using the R-package Sybil [47]. For this analysis, we 
generated a reduced universe of reactions comprised of the union of the sets of 
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reactions present in the 61 metabolic networks. This universe altogether contains 
3404 internal reactions, 3156 transport reactions, and a different biomass reaction for 
each organism. As potential carbon sources, we used all 137 carbon-containing 
metabolites that occurred as metabolites external to at least one organism in the 
database, and thus assigned a phenotype vector of length 137 to each metabolic 
network using FBA.  
To model recombination among the metabolic networks of these 61 organisms, we 
used one main approach, which incorporates information about the linkage of the 
genes encoding metabolic reactions. To this end, we used the gene-reaction 
association rules defined in the BiGG database for each organism (in MAT files, 
grRules) [46], and ordered the genes in each organism based on their genomic 
position, as obtained from the RefSeq microbial genome database [48].  
For a specific recombination event between a donor and a recipient organism, we first 
chose at random a stretch of DNA from the donor organism that contains a given 
number of metabolic genes. To generate a recombinant offspring we added this 
stretch of DNA to the recipient, and subsequently deleted a randomly selected stretch 
of DNA from the recipient genome. We translated the added and deleted genes into 
reactions based on the gene-reaction rules for the donor and recipient organism. We 
set the number of genes in every donor DNA stretch such that on average (among all 
recombination events between all metabolic network pairs) a given number of n 
reactions are added to the recipient metabolic network, and an equal number n of 
reactions are deleted from it. Because gene-reaction associations are not generally 
one-to-one and can be very complicated, and because most of the reactions that are 
encoded in a given stretch of DNA may already be present in the recipient metabolic 
network, the number of metabolic genes in donor DNA required for adding n 
reactions will be higher than n (usually ≈2n). In contrast, we found that including 
≈0.9n metabolic genes into a DNA stretch to be deleted from the recipient genome 
usually sufficed to eliminate n reactions from the recipient metabolic network, 
because deletion of a single metabolic gene often causes elimination of multiple 
reactions 
In a second approach for recombining prokaryotic genomes, we neglected linkage 
between metabolic genes and added or deleted reactions randomly, just as we had 
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done for randomly sampled viable metabolic networks, irrespective of the genomic 
position of metabolic genes encoding these reactions.  
Text S2: An alternative MCMC approach to generate parental metabolic 
networks with a given genotypic distance (D) 
In addition to our first and main approach (see text S1f) for creating metabolic 
networks with a given genotypic distance D, we also pursued a second approach. This 
second approach starts from a parental metabolic network M1 and generates a 
recombination partner M2 through a sequence of MCMC random walks, which 
preserves the phenotype of M1 but increases the genotypic distance to M2, until a 
desired D between M1 and M2 is reached. Because this method resembles the 
divergence of species from a common ancestor, it is biologically motivated, but it has 
a technical limitation that is associated with inactive (blocked) reactions – reactions 
having zero metabolic flux for stoichiometric reasons [24,25]. Probably due to the 
shorter MCMC random walks in this second approach, a greater percentage of the D 
reactions that are not shared between two metabolic networks are blocked reactions in 
the second approach (90.09%) compared to the first one (66.78% of reactions). The 
innovation potential of inactive reactions is almost negligible in comparison to active 
reactions (Figure S2), and the fraction of innovative offspring is thus considerably 
(almost an order of magnitude) lower for the second approach than for the first 
approach.  
To render results from the two approaches comparable, one can adjust the ratio of 
inactive reactions in the D non-shared reactions between metabolic network pairs, as 
illustrated in the following example. Let us assume a given parental metabolic 
network pair obtained with the second method has D=1000 non-shared reactions, and 
since ≈90% of these reactions are inactive (blocked), only around 100 of them will be 
active. To make the ratio of active to inactive reactions among these non-shared 
reactions equal to the 66.78% (≈2/3) that are characteristic of parental metabolic 
network pairs obtained with the first method, one would require almost 200 inactive 
reactions (200/(100+200)= 2/3). Thus, whenever one wants to transfer a given 
number of reactions (n) from donor to recipient, one can first select 200 inactive 
reactions from the 900 inactive reactions and then select the n reactions to be 
recombined from a set that includes these 200 inactive reaction and 100 active 
	 72	
reactions. This ensures that a comparable proportion of active reactions are 
transferred from donor to recipient in the two approaches. After this adjustment, the 
two approaches yield virtually identical observations (Compare figure1 with figure 
S3). However, the manipulations required in the second approach make it less useful. 
We therefore chose to rely on the first approach throughout this study.                                                                                      
Text S3: Robustness of genome-scale metabolic networks decreases 
exponentially with increasing the number of deleted reactions 
Recombination that involves both the addition and deletion of reactions has the 
potential to create inviable recombinant offspring. The greater the number of 
reactions that are deleted in a recombination event, the greater will be this fraction of 
inviable offspring. Before embarking on a systematic analysis of recombination’s 
effects, we needed to find out how large the number of reactions deleted in a 
recombination event (n/2) can become, before the number of viable offspring 
becomes too small for computational analysis.  To this end, we generated 1000 
random genome-scale metabolic networks that we required to be viable only on 
glucose as the sole carbon source. For each of these randomly sampled viable 
metabolic networks and for each value of n between one and sixty, we created 1000 
offspring in which we deleted n/2 randomly chosen reactions. Figure S1 shows a box 
plot of the fraction of metabolic networks that remain viable on glucose as the sole 
carbon source after this procedure.  
The fraction of viable metabolic networks declines exponentially with the number of 
deleted reactions. For (n/2)>30 the fraction of metabolic networks that retain 
viability becomes very low, e.g., it declines below 0.001 for viability on glucose, 
such that fewer than one of 1000 offspring would be viable on glucose. At numbers 
beyond (n/2)>30, the number of recombination events needed to create any viable 
metabolic networks becomes computationally prohibitive.  For this reason, we chose 
n=60 as the highest value of n for our recombination analysis.    
Text S4: The rate of recombination between bacterial species decreases 
exponentially by increasing metabolic distance  
We wanted to obtain a crude estimate of the relationship between the metabolic 
distance of two bacterial species and the likelihood that such species undergo a 
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successful homologous recombination event. To estimate this relationship, we 
pursued a three-step procedure. 
In the first step, we estimated the DNA-based genotypic distance between two 
bacterial species whose metabolic networks differ by a given number of reactions. To 
this end, we used curated metabolic networks from 51 bacterial species, which had 
been obtained through state-of-the art techniques for genome annotation, generation 
of biomass reactions, reaction network assembly, and thermodynamic analysis of 
reaction reversibility [49]. We define the normalized metabolic genotype distance d 
of two prokaryotes as the number D of reactions differing between their metabolic 
networks, divided by the total number of reactions present in at least one of the two 
metabolic networks and computed this distance for all pairs of the 51 metabolic 
networks. On average, a relative metabolic distance of d=0.1 corresponds to an 
absolute difference of D≅150 in reaction number, but we note that the relationship 
between d and D depends on the total number of reactions in each metabolic 
network.  
We then aimed to relate metabolic divergence to DNA sequence divergence between 
these species. To this end, we used the housekeeping gene rpoB, which encodes the 
β-subunit of RNA polymerase. We obtained the rpoB coding sequences for these 51 
species from NCBI (http://www.ncbi.nlm.nih.gov), and aligned them with the 
PAL2NAL web server, which provides robust alignment of DNA sequences based 
on the corresponding protein sequences [50]. We then computed all pairwise 
Hamming distances from the aligned rpoB sequence alignment for these 51 species, 
normalized these quantities to the interval (0,1), and used them as our measure of 
sequence divergence.  
We note that even species with modest sequence divergence can have considerable 
metabolic distance. For example, the species pair Buchnera aphidicola and Yersinia 
pestis have an rpoB DNA sequence distance of 0.29, but a metabolic distance d of 
0.65, which corresponds to an absolute difference of 1004 reactions. Examples of 
moderately high metabolic divergence exist even from strains of the same organisms, 
such as Streptococcus pneumoniae TIGR4 and R6, which differ in 64 reactions or a 
fraction d=0.068 of their metabolic networks. At greater sequence distances of 0.45, 
metabolic distances reach values up to d=0.69 (e.g., Yersinia pestis and Rickettsia 
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prowazekki have rpoB DNA sequence divergence 0.45 and a metabolic distance of 
d=0.684, corresponding to 1066 reaction differences.) Metabolic distance and 
sequence divergence are significantly correlated (Pearson’s r=0.60, P<10-40), and a 
linear regression analysis (red line in figure S4a) yields a regression coefficient of 
0.82 with an intercept of 0.1. We use this regression analysis to translate metabolic 
distance into sequence divergence and vice versa. 
In the second step, we took advantage of experimental data on the exponential 
relationship between the likelihood of a successful recombination event and (rpoB-
based) sequence divergence between recombining species [33,51]. Specifically, we 
used such data for 19 species pairs in the genera Bacillus and Streptococcus. Figure 
S4b shows that the logarithm of the relative recombination rate decreases linearly 
with increasing sequence divergence between the donor and recipient species. A 
linear regression analysis (black line in the figure) yields a regression coefficient of -
18.40 with an intercept of 0.11. 
In the third step, we integrated data from step one and two to relate metabolic 
distance to the likelihood of a successful recombination event (Figure S4c). The 
figure shows that the logarithm of the relative recombination rate linearly decreases 
with increasing metabolic distance between the donor and recipient species. A linear 
regression analysis (red line in the figure) yields a regression coefficient of -22.57 
with an intercept of 0.62. In sum, sequence and recombination data suggests that the 
likelihood of a successful recombination event between two species would decrease 
exponentially with their metabolic distance. This also holds if we exclude 
endosymbiotic or host-associated pathogens from our analysis.  
Importantly, we note that metabolic distance will not be the only determinant of 
successful recombination between bacteria of different species. Part of the reason is 
that only a minority of genes in any bacterial genome are typically involved in 
metabolic network (e.g., 31% in E. coli). In addition, other incompatibilities, such as 
those between restriction-methylation systems [52] or DNA repair mechanisms [53] 
may hinder recombination. Our analysis merely goes to show that the minimal 
recombination distances of D=100 we use are not unrealistically low. Many bacteria 
that would successfully recombine in the wild have greater metabolic distances 
(Figure S4c). 
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Text S5: Phenotypically more diverse parental metabolic networks are more 
likely to generate metabolically innovative offspring 
We asked whether the phenotypic diversity of recombining parents influences the 
incidence of innovative offspring. On the one hand, recombining parents viable on 
the same combination of carbon sources might create a greater fraction of viable 
offspring, which might also increase the incidence of offspring with novel metabolic 
abilities. On the other hand, recombining parents viable on different combinations of 
carbon sources might produce recombinant offspring with a greater number of novel 
reaction combinations, and thus a greater number of metabolic innovations. 
To find out whether one of these hypotheses is correct, we created pairs of metabolic 
networks at a fixed genotypic distance (D=100), but with different metabolic 
phenotypes P1 and P2 and with identical phenotypic distances (ΔP), that is, identical 
number of carbon sources on which one parent is viable but the other isn't, or vice 
versa. To prevent confounding our analysis by the number of carbon sources ||P|| on 
which a metabolic network is viable, we kept ||P|| constant and required that each 
parent was viable on exactly 10 carbon sources. (In other words, all metabolic 
networks in this analysis are viable on glucose and on nine other carbon sources.) We 
then varied ΔP in four steps between 0 and 16, created 1000 metabolic network pairs 
for each value of ΔP, and from each pair we created 1000 recombinant offspring in 
which n reactions were altered through recombination. We then determined for each 
offspring whether it was viable on any carbon source that neither of the parents were 
viable on. Figure 2c (main text) shows that regardless of the number n of altered 
reactions, the fraction of innovative offspring (finnov) increases with the phenotypic 
distance ΔP among parents.  
The increase of innovation with parental phenotypic diversity cannot just be 
explained by a greater fraction of viable offspring, because parental phenotypic 
diversity does not influence this fraction (Figure S10a and S10b). In contrast, as ΔP 
increases, so does the fraction of reactions with ISE >0.5 that can potentially be 
transferred from donor to recipient (Figure 2d (main text)), once again highlighting 
the role of this process in innovation. Parental phenotypic diversity ΔP does have no 
impact on the number of carbon sources on which innovative offspring gain viability. 
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Specifically, we observed that innovative offspring typically gains viability on two to 
three additional carbon sources, and shows an average phenotypic distance between 
four and five, regardless of whether it arose through recombination or mutation, and 
independent of parental genotypic or phenotypic features. 
We complemented these analyses by focusing on an alternative way of defining 
phenotypic heterogeneity that is based on viability on two specific classes of carbon 
sources, namely those involved primarily in glycolysis, and those involved primarily 
in gluconeogenesis (See Text S1c). We found that offspring of parents viable on 
different classes of carbon sources display a greater incidence of innovation, 
compared to offspring of parents that are viable on the same class of carbon sources 
(Text S6).  
Text S6: Parental metabolic networks viable on different classes of carbon 
sources are more likely to generate innovative offspring than parents that are 
viable on the same classes of carbon sources 
In this analysis, we focused on two specific classes of carbon sources, namely those 
involved primarily in glycolysis, and those involved primarily in gluconeogenesis 
(Text S1c). In a previous contribution, we had shown that metabolic networks 
required to be viable on one glycolytic (gluconeogenic) carbon source tended to be 
viable also on other glycolytic (gluconeogenic) carbon sources [54]. We wanted to 
find out whether parental viability on either glycolytic, gluconeogenesis, or both 
kinds of carbon sources influenced the incidence of novel metabolic traits in the 
offspring. To this end, we created 1000 pairs of donor – recipient metabolic networks 
(genotype distance D=100) with each of the following properties (i) both parents are 
viable on five glycolytic carbon sources, (ii) both parents are viable on five 
gluconeogenic carbon sources, (iii) all donor metabolic networks are viable on five 
gluconeogenic carbon sources, and all recipient metabolic networks are viable on five 
glycolytic carbon sources, and (iv) all donor metabolic networks are viable on five 
glycolytic carbon sources, and all recipient metabolic networks are viable on five 
gluconeogenic carbon sources. To exclude parental phenotypic diversity as a 
confounding factor, we ensured that it had a constant value of ΔP=10 for all parents 
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in all three categories. Aside from these constraints, we chose glycolytic and 
gluconeogenic carbon sources at random. 
For each pair of metabolic networks we created 1000 offspring with a fixed number 
of altered reactions, and found that recombinants of parents viable on different kinds 
of carbon sources (i.e. gluconeogenic-glycolytic) display a greater incidence of 
innovation (Figure S11a). This greater incidence of innovation cannot solely be 
explained by a greater fraction of viable offspring, because parental viability on 
different classes of carbon sources does not influence the fraction of viable offspring 
(Figure S11b).  Thus, we conclude that phenotypically more heterogeneous parental 
metabolic networks are more likely to generate innovative recombinants.  
Text S7: Phenotypically less complex parental metabolic networks are more 
likely to generate metabolically innovative offspring 
We also investigated the impact of phenotypic complexity on metabolic innovation. 
We define the complexity of a phenotype P as the number ||P|| of carbon sources on 
which it is viable. For this analysis, we generated parental metabolic networks with 
the same genotypic distance D=100 but with varying phenotypic complexity. In 
addition, we required that both metabolic networks in a pair are viable not only on the 
same number of carbon sources, but also on the exact same carbon sources. 
Specifically, we analyzed 1000 pairs of random parental metabolic networks viable 
on ||P||=1, 5, or 10 carbon sources. For each of the 1000 pairs at each value of ||P||, 
we created 1000 recombinant offspring with n altered reactions. Figure 2e (main text) 
shows that the fraction of innovative offspring (finnov) decreases with increasing 
phenotypic complexity. The more carbon sources a metabolic network is viable on, 
the smaller the likelihood that recombination creates viability on further carbon 
sources. This difference is not simply caused by a decrease in the fraction of viable 
offspring with increasing phenotypic complexity (Figures S12a and S12b). Also, ||P|| 
does not impact the number of additional carbon sources that an innovative offspring 
gains viability on. The fraction of exchangeable reactions with ISE >0.5 (fsuper) 
decreases with increasing phenotypic complexity (Figure 2f (main text)).  
We also wished to analyze the effect of phenotypic complexity on metabolic 
innovation for metabolic networks viable on more than 10 carbon sources (i.e., 
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||P||=20, 30, 40). However, creating 1000 metabolic network pairs with these values 
of ||P|| that were viable on the exact same combination of carbon sources was 
computationally infeasible. We thus created 1000 metabolic network pairs whose 
phenotype vectors differed in a fixed number of 10 non-zero entries. For example, in 
such a pair with ||P||=30, both members would be viable on the same 25 carbon 
sources. In addition one member would be viable on five carbon sources that the 
other one is not viable on, and vice versa. Furthermore, we required a fixed 
genotypic distance D=100 for all metabolic network pairs in this analysis.  For each 
value of ||P|| subject to these constraints, we created 1000 recombinant offspring 
with n altered reactions for each of the 1000 parental metabolic network pairs. 
Consistent with data from figure 2e (main text), the fraction of innovative offspring 
(finnov) decreases with increasing phenotypic complexity (Figure S13a). Figures S13b 
and S13c show that this difference is not simply caused by a decrease in the fraction 
of viable offspring with increasing phenotypic complexity. Figure S13d shows that 
fraction of reactions with superessentiality higher than 0.5 (fsuper) decreases with 
increasing phenotypic complexity.  
Text S8: Larger parental metabolic networks are recombinationally more 
robust and so more likely to generate metabolically innovative offspring 
We define the genotypic complexity of a metabolic network as the number of 
reactions (||G||) present in this metabolic network. We wanted to find out whether it 
affects recombinational robustness and the incidence of novel phenotypes among 
recombinant offspring. To this end, we analyzed metabolic networks with sizes that 
vary between ||G||=1500 and ||G||=2000 reactions. Specifically, we created 1000 
random viable donor recipient pairs with constant genotype distance D=100 for each 
size class, where we required the parental metabolic networks to be viable only on 
glucose. We then created from each parental pair 1000 recombinant offspring with a 
specific number n of altered reactions. 
Figure S14a shows that recombinational robustness increases with increasing 
genotypic complexity of the parents. For example, at n=10 recombined reactions the 
fraction of viable offspring is three times higher for parental metabolic networks with 
||G||=2000 reactions than for parental metabolic networks with ||G||=1500 reactions 
(0.3 vs. 0.1, Figure S14a). We observe the same result, when we use parental 
	 79	
metabolic networks viable on acetate for this analysis (Figure S14b).  Moreover, we 
observed that the fraction of innovative offspring (finnov) also increases with 
increasing metabolic network size ||G|| (Figure S14c). Again this result does not 
change if parental metabolic networks are viable on acetate instead of on glucose 
(Figure S14d).  
In sum, unlike other quantities such as genotypic distance and phenotypic diversity of 
parents, which do not impact recombinational robustness, and thus influence 
innovation directly, parental genotypic complexity (||G||) increases recombinational 
robustness, and can thus enhance innovation indirectly by increasing robustness. 
Text S9: Effects of genotypic and phenotypic features of prokaryotic parental 
metabolic networks on recombinational robustness and innovation 
Unlike our analyses of random viable metabolic networks, where we were able to 
control genotypic parameters such as the number of reactions, and phenotypic 
parameters such as phenotypic complexity by sampling genotype space appropriately, 
these parameters are fixed properties of the 61 specific prokaryotic metabolic 
networks we analyzed. Moreover, when analyzing random viable networks we could 
sample metabolic network pairs that varied in only one parameter, which is not 
possible for prokaryotic metabolic networks. However, to control relevant parameters 
to some extent, we took the following steps.  
First, to prevent size variation in metabolic networks from confounding our analysis, 
we observed that the majority (47 of 61) of prokaryotic metabolic networks show a 
narrow size range between 1250 and 1350 internal reactions (Figure S16a), and 
focused our analysis on these metabolic networks.  (278 among all 472  possible 
pairs of these metabolic network pairs have at least one offspring that is viable on a 
new carbon source.)  
Second, we observed that the distribution of parental genotypic distance (D), 
phenotypic distance (ΔP), and phenotypic complexity (||P||) is distinctly bimodal for 
these 278 parental metabolic networks (Figures S16b, S16c, and S16d). No parental 
metabolic network has intermediate values for any of these parameters, such that 
metabolic networks can be subdivided into “high” and ”low” categories for each 
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parameter. Moreover, metabolic networks with high ΔP have low ||P|| (Figure S16e). 
Based on these observations, we subdivided parental metabolic network pairs into 4 
categories: i) high D and low ΔP (high ||P||), ii) low D and low ΔP (high ||P||), iii) 
high D and high ΔP (low ||P||), iv) low D and high ΔP (low ||P||). The number of 
parental metabolic networks in categories (i) through (iv) was 96, 106, 12, and 64, 
respectively.  Recombinational robustness differs little among metabolic networks in 
these four categories (Figures S17b and S17c), and so these parameters do not 
strongly influence robustness, which is consistent with our observations from random 
viable metabolic networks. In contrast, the fraction of innovative offspring of parental 
metabolic networks in the fourth category (with low D and high ΔP (low ||P||)) is 
highest, and it is lowest for metabolic networks in the first category (with high D and 
low ΔP (high ||P||)) (Figures 3c and S17a). This is again consistent with our 
observations from random viable metabolic networks, where parents with low 
genotypic distance, high phenotypic distance, and low phenotypic complexity are 
more likely to generate innovative offspring. 
Text S10: Superessential reactions can explain the effect of parental genotypic 
and phenotypic diversity and complexity on metabolic innovation. 
Superessential reactions that are involved in recombination events can explain a 
series of patterns in our data. The first is that a given number of reaction changes can 
elicit more metabolic innovation when caused by recombination rather than by 
mutation. While recombination adds reactions to a recipient that already occur in a 
(viable) donor, random mutations add reactions unrelated to the metabolic network of 
the donor. Because this reaction universe contains fewer highly super-essential 
reactions than any donor, adding reactions from it is less likely to yield innovations 
(electronic supplementary material, figure S18).  Put differently, when recombination 
introduces new metabolic reactions into an organism, it preferentially introduces 
reactions that have been “pretested” by evolution, because they form part of a related 
viable genotype. In contrast, mutations may introduce reactions that are incompatible 
with this genotypic background, in the sense that they cannot interact productively 
with it. This observation is consistent with observations from other systems, such as 
proteins [55,56] and model gene regulatory networks [57,58].  
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Super-essential reactions can also help explain that the incidence of metabolic 
innovation rises with the number of transferred reactions (Figure 1a, main text). As 
we showed in the main text, addition of a single reaction is usually sufficient to cause 
metabolic innovation.  By increasing the number of transferred reactions, the 
probability increases that at least one highly superessential reaction is transferred, and 
so the incidence of metabolic innovation increases.  
In addition, the transfer of superessential reactions can help explain that increasing 
genotypic distance between donor and recipient decreases the incidence of metabolic 
innovation (figure 2a, main text). Since the number of highly superessential reactions 
is limited [59], increasing the genotypic distance between donor and recipient 
decreases the fraction of such reactions that are not already in the recipient. In 
consequence, the incidence of innovative offspring decreases as well.  
Superessential reactions can also help explain why the incidence of innovation 
increases with increasing parental phenotypic diversity ΔP – an increasing number of 
carbon sources on which one but not the other parent is viable. Any phenotypic 
difference between parents must be caused by the set of D reactions that are not 
shared between the parents. As ΔP increases, an increasing number of these non-
shared reactions would be involved in viability on at least one of the carbon sources 
on which the parents are viable, and such reactions tend to have a higher super-
essentiality index [59]. These are also the reactions that will lead to innovation when 
affected by a recombination event (figure S7). Therefore, parents with higher ΔP are 
expected to have a higher fraction of exchangeable reactions with high super 
essentiality index (Figure 2d in main text), and consequently higher fraction of 
innovative offspring (Figure 2c in main text).     
Finally, with increasing phenotypic complexity ||P|| – the number of carbon 
sources on which a metabolic network is viable – of parental metabolic 
networks with the same phenotype the incidence of innovation by 
recombination decreases. To explain this pattern, consider two genotypically 
distinct metabolic networks with the same phenotype. Their non-shared 
reactions are less likely to be essential for viability than their shared 
reactions, and so the superessentiality index of the non-shared reactions is 
expected to be low. As ||P|| increases, the fraction of non-shared reactions 
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with high superessentiality index is expected to decrease further, exactly as 
we observed (Figures 2f (main text) and S13d), which leads to a lower 
incidence of innovation (Figures 2e (main text) and S13a). 
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Figure S1: Distribution of the fraction of randomly sampled viable metabolic networks (boxes) that 
retain viability on glucose (y-axis, note the logarithmic scale) as compared with that of E. coli (cyan 
circles) after deleting a given number of reactions (x-axis). All boxes span the 25-th to 75-th percentile. 
Horizontal bars in a box indicate the median, and whiskers indicate maxima and minima. Red asterisks 
indicate outliers.     
 
 
 
 
 
 
 
Figure S2: Mean (bar), and standard error (vertical line) of the fraction of innovative offspring (finnov) 
generated from 1000 random parental metabolic networks viable only on glucose with a fixed 
genotype distance D=100, by adding 5 randomly chosen i) inactive (blocked), ii) active reactions, iii) 
highly superessential, and iv) mixed (including all types) reactions from a donor metabolic network to 
the recipient, followed by deleting 5 randomly chosen reactions from the recipient metabolic network. 
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Figure S3: Vertical axes in panels (a), (b), and (c) show mean (bars) and standard error (vertical lines) 
of the fraction of innovative offspring (finnov) generated by recombination (red) versus mutation (black), 
as a function of the number of reaction changes (n, x-axis) among those offspring retaining viability 
respectively on (a) glucose, (b) acetate, and (c) acetate. Parental metabolic network pairs are sampled 
based on the (a) second, (b) second, and (c) first approach (See texts S1e, and S2). Vertical axes in 
panels (d), (e), and (f) show recombinational robustness (red) versus mutational robustness (black) , 
that are defined as the fraction of recombinant (or mutant) offspring retaining viability respectively on 
(d) glucose, (e) acetate, and (f) acetate. Parental metabolic network pairs are sampled based on the (d), 
second (e) second, and (f) first approach (See texts S1f, and S2). All boxes span the 25-th to 75-th 
percentile, horizontal bars in a box indicate the median, and whiskers indicate maxima and minima. 
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Figure S4: Relative recombination rates. 
(a) Metabolic divergence, defined as the 
normalized Hamming distance between the 
genotype vectors of two metabolic 
networks, is correlated (Pearson’s r=0.60, 
P<10-40) with sequence divergence, defined 
as the normalized Hamming distance 
between rpoB (RNA polymerase) sequences 
of the corresponding pair of species. Each 
point corresponds to one of 512  possible species pairs chosen from 51 
distinct species (inset) whose pairwise rpoB 
sequence divergence lies below 0.5 [49]. (b) 
Relative rate of recombination, for a range 
of related donor species as a function of 
sequence divergence for a variety of 
bacterial recipients: Bacillus subtilis (blue), 
Bacillus mojavensis (red), and 
Streptococcus pneumoniae (green). The best 
log-linear fit is shown (black line), with an 
intercept of 0.11 and a slope of -18.40. Data 
is based on [50,51]. (c) Relative 
recombination rate (logarithmic scale, y-
axis) as a function of metabolic divergence 
(x-axis) for metabolic network pairs with 
metabolic divergence lower than 0.3, 
chosen among the set of all possible 
metabolic network pairs (inset). The red line 
is the result of a linear regression with a 
regression coefficient of -22.57, and an 
intercept of 0.62. Data in (c) is based on the 
linear relationship from (b), and the 
metabolic divergence of (a).   
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Figure S5: Phenotypic diversity among innovative offspring. Vertical axis shows mean (bars) and 
standard error (vertical lines) of the phenotypic distance among all pairs of innovative offspring 
generated by recombination (red) versus mutation (black), as a function of the number of reaction 
changes (n, x-axis). Phenotypic distance (ΔP) between a given pair of innovative offspring is measured 
as the number of carbon sources on which only one offspring but not the other is viable on. 
 
Figure S6: Mean (bar) and standard error (vertical line) of the biomass growth flux of innovative 
offspring (blue), and non-innovative offspring (red), divided by the parental growth rate, as a function 
of the number of recombined reactions (n). For this analysis, we created 1000 random metabolic 
network pairs viable only on glucose and with a difference in growth rate less than 0.25 percent. 
Regardless of n, the relative growth rate of non-innovative offspring is approximately equal to one, 
meaning that their growth rate is equal to the parental growth rate. In contrast, the relative growth rate 
for innovative offspring exceeds 1.4 for all n, and so innovative offspring even on the original carbon 
source can grow more than 40 percent faster than their parents.  
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Figure S7: Superessential reactions and 
metabolic innovation. (a) Mean (bars) and 
standard error (vertical lines) of the 
superessentiality index of reactions that (i) 
cause innovation in more than 100 innovative 
offspring (left), (ii) cause innovation in fewer 
than 100 innovative offspring (middle), and 
(iii) never cause innovation (right). (b) 
Scatterplot of superessentiality index (ISE; y-
axis) versus number of innovations (x-axis) 
caused by innovation-causing reactions 
(positive correlation: (Pearson’s r=0.47, 
P<10-9)). Horizontal axis in the inset is shown 
in logarithmic scale to improve visual clarity. 
(c) The fraction of innovative recombinant 
offspring (finnov, y-axis) is significantly 
correlated   (Pearson’s r=0.18, P<10-8) with 
the fraction of reactions with superessentiality 
index higher than 0.5 (fsuper, x-axis) among 
reactions that can potentially be transferred 
from donor to the recipient.  
When studying metabolic innovation, it is 
important to distinguish two classes of 
reactions with high superessentiality index. 
The first comprises reactions with 
superessentiality index ISE=1, which are 
needed in all viable metabolic networks [59]. 
These reactions are crucial for 
retaining viability on parental carbon sources, but they play no role in metabolic innovation, because 
all metabolic networks must have them. The second class includes reactions where 0.5< ISE <1. These 
reactions are less crucial for retaining viability on parental carbon sources, but important for gaining 
viability on novel carbon sources. They can be absent in some metabolic networks, because metabolic 
pathways that by-pass them exist, which means that they can be involved in recombinational exchange, 
and thus in the origin of novel phenotypes. Our analysis above highlights the special importance of 
these reactions for metabolic innovation.  
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Figure S8: Effect of parental genotypic diversity on recombinational robustness. The vertical axis 
shows recombinational robustness, that is, the fraction of offspring that retain viability on glucose and 
that are generated by recombination between parental metabolic networks with genotypic distance 
(D), where D is color-coded according to the legend. The horizontal axis shows the number of 
recombined reactions (n). All boxes span the 25-th to 75-th percentile, horizontal bars in a box 
indicate the median, and whiskers indicate maxima and minima. 
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Figure S9: Effect of parental genotypic 
diversity on recombinational innovation 
and robustness (parental metabolic 
networks are required to be viable on 
acetate). (a) the mean (bar) and standard error 
(vertical line) of the fraction of innovative 
offspring (finnov), generated by recombination 
between parental metabolic networks viable 
on acetate with genotypic distance (D), where 
D is color-coded according to the legend. The 
horizontal axis shows the number of 
recombined reactions (n). (b) The vertical axis 
shows recombinational robustness, that is, the 
fraction of offspring that retain viability on 
acetate and are generated by recombination 
between parental metabolic networks with 
genotypic distance (D), where D is color-
coded according to the legend of panel (a). 
The horizontal axis shows the number of 
recombined reactions (n). (c) The fraction of 
reactions with superessentiality index higher 
than 0.5 (fsuper, x-axis) among reactions that 
can potentially be transferred from the 
parental donor to the recipient metabolic 
network, with genotypic distance (D, x-axis). 
Note that parental metabolic networks are 
required to be viable on acetate instead of 
glucose. All boxes span the 25-th to 75-th 
percentile, horizontal bars in a box indicate 
the median, and whiskers indicate maxima 
and minima. 
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Figure S10: Effect of parental phenotypic diversity on recombinational robustness. The vertical 
axes show (a) the fraction of recombinant offspring retaining viability on glucose (i.e. robustness), 
and in (b) the fraction of recombinant offspring retaining viability on all carbon sources (not only 
glucose) on which the corresponding recipient parental metabolic network is viable. Offspring were 
generated by recombination between parental metabolic networks with phenotypic complexity ΔP 
(color-coded as shown in the legend in panel (a)). The horizontal axes show the number of 
recombined reactions (n). Boxes  span the 25-th to 75-th percentile, and whiskers indicate maxima and 
minima. 
 
 
Figure S11: Effect of parental carbon source classes on metabolic innovation. The vertical axes in  
(a)  show the mean (bar) and standard error (vertical line) of the fraction of innovative offspring 
(finnov), and in  (b) the fraction of recombinant offspring retaining viability on glucose (for those 
recipients viable on glycolytic carbon sources) or acetate (for those recipients viable on gluconeogenic 
carbon sources).  The horizontal axes show the number of recombined reactions (n). For this analysis 
we generated offspring by recombination between parental metabolic networks in which (i) the donor 
was viable on 5 glycolytic carbon sources and the recipient was viable on 5 other glycolytic carbon 
sources (blue), (ii) the donor was viable on 5 gluconeogenic carbon sources and the recipient was 
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viable on 5 other gluconeogenic carbon sources (green), (iii) the donor was viable on 5 gluconeogenic 
carbon sources and the recipient was viable on 5 glycolytic carbon sources (yellow), and (iv) the 
donor was viable on 5 glycolytic carbon sources and the recipient was viable on 5 gluconeogenic 
carbon sources (red). All boxes span the 25-th to 75-th percentile, horizontal bars in a box indicate the 
median, and whiskers indicate maxima and minima. 
 
 
Figure S12: Effect of parental phenotypic complexity on metabolic robustness (for | 𝑷 | ≤ 𝟏𝟎, 
and ΔP=0). The vertical axes show (a) the fraction of recombinant offspring retaining viability on 
glucose (i.e. robustness), and in (b) the fraction of recombinant offspring retaining viability on all 
carbon sources (not only glucose) on which the corresponding recipient parental metabolic network is 
viable. Offspring were generated by recombination between parental metabolic networks with 
phenotypic complexity ||P|| (color-coded as shown in the legend in panel (a)). The horizontal axes 
show the number of recombined reactions (n). All boxes span the 25-th to 75-th percentile, horizontal 
bars in a box indicate the median, and whiskers indicate maxima and minima  
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Figure S13: Effect of parental phenotypic complexity on metabolic innovation (for 𝑷 > 𝟏𝟎, 
and ΔP=10). The vertical axes show in (a) the mean (bar) and standard error (vertical line) of the 
fraction of innovative offspring (finnov), in (b) the fraction of recombinant offspring retaining viability 
on glucose (i.e. robustness), and in (c) the fraction of recombinant offspring retaining viability on all 
carbon sources (not only glucose) on which the corresponding recipient parental metabolic network is 
viable. Offspring were generated by recombination between parental metabolic networks with 
phenotypic complexity ||P|| (color-coded as shown in the legend in panel (a)). The horizontal axes 
show the number of recombined reactions (n). (d) Distribution of the fraction of reactions with 
superessentiality index exceeding 0.5 (y-axis) among the reactions that can potentially be transferred 
from the parental donor metabolic network to the recipient, with phenotypic complexity (||P||, x-ais). 
All boxes span the 25-th to 75-th percentile, horizontal bars in a box indicate the median, and whiskers 
indicate maxima and minima. 
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Figure S14: Effect of genotypic complexity (metabolic network size (||G||)) on recombinational 
innovation. Vertical axes in panels (a), and (b) show the fraction of recombinant offspring retaining 
viability (i.e. robustness, vertical axis), on (a) glucose, and (b) acetate, are shown as a function of the 
number of recombined reactions (n). All boxes span the 25-th to 75-th percentile, horizontal bars in a 
box indicate the median, and whiskers indicate maxima and minima. Panels (c), and (d) show mean 
(bar) and standard error (vertical line) of the fraction of innovative offspring (finnov), generated by 
recombination between parental metabolic networks required to be viable on (c) glucose, and (d) 
acetate, with size (||G||) color-coded as in the legend, are shown as a function of the number of 
recombined reactions (n). 
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Figure S15: (a) Fraction of robust recombinant offspring, i.e., offspring retaining viability on all the 
carbon sources that the recipient parental metabolic network is viable on (y-axis), as a function of the 
number of recombined reactions (x-axis). Offspring were generated by i) linkage-based recombination 
between prokaryotic metabolic networks (black), and ii) free recombination between prokaryotic 
metabolic networks (gray). All boxes span the 25-th to 75-th percentile, horizontal bars in a box 
indicate the median, and whiskers indicate maxima and minima. (b) Mean (bar) and standard error 
(vertical line) of the fraction of innovative offspring (finnov) generated by (i) linkage-based 
recombination (black), and (ii) free recombination between prokaryotic metabolic networks (gray). (c) 
Mean (bars) and standard error (vertical lines) of the superessentiality index of reactions that cause 
innovation (left) as compared with those never causing innovation (right). (d) The fraction of 
innovative recombinant offspring (finnov, y-axis) is significantly associated (Pearson’s r=0.13, P<10-5) 
with the fraction of reactions with superessentiality index higher than 0.5 (x-axis) among the set of 
reactions that can potentially be transferred from the parental donor to the recipient metabolic network. 
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Figure S16: Distribution of parental genotypic and phenotypic features among prokaryotic 
metabolic networks. (a) Histogram of the number of metabolic networks with a given metabolic 
network size (approximated by the number of internal reactions) specified on the x-axis. Vertical axes 
in panels (b), (c), and (d) show the number of parental metabolic network pairs with a given b) 
genotypic distance (D), c) phenotypic distance (ΔP), and d) phenotypic complexity (||P||), as specified 
on the x-axes. (e) Each circle represents a given parental metabolic network pairs with a given 
phenotypic distance (ΔP, x-axis), and phenotypic complexity (||P||, y-axis). 
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Figure S17: The vertical axes show (a) mean 
(bar) and standard error (vertical line) of the 
fraction of innovative offspring (finnov), (b) 
robustness to linkage-based, and (c) robustness 
to “free”recombination. Here we define 
robustness as the fraction of recombinant 
offspring retaining viability on at least one of 
the carbon source(s) on which the parental 
recipient metabolic networks are viable. 
Offspring are generated by recombination 
between prokaryotic parental metabolic 
networks with i) high genotypic distance 
(D>40), low phenotypic distance (ΔP<30), 
and high phenotypic complexity (||P||>60) 
(blue, N=96 parental pairs), ii) high genotypic 
distance (D>40), high phenotypic distance 
(ΔP>40), and low phenotypic complexity 
(||P||<40) (green, N=12 parental pairs),  iii) 
low genotypic distance (D<30), low 
phenotypic distance (ΔP<30), and high 
phenotypic complexity (||P||>60) (yellow, 
N=106 parental pairs), and iv) low genotypic 
distance (D<30), high phenotypic distance 
(ΔP>40), and low phenotypic complexity 
(||P||<40) (red, N=64 parental pairs). 
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Figure S18: The fraction of reactions with superessentiality index higher than 0.5 (fsuper, x-
axis) among the set of reactions that can potentially be transferred to the recipient metabolic 
network via recombination (red box) versus random mutation (black box). Boxes span the 25-
th to 75-th percentile, horizontal bars in a box indicate the median, and whiskers indicate 
maxima and minima.  
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 Genomic organization underlying deletional robustness in 
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3.1. Abstract 
Large scale DNA deletions and gene loss are pervasive in bacterial genomes. This 
observation raises the possibility that evolutionary adaptation has altered bacterial 
genome organization to increase its robustness to large-scale tandem gene deletions. To 
find out, we systematically analyzed 55 bacterial genome-scale metabolisms, and 
showed that metabolic gene ordering renders an organism’s viability in multiple 
nutrient environments significantly more robust against tandem multi-gene deletions 
than expected by chance.  This  excess robustness is caused by multiple factors, which 
include the clustering of essential metabolic genes, a greater than expected distance of 
synthetic lethal non-essential metabolic gene pairs, and the clustering of non-essential 
metabolic genes. By computationally creating minimal genomes, we show that a non-
adaptive origin of such clustering could in principle arise as a passive by-product of 
bacterial genome growth. However, because genome randomization forces such as 
translocation and inversion would eventualy erode such clustering, adaptive processes 
are necessary to sustain it. Our analyses of essential metabolic genes in operons are 
consistent with the notion that gene deletions are important for this adaptation. Also, 
we provide evidence that horizontal gene transfer contributes to sustain essential gene 
clustering. Our observations suggest that the genome organization of bacteria is driven 
by adaptive processes that provide phenotypic robustness in response to large-scale 
gene deletions. This robustness may be especially important for bacterial populations 
that take advantage of gene loss to adapt to new environments.    
 
 
 
 
 
 
 
 
 
 
	 104	
3.2. Significance 
From the organismal and the anatomical levels down to the molecular level, all 
complex biological systems manifest astonishing organization and order that are 
counter-intuitive and challenging to explain by evolutionary mechanisms. In this 
study, we focus specifically on one aspect of this biological organization, the 
arrangement of metabolic genes in bacterial genomes. We show that this organization 
ensures a substantially higher robustness to large-scale gene deletions than expected 
from random genomic ordering. We systematically investigate the possible 
evolutionary mechanisms behind the emergence of such robust organizations. Our 
analysis provides several lines of evidence indicating that bacteria may have gained a 
robust genome organization through pervasive gene loss events. 
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3.3. Introduction 
Bacterial genomes evolve highly dynamically. On the one hand, they expand through 
gene gain mechanisms such as horizontal gene transfer (HGT) (1). On the other hand, 
they contract via large scale gene loss (2). Large-scale gene deletion events were first 
documented in obligate pathogens and symbionts (3, 4), but later comparative genomic 
studies showed that they are surprisingly pervasive in bacterial genomes in general (5, 
6). Importantly, bacterial genomes experience a well-known general bias towards DNA 
deletion, that is, genome size reduction events prevail over genome size expansion 
events (7, 8). Moreover, according to experimental evolution studies, extensive gene 
loss by large-scale deletions can readily occur on short evolutionary time-scales (9–11). 
Does the high incidence of large-scale gene deletions leave evolutionary signatures in 
bacterial genomes? We hypothesized that bacterial genomes have evolved an 
organization that provides robustness against the deleterious phenotypic effects of 
large-scale gene losses. Because large-scale deletional events typically delete multiple 
contiguous (linked) genes, such a robust genome organization should ensure that a 
tandem deletion of multiple linked genes is on average more tolerable than a deletion of 
the same number of genes randomly drawn from the genome without regard to linkage. 
In other words, bacterial genomes should be more robust to tandem deletion than 
random deletion of the same number of genes. 
To validate this hypothesis, we focused on metabolic genomes, which encode the 
enzymes catalyzing the chemical reactions of metabolism. Compared to other 
biological systems, metabolism is particularly appropriate for such validation, because 
well-established and experimentally validated computational methods to predict 
complex phenotypes – especially a cell’s viability in specific environments – from 
genomic information are available (12). What is more, well-annotated genome-scale 
metabolic networks with information about metabolic genes, reactions, gene-reaction 
association rules, and the relative genomic order of metabolic genes are available for 
multiple bacterial genomes (13, 14). Our analysis is based on such information from 
55 well-studied bacterial species or strains (14). 
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3.4. Results and discussion 
To quantify how metabolic gene order affects the phenotypic robustness of a 
metabolism to gene deletions, we subjected the metabolic genome of Escherichia coli 
K-12 G1655 to two different kinds of multi-gene deletions. First, in tandem deletions, 
we deleted a given number of n metabolic genes in the order in which they occur in the 
E. coli genome. Second, in random deletions, we deleted n randomly chosen metabolic 
genes irrespective of their order in the genome. More specifically, for every value of n 
between 1 and 50, tandem deletion involved deleting all possible consecutive n-tuples 
of these genes (see methods). For random deletions, we deleted an equivalent number 
of randomly chosen n-tuples of genes. Next, we mapped the eliminated genes in these 
deletion variants to eliminated reactions in the E. coli metabolism and determined the 
viability of each deletion variant on up to 103 carbon sources using flux balance 
analysis (12) (table S1). We computed the robustness R of the E. coli metabolic 
genome to such gene deletions as the fraction of deletion variants that retain viability 
on at least one of the carbon sources, either for tandem deletion (Rtandem) or random 
deletion (Rrandom).  
 
Figure 1: Robustness to tandem deletion versus random deletion. A) The vertical axis shows the 
robustness of Escherichia coli K-12 G1655 (iJO1366) to tandem (blue) and random (red) deletion of 
metabolic genes, averaged over all deletional variants we examined, as a function of the number of 
deleted genes (horizontal axis). B) Excess robustness to tandem deletion defined as the ratio of 
robustness to tandem deletion and robustness to random deletion (Rtandem/Rrandom), for all 55 bacterial 
genomes, as a function of the number of deleted genes (horizontal axis). In panels A and B, robustness is 
defined as the fraction of deletional variants that retain viability on at least one carbon source.  
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We observed that robustness to tandem deletions is higher for all numbers n>1 of 
deleted genes, and sometimes considerably so (Figure 1a). The same observation holds 
when we used a more strict definition of robustness; namely the fraction of deletional 
variants that retain viability on all carbon sources on which the wild type E. coli is 
viable (figure S1). We also repeated this analysis for the 54 other prokaryotic genomes, 
and observed the same patterns in all of them (See figure S2 for two examples). To 
quantify by how much robustness to tandem deletions is higher than to random 
deletions, we computed the ratio Rtandem/Rrandom, which we call the excess robustness 
under tandem deletion. For example, for deletions of 20 genes, robustness to tandem 
deletions is on average 3.63-fold higher than to random deletion (Figure 1b).  This 
excess robustness increases with the number of deleted genes (Figures 1b and S3). In 
other words, gene order increases in its importance for deletional robustness as 
deletions become larger. Moreover, by considering robustness based on viability on 
single individual carbon sources, we observed that robustness to tandem deletion is 
more conserved among bacterial species or strains than robustness to random deletion 
(figure S4). We also noted that robustness varied to a greater extent among carbon 
sources for tandem deletion, than for random deletion (Figures S5 and S6). 
Next, we aimed to identify the underlying causes of the excess robustness to tandem 
deletion. We first wanted to find out whether our observations might be trivially 
explained by the selfish operon hypothesis (15), which was proposed to explain the 
clustering of functionally related genes into operons. This hypothesis asserts that the 
organization of genes into operons is not necessarily beneficial for a host genome, but 
for the constituent genes, because an operon enables the spreading of its genes to new 
cells and species by horizontal gene transfer. The hypothesis, which has been criticized 
before (16, 17), also predicts that horizontally transferred operons would harbor genes 
with peripheral (i.e. non-essential) metabolic functions (15), such that their deletion 
would be more tolerable than the deletion of other genes in the genome. Using the 
DOOR database (18, 19), a comprehensive database for operon information, we 
showed that the excess tandem robustness we observe is not simply explained by the 
dispensability of operonic genes as implied by the selfish operon hypothesis (see text 
S1, figure S7, and table S2).  
We then focused on an important class of metabolic genes called essential genes.  
Deletion of an essential metabolic gene alone would be enough for a metabolism to 
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lose viability in a given environment. These genes and their organization might 
therefore be important to explain a genome’s excess robustness to tandem gene 
deletions. It has been shown previously that essential genes play a key role in shaping 
chromosome organization (20), and that they are not uniformly distributed but clustered 
in bacterial genomes (21, 22). Such clustering can increase the robustness of a genome 
to tandem multi-gene deletions. If essential genes were distributed uniformly in the 
genome, each region of genome would have an approximately equal chance to include 
at least one essential gene, whose deletion would be lethal. In contrast, if essential 
genes are densely packed in some genomic regions (i.e. clustered), other regions must 
be depleted of essential genes. Deletions in the latter regions would be non-lethal, such 
that this genome organization effectively increases robustness to multi-gene deletions 
(figure S8). Because we have used multiple environments in our analysis, we 
distinguished two types of essential metabolic genes: i) strictly essential genes, which 
are essential on all carbon sources, and ii) conditionally essential genes, which are 
essential on at least one carbon source. Using Kuiper’s test (23) we showed that in the 
vast majority of the bacterial genomes both types of essential metabolic genes are 
significantly clustered (see text S2 and tables S3, S4 and S5).  
We then asked how these clusters were originally formed in bacterial genomes. The 
most fundamental question is whether they originated non-adaptively or adaptively, 
e.g., in response to ongoing large-scale gene deletions? To answer this question, we 
first examined a simple non-adaptive scenario that ignores the effects of gene deletions. 
This scenario is inspired by the concept of a minimal genome, which has been used by 
multiple researchers as a model for the genome of early DNA-based life forms (24–27). 
In a minimal metabolic genome, no one gene can be removed without destroying 
viability, so every gene is essential. A minimal genome is basically a single cluster of 
essential genes. If present-day genomes evolved from minimal genomes largely by the 
insertion of genes, then the observed present day clustering of essential genes might be 
a mere remnant of their clustering in the minimal genome, and thus a non-adaptive 
byproduct of evolutionary genome growth. To validate this hypothesis, we used a 
previously established algorithm (28) (see methods) that serially deletes individual 
genes to generate minimal (metabolic) genomes that can sustain life on a given carbon 
source. We then re-inserted the missing metabolic genes step-by-step in random 
locations until we had reinstated a genome with the same number and identity of genes 
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but a different gene order. Applying this method to the genomes of three bacterial 
species showed that the extent of essential gene clustering is similar to that of the 
corresponding wild-type genomes (see text S3, and figures S9-S12). Thus, a simple 
non-adaptive process can in principle explain the extent of essential gene clustering 
observed in modern genomes. 
However, this simplistic model of genome evolution has several limitations. First, 
although the minimal genome approach is popular (24–27), the minimal genomes it 
creates may not approximate the genome organization of early cells. Second, genome 
evolution involves many more processes, including ongoing gene deletions and 
duplications. A similar analysis that includes such processes shows that gene deletions 
enhance the clustering of essential genes further, whereas gene duplications reduce it 
somewhat (see text S3 and figures S9-S12). This implies that adaptive processes in 
which selective pressure is imposed by large-scale gene deletions can also contribute to 
the clustering of the essential genes. Thus, the origin of their clustering may not be 
purely non-adaptive. Finally and most importantly, frequently occuring genome 
rearrangement processes (29, 30) like translocation and inversion may cause clusters of 
essential genes to erode (see text S4 and figures S13 and S14). Thus, even if non-
adaptive mechanisms may have created essential gene clustering, other mechanisms 
may be needed to maintain such clustering.  
We aimed to detect potential signatures of such adaptive processes. In doing so, we 
focused first on operons, because operons are continually built, destroyed, and 
reshuffled in the course of evolution (31). If large-scale gene deletions impose 
substantial selective pressure on genome organization, then operons that contribute to 
robustness to gene deletions, because their  essential genes are clustered, would be 
preferentially preserved under deletion pressure. If so, then operons that exist in 
present-day bacterial genomes should show significantly greater clustering of essential 
genes than expected by chance.  
To find out, we used operonic information for 52 bacterial genomes from the DOOR 
databse. We first observed that in each of these bacterial genomes approximately 40% 
and 20% of operons contain at least one conditionally essential metabolic gene and at 
least one strictly essential metabolic gene, respectively (table S9). Importantly, we 
observed that essential metabolic genes are more likely to be part of an operon than 
other metabolic genes (figures 2a and S15, and tables S10 and S11). We then 
	 110	
partitioned each genome’s set of strictly essential metabolic genes into operonic genes 
and non-operonic ones. Using Kuiper’s test we quantified the clustering of genes in 
each group separately. Operonic essential genes are significantly clustered in all 
bacterial genomes, but non-operonic genes are significantly clustered only in 12 
genomes (23.07%; Figure 2b and table S12). The same association exists when we 
consider genes that are essential for viability on a single carbon source such as glucose 
(figure S16).  
 
Figure 2: Operons and essential genes. A) Histogram of the fraction of all metabolic genes (black), and 
the fraction of strictly essential metabolic genes (blue) which belong to an operon, based on the 52 
species or strains used in this analysis. We consider a metabolic gene as strictly essential, if its deletion 
results in losing viability on all the carbon sources on which the wild type metabolism is viable. B) In 
this analysis, we subdivided all strictly essential genes in each of 52 metabolic genomes into two groups 
i) those belonging to an operon and ii) those not belonging to an operon. For each genomes, we 
determined the extent of gene clustering using the P-value generated by Kuiper’s test. Each circle in this 
figure corresponds to a given species or strain. The horizontal and vertical axes show the extent of 
clustering for genes that are part of an operon and not part of an operon, respectively. The blue lines 
correspond to a significance threshold of P=0.05 (−𝑙𝑜𝑔!"0.05), and the red line is the identity line. Note 
that operonic genes are significantly clustered in more genomes. Whereas none of our 52 genomes show 
evidence for clustering of essential genes outside operons (at P=0.05), essential genes in operons are 
clustered in 40 of the 52 (76.93%) genomes. Moreover, in all 52 genomes, operonic genes are more 
significantly clustered (lower P-value) than genes outside operons. C) Data in this figure are based on 
partially or completely randomized Escherichia coli K-12 G1655 (iJO1366) genomes. We generated 
four sets of 100 randomized genomes, with randomized orders of  i) all genes (black), ii) non-operonic 
genes (blue), iii) operonic genes (red), and iv) entire operons (yellow, without changing intra-operonic 
gene orders). The vertical axis shows the extent of clustering of strictly essential genes in the 100 
randomized genomes, as indicated by the P-value of Kuiper’s test statistic. Boxes span the 25-th to 75-th 
percentile, and whiskers indicate maxima and minima. The blue horizontal line indicates the clustering of 
strictly essential genes in the wild type Escherichia coli K-12 G1655 (iJO1366) genome, and the red 
horizontal line shows a minimal threshold of significant clustering (i.e., where Kuiper’s test yields 
P<0.05). 
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Furthermore, using randomization of metabolic gene orders in the E. coli K12 genome, 
we observed that in a partially reshuffled genome where only the positions of operonic 
genes are randomly reshuffled, the clustering of essential genes is as low as that of 
completely reshuffled genomes (Figure 2c).In contrast, when we only reshuffled the 
positions of non-operonic genes, the clustering of essential genes remains similar to 
that of the wild-type genome. Moreover, when we reshuffled the relative ordering of 
operons without changing the orders of genes inside any given operon, we also 
observed a reduction in the clustering of essential metabolic genes (Figure 2c). Similar 
observations hold for genomes different from that of E. coli (figure S17). Thus, we 
conclude that the metabolic genes in operons that have preserved under deletion 
pressure and so remained in present-day bacterial genomes contribute to the clustering 
of essential genes more profoundly than non-operonic metabolic genes. These 
observations are consistent with the importance of gene deletions in the organization of 
essential metabolic genes. 
Next, we focused on horizontal gene transfer (HGT) to find further signatures of 
adaptation underlying the clustering of essential genes. If a genome does not 
experience gene deletions, HGT-acquired genes cannot become essential in the 
environment in which they have been transferred, because the organism is already 
viable without the newly transferred genes. However, in the presence of gene deletions, 
newly and initially non-essential HGT-acquired genes can become essential, for 
example when other, previously essential genes undergo deletion. Thus, the presence of 
HGT-acquired essential metabolic genes is a signature of gene deletion events in the 
genome. Note however that this argument applies only to strictly essential genes (i.e. 
essential in all environments), not conditionally essential genes, because HGT-aquired 
genes can become essential in new environments without the need for gene deletions 
(32).       
To search for these signatures of gene deletion, we first identified all HGT-acquired 
metabolic genes in 43 of the bacterial genomes using the HGTree database (33) (see 
methods). We then determined what fraction of essential metabolic genes are acquired 
by HGT. Intriguingly, essential metabolic genes, and in particular strictly essential 
ones, are more likely to be acquired by HGT than other metabolic genes (figures 3a and 
S18 and tables S6 and S7). This observation is consistent with a recent experimental 
study showing that  HGT-aquired genes are frequently indispensable (34).  
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Figure 3: Horizontal gene transfer and the essential genes. A) Histogram of the fraction of metabolic 
genes (black), and the fraction of strictly essential metabolic genes (red) which have been acquired 
through horizontal gene transfer (HGT) among the 43 species (strains) used in this analysis. We consider 
a metabolic gene as strictly essential, if its deletion results in losing viability on all the carbon sources on 
which the wild type metabolism is viable. B) In this analysis, we subdivided all strictly essential genes in 
each metabolic genome into two groups: i) those acquired by horizontal gene transfer (HGT) and ii) 
those not acquired by horizontal gene transfer. For each of the 43 genomes, and separately for strictly 
essential genes in each of the two groups, we determined the extent of gene clustering using the P-value 
generated by Kuiper’s test. Each circle in this figure corresponds to a given species or strain. The 
horizontal and vertical axes show the extent of clustering for genes acquired and not acquired by HGT, 
respectively. The blue lines correspond to a significance threshold of P=0.05 (−𝑙𝑜𝑔!"0.05), and the red 
line is the identity line. Note that horizontally transferred genes show greater clusterin in the vast 
majority of genomes. Whereas the clustering of horizontally transferred genes is significant at P=0.05 in 
39 among 43 genomes (90.7%), that of not horizontally transferred genes is significant only in 23 
genomes (53.48%). Moreover, horizontally transferred genes are more clustered (higher P-value) than 
not horizontally transferred genes in 38 genomes (88.37%).  
Moreover, significant clustering of HGT-acquired essential genes would provide 
additional support for gene deletions as an evolutionary force to cluster essential genes. 
We thus checked whether HGT contributes also to the organization of essential genes 
in bacterial genomes. To do so we partitioned a genome’s set of strictly essential genes 
into two groups, those acquired by HGT, and those not acquired by HGT. Then, we 
quantified the clustering of genes in each group separately, using Kuiper’s test. In 39 of 
43 (90.7%) of our bacterial genomes HGT-acquired essential metabolic genes are 
significantly clustered. In contrast, non HGT-acquired essential metabolic genes are 
significantly clustered only in 23 genomes (53.48%; Figure 3b and table S8). Similar 
observations hold for genes essential for viability on single carbon sources like glucose 
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(figure S19). In sum, HGT-acquired genes are preferentially essential, and HGT-
acquired essential genes are also more clustered than other essential genes, implying 
that gene deletion contributes to the clustering of essential genes.  
So far we have focused on the organization of essential genes, but the organization of 
non-essential genes may also be important for robustness to large-scale deletions. To 
find out whether this is so, we first focused on pairs of genes that are individually non-
essential but jointly essential, i.e., their simultaneous delection disrupts viability. Such 
gene pairs are also called synthetic lethals. If two synthetically lethal genes are closely 
linked in a genome, they are more likely to be deleted together in a tandem deletion. In 
contrast, if they are far away from each other, the likelihood that both of them are 
deleted in the same tandem deletion is much lower. Thus, synthetically lethal genes that 
are further apart than expected by chance alone could lead to increasing robustness to 
tandem gene deletion. We refer to such synthetically lethal genes as being in repulsion.  
To find out whether synthetically lethal genes are in repulsion, we created pairwise 
deletions of all non-essential metabolic genes in all 55 prokaryotic genomes, and 
determined their viability. In this analysis, we made a distinction between two types of 
synthetically lethal genes. The first comprises strictly synthetically lethal gene pairs, 
whose joint deletion is lethal in all carbon source environments we consider. The 
second comprises conditionally synthetic lethal gene pairs, whose deletion is lethal in 
at least one but not all environments. We determined the distance between two strictly 
synthetically lethal metabolic genes as the number of metabolic genes that lie between 
them. In the majority of genomes (41 out of 55; 74.54%), at least 50 genes lie between 
all strictly synthetic lethal gene pairs (table S13), and the paucity of strictly 
synthetically lethal gene pairs with a distance below 50 is statistically significant (table 
S14; Fisher’s exact test). This repulsion is also evident from a circos plot of the E. coli 
genome (figure 4a), and it disappears after random genome shuffling (Figure 4b). No 
short-range synthetic lethal interactions exist in the E. coli genome, but in the 
randomized genome, such interactions are abundant (Figures 4b and 4c). Similar 
patterns exist in other species (Figures S20 and S21). The same does not hold for 
conditionally lethal gene pairs (tables S15 and S16) and some bacterial species with 
small metabolic genome sizes (Figure S22), which suggests that this repulsion might be 
the result of long DNA insertions during bacterial genome growth.   
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Figure 4: Repulsion of synthetic lethal genes. A) Circos plot of the Escherichia coli K-12 G1655 
(iJO1366) genome, in which metabolic genes are arranged according to their order in the genome. An arc 
connects two genes if they form an unconditionally synthetic lethal pair. B) Same as A, but for 
randomized gene order. Note the many more short-ranged synthetic lethality interactions after gene order 
randomization. C) Barplot of the genomic distance (in number of intervening genes) between 
unconditionally synthetic lethal metabolic gene pairs in the wild-type (blue) and randomized (yellow) 
Escherichia coli K-12 G1655 (iJO1366) genome. Note the lack of short-distance  synthetic lethal pairs 
with fewer than 50 intervening genes in the wild type genome.  
The role of nonessential genes in robustness to gene deletions may not be restricted to 
pairs of such genes, but could be extended to three or more genes that are individually 
nonessential but jointly essential. Beyond two genes the number of possible 
combinations of such synthetically lethal n-tuples of genes becomes too large for 
exhaustive analysis. However, if such genes are in repulsion, genomes might be 
enriched in long clusters of genes that harbor no essential genes, and whose joint 
deletion is not lethal. We showed that such gene clusters do indeed exist (see text S5, 
figure S23, and tables S17 and S18). However, similar to what we observed for clusters 
of essential genes, genome randomization forces such as translocation and inversion 
can erode non-essential gene clusters (figures S24 and S25). Thus, the maintenance of 
these non-essential clusters in the genome would also require similar adaptive 
processes. 
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In summary, we have shown that the ordering of metabolic genes in bacterial genomes 
provides phenotypic robustness against deleterious effects of large-scale gene deletions. 
This robustness can endow bacterial populations with the flexibility to survive large-
scale gene deletion events, which could potentially help them adapt to new 
environments (particularly in pathogenic species) (35–38). Underlying this excess 
robustness is a non-random distribution of both essential and non-essential metabolic 
genes, which is manifested as clustering of essential genes and repulsion of synthetic 
lethal genes. Although a genome growth process starting from minimal genomes shows 
that clustering of essential genes could in principle have non-adaptive origins, the 
significant contribution of HGT and operons to this organization raises the possibility 
that the emergence of this genomic ordering from randomness is an adaptation to 
frequently-occuring large-scale gene deletions. 
 
3.5. Methods 
Bacterial genome-scale metabolic networks: We used 55 reconstructed bacterial 
genome-scale metabolic networks from the BiGG database (14), which provides 
comprehensive information about biochemical reactions, metabolites, metabolic genes, 
and gene-reaction association rules for each bacterial species. We ordered the genes in 
each species based on their genomic location, as obtained from the RefSeq microbial 
genome database (39). We used the R-package Sybil (40) to parse the BiGG models.  
Phenotype prediction from genomic information: We focus our analyses on a 
qualitative definition of metabolic phenotypes, that is, on whether a given metabolism 
is viable or inviable in a given minimal chemical environment (medium) that contains 
only a single carbon source. More specifically, we consider a genotype viable if it can 
produce all essential biomass precursors from the resources in this medium. We use 
Flux Balance Analysis (FBA, See text S6) to predict viability (12).  
Among the 55 bacterial metabolisms we study, we identified 137 unique carbon-
containing metabolites that occur in the metabolism of all species. Thus, we considered 
137 minimal growth environments that were distinguished by these carbon sources. 
Each of these environments included one carbon source, as well as oxygen, 
ammonium, inorganic phosphate, sulfate, sodium, potassium, cobalt, iron (Fe2+ and 
Fe3+), protons, water, molybdate, copper, calcium, chloride, magnesium, manganese, 
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and zinc. In other words, we varied the carbon source while keeping all other nutrients 
constant. None of the 55 species we studied were viable on 34 of these 137 minimal 
environments, so we excluded the corresponding carbon sources from this study, and 
performed our analysis with the remaining 103 minimal environments, whose carbon 
sources are listed in table S1.  
To systematically examine viability after deleting a metabolic gene or a set of 
metabolic genes, we used gene-reaction association rules for each species obtained 
from the BiGG database(14). Based on these rules, we translated metabolic gene 
deletions into deleted reactions. For more than 10% of reactions, genes and reactions 
do not show a one-to-one association. Some reactions are catalyzed by one or more 
enzymatic complexes, which may be encoded by more than one metabolic gene. In this 
case, deletion of a single gene whose product participates in a given enzymatic 
complex is enough to inactivate the complex (i.e., a Boolean AND function of gene 
presence/absence determines whether a reaction can be catalyzed). Other reactions can 
be catalyzed independently by multiple enzymatic complexes. In this case, all 
complexes need to be inactivated by deletion of individual genes to eliminate a reaction 
from the metabolic network (corresponding to a Boolean OR function of complex 
activity/inactivity). Finally, some gene products may participate in multiple enzymatic 
reactions, such that deletion of a single gene would eliminate multiple reactions. We 
took these associations into account when translating gene deletions into reaction 
deletions. After any one such deletion, we determined with FBA whether the resulting 
metabolic network is still viable in any one environment.    
Quantification of robustness to multiple gene deletions: To quantify the robustness 
of a given genome (metabolism) with 𝑛 metabolic genes to “tandem deletions” of 
length 𝑙 genes in a given environment (carbon source), we considered all possible (n) 
deletional variants in each of which 𝑙 consecutive metabolic genes are deleted. For each 
deletional variant, we determined the reactions to be deleted from the wild-type 
metabolic network, based on the gene-reaction association rules (14). Subsequently, we 
determined metabolic viability of each variant by FBA, and quantified the robustness to 
tandem deletion as the fraction of deletional variants that retain viability on the given 
carbon source.  
To quantify the robustness of a given genome (metabolism) with 𝑛 metabolic genes to a 
“random deletion” of length 𝑙, in a given environment, we generated the same number 
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n of deletional variants as for tandem deletions. In each of these variants l randomly 
chosen metabolic genes in the genome are deleted (irrespective of their genomic 
location). We quantified robustness to random gene deletion with the same procedure 
described above, as the fraction of random deletional variants that retain viability on 
the carbon source. 
Quantification of gene essentiality: To determine whether a metabolic gene is 
essential for viability on a given carbon source, we removed the corresponding 
reaction(s) from the wild-type metabolic network, and determined viability using FBA. 
For each bacterial genome, we determined the essentiality of every metabolic gene in 
every environment on which the wild-type metabolism is viable. We consider a 
metabolic gene as ”strictly essential” in a given genome, if its deletion results in losing 
viability on all carbon sources on which the wild-type metabolism is viable, and we 
consider a metabolic gene as  “conditionally essential” if its deletion abolishes 
viability on at least one carbon source. Note that strictly essential genes are a subset of 
conditionally essential genes.  
Likewise, we call a metabolic gene  “strictly non-essential” if its deletion does not 
abolish viability on any carbon source, and we indicate a metabolic gene as 
“conditionally non-essential” if its deletion does not abolish viability on at least one 
carbon source. Strictly non-essential genes are a subset of conditionally non-essential 
genes.  
Quantification of the clustering of essential genes in a given genome: We used 
Kuiper's test (23) to assess whether the distribution of essential genes in a given 
genome is uniform or not. This test is closely related to the Kolmogorov-Smirnov test 
(K-S test), which computes the discrepancy statistics D+ and D− that represent the 
absolute sizes of the most positive and most negative differences between two 
cumulative probability distribution functions that are being compared. Because, the K-
S test is not invariant under cyclic transformations, it is not useful to detect clusters of 
genes distributed in a circular bacterial genome.  Kuiper’s test allows cyclic 
transformations while taking advantage of the D+ and D- test statistics. 
Generation of minimal metabolic genome: We define a minimal metabolic genome 
as a set of metabolic genes of a given species that are all necessary to produce essential 
biomass precursors from external nutrients available in a given environment. To create 
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a minimal genome, one needs to delete the non-essential genes step by step until no 
non-essential metabolic genes remain. Note that the size of minimal genome may be 
larger than the number of essential genes in a wild-type (full-sized) genome, because 
after deleting a given gene, some previously non-essential genes may become essential. 
Moreover, genome size and gene identities in a minimal genome depend on the order 
of gene deletions that occur during genome reduction(28).  
To generate a minimal genome from a given full-size genome, we apply a previously 
established stepwise stochastic algorithm(28). In each step, we remove a randomly 
chosen metabolic gene from the genome and determine the viability of the resulting 
metabolism in the given environment. If the metabolism is still viable (i.e. it can 
produce all biomass precursors), we accept the deletion and remove the gene from the 
genome; otherwise, the gene is restored to the genome. This procedure is repeated until 
no further genes can be deleted, that is, until all remaining metabolic genes are essential 
for survival in the given environment. We applied this procedure to three different 
genomes, namely to Escherichia coli K-12 G1655 (iJO1366), Bacillus subtilis, and 
Salmonella enterica, using glucose or acetate as carbon sources. From each genome 
and on each carbon source, we generated 100 different minimal genomes. 
Identification of horizontally transferred metabolic genes: We used the HGTree 
database (33) to identify the metabolic genes that any one genome has likely obtained 
through horizontal gene transfer. In this database, horizontally transferred genes are 
predicted based on a tree reconciliation method, which reconstructs approximate 
maximum likelihood phylogenetic trees for each orthologous gene and corresponding 
16S rRNA reference species sets, and then reconciles the two trees using maximum 
framework. Because 43 of the 55 bacterial species that we considered were included in 
this database, we focused this part of our analysis on 43 bacterial genomes. 
Identification of operons in bacterial genomes: To identify operons, we used the 
DOOR database(18), which is a comprehensive database for prokaryotic operon 
information to identify metabolic genes that belong to an operon. It predicts operons 
based on a computational method(19) that was ranked first in an independent 
assessment of 14 operon prediction methods(41). For genomes with many 
experimentally validated operons, this method predicts operons based on a decision-
tree based classifier that uses both genome-specific features such as conserved gene 
neighborhood, phylogenetic profiles and intergenic distances, and general features such 
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as the length ratio between a pair of adjacent genes, Gene Ontology (GO)-based 
functional similarity between adjacent genes and the frequency of a specific DNA 
motif in the intergenic region. In contrast, for genomes with only limited experimental 
data on operons, the program applies a logistic function-based classifier using solely 
general genome features. The DOOR database contained operon information for 52 of 
our 55 bacterial genomes. 
Identification of pairs of synthetic lethal genes: For any given genome (metabolism), 
we identified all genes that are non-essential for viability in a given environment. Then, 
we examined all pairs of non-essential genes to determine whether simultaneous 
deletion of these genes is lethal. If yes, we consider the pair of genes as a synthetic 
lethal pair in this environment. We call a pair of genes that are synthetic lethal in all 
environments on which a wild-type metabolism is viable, unconditionally synthetic 
lethal genes. Conversely, we call pairs of genes that are synthetically lethal in some but 
not all environments conditionally synthetically lethal. 
Identification of non-essential clusters of non-essential metabolic genes: Any two 
successive strictly essential metabolic genes are either adjacent in the metabolic 
genome or non-adjacent, i.e., separated by one, two, or a larger cluster of non-essential 
metabolic genes. The non-essential genes belonging to such a cluster are at least 
conditionally non-essential, meaning that they are non-essential on at least one carbon 
source, but they are not necessarily strictly non-essential. Thus, we call a cluster of 
non-essential metabolic genes intervening between two successive strictly essential 
metabolic genes a “cluster of conditionally non-essential metabolic genes”.  After 
identifying all clusters of conditionally non-essential metabolic genes, we aimed to 
determine whether each such cluster is essential for viability on the carbon sources we 
consider. To do so, we deleted all metabolic genes in a given cluster, translated the 
gene deletions into reaction deletions, and used FBA to determine the resulting 
metabolism’s viability on the set of carbon sources on which the wild-type metabolism 
(before deletion) was viable. If the deletion did not abolish viability on any of these 
carbon sources, we called such a cluster a “strictly non-essential cluster of 
conditionally non-essential metabolic genes”. Moreover, if the deletion did not abolish 
viability on at least one carbon source on which the wild-type metabolism was viable, 
we called the cluster a “conditionally non-essential cluster of conditionally non-
essential metabolic genes”. Note that the set of strictly non-essential clusters (of 
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conditionally non-essential metabolic genes) is a subset of the set of conditionally non-
essential clusters (of conditionally non-essential metabolic genes). 
We can apply a similar procedure for any cluster of strictly non-essential metabolic 
genes intervening between two successive (but not adjacent) conditionally essential 
metabolic genes. In this way, we can identify strictly non-essential clusters of strictly 
non-essential metabolic genes and conditionally non-essential clusters of strictly non-
essential metabolic genes. Note that again the set of strictly non-essential clusters (of 
strictly non-essential metabolic genes) are a subset of the set of conditionally non-
essential clusters (of strictly non-essential metabolic genes). However, the set of 
clusters of strictly non-essential metabolic genes are not a subset of the set of the 
clusters of conditionally non-essential metabolic genes.  
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3.7. Supplementary Information 
 
Text S1: The selfish operon hypothesis cannot explain the excess robustness to 
tandem gene deletions  
In this analysis, we identified all operons and their corresponding metabolic genes in 
52 bacterial genomes using the DOOR database(1). For each genome, we generated 
all operon deletion variants, i.e., we selected one of the operons and deleted all 
metabolic genes belonging to it, and repeated this procedure for all operons. We then 
used flux balance analysis to determine the viability of each operon deletion variant 
on 102 distinct carbon sources. We quantified the robustness of a given genome to 
operon deletion (𝑅!"#$%&'() as the fraction of operon deletion variants that retain 
viability in a given environment or environments. To compare this robustness with the 
average robustness to tandem deletions of the same length for a given bacterial 
genome, we measured the weighted average of robustness to tandem deletions 
(𝑅!"#$%&), which we define as 𝑅!"#$%& = 𝑤!!"!!! 𝑅!"#$%&! , where 𝑤! is the fraction 
of operons with n metabolic genes in the analyzed genome, and 𝑅!"#$%&!  is the 
genome’s robustness to tandem deletions of n metabolic genes. Note that n varies 
between 2 and 20, because the smallest and largest operons in our study genomes 
have this respective number of genes. This weighted average ensures that the average 
length of tandem deletions that enter the calculation is the same as the average length 
of operons in any given genome. Figure S7 and table S2 show that robustness to 
operon deletion is slightly higher than the average robustness to tandem deletion, but 
the difference is not as dramatic as that between robustness to tandem deletion and 
random deletion. Thus, the dispensability of operons as implied by selfish operon 
theory cannot fully explain the excess robustness to tandem deletions.   
Text S2: Essential metabolic genes are clustered in bacterial genomes 
We hypothesized that the clustering of essential genes can increase the robustness of 
the genome to simultaneous deletion of multiple successive (tandem) genes. In 
contrast, it should not impact robustness to simultaneous deletions of multiple genes, 
chosen at random, regardless of their genomic location. If so, the clustering of 
essential genes might to a large extent explain the excess robustness to tandem 
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deletions. To find out whether this is the case, we first identified all essential 
metabolic genes in each of our 55 study genomes and in each of the 102 minimal 
environments (Table S3). We then used the test statistic of Kuiper’s test (Methods) to 
calculate a measure of clustering, i.e., the extent to which the distribution of essential 
genes differs from a uniform distribution. In this analysis we distinguished two types 
of essential genes: 𝑖) strictly essential metabolic genes, which are essential on all 
carbon sources, and 𝑖𝑖) conditionally essential metabolic genes, which are essential on 
at least one carbon source (see methods). In the vast majority of the species, both 
types of essential genes are significantly clustered in the genome (Tables S4 and S5). 
What is more, we observed a positive correlation between the degree of essential gene 
clustering and robustness to tandem gene deletions (deletion length 5: Pearson’s r=-
0.26, and P=0.05; length 10; r=0.35, and P =0.009)), but no significant correlation 
with robustness to random deletions (of length 5 (Pearson’s r=-0.04, and P-
value=0.77) and of length 10 (Pearson’s r=-0.01, and P-value=0.95)). This confirms 
the importance of essential gene clustering for robustness to tandem gene deletions. 
Text S3: Passive emergence of the clusters of essential genes  
We hypothesized that an evolutionary genome expansion scenario could explain 
essential gene clustering in present-day bacterial genomes. To validate this 
hypothesis, we started from minimal genomes(2), that is, sets of metabolic genes from 
which not a single gene can be removed without abolishing viability on a specific 
carbon source (See methods in the main text). Specifically, we started with 100 
distinct minimal metabolic genomes, which we had derived from the E. coli K12 wild 
type genome through stepwise elimination of genes that are nonessential for viability 
on glucose as the sole carbon source. Starting from one of these minimal genomes, we 
then chose randomly (with a uniform distribution) between 1 and 5 not necessarily 
contiguous metabolic genes from the wild type E. coli K12 genome that are not 
already included in the minimal genome. We then inserted the selected genes as a 
contiguous set of genes into a randomly chosen position in the genome. This 
procedure implies that during an insertion event on average 3 genes are added to the 
genome. This choice of including multiple genes in an insertion event is motivated 
based on ample empirical evidence in favor of co-acquisition and co-insertion of 
multiple genes into bacterial genomes, for example during horizontal gene transfer 
events(3–7). We repeated this insertion process, taking care to only choose genes for 
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insertion that were not already present in the growing recipient genome, until our 
genome had reached the size of the wild type E. coli K12 genome. We note that the 
gene content of the resulting genome is identical to that of the wild type genome, but 
its gene order is not. We repeated this procedure for all 100 starting minimal 
genomes. We observed that the robustness of the resulting genomes to tandem gene 
deletion (figure S9a (blue boxes)) is considerably higher than that of a randomly 
reshuffled E. coli K-12 genome (figure S9a (black boxes)), and comparable to that of 
the E. coli K-12 wild-type genome (figure S9a (blue horizontal line)). Because the 
final genomes produced by these simulations have the same set of genes as that of E. 
coli K-12, the fraction of essential genes is exactly the same as that of E. coli K-12 
(Figure S9b). A difference in this fraction to the E. coli K-12 can thus not possibly be 
responsible for the increase in robustness (figure S9b). In the majority of the resulting 
genomes, essential genes are also significantly clustered (figure S9c). Thus, essential 
genes can passively get clustered in the genome as a byproduct of increasing genomic 
complexity. 
We then examined additional evolutionary forces, such as gene deletion and 
duplication, which might further enhance robustness to tandem deletions. More 
specifically, we compared four different kinds of genome-altering changes to expand 
each of 100 minimal genomes derived from the E. coli K-12 genome and viable on 
glucose to a size that is identical to that of the E. coli K-12 genome. That is, we 
expanded genomes through: 𝑖) insertion events alone (as just described), 𝑖𝑖) insertion 
and deletion events, 𝑖𝑖𝑖) insertion and duplication events, and 𝑖𝑣) insertion, 
duplication, and deletion events, as described below: 
Insertion + deletion: We started with 100 distinct minimal genomes derived from the 
E. coli K-12 genome and viable on glucose. For each of these genomes, we performed 
the following iterative procedure in each step of which we either 𝑖) (with 75% 
probability) randomly and with a uniform distribution chose between 1 to 5 (not 
necessarily contiguous) metabolic genes from the set of genes that were present in the 
full-size genome, but absent from the minimal genome, and inserted them as a 
contiguous gene cluster at a randomly chosen position in the recipient genome, or 𝑖𝑖) 
(with 25% probability) deleted a randomly chosen non-essential cluster of genes in 
the growing genome. We iterated this procedure until the growing genome had 
reached a size equal to that of the focal species. Note that this procedure also avoids 
	 126	
duplication of genes in the growing genome, and ensures that all genes in the full-size 
wild type genome will be included in the final genomes. The higher insertion than 
deletion probability ensures that genome size grows over time. Note that including 
deletions implies that more steps are needed to reach the final genome size. 
Insertion + duplication: We started with 100 distinct minimal genomes derived from 
the E. coli K-12 genome and viable on glucose. For each of these genomes, we 
performed the following iterative procedure in each step of which we either 𝑖) (with 
75% probability) randomly and with a uniform distribution chose between 1 to 5 (not 
necessarily contiguous) metabolic genes from the set of genes that were present in the 
full-size genome, but absent from the minimal genome, and inserted them as a 
contiguous gene cluster at a randomly chosen position in the recipient genome, or 𝑖𝑖) 
(with 25% probability) we duplicated a given number of genes chosen at random. We 
iterated this procedure until the growing genome had reached a size equal to that of 
the focal species. In these simulations, gene duplications contributed to 25% of the 
added genes, which implies that the final genome will not contain some of the genes 
in the wild-type genome of the focal species. 
Insertion + duplication + deletion: We started with 100 distinct minimal genomes 
derived from the E. coli K-12 genome and viable on glucose. For each of these 
genomes, we performed the following iterative procedure in each step of which we 
either 𝑖) (with 50% probability) randomly and uniformly chose between 1 to 5 (not 
necessarily contiguous) metabolic genes from the set of genes that were present in the 
full-size genome, but absent from the minimal genome, and inserted them as a 
contiguous gene cluster at a randomly chosen position in the recipient genome, or 𝑖𝑖) 
(with 25% probability) duplicated a given number of genes chosen at random, or 𝑖𝑖𝑖)  
(with 25% probability) deleted a randomly chosen non-essential cluster of genes in 
the growing genome. We iterated this procedure until the growing genome had 
reached a size equal to that of the focal species.  
At the end of each simulation, and for each of the 100 final full-sized genomes, we 
quantified metabolic robustness to tandem deletions of length 5, identified essential 
genes in each genome, and studied whether these genes are clustered.  
We observed that most of the genomes subject to both insertion and deletion reached 
higher final robustness to tandem deletions than for the other three scenarios, and 
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even higher robustness than wild-type E. coli (figure S9a (cyan boxes)). Thus, 
exposing our simulated genomes to tandem deletions leads to higher robustness to 
such deletions. Including duplications slightly lowers robustness compared to the 
insertion-only scenario. To understand why, consider the following. In the absence of 
gene duplication, the final genome contains the same genes as that of E. coli K12, 
albeit with different order. In the presence of duplication, however, some E. coli K12 
genes may have multiple copies in the final genome, whereas others may be missing. 
The fraction of essential genes is the same as that of E. coli K12 in the absence of 
duplication, but it is smaller in the presence of duplication, because duplication of an 
essential gene results in two individually non-essential genes (figure S9b). 
Furthermore, in the presence of gene duplication, essential genes do not become 
significantly clustered, whereas under insertion and deletion alone, essential genes in 
the second scenario are more strongly clustered than E. coli K12 (figure S9c). 
Because gene duplication disrupts clusters of essential genes, it does not increase 
robustness to tandem gene deletion despite lowering the fraction of individually 
essential genes.  
To check whether the ordering of the metabolic genes in the initial minimal genomes 
is important for the patterns we observed, we repeated the above procedure starting 
with minimal genomes in which the ordering of the metabolic genes are randomly 
reshuffled. Using this approach we observed the same patterns (figure S10). 
Moreover, our observations remain the same when we use acetate instead of glucose 
as the sole carbon source in the minimal medium (figure S11). Finally, we get similar 
results when we repeat this procedure for other bacterial species (figure S12). 
In sum, we conclude that clusters of non-essential genes observed in wild-type 
genomes might originate non-adaptively. In other words, they can emerge passively 
through sequential insertion of new genes into a minimal genome. Moreover, 
exposure to gene deletion enhances clustering of essential genes, but duplication can 
disrupt clusters of essential genes.     
Text S4: Genome rearrangement can disrupt essential gene clusters 
To study the effects of genome rearrangements on the organization of bacterial 
genomes, we used computer simulations that start out with 100 copies of wild type 
genomes of E. coli K12, and 100 copies of the wild type genomes of Salmonella 
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enterica. We subjected each genome to 1000 independent stochastic genomic 
rearrangement events, studying three distinct scenarios of genome rearrangement 
events: i) translocation alone, ii) inversion alone, and iii) translocation + inversion. In 
any translocation step, a given number of consecutive metabolic genes (between 2 to 
10) is randomly chosen and is translocated to a randomly chosen position in the 
genome, while in an inversion step, the genes are left in place but the relative ordering 
of the genes is reversed. After each rearrangement step, we quantified the robustness 
of each of the 100 genomes to tandem gene deletions, as determined by the fraction of 
encoded metabolisms viable on glucose and acetate. Moreover, we identified essential 
genes in each genome and studied whether these genes are clustered.  
In all three scenarios, genome rearrangement events gradually reduce, for both 
species, robustness to tandem gene deletions on glucose (Figure S13a-c). Inversion 
alone reduces robustness to a lesser extent than the other two scenarios. Moreover, 
translocation reduces the clustering of essential genes, but inversion alone does not 
affect this clustering (Figure S13d-f). The same holds on acetate instead of glucose 
(Figure S14). Further analysis shows that inversion reduces robustness only by 
shrinking clusters of non-essential genes, whereas translocation both disrupts essential 
gene clusters and shrinks clusters of non-essential genes  (see text S5 and figures S24 
and S25).    
Text S5: Long non-essential clusters of non-essential genes 
We observed that bacterial genomes harbor long clusters of non-essential metabolic 
genes that are not interrupted by any essential genes. If simultaneous deletion of all 
these non-essential genes does not abolish viability, then this arrangement in itself 
increases the robustness of bacterial genomes to tandem deletions. We distinguish 
between two different types of non-essential metabolic genes: i) strictly non-essential 
genes that are not essential on any carbon sources, and ii) conditionally non-essential 
genes that are not essential on at least one carbon source. By definition, a cluster of 
strictly non-essential genes intervenes between two successive but non-adjacent 
conditionally essential genes, and a cluster of conditionally non-essential genes 
intervenes between two successive but non-adjacent strictly essential genes.  
We observed that both strictly and conditionally non-essential genes are organized 
into fewer but longer clusters in wild-type genomes than in randomized genomes 
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(Figure S23). For example, in Escherichia coli K-12 G1655 (iJO1366), we observed a 
long cluster of 32 consecutive strictly non-essential metabolic genes and a cluster of 
65 consecutive conditionally non-essential metabolic genes. We observed that 
simultaneous deletion of all the genes in a given cluster of strictly non-essential 
metabolic genes does not abolish viability on any carbon sources in more than 95% of 
the clusters, and it does not abolish viability on at least one carbon source in more 
than 99% of the clusters for the vast majority of the genomes (50 out of 55, that is 
90.9%) (See table S17). Moreover, in around 90% of the clusters of conditionally 
non-essential metabolic genes, simultaneous deletion of all the genes belonging to the 
cluster does not abolish viability on at least one carbon source, and in around 50% of 
these clusters in all genomes, it does not abolish viability on any carbon source (See 
table S18). This carbon-source dependent viability loss caused by deletion of the 
clusters of non-essential genes can explain the variability among different carbon 
sources that we observed (Figures S5 and S6). 
Finally, we showed that genome rearrangements like translocations and inversions 
shrink the length of non-essential gene clusters (figures S24 and S25). In figures S13 
and S14 we observed that inversions alone causes a gradual decline in robustness to 
tandem gene deletions without any reduction in the clustering of essential genes. 
Thus, it is the shortening of the clusters of non-essential genes caused by gene 
inversions that reduces robustness to tandem deletions (Figures S24 and S25).   
Text S6: Flux balance Analysis  
Flux balance analysis (FBA) is a widely used computational method for the 
quantitative analysis and modeling of metabolic networks (8). FBA predicts the 
metabolic flux through each reaction in a given metabolic network using the 
stoichiometric coefficients of metabolites participating in the network’s reactions. 
Stoichiometric coefficients are stored in a stoichiometric matrix S, which is of 
dimension m×n, where m and n, respectively, denote the number of metabolites and 
the number of reactions in a metabolic network. FBA constrains the flux through each 
reaction based on the assumption that the metabolic network is in a steady state in 
which metabolite concentrations do not change, i.e., 𝑆𝑣 = 0, where v is the vector of 
metabolic fluxes vi through reaction i. The solutions of the equation 𝑆𝑣 = 0, that is, 
the null space of the matrix S, comprises all flux vectors that are allowable in steady 
state. The null space can be further constrained by physicochemical information 
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regarding the maximally and minimally possible fluxes through each reaction. FBA 
relies on linear programming to identify those allowable flux vector(s) that maximize 
an objective function Z. This task can be formulated as finding a flux vector v* with 
the property 
v*=maxv Z(v)= maxv { cTv | Sv=0, a≤v≤ 𝑏}, 
where the vector c contains a set of scalar coefficients representing the maximization 
criterion, and each entry ai and bi of vectors 𝑎 and 𝑏, respectively, indicate the 
minimally and maximally possible flux through reaction i. The vector c represents the 
proportions of each small biomass molecule in a cell’s biomass. The quantity v* 
maximizes the biomass growth flux, that is, the rate at which a metabolic network can 
produce biomass (8). Here we use FBA to predict qualitatively whether a given 
metabolic network is viable in a given environment, and we consider a metabolic 
network viable if it can produce all essential biomass precursors. In a free-living 
bacterium like E. coli, there are approximately 60 such molecules including 20 amino 
acids, DNA, and RNA precursors, lipids and cofactors. We used the biomass 
composition of the E. coli metabolic model iAF1260 to define the vector c (9). 
Moreover, we used the packages CPLEX (11.0, ILOG; http://www.ilog.com/) and 
CLP (1.4, Coin-OR; https://projects/coin-or.org/Clp) to solve the linear programming 
problem of FBA. The major limitation of FBA is that it neglects regulatory constraints 
that can arise through suboptimal expression or regulation of enzymes. Newly 
horizontally transferred genes cannot easily establish regulatory interactions with their 
host genes, and it may thus take considerable adaptive evolution until they become 
expressed at a maximal or optimal level (10). Such regulatory constraints would be 
especially important if we focused on quantitative predictions of biomass growth (11). 
However, we use FBA solely for qualitative predictions of viability. This focus on 
qualitative phenotypes is biologically sensible. The reason is that many organisms 
grow slowly in their native environment (12, 13), implying that regulation for maximal 
biomass production is far from universal. Moreover, we note that regulatory 
constraints can easily be broken in evolution, even on the short time scales of 
laboratory evolution experiments (11, 14, 15). 
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Supplementary Figures 
 
	
Figure S1: Robustness to tandem deletion versus random deletion (strict phenotype definition). 
A) The vertical axis shows the robustness of Escherichia coli K-12 G1655 (iJO1366) to tandem (blue) 
and random (red) deletion of metabolic genes, averaged over all deletional variants we examined, as a 
function of the number of deleted genes (horizontal axis). In this analysis, robustness is defined as the 
fraction of deletional variants that retain viability on all 97 carbon sources on which the wild type 
Escherichia coli K-12 G1655 (iJO1366) is viable. Interpolation between data points is linear and is 
displayed as a visual guide. 
 
 
Figure S2: Robustness to tandem deletion versus random deletion (using alternative bacterial 
genomes). The vertical axes show the robustness of Salmonella enterica (panels A and B) and Bacillus 
subtillis (panels C and D) to tandem (blue) and random (red) deletion of metabolic genes, averaged 
over all deletional variants we examined, as a function of the number of deleted genes (horizontal axis). 
Robustness in panels A and C is defined conditionally, i.e., as the fraction of deletional variants that 
retain viability on at least one carbon source, while in panels B and D it is defined strictly, i.e., as the 
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fraction of deletional variants that retain viability on all carbon sources on which the wild type 
metabolism is viable. Interpolation between data points is linear and is displayed as a visual guide. 
 
Figure S3: Excess robustness to tandem deletion (strict phenotype definition). The vertical axis 
shows the excess robustness to tandem deletion, defined as the ratio of robustness to tandem deletion 
and robustness to random deletion (Rtandem/Rrandom), for all 55 bacterial genomes, as a function of the 
number of deleted genes (horizontal axis). In this analysis, robustness is defined as the fraction of 
deletional variants that retain viability on all carbon sources on which the wild type metabolism is 
viable. Boxes span the 25-th to 75-th percentile, whiskers indicate maxima and minima, and red ‘+’ 
signs show outliers.  
 
 
Figure S4: Higher correlation among carbon sources for tandem robustness as compared to 
random robustness. The same metabolism may show different robustness to tandem or random 
deletions of a given number of genes, depending on the carbon source environment in which this 
robustness is evaluated. We computed the robustness (Rtandem) of all our 55 prokaryotic metabolisms to 
tandem deletions of five genes on all carbon sources on which these metabolisms are viable, and then 
determined Spearman’s rank correlation coefficients between Rtandem on these carbon sources, for all 
pairs of metabolisms. We performed an analogous calculation for robustness (Rrandom) to random 
deletions of five genes.  Boxes indicate the distribution of Spearman’s rank correlation coefficient of 
robustness to tandem deletions of five genes (Rtandem, blue) and random deletions of five genes (Rrandom, 
red) for those carbon sources on which both metabolisms in a given pair are viable. Boxes span the 25-
th to 75-th percentile, and whiskers indicate maxima and minima. In box-whisker plots, boxes span the 
25-th to 75-th percentile, whiskers indicate maxima and minima, and red ‘+’ signs show outliers.  
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Figure S5: Higher variability among carbon sources in robustness to tandem deletion than 
random deletion. Each panel shows A) 97 blue curves and 97 red curves, B) 68 blue curves and 68 red 
curves, and C) 87 blue curves and 87 red curves indicating robustness to tandem (blue) and random 
(red) deletion for each of the A) 97, B) 68, and C) 87 carbon sources on which A) Escherichia coli K-
12 G1655 (iJO1366), B) Bacillus subtillis and C) Salmonella enterica are viable as a function of the 
number of deleted metabolic genes (horizontal axis). Each curve is obtained by a linear interploation 
betrween 50 data points.  
 
Figure S6: Excess variability in robustness to tandem deletions. The vertical axis shows the excess 
variability in robustness to tandem deletion among different carbon sources defined as the ratio of the 
standard deviation of robustness to tandem deletion (among different carbon sources) and the standard 
deviation of robustness to random deletion (Std(Rtandem)/Std(Rrandom)), for all 55 bacterial genomes, 
using three different number of deleted genes (horizontal axis). Boxes span the 25-th to 75-th 
percentile, whiskers indicate maxima and minima, and red ‘+’ signs show outliers.  
 
Figure S7: Robustness to operon deletion. Boxplots of robustness to operon deletion (𝑅!"#$%&'(, 
blue) and of average robustness to tandem deletion of the same length (𝑅!"#$%&, red, see text S1), 
computed for 52 bacterial species. For the boxplots of the left-hand side, robustness is defined based on 
retaining viability on all carbon sources on which the wild-type genome is viable, while for the 
boxplots of the right hand side robustness is defined based on retaining viability on at least one carbon 
source. 
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Figure S8: Clustering of essential genes can enhance robustness to tandem gene deletion. The 
figure illustrates two different hypothetical genome organizations, each of which has the same number 
of genes (12) and the same number of essential genes (4, shown as black boxes). Whereas in the left 
genome the essential genes are uniformly distributed, in the right genome they are clustered (i.e. 
conentrated in one region of the genome). Each curly bracket indicates tandem deletions of 3 specific 
consecutive genes. Red crosses and green check marks indicate whether any one deletion would disrupt 
or preserve viability. In the left genome, each tandem deletion includes one essential gene and will thus 
disrupt viability. In contrast, for the right genome, only the left-most four deletional variants include an 
essential gene, implying that 60% of deletions preserve viability, such that the robustness to deletions 
is 0.6. Note that we have made the simplifying assumption that simultaneous deletion of multiple non-
essential genes is not lethal.    
 
 
 
Figure S9: Emergence of essential gene clusters through gradual genomic expansion from a 
minimal towards a full-sized genome. Data is based on 100 genomes “grown” from a minimal 
genome that is viable on glucose and derived from Escherichia coli K-12 G1655 (iJO1366), towards a 
final genome of equal size as the wild-type Escherichia coli K-12 genome. We simulated genome 
“growth” in four different ways (see legend): insertion of genes alone (blue), insertion + deletion 
(cyan), insertion + duplication (green), and insertion + duplication + deletion (yellow). As a control we 
generated 100 genomes obtained by random reshuffling of the wild-type Escherichia coli K-12 genome 
(black). Vertical axes indicate A) robustness to tandem deletions of five genes, B) fractions of essential 
genes, and C) clustering of essential genes in the final 100 full-sized genomes, as indicated by Kuiper’s 
test statistic. Boxes span the 25-th to 75-th percentile, and whiskers indicate maxima and minima. The 
blue horizontal line in panel A) indicates metabolic robustness of the wild type Escherichia coli K-12 
genome to tandem deletions of five metabolic genes in glucose minimal medium. The blue horizontal 
line in C) shows the clustering of essential metabolic genes in the wild type Escherichia coli K-12 
genome, as computed by Kuiper’s statistics. The black horizontal line in panel C shows the minimal 
clustering above which the essential genes in a genome are considered significantly clustered (i.e. 
above which the P-value of the Kuiper’s test is below 0.05). Where genome “growth” includes gene 
duplication, the numbers of essential genes is lowered (panel B), and the minimum clustering threshold 
increases (panel C).  
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Figure S10: Emergence of essential gene clusters through gradual genomic expansion from a 
minimal towards a full-sized genome (using randomly reshuffled minimal genomes). Data is based 
on 100 genomes “grown” from a minimal genome that is viable on glucose and derived from 
Escherichia coli K-12 G1655 (iJO1366), towards a final genome of equal size as the wild-type 
Escherichia coli K-12 genome. Importantly, in this analysis, we have reshuffled the relative ordering of 
the genes in the minimal genome. We simulated genome “growth” in four different ways (see legend): 
insertion of genes alone (blue), insertion + deletion (cyan), insertion + duplication (green), and 
insertion + duplication + deletion (yellow). As a control we generated 100 genomes obtained by 
random reshuffling of the wild-type Escherichia coli K-12 genome (black). Vertical axes indicate A) 
robustness to tandem deletions of five genes, B) fractions of essential genes, and C) clustering of 
essential genes in the final 100 full-sized genomes, as indicated by the Kuiper’s test statistic. Boxes 
span the 25-th to 75-th percentile, and whiskers indicate maxima and minima. The blue horizontal line 
in panel A) indicates metabolic robustness of the wild type Escherichia coli K-12 genome to tandem 
deletions of five metabolic genes in glucose minimal medium. The blue horizontal line in C) shows the 
clustering of essential metabolic genes in the wild type Escherichia coli K-12 genome, as computed by 
Kuiper’s statistics. The black horizontal line in panel C shows the minimal clustering above which the 
essential genes in a genome are considered significantly clustered (i.e. above which the P-value of the 
Kuiper’s test is below 0.05). Where genome “growth” includes gene duplication, the number of 
essential genes is lowered (panel B), and the minimum clustering threshold increases (panel C). 
 
 
Figure S11: Emergence of essential gene clusters through gradual genomic expansion from a 
minimal towards a full-sized genome (using acetate as the carbon source). Data is based on 100 
genomes “grown” from a minimal genome that is viable on acetate and derived from Escherichia coli 
K-12 G1655 (iJO1366), towards a final genome of equal size as the wild-type Escherichia coli K-12 
genome. We simulated genome “growth” in four different ways (see legend): insertion of genes alone 
(blue), insertion + deletion (cyan), insertion + duplication (green), and insertion + duplication + 
deletion (yellow). As a control we generated 100 genomes obtained by random reshuffling of the wild-
type Escherichia coli K-12 genome (black). Vertical axes indicate A) robustness to tandem deletions of 
five genes, B) fractions of essential genes, and C) clustering of essential genes in the final 100 full-
sized genomes, as indicated by the Kuiper’s test statistic. Boxes span the 25-th to 75-th percentile, and 
whiskers indicate maxima and minima. The blue horizontal line in panel A) indicates metabolic 
robustness of the wild type Escherichia coli K-12 genome to tandem deletions of five metabolic genes 
in acetate minimal medium. The blue horizontal line in C) shows the clustering of essential metabolic 
genes in the wild type Escherichia coli K-12 genome, as computed by Kuiper’s statistics. The black 
horizontal line in panel C shows the minimal clustering above which the essential genes in a genome 
are considered significantly clustered (i.e. above which the P-value of the Kuiper’s test is below 0.05). 
Where genome “growth” includes gene duplication, the number of essential genes is lowered (panel B), 
and the minimum clustering threshold increases (panel C).  
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Figure S12: Emergence of essential gene clusters through gradual genomic expansion from a 
minimal towards a full-sized genome. Data in panels A-C is based on 100 genomes “grown” from a 
minimal genome that is viable on glucose and derived from Bacillus subtilis, towards a final genome of 
equal size as the wild-type Bacillus subtilis genome, and the data in panels D-F is based on 100 
genomes “grown” from a minimal genome that is viable on glucose and derived from Salmonella 
enterica, towards a final genome of equal size as the wild-type Salmonella enterica genome. We 
simulated genome “growth” in four different ways (see legend): insertion of genes alone (blue), 
insertion + deletion (cyan), insertion + duplication (green), and insertion + duplication + deletion 
(yellow). As a control we generated 100 genomes obtained by random reshuffling of the wild-type 
genome (black). Vertical axes indicate in panels A) and D) robustness to tandem deletions of five 
genes, in panels B) and E) fractions of essential genes, and in panels C) and F) clustering of essential 
genes in the final 100 full-sized genomes, as indicated by the Kuiper’s test statistic.  Boxes span the 25-
th to 75-th percentile, and whiskers indicate maxima and minima. The blue horizontal line in panels A 
and D indicates metabolic robustness of the wild type Bacillus subtilis and Salmonella enterica genome 
to tandem deletions of five metabolic genes in glucose minimal medium. The blue horizontal line in 
panels C and F shows the clustering of essential metabolic genes in the wild type Escherichia coli K-12 
genome, as computed by Kuiper’s statistics. The black horizontal line in panels C and F shows the 
minimal clustering above which the essential genes in a genome are considered significantly clustered 
(i.e. above which the P-value of the Kuiper’s test is below 0.05). Where genome “growth” includes 
gene duplication, the number of essential genes is lowered (panels B and E), and the minimum 
clustering threshold increases (panels C and F). 
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Figure S13: Genome rearrangement can reduce deletional robustness by disrupting the clusters 
of essential genes (on glucose). In each panel, the horizontal axis shows the number of steps in a 
simulated genome rearrangement process applied independently to 100 initial genomes derived from 
the wild-type genomes of two organisms (see legend). In each step, each genome is subjected to a 
genome rearrangement event (translocation (panels A and D), inversion (panels B and E), and 
translocation or inversion (panels C and F); see methods). The vertical axes in panels A-C show the 
average robustness to tandem deletions of five genes. In panels D-F they show the average clustering 
of essential metabolic genes, as computed by Kuiper’s statistics, averaged over all 100 genomes. All 
simulation data reported are based on minimal media containing glucose as the sole carbon source.  
 
 
 
 
Figure S14: Genome rearrangement can reduce deletional robustness by disrupting the clusters 
of essential genes (on acetate). In each panel, the horizontal axis shows the number of steps in a 
simulated genome rearrangement process applied independently to 100 initial genomes derived from 
the wild-type genomes of two organisms (see legend). In each step, each genome is subjected to a 
genome rearrangement event (translocation (panels A and D), inversion (panels B and E), and 
translocation or inversion (panels C and F); see methods). The vertical axes in panels A-C show the 
average robustness to tandem deletions of five genes, and in panels D-F they show the average 
clustering of essential metabolic genes, as computed by Kuiper’s statistics, averaged over all 100 
genomes. All simulation data reported are based on minimal media containing acetate as the sole 
carbon source. 
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Figure S15: Operons and conditionally essential genes. Histogram of the fraction of all metabolic 
genes (black), and the fraction of conditionally essential metabolic genes (blue) which belong to an 
operon among the 52 species (strains) used in this analysis. We consider a metabolic gene as 
conditionally essential, if its deletion results in losing viability on at least one of the carbon sources on 
which the wild type metabolism is viable. 
 
 
 
 
 
Figure S16: Operons and the essential genes (on glucose as minimal media). A) Histogram of the 
fraction of metabolic genes (black), and the fraction of essential metabolic genes (blue) which belong 
to an operon among the 52 species (strains) used in this analysis is shown. We consider a metabolic 
gene as essential, if its deletion results in losing viability on glucose. B) In this analysis, we subdivided 
all strictly essential genes in each of 52 metabolic genomes into two groups i) those belonging to an 
operon and ii) those not belonging to an operon. For each genome, we determined the extent of gene 
clustering using the P-value generated by Kuiper’s test. Each circle in this figure corresponds to a 
given species or strain. The horizontal and vertical axes show the extent of clustering for essential 
genes that are part of an operon and not part of an operon, respectively. The blue lines correspond to a 
significance threshold of P=0.05 (−𝑙𝑜𝑔!"0.05), and the red line is the identity line. Note that operonic 
essential genes are significantly clustered in more genomes. Whereas only 2 of the 52 genomes 
(3.84%) show evidence for clustering of essential genes outside operons (at P=0.05), essential genes in 
operons are clustered in all 52 genomes. Moreover, in all 52 genomes, operonic genes are more 
significantly clustered (lower P-value) than genes outside operons. 
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Figure S17: Impact of operonic genes and operon orders on the clustering of essential genes. Data 
in this figure are based on partially or completely randomized A) Salmonella enterica genome, and B) 
Bacillus subtilis genome, with randomized orders of i) all genes (black), ii) non-operonic genes (blue), 
iii) operonic genes (red), and iv) entire operons (yellow, without changing the intra-operonic gene 
orders). The vertical axes show the extent of clustering of strictly essential genes in the 100 
randomized genomes, as indicated by the Kuiper’s test statistic. Boxes span the 25-th to 75-th 
percentile, and whiskers indicate maxima and minima. The blue horizontal line indicates the clustering 
of strictly essential genes in the corresponding wild type genomes as indicated by the Kuiper’s test 
statistic, and the red horizontal line shows a minimal threshold of significant clustering (i.e. where 
Kuiper’s test yields P<0.05). 
 
 
 
 
 
Figure S18: Horizontal gene transfer and the conditionally essential genes. A) Histogram of the 
fraction of metabolic genes (black), and the fraction of conditionally essential metabolic genes (red) 
which have been acquired through horizontal gene transfer (HGT) among the 43 species (strains) used 
in this analysis. We consider a metabolic gene as conditionally essential, if its deletion results in losing 
viability on at least one of the carbon sources on which the wild type metabolism is viable. 
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Figure S19: Horizontal gene transfer and the essential genes (on glucose as minimal media). A) 
Histogram of the fraction of metabolic genes (black), and the fraction of essential metabolic genes 
(red), which have been acquired through horizontal gene transfer (HGT) among the 43 species (strains) 
used in this analysis. We consider a metabolic gene as essential if its deletion results in losing viability 
on glucose. B) In this analysis, we subdivided all the essential genes in each metabolic genome into 
two groups: i) those acquired by horizontal gene transfer (HGT) and ii) those not acquired by 
horizontal gene transfer. For each of the 43 genomes, and separetely for essential genes (on glucose) in 
each of the two groups, we determined the extent of gene clustering using the P-value generated by 
Kuiper’s test. Each circle in this figure corresponds to a given species or strain. The horizontal and 
vertical axes show the extent of clustering for essential genes acquired and not acquired by HGT, 
respectively. The blue lines correspond to a significance threshold of P=0.05 (−𝑙𝑜𝑔!"0.05), and the 
red line is the identity line. Note that horizontally transferred essential genes show greater clustering in 
the vast majority of genomes. Whereas the clustering of horizontally transferred essential genes is 
significant at P=0.05 in 40 among 43 genomes (93.02%), that of not horizontally transferred essential 
genes is significant only in 21 genomes (48.83%). Moreover, horizontally transferred essential genes 
are more clustered (lower P-value) than not horizontally transferred essential genes in 40 genomes 
(93.02%).  
 
 
Figure S20: Repulsion of synthetic lethal genes in the E. coli 083:H1 genome. A) Circos plot of 
Escherichia coli K-12 083:H1 genome, in which metabolic genes are arranged according to their order 
in the genome. An arc connects two genes if they form an unconditionally synthetic lethal pair. B) 
Same as A, but for randomized gene order. Note the many short-ranged synthetic lethality interactions 
after gene order randomization. C) Barplot of the genomic distance (in number of intervening genes) 
between unconditionally synthetic lethal metabolic gene pairs in the wild-type (blue) and randomized 
(yellow) Escherichia coli K-12 083:H1 genome. Note the lack of short-distance synthetic lethal pairs 
with fewer than 5o intervening genes in the wild type genome.  
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Figure S21: Repulsion of synthetic lethal genes in the Shigella flexneri genome. A) Circos plot of 
Shigella flexneri genome, in which metabolic genes are arranged according to their order in the 
genome. An arc connects two genes if they form an unconditionally synthetic lethal pair. B) Same as 
A, but for randomized gene order. Note the many short-ranged synthetic lethality interactions after 
gene order randomization. C) Barplot of the genomic distance (in number of intervening genes) 
between unconditionally synthetic lethal metabolic gene pairs in the wild-type (blue) and randomized 
(yellow) Shigella flexneri genome. Note the lack of short-distance synthetic lethal pairs with fewer than 
5o intervening genes in the wild type genome.  
 
 
 
 
Figure S22: Metabolic genomes in which strictly synthetic lethal genes are in repulsion tend to be 
larger than those in which strictly synthetic lethal genes are not in repulsion (t-test P-value<10-4). In 
none of our genomes with fewer than 1200 metabolic genes were synthetically lethal genes in 
repulsion. 
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Figure S23: Long clusters of non-essential genes in bacterial genomes. Histogram of the number of 
clusters of A) strictly non-essential metabolic genes, and C) conditionally non-essential metabolic 
genes, and the average length of clusters of B) strictly non-essential metabolic genes and D) 
conditionally non–essential metabolic genes, among the 55 wild-type bacterial genomes (blue) and the 
corresponding 55 randomized genomes (red). We consider a metabolic gene as conditionally non-
essential if its deletion does not abolish viability on at least one carbon source, and consider a 
metabolic gene as strictly non-essential if its deletion does not abolish viability on any carbon source. 
A cluster of conditionally non-essential metabolic genes is a set of consecutive non-essential metabolic 
genes that intervene between two successive but non-adjacent strictly essential metabolic genes. 
Likewise, a cluster of strictly non-essential metabolic genes is a set of consecutive non-essential 
metabolic genes that intervene between two successive but non-adjacent conditionally essential 
metabolic genes. 
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Figure S24: Genome rearrangement can reduce deletional robustness by shrinking the clusters of 
non-essential genes (on glucose). In each panel, the horizontal axis shows the number of steps in a 
simulated genome rearrangement process applied independently to 100 initial genomes derived from 
the wild-type genomes of two organisms (see legend). In each step, each genome is subjected to a 
genome rearrangement event (translocation (panels A and D), inversion (panels B and E), and 
translocation or inversion (panels C and F); see methods). The vertical axes in panels A-C show the 
average length of the clusters of non-essential genes. In panels D-F they show the number of the 
clusters of non-essential genes, averaged over all 100 genomes. All simulation data reported are based 
on minimal media containing glucose as the sole carbon source. In this analysis, a cluster of non-
essential genes are defined as a set of metabolic genes that are not essential on glucose and intervene 
between two nearest metabolic genes that are essential on glucose.  
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Figure S25: Genome rearrangement can reduce deletional robustness by shrinking the clusters of 
non-essential genes (on acetate). In each panel, the horizontal axis shows the number of steps in a 
simulated genome rearrangement process applied independently to 100 initial genomes derived from 
the wild-type genomes of two organisms (see legend). In each step, each genome is subjected to a 
genome rearrangement event (translocation (panels A and D), inversion (panels B and E), and 
translocation or inversion (panels C and F); see methods). The vertical axes in panels A-C show the 
average length of the clusters of non-essential genes. In panels D-F show the number of the clusters of 
non-essential genes, averaged over all 100 genomes. All simulation data reported are based on minimal 
media containing acetate as the sole carbon source. In this analysis, a cluster of non-essential genes are 
defined as a set of metabolic genes that are not essential on acetate and intervene between two nearest 
metabolic genes that are essential on acetate.  
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Supplementary tables: 
 
Index Carbon source Index Carbon source 
1 D-Glucose 52 L-Tryptophan 
2 Uracil 53 Maltose 
3 Acetoacetate 54 L-Asparagine 
4 3-(3-hydroxy-phenyl)propionate 55 L-Lactate 
5 N-Acetyl-D-glucosamine 56 (S)-Propane-1 
6 Acetaldehyde 57 D-Ribose 
7 N-Acetyl-D-mannosamine 58 Sucrose 
8 L-Cysteine 59 Thymidine 
9 2-Dehydro-3-deoxy-D-gluconate 60 D-serine 
10 Tetradecanoate (n-C14:0) 61 D-Galactose 
11 N-Acetylneuraminate 62 Lactose 
12 L-Glutamate 63 L-Malate 
13 Uridine 64 L-Aspartate 
14 Xanthine 65 Putrescine 
15 L-Arginine 66 D-Glucose 6-phosphate 
16 L-Alanine 67 Phenylpropanoate 
17 Glycolate 68 Butyrate (n-C4:0) 
18 Guanine 69 Octadecanoate (n-C18:0) 
19 Glycine 70 Trehalose 
20 4-Aminobutanoate 71 L-Histidine 
21 L-Glutamine 72 Pyruvate 
22 Adenine 73 D-Mannitol 
23 Guanosine 74 Citrate 
24 Glycerol 3-phosphate 75 L-tartrate 
25 D-Glucuronate 76 L-Threonine 
26 Glycerol 77 Ornithine 
27 Hexadecanoate (n-C16:0) 78 Maltopentaose 
28 Adenosine 79 Maltotriose 
29 D-Glyceraldehyde 80 Maltohexaose 
30 D-Glucosamine 81 L-Rhamnose 
31 D-Galacturonate 82 Succinate 
32 D-Galactonate 83 D-Mannose 
33 D-Glucarate 84 Cytidine 
34 Hypoxanthine 85 D-Sorbitol 
35 D-Gluconate 86 Deoxyadenosine 
36 2-Oxoglutarate 87 Maltotetraose 
37 Galactitol 88 Melibiose 
38 3-hydroxycinnamic acid 89 D-Mannose 6-phosphate 
39 Allantoin 90 Deoxycytidine 
40 D-Galactarate 91 L-Fucose 
41 D-Xylose 92 L-Serine 
42 L-Idonate 93 D-Fructose 
43 Acetate 94 Deoxyguanosine 
44 Xanthosine 95 Dihydroxyacetone 
45 AMP 96 Fumarate 
46 L-Isoleucine 97 Cytosine 
47 Inosine 98 Deoxyinosine 
48 L-Arabinose 99 D-Alanine 
49 L-Valine 100 Deoxyuridine 
50 D-Lactate 101 Formate 
51 L-Proline 102 Ethanol 
 
Table S1: List of carbon sources used in this study.
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Species (strains) 
 
Number of 
operons 
Average number 
of genes per 
operon 
 Average 
robustness to 
operon deletion 
(strict definition) 
Average 
(normalized) 
robustness of 
genome (strict 
definition) 
Excess robustness 
to operon deletion 
(strict definition) 
Average 
robustness to 
operon deletion 
(moderate 
definition) 
Average 
(normalized) 
robustness of 
genome 
(moderate 
definition) 
Excess 
robustness to 
operon deletion 
(moderate 
definition) 
E. coli K-12 MG1655 [iAF1260] 241 3.07 0.6 0.56 1.08 0.8 0.77 1.03 
Methanosarcina barkeri str. Fusaro 91 2.75 0.77 0.62 1.23 0.77 0.62 1.23 
Geobacter metallireducens GS-15 203 3.12 0.66 0.56 1.17 0.66 0.56 1.17 
E. coli APEC O1 247 2.94 0.59 0.57 1.04 0.79 0.76 1.04 
E. coli BL21(DE3) [iB21 1397] 277 3.19 0.6 0.57 1.07 0.78 0.75 1.03 
E. coli BW2952 247 3.14 0.54 0.52 1.03 0.72 0.69 1.03 
E. coli CFT073 260 2.8 0.77 0.72 1.06 0.77 0.72 1.06 
E. coli O127:H6 244 3.01 0.6 0.57 1.05 0.78 0.76 1.03 
E. coli 042 252 3.07 0.6 0.56 1.06 0.78 0.76 1.03 
E. coli 55989 257 3.05 0.61 0.57 1.06 0.78 0.76 1.02 
E. coli ABU 83972 247 3.07 0.6 0.57 1.04 0.79 0.76 1.04 
E. coli B str. REL606 256 3 0.61 0.57 1.06 0.78 0.77 1.02 
E. coli BL21-Gold(DE3)pLysS AG 256 3.05 0.61 0.58 1.06 0.78 0.76 1.02 
E. coli BL21(DE3) [iECD1391] 253 3.02 0.6 0.57 1.06 0.77 0.76 1.02 
E. coli DH1 [iEcDH1 1363] 260 3.09 0.61 0.58 1.04 0.78 0.77 1.01 
E. coli DH1 [iECDH1ME8569 1439] 255 3.1 0.6 0.61 0.98 0.78 0.79 0.99 
E. coli E24377A 260 2.98 0.61 0.58 1.05 0.79 0.77 1.02 
E. coli ED1a 242 3 0.57 0.56 1.02 0.78 0.76 1.03 
E. coli O157:H7 240 2.95 0.59 0.56 1.05 0.77 0.76 1.02 
E. coli HS 253 3.06 0.6 0.57 1.06 0.78 0.76 1.02 
E. coli NA114 245 3.03 0.6 0.57 1.05 0.78 0.76 1.03 
E. coli O103:H2 str. 12009 250 3.06 0.6 0.58 1.04 0.78 0.76 1.02 
E. coli O111:H- str. 11128 251 3.05 0.61 0.58 1.05 0.78 0.76 1.02 
E. coli O26:H11 str. 11368 261 3.04 0.61 0.58 1.06 0.79 0.77 1.02 
E. coli IHE3034 242 3.01 0.59 0.57 1.04 0.79 0.76 1.03 
E. coli ATCC 8739 258 3.1 0.62 0.58 1.06 0.79 0.77 1.02 
E. coli 536 248 2.97 0.59 0.57 1.04 0.79 0.76 1.03 
E. coli O157:H7 str. Sakai 248 2.99 0.6 0.57 1.05 0.78 0.76 1.02 
E. coli S88 248 3.01 0.6 0.57 1.04 0.79 0.76 1.04 
E. coli SE11 259 3.08 0.61 0.58 1.05 0.78 0.77 1.02 
E. coli SE15 251 3.07 0.53 0.51 1.04 0.73 0.7 1.05 
E. coli SMS-3-5 260 3.08 0.6 0.57 1.05 0.78 0.76 1.03 
E. coli O157:H7 str. TW14359 245 3 0.6 0.57 1.04 0.77 0.76 1.01 
E. coli UMN026 259 3.05 0.61 0.57 1.08 0.79 0.76 1.03 
E. coli W [iECW_1372] 259 3.03 0.61 0.59 1.04 0.78 0.77 1.01 
	 148	
E. coli KO11FL 258 3.09 0.62 0.58 1.06 0.79 0.77 1.03 
E. coli ETEC H10407 257 3.01 0.61 0.58 1.04 0.78 0.77 1.02 
E. coli O55:H7 str. CB9615 247 3.02 0.59 0.55 1.07 0.78 0.76 1.03 
E. coli K-12 MG1655 [iJO1366] 262 3.12 0.56 0.52 1.07 0.74 0.71 1.04 
E. coli K-12 MG1655 [iJR904] 181 2.87 0.55 0.43 1.28 0.81 0.72 1.11 
E. coli LF82 246 3.02 0.6 0.58 1.03 0.78 0.77 1.01 
Mycobacterium tuberculosis H37Rv 122 2.82 0.55 0.48 1.15 0.55 0.48 1.15 
E. coli O83:H1 str. NRG 857C 248 3.03 0.6 0.58 1.03 0.78 0.76 1.03 
Shigella flexneri 2a str. 2457T 218 2.93 0.58 0.55 1.04 0.73 0.73 1 
Shigella flexneri 5 str. 8401 218 2.94 0.6 0.53 1.13 0.75 0.81 0.93 
E. coli UM146 249 3 0.6 0.55 1.08 0.79 0.73 1.08 
E. coli UMNK88 259 3.03 0.62 0.57 1.07 0.78 0.76 1.03 
E. coli UTI89 259 2.95 0.61 0.57 1.06 0.79 0.75 1.06 
Klebsiella pneumoniae  MGH78578 227 3 0.68 0.57 1.19 0.89 0.76 1.16 
Bacillus subtilis str. 168 161 3.24 0.51 0.58 0.88 0.79 0.76 1.03 
E. coli O157:H7 str. EDL933 253 3.02 0.61 0.58 1.04 0.78 0.77 1.01 
Salmonella Typhimurium str. LT2 247 2.95 0.66 0.63 1.05 0.82 0.85 0.96 
 
 
Table S2: Operons and deletional robustness. Each row corresponds to a given species or strain. Columns, from left to right, show species or strain names, the total 
number of operons in the genome, the average number of genes per operon, the average robustness to operon deletion, average normalized robustness to tandem gene deletion 
(see text S1), excess robustness to operon deletion, that is, the robustness to operon deletion divided by the average robustness to tandem deletion. In columns 4-6, robustness 
requires retaining viability on all carbon sources. Columns 7 to 9 shows the same information as columns 4-6 respectively but for a less stringent definition of robustness that 
requires retaining viability on at least one carbon source.
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Species (strain) 
Number of strictly 
essential genes 
Number of conditionally 
essential genes 
E. coli K-12 MG1655 [iAF1260] 144 322 
Methanosarcina barkeri str. Fusaro 139 139 
Geobacter metallireducens GS-15 268 268 
E. coli APEC O1 160 320 
E. coli BL21(DE3) [iB21 1397] 164 326 
E. coli BW2952 210 367 
E. coli CFT073 204 204 
E. coli O127:H6 160 313 
E. coli 042 159 329 
E. coli 55989 159 326 
E. coli ABU 83972 160 320 
E. coli B str. REL606 159 327 
E. coli BL21-Gold(DE3)pLysS AG 164 326 
E. coli BL21(DE3) [iECD1391] 164 327 
E. coli DH1 [iEcDH1 1363] 159 323 
E. coli DH1 [iECDH1ME8569 1439] 158 322 
E. coli E24377A 157 324 
E. coli ED1a 161 319 
E. coli O157:H7 159 357 
E. coli HS 159 336 
E. coli NA114 158 320 
E. coli O103:H2 str. 12009 159 322 
E. coli O111:H- str. 11128 159 346 
E. coli O26:H11 str. 11368 159 337 
E. coli IHE3034 160 320 
E. coli ATCC 8739 159 323 
E. coli 536 160 320 
E. coli O157:H7 str. Sakai 159 323 
E. coli S88 160 319 
E. coli SE11 159 323 
E. coli SE15 210 375 
E. coli SMS-3-5 159 328 
E. coli O157:H7 str. TW14359 159 322 
E. coli UMN026 158 332 
E. coli W [iECW_1372] 158 326 
E. coli KO11FL 158 321 
E. coli ETEC H10407 159 333 
E. coli O55:H7 str. CB9615 159 337 
E. coli K-12 MG1655 [iJO1366] 207 383 
E. coli K-12 MG1655 [iJR904] 134 316 
E. coli LF82 182 403 
Mycobacterium tuberculosis H37Rv 197 197 
E. coli O83:H1 str. NRG 857C 160 317 
Shigella flexneri 2a str. 2457T 167 334 
Staphylococcus aureus N315 61 205 
Shigella flexneri 5 str. 8401 164 320 
E. coli UM146 159 319 
E. coli UMNK88 159 319 
E. coli UTI89 160 320 
E. coli W [iWFL 1372] 158 326 
E. coli str. K-12 W3110 159 329 
Klebsiella pneumoniae  MGH78578 89 402 
Bacillus subtilis str. 168 120 288 
E. coli O157:H7 str. EDL933 159 322 
Salmonella Typhimurium str. LT2 140 293 
 
Table S3: Each row corresponds to a bacterial species or strain. Columns, from left to right, show 
species (strain) name, number of strictly essential metabolic genes, and number of conditionally 
essential metabolic genes. We consider a metabolic gene strictly essential, if its deletion abolishes 
viability on all carbon sources on which the wild-type metabolism is viable, and we consider a 
metabolic gene conditionally essential, if its deletion abolishes viability on at least one carbon source. 
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Species (strain) 
Hypothesis 
rejected P-value 
Kuiper test 
statistic Critical value 
E. coli K-12 MG1655 [iAF1260] 1 5.48E-03 0.1713 0.1435 
Methanosarcina barkeri str. Fusaro 0 2.53E-01 0.1211 0.1492 
Geobacter metallireducens GS-15 1 1.84E-05 0.1688 0.1078 
E. coli APEC O1 1 4.16E-05 0.2082 0.1371 
E. coli BL21(DE3) [iB21 1397] 1 3.76E-03 0.1656 0.1354 
E. coli BW2952 1 2.31E-04 0.1694 0.1197 
E. coli CFT073 1 5.52E-04 0.1687 0.1242 
E. coli O127:H6 1 2.15E-03 0.1733 0.1371 
E. coli 042 1 7.55E-04 0.1839 0.1375 
E. coli 55989 1 6.16E-04 0.1858 0.1375 
E. coli ABU 83972 1 1.17E-03 0.1792 0.1371 
E. coli B str. REL606 1 3.72E-03 0.1682 0.1375 
E. coli BL21-Gold(DE3)pLysS AG 1 6.43E-03 0.1599 0.1354 
E. coli BL21(DE3) [iECD1391] 1 2.63E-03 0.1692 0.1354 
E. coli DH1 [iEcDH1 1363] 1 6.30E-04 0.1856 0.1375 
E. coli DH1 [iECDH1ME8569 1439] 1 2.42E-02 0.1474 0.138 
E. coli E24377A 1 6.38E-04 0.1855 0.1375 
E. coli ED1a 1 5.07E-03 0.164 0.1367 
E. coli O157:H7 1 9.67E-04 0.1816 0.1375 
E. coli HS 1 1.74E-03 0.1759 0.1375 
E. coli NA114 1 2.84E-03 0.1716 0.138 
E. coli O103:H2 str. 12009 1 1.37E-03 0.1782 0.1375 
E. coli O111:H- str. 11128 1 8.53E-04 0.1828 0.1375 
E. coli O26:H11 str. 11368 1 8.09E-04 0.1833 0.1375 
E. coli IHE3034 1 2.31E-03 0.1726 0.1371 
E. coli ATCC 8739 1 1.15E-03 0.18 0.1375 
E. coli 536 1 1.31E-03 0.1782 0.1371 
E. coli O157:H7 str. Sakai 1 1.00E-03 0.1812 0.1375 
E. coli S88 1 2.07E-03 0.1737 0.1371 
E. coli SE11 1 6.58E-04 0.1852 0.1375 
E. coli SE15 1 1.51E-03 0.1543 0.1197 
E. coli SMS-3-5 1 7.94E-04 0.1835 0.1375 
E. coli O157:H7 str. TW14359 1 1.15E-03 0.1799 0.1375 
E. coli UMN026 1 1.27E-03 0.1785 0.1371 
E. coli W [iECW_1372] 1 2.09E-04 0.196 0.138 
E. coli KO11FL 1 5.37E-04 0.1876 0.138 
E. coli ETEC H10407 1 7.23E-04 0.1843 0.1375 
E. coli O55:H7 str. CB9615 1 3.12E-04 0.192 0.1375 
E. coli K-12 MG1655 [iJO1366] 1 8.37E-04 0.1596 0.12 
E. coli K-12 MG1655 [iJR904] 1 3.15E-02 0.1565 0.1498 
E. coli LF82 1 2.06E-09 0.275 0.1371 
Mycobacterium tuberculosis H37Rv 0 2.95E-01 0.097 0.123 
E. coli O83:H1 str. NRG 857C 1 1.59E-03 0.1763 0.1371 
Shigella flexneri 2a str. 2457T 1 1.13E-02 0.1533 0.135 
Staphylococcus aureus N315 0 6.50E-02 0.2198 0.2255 
Shigella flexneri 5 str. 8401 1 9.77E-03 0.1554 0.1354 
E. coli UM146 1 7.51E-04 0.184 0.1375 
E. coli UMNK88 0 1.73E-01 0.1185 0.1375 
E. coli UTI89 1 1.30E-03 0.1782 0.1371 
E. coli W [iWFL 1372] 1 2.09E-04 0.196 0.138 
E. coli str. K-12 W3110 1 9.73E-04 0.1815 0.1375 
Klebsiella pneumoniae  MGH78578 1 4.24E-02 0.1922 0.1887 
Bacillus subtilis str. 168 1 4.12E-04 0.218 0.1583 
E. coli O157:H7 str. EDL933 1 3.00E-04 0.1923 0.1375 
Salmonella Typhimurium str. LT2 1 3.02E-04 0.2048 0.1465 
 
Table S4: Clustering of the strictly essential genes. Each row corresponds to a bacterial species or 
strain. Columns, from left to right, show species (strain) name, whether the null hypothesis of a 
uniform distribution of strictly essential genes is rejected by Kuiper’s test (1) or not (0), the P-value of 
Kuiper’s test, Kuiper’s test statistics, and the critical value of this statistic above which the null 
hypothesis is rejected. In 51 among the 55 species the null hypothesis is rejected, i.e., essential genes 
are significantly clustered. We consider a metabolic gene strictly essential if its deletion abolishes 
viability on all carbon sources on which the wild-type metabolism is viable. 
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Species (strain) 
Hypothesis 
rejected P-value 
Kuiper test 
statistic Critical value 
E. coli K-12 MG1655 [iAF1260] 1 2.47E-06 0.1615 0.0965 
Methanosarcina barkeri str. Fusaro 0 2.97E-01 0.1151 0.146 
Geobacter metallireducens GS-15 1 2.16E-05 0.1644 0.1056 
E. coli APEC O1 1 5.29E-05 0.1456 0.0968 
E. coli BL21(DE3) [iB21 1397] 1 1.38E-05 0.1516 0.0959 
E. coli BW2952 1 1.03E-05 0.1444 0.0904 
E. coli CFT073 1 1.50E-04 0.1743 0.1209 
E. coli O127:H6 1 1.73E-04 0.1402 0.0978 
E. coli 042 1 3.57E-06 0.1579 0.0954 
E. coli 55989 1 8.51E-08 0.1764 0.0959 
E. coli ABU 83972 1 8.84E-06 0.1554 0.0968 
E. coli B str. REL606 1 6.29E-06 0.1555 0.0957 
E. coli BL21-Gold(DE3)pLysS AG 1 3.51E-05 0.1465 0.0959 
E. coli BL21(DE3) [iECD1391] 1 5.90E-06 0.1558 0.0957 
E. coli DH1 [iEcDH1 1363] 1 1.78E-06 0.1629 0.0963 
E. coli DH1 [iECDH1ME8569 1439] 1 1.33E-05 0.1527 0.0965 
E. coli E24377A 1 2.53E-07 0.172 0.0962 
E. coli ED1a 1 2.67E-04 0.1362 0.0969 
E. coli O157:H7 1 8.94E-05 0.1351 0.0917 
E. coli HS 1 1.56E-06 0.1603 0.0945 
E. coli NA114 1 3.42E-05 0.1481 0.0968 
E. coli O103:H2 str. 12009 1 1.82E-06 0.163 0.0965 
E. coli O111:H- str. 11128 1 2.57E-02 0.099 0.0931 
E. coli O26:H11 str. 11368 1 1.48E-08 0.1811 0.0943 
E. coli IHE3034 1 1.52E-05 0.1525 0.0968 
E. coli ATCC 8739 1 2.33E-06 0.1615 0.0963 
E. coli 536 1 5.57E-06 0.1578 0.0968 
E. coli O157:H7 str. Sakai 1 1.55E-06 0.1635 0.0963 
E. coli S88 1 3.53E-05 0.1481 0.0969 
E. coli SE11 1 6.52E-07 0.1678 0.0963 
E. coli SE15 1 5.42E-05 0.1345 0.0895 
E. coli SMS-3-5 1 6.30E-06 0.1553 0.0956 
E. coli O157:H7 str. TW14359 1 2.66E-06 0.1611 0.0965 
E. coli UMN026 1 3.80E-06 0.1569 0.095 
E. coli W [iECW_1372] 1 3.52E-07 0.1699 0.0959 
E. coli KO11FL 1 1.41E-06 0.1645 0.0966 
E. coli ETEC H10407 1 4.25E-08 0.1776 0.0949 
E. coli O55:H7 str. CB9615 1 6.88E-07 0.164 0.0943 
E. coli K-12 MG1655 [iJO1366] 1 2.98E-06 0.1473 0.0885 
E. coli K-12 MG1655 [iJR904] 1 2.93E-03 0.1209 0.0974 
E. coli LF82 1 5.38E-04 0.1174 0.0863 
Mycobacterium tuberculosis H37Rv 0 2.95E-01 0.097 0.123 
E. coli O83:H1 str. NRG 857C 1 7.04E-06 0.1573 0.0972 
Shigella flexneri 2a str. 2457T 1 6.89E-06 0.1534 0.0947 
Staphylococcus aureus N315 1 6.73E-04 0.1622 0.1206 
Shigella flexneri 5 str. 8401 1 1.82E-05 0.1515 0.0968 
E. coli UM146 1 1.71E-05 0.1521 0.0969 
E. coli UMNK88 1 1.43E-05 0.1531 0.0969 
E. coli UTI89 1 6.20E-06 0.1573 0.0968 
E. coli W [iWFL 1372] 1 3.52E-07 0.1699 0.0959 
E. coli str. K-12 W3110 1 7.75E-08 0.176 0.0954 
Klebsiella pneumoniae  MGH78578 1 1.27E-17 0.2322 0.0864 
Bacillus subtilis str. 168 0 4.62E-01 0.0729 0.1019 
E. coli O157:H7 str. EDL933 1 2.36E-07 0.1728 0.0965 
Salmonella Typhimurium str. LT2 1 4.15E-04 0.1392 0.1011 
 
Table S5: Clustering of the conditionally essential genes. Each row corresponds to a bacterial 
species or strain. Columns, from left to right, show species (strain) name, whether the null hypothesis 
of uniform distribution of the conditionally essential genes is rejected by Kuiper’s test (1) or not (0), 
the P-value of the test, Kuiper’s test statistics, and the critical value of this statistic above which the 
null hypothesis is rejected. In 52 among the 55 species the null hypothesis is rejected, i.e., conditionally 
essential genes are significantly clustered. We consider a metabolic gene conditionally essential, if its 
deletion abolishes viability on at least one carbon source. Note that clustering of conditionally essential 
genes may be of limited biological relevance, because different conditionally essential genes may not 
be essential on the same set of carbon sources. 
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Species (strain) (--) (-+) (+-) (++) P-value 
Odds 
ratio 
Hypothesis 
rejected 
Methanosarcina barkeri str. Fusaro 357 196 76 63 3.92E-02 1.5099 1 
Geobacter metallireducens GS-15 535 184 189 79 2.25E-01 1.2153 0 
E. coli BL21(DE3) [iB21 1397] 932 241 106 58 5.31E-05 2.116 1 
E. coli BW2952 888 230 140 70 9.97E-05 1.9304 1 
E. coli CFT073 896 207 147 57 4.24E-03 1.6784 1 
E. coli O127:H6 898 226 105 55 9.29E-05 2.0813 1 
E. coli 042 903 252 94 65 5.54E-07 2.4778 1 
E. coli 55989 928 243 99 60 4.84E-06 2.3145 1 
E. coli ABU 83972 910 250 96 64 9.58E-07 2.4267 1 
E. coli B str. REL606 928 242 99 60 4.57E-06 2.3241 1 
E. coli BL21-Gold(DE3)pLysS AG 946 244 105 59 2.25E-05 2.1785 1 
E. coli BL21(DE3) [iECD1391] 967 202 115 49 2.54E-04 2.0397 1 
E. coli DH1 [iEcDH1 1363] 960 244 99 60 2.39E-06 2.3845 1 
E. coli O157:H7 872 231 98 61 4.51E-06 2.3497 1 
E. coli HS 916 246 96 63 1.15E-06 2.4436 1 
E. coli NA114 897 246 99 59 3.30E-05 2.1731 1 
E. coli O103:H2 str. 12009 921 247 96 63 1.14E-06 2.447 1 
E. coli O111:H- str. 11128 919 250 100 59 3.40E-05 2.1688 1 
E. coli O26:H11 str. 11368 953 243 99 60 2.51E-06 2.3769 1 
E. coli IHE3034 914 230 99 61 1.34E-06 2.4486 1 
E. coli ATCC 8739 956 253 96 63 6.55E-07 2.4797 1 
E. coli 536 898 251 97 63 4.16E-06 2.3237 1 
E. coli O157:H7 str. Sakai 913 229 100 59 5.44E-06 2.3523 1 
E. coli S88 920 225 100 60 1.20E-06 2.4533 1 
E. coli SE11 936 253 100 59 2.22E-05 2.1828 1 
E. coli SE15 894 223 134 76 8.92E-07 2.2737 1 
E. coli SMS-3-5 926 262 96 63 4.27E-06 2.3194 1 
E. coli O157:H7 str. TW14359 899 241 97 62 2.02E-06 2.3843 1 
E. coli W [iECW_1372] 962 252 99 59 1.09E-05 2.2751 1 
E. coli KO11FL 951 245 96 62 5.29E-07 2.5069 1 
E. coli ETEC H10407 917 257 99 60 2.61E-05 2.1625 1 
E. coli O55:H7 str. CB9615 869 255 99 60 7.39E-05 2.0654 1 
E. coli LF82 896 224 118 64 1.25E-05 2.1695 1 
E. coli O83:H1 str. NRG 857C 918 233 103 57 2.70E-05 2.1803 1 
Shigella flexneri 2a str. 2457T 784 237 104 63 1.12E-04 2.0039 1 
Shigella flexneri 5 str. 8401 763 257 97 67 6.48E-05 2.0507 1 
E. coli UM146 935 225 100 59 1.58E-06 2.4518 1 
E. coli UMNK88 919 275 96 63 1.47E-05 2.1931 1 
E. coli UTI89 915 235 98 62 9.38E-07 2.4633 1 
E. coli str. K-12 W3110 1141 58 130 29 2.48E-08 4.3885 1 
Klebsiella pneumoniae  MGH78578 844 296 60 29 1.72E-01 1.3782 0 
Bacillus subtilis str. 168 561 163 92 28 8.15E-01 1.0475 0 
Salmonella Typhimurium str. LT2 892 239 80 60 7.35E-08 2.7992 1 
 
Table S6: Horizontal gene transfer and strictly essential genes. Each row corresponds to one of the 
43 species strains for which information about horizontally transferred genes (HGT) is available in the 
HGTree database. Columns, from left to right, show the species (strain) name, the number of metabolic 
genes that are neither strictly essential nor HGT-acquired (− −), the number of metabolic genes that 
are not strictly essential, but HGT-acquired (− +), the number of metabolic genes that are strictly 
essential, but are not HGT-acquired (+ −), and the number of metabolic genes that are both strictly 
essential and HGT-acquired (+ +), the P value of a Fisher exact test on this data, the odds ratio 
(defined as the odds of being strictly essential among HGT-acquired genes divided by the odds of 
being strictly essential among non-HGT acquired essential genes), and whether the null hypothesis of a 
lack of association between a gene’s strict essentiality and horizontal transfer is rejected (1) or not (0). 
In 40 of the 43 species (93.02%) the null hypothesis is rejected. Note that we consider a metabolic gene 
strictly essential, if its deletion abolishes viability on all carbon sources on which the wild-type 
metabolism is viable. 
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Species (strain) (--) (-+) (+-) (++) P-value 
Odds 
ratio 
Hypothesis 
rejected 
Methanosarcina barkeri str. Fusaro 357 196 76 63 3.92E-02 1.5099 1 
Geobacter metallireducens GS-15 535 184 189 79 2.25E-01 1.2153 0 
E. coli BL21(DE3) [iB21 1397] 808 203 230 96 5.68E-04 1.6613 1 
E. coli BW2952 764 197 264 103 4.15E-03 1.5131 1 
E. coli CFT073 896 207 147 57 4.24E-03 1.6784 1 
E. coli O127:H6 775 196 228 85 1.18E-02 1.4741 1 
E. coli 042 770 215 227 102 1.03E-03 1.6093 1 
E. coli 55989 799 205 228 98 4.55E-04 1.6753 1 
E. coli ABU 83972 779 221 227 93 1.27E-02 1.4441 1 
E. coli B str. REL606 799 203 228 99 2.55E-04 1.709 1 
E. coli BL21-Gold(DE3)pLysS AG 823 205 228 98 1.83E-04 1.7256 1 
E. coli BL21(DE3) [iECD1391] 842 164 240 87 6.14E-05 1.8611 1 
E. coli DH1 [iEcDH1 1363] 832 208 227 96 4.12E-04 1.6916 1 
E. coli O157:H7 712 193 258 99 1.76E-02 1.4156 1 
E. coli HS 778 207 234 102 5.95E-04 1.6383 1 
E. coli NA114 768 213 228 92 1.21E-02 1.4549 1 
E. coli O103:H2 str. 12009 796 209 221 101 1.47E-04 1.7406 1 
E. coli O111:H- str. 11128 778 204 241 105 3.78E-04 1.6616 1 
E. coli O26:H11 str. 11368 813 205 239 98 8.81E-04 1.6262 1 
E. coli IHE3034 786 198 227 93 1.14E-03 1.6264 1 
E. coli ATCC 8739 830 215 222 101 1.11E-04 1.7563 1 
E. coli 536 767 222 228 92 2.39E-02 1.3941 1 
E. coli O157:H7 str. Sakai 785 193 228 95 3.72E-04 1.6947 1 
E. coli S88 792 194 228 91 1.35E-03 1.6294 1 
E. coli SE11 810 215 226 97 1.11E-03 1.617 1 
E. coli SE15 763 189 265 110 2.59E-04 1.6758 1 
E. coli SMS-3-5 796 223 226 102 1.06E-03 1.611 1 
E. coli O157:H7 str. TW14359 771 206 225 97 1.08E-03 1.6135 1 
E. coli W [iECW_1372] 832 214 229 97 6.36E-04 1.6468 1 
E. coli KO11FL 825 208 222 99 9.54E-05 1.7688 1 
E. coli ETEC H10407 781 219 235 98 5.96E-03 1.4872 1 
E. coli O55:H7 str. CB9615 730 216 238 99 1.84E-02 1.4058 1 
E. coli LF82 712 187 302 101 9.66E-02 1.2734 0 
E. coli O83:H1 str. NRG 857C 792 202 229 88 6.49E-03 1.5067 1 
Shigella flexneri 2a str. 2457T 645 209 243 91 3.35E-01 1.1557 0 
Shigella flexneri 5 str. 8401 639 225 221 99 1.06E-01 1.2722 0 
E. coli UM146 806 194 229 90 1.30E-03 1.6328 1 
E. coli UMNK88 799 235 216 103 8.44E-04 1.6213 1 
E. coli UTI89 787 203 226 94 1.24E-03 1.6125 1 
E. coli str. K-12 W3110 981 48 290 39 1.36E-05 2.7485 1 
Klebsiella pneumoniae  MGH78578 608 219 296 106 1.00E+00 0.9942 0 
Bacillus subtilis str. 168 425 131 228 60 3.87E-01 0.8538 0 
Salmonella Typhimurium str. LT2 773 205 199 94 1.17E-04 1.7811 1 
 
Table S7: Horizontal gene transfer and conditionally essential genes. Each row corresponds to one 
of the 43 species (strain) for which information about horizontally transferred genes (HGT) is available 
in the HGTree database. Columns, from left to right, show the species (strain) name, the number of 
metabolic genes that are neither conditionally essential nor HGT-acquired (− −), the number of 
metabolic genes that are not conditionally essential, but HGT-acquired (− +), the number of metabolic 
genes that are conditionally essential, but are not HGT-acquired (+ −), and the number of metabolic 
genes that are both conditionally essential and HGT-acquired (+ +), the P value of a Fisher exact test 
on this data, the odds ratio (defined as the odds of being conditionally essential among HGT acquired 
metabolic genes divided by the odds of being conditionally essential among non-HGT acquired 
metabolic genes), and whether the null hypothesis of a lack of association between a gene’s conditional 
essentiality and horizontal transfer is rejected (1) or not (0). In 37 of the 43 species (86.05%) the null 
hypothesis is rejected. Note that we consider a metabolic gene conditionally essential, if its deletion 
abolishes viability on at least one carbon source
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 HGT-acquired essential genes Non-HGT acquired essential genes  All essential genes 
Species(strain) 
Hypothesis 
rejected P-value 
Kuiper test 
statistic 
Critical 
value 
Hypothesis 
rejected P-value 
Kuiper test 
statistic Critical value 
Hypothesis 
rejected P-value 
Kuiper test 
statistic 
Critical 
value 
Methanosarcina barkeri str. Fusaro 0 7.87E-01 0.1285 0.2182 0 3.30E-01 0.1556 0.2011 0 2.53E-01 0.1211 0.1492 
Geobacter metallireducens GS-15 0 2.99E-01 0.1517 0.1922 1 1.72E-05 0.2029 0.1293 1 1.84E-05 0.1688 0.1078 
E. coli BL21(DE3) [iB21 1397] 1 9.14E-03 0.2581 0.2236 0 2.51E-01 0.1368 0.1684 1 3.76E-03 0.1656 0.1354 
E. coli BW2952 1 1.51E-03 0.2635 0.204 1 3.50E-02 0.1516 0.1465 1 2.31E-04 0.1694 0.1197 
E. coli CFT073 1 6.02E-04 0.3108 0.2295 1 1.59E-02 0.1621 0.1465 1 5.52E-04 0.1687 0.1242 
E. coli O127:H6 1 4.04E-03 0.2796 0.2295 0 1.26E-01 0.1524 0.1692 1 2.15E-03 0.1733 0.1371 
E. coli 042 1 7.24E-03 0.2482 0.2114 1 2.95E-02 0.1879 0.1786 1 7.55E-04 0.1839 0.1375 
E. coli 55989 1 2.71E-03 0.2747 0.22 1 2.98E-02 0.1829 0.1744 1 6.16E-04 0.1858 0.1375 
E. coli ABU 83972 1 5.13E-03 0.2559 0.213 0 7.41E-02 0.1698 0.1769 1 1.17E-03 0.1792 0.1371 
E. coli B str. REL606 1 6.45E-03 0.2601 0.22 0 8.18E-02 0.1654 0.1744 1 3.72E-03 0.1682 0.1375 
E. coli BL21-Gold(DE3)pLysS AG 1 2.32E-03 0.2794 0.2218 0 3.43E-01 0.1296 0.1692 1 6.43E-03 0.1599 0.1354 
E. coli BL21(DE3) [iECD1391] 1 7.69E-03 0.2835 0.2432 0 1.41E-01 0.1434 0.1617 1 2.63E-03 0.1692 0.1354 
E. coli DH1 [iEcDH1 1363] 1 2.31E-03 0.2773 0.22 1 2.55E-02 0.1854 0.1744 1 6.30E-04 0.1856 0.1375 
E. coli O157:H7 1 1.75E-02 0.2399 0.2182 1 1.50E-02 0.1946 0.1752 1 9.67E-04 0.1816 0.1375 
E. coli HS 1 1.31E-02 0.2415 0.2147 1 2.32E-02 0.1898 0.1769 1 1.74E-03 0.1759 0.1375 
E. coli NA114 1 1.17E-02 0.2514 0.2218 1 1.11E-02 0.1981 0.1744 1 2.84E-03 0.1716 0.138 
E. coli O103:H2 str. 12009 1 1.62E-02 0.2376 0.2147 1 2.00E-02 0.1921 0.1769 1 1.37E-03 0.1782 0.1375 
E. coli O111:H- str. 11128 1 2.82E-03 0.2763 0.2218 1 1.98E-02 0.1884 0.1736 1 8.53E-04 0.1828 0.1375 
E. coli O26:H11 str. 11368 1 1.16E-02 0.2496 0.22 1 3.48E-02 0.1804 0.1744 1 8.09E-04 0.1833 0.1375 
E. coli IHE3034 1 3.41E-03 0.2687 0.2182 0 1.65E-01 0.1512 0.1744 1 2.31E-03 0.1726 0.1371 
E. coli ATCC 8739 1 2.40E-03 0.2702 0.2147 0 6.37E-02 0.1726 0.1769 1 1.15E-03 0.18 0.1375 
E. coli 536 1 1.73E-02 0.2363 0.2147 1 4.72E-02 0.177 0.176 1 1.31E-03 0.1782 0.1371 
E. coli O157:H7 str. Sakai 1 1.00E-03 0.2927 0.2218 0 8.97E-02 0.1628 0.1736 1 1.00E-03 0.1812 0.1375 
E. coli S88 1 6.01E-03 0.2613 0.22 0 6.71E-02 0.1682 0.1736 1 2.07E-03 0.1737 0.1371 
E. coli SE11 1 5.72E-03 0.2643 0.2218 1 2.15E-02 0.1871 0.1736 1 6.58E-04 0.1852 0.1375 
E. coli SE15 1 3.79E-04 0.2715 0.1958 0 1.46E-01 0.1322 0.1498 1 1.51E-03 0.1543 0.1197 
E. coli SMS-3-5 1 4.64E-03 0.2595 0.2147 0 9.30E-02 0.1654 0.1769 1 7.94E-04 0.1835 0.1375 
E. coli O157:H7 str. TW14359 1 9.58E-03 0.249 0.2164 1 4.57E-02 0.1776 0.176 1 1.15E-03 0.1799 0.1375 
E. coli W [iECW_1372] 1 1.39E-03 0.2876 0.2218 1 1.93E-02 0.1898 0.1744 1 2.09E-04 0.196 0.138 
E. coli KO11FL 1 6.65E-03 0.2554 0.2164 1 1.02E-02 0.2024 0.1769 1 5.37E-04 0.1876 0.138 
E. coli ETEC H10407 1 3.00E-03 0.273 0.22 1 3.26E-02 0.1814 0.1744 1 7.23E-04 0.1843 0.1375 
E. coli O55:H7 str. CB9615 1 7.71E-03 0.2569 0.22 1 2.02E-02 0.1891 0.1744 1 3.12E-04 0.192 0.1375 
E. coli LF82 1 1.40E-05 0.3511 0.2218 1 6.74E-04 0.232 0.1728 1 2.06E-09 0.275 0.1371 
E. coli O83:H1 str. NRG 857C 1 4.10E-03 0.2746 0.2255 0 7.09E-02 0.1647 0.1708 1 1.59E-03 0.1763 0.1371 
Shigella flexneri 2a str. 2457T 1 7.07E-03 0.2524 0.2147 0 1.54E-01 0.1505 0.172 1 1.13E-02 0.1533 0.135 
Shigella flexneri 5 str. 8401 1 1.71E-02 0.2295 0.2083 0 1.85E-01 0.1502 0.176 1 9.77E-03 0.1554 0.1354 
E. coli UM146 1 6.30E-03 0.2626 0.2218 0 6.40E-02 0.169 0.1736 1 7.51E-04 0.184 0.1375 
E. coli UMNK88 0 4.37E-01 0.156 0.2147 0 2.20E-01 0.1469 0.1769 0 1.73E-01 0.1185 0.1375 
E. coli UTI89 1 2.38E-03 0.2724 0.2164 0 8.33E-02 0.1659 0.1752 1 1.30E-03 0.1782 0.1371 
E. coli str. K-12 W3110 1 2.26E-03 0.3942 0.3115 1 2.87E-02 0.1602 0.1521 1 9.73E-04 0.1815 0.1375 
Klebsiella pneumoniae  MGH78578 1 1.15E-02 0.3546 0.3115 0 2.98E-01 0.1842 0.2339 1 4.24E-02 0.1922 0.1887 
Bacillus subtilis str. 168 0 2.27E-01 0.2629 0.3163 1 1.99E-04 0.2574 0.1804 1 4.12E-04 0.218 0.1583 
Salmonella Typhimurium str. LT2 1 6.13E-04 0.2977 0.22 1 4.30E-02 0.1967 0.1933 1 3.02E-04 0.2048 0.1465 
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Table S8: Horizontal gene transfer plays an active role in the clustering of the strictly essential 
genes. In this analysis we divided the set of strictly non-essential genes into two groups: i) those 
acquired via horizontal gene transfer, and ii) those not acquired through horizontal gene transfer. Using 
Kuiper’s test, we examined the clustering of i) the first group of strictly essential genes alone (columns 
2-5; labeled red in the first row), ii) the second group of strictly essential genes alone (columns 6-9; 
labeled blue in the first row), and iii) all strictly essential genes together (columns 10-13; labeled  black 
in the first row). Each row corresponds to a bacterial species (strain). The first column is the species or 
strain name, and in each of the three sets of four columns, from left to right, columns show whether the 
null hypothesis of uniform distribution of strictly essential genes is rejected by Kuiper’s test (1) or not 
(0), the P-value of the test, Kuiper’s test statistics, and the critical value of this statistic above which the 
null hypothesis is rejected. In 18 out of the 43 genomes (41.86%, colored blue) used in this analysis, 
the strictly essential genes acquired by horizontal gene transfer are significantly clustered (first group), 
but the strictly essential genes not acquired by horizontal gene transfer (second group) are not 
significantly clustered. Only in two species (4.65%, colored red) are the strictly essential genes of the 
second group  significantly clustered but genes in the first group are not. In two other species neither of 
the groups of strictly essential genes are significantly clustered (4.65%, colored green). Finally, in 21 
out of the 43 genomes (48.83%, colored black) the strictly essential genes of both groups are 
significantly clustered. Note that we consider a metabolic gene strictly essential, if its deletion 
abolishes viability on all carbon sources on which the wild-type metabolism is viable. 
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Species (strains) 
Number 
of 
operons 
Average 
number 
of genes 
per 
operon 
 Number of 
operons with 
at least one 
conditionally 
essential gene 
 Fraction of 
operons with 
at least one 
conditionally 
essential gene 
Number of 
operons with 
more than one 
conditionally 
essential gene 
 Fraction of 
operons with 
more than one 
conditionally 
essential gene 
 Number of 
operons 
with at least 
one strictly 
essential 
gene 
 Fraction of 
operons 
with at least 
one strictly 
essential 
gene 
Number of 
operons 
with more 
than one 
strictly 
essential 
gene 
 Fraction of 
operons with 
more than one 
strictly 
essential gene 
E. coli K-12 MG1655 [iAF1260] 241 3.07 95 0.39 62 0.26 48 0.2 25 0.1 
Methanosarcina barkeri str. Fusaro 91 2.75 20 0.22 15 0.16 20 0.22 15 0.16 
Geobacter metallireducens GS-15 203 3.12 67 0.33 47 0.23 67 0.33 47 0.23 
E. coli APEC O1 247 2.94 101 0.41 59 0.24 52 0.21 29 0.12 
E. coli BL21(DE3) [iB21 1397] 277 3.19 108 0.39 63 0.23 59 0.21 31 0.11 
E. coli BW2952 247 3.14 113 0.46 71 0.29 69 0.28 41 0.17 
E. coli CFT073 260 2.8 61 0.23 31 0.12 61 0.23 31 0.12 
E. coli O127:H6 244 3.01 97 0.4 59 0.24 53 0.22 29 0.12 
E. coli 042 252 3.07 100 0.4 64 0.25 54 0.21 30 0.12 
E. coli 55989 257 3.05 101 0.39 61 0.24 55 0.21 29 0.11 
E. coli ABU 83972 247 3.07 99 0.4 61 0.25 51 0.21 29 0.12 
E. coli B str. REL606 256 3 99 0.39 62 0.24 55 0.21 29 0.11 
E. coli BL21-Gold(DE3)pLysS AG 256 3.05 98 0.38 62 0.24 56 0.22 31 0.12 
E. coli BL21(DE3) [iECD1391] 253 3.02 99 0.39 63 0.25 56 0.22 31 0.12 
E. coli DH1 [iEcDH1 1363] 260 3.09 101 0.39 60 0.23 56 0.22 29 0.11 
E. coli DH1 [iECDH1ME8569 1439] 255 3.1 101 0.4 60 0.24 56 0.22 29 0.11 
E. coli E24377A 260 2.98 99 0.38 61 0.23 54 0.21 29 0.11 
E. coli ED1a 242 3 103 0.43 57 0.24 53 0.22 28 0.12 
E. coli O157:H7 240 2.95 98 0.41 58 0.24 54 0.23 28 0.12 
E. coli HS 253 3.06 100 0.4 62 0.25 55 0.22 29 0.11 
E. coli NA114 245 3.03 98 0.4 60 0.24 52 0.21 29 0.12 
E. coli O103:H2 str. 12009 250 3.06 99 0.4 59 0.24 55 0.22 29 0.12 
E. coli O111:H- str. 11128 251 3.05 97 0.39 57 0.23 55 0.22 29 0.12 
E. coli O26:H11 str. 11368 261 3.04 100 0.38 58 0.22 55 0.21 29 0.11 
E. coli IHE3034 242 3.01 99 0.41 59 0.24 51 0.21 28 0.12 
E. coli ATCC 8739 258 3.1 98 0.38 61 0.24 54 0.21 29 0.11 
E. coli 536 248 2.97 100 0.4 61 0.25 52 0.21 29 0.12 
E. coli O157:H7 str. Sakai 248 2.99 98 0.4 58 0.23 54 0.22 28 0.11 
E. coli S88 248 3.01 99 0.4 60 0.24 51 0.21 29 0.12 
E. coli SE11 259 3.08 100 0.39 60 0.23 55 0.21 29 0.11 
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E. coli SE15 251 3.07 117 0.47 73 0.29 67 0.27 41 0.16 
E. coli SMS-3-5 260 3.08 103 0.4 66 0.25 55 0.21 30 0.12 
E. coli O157:H7 str. TW14359 245 3 99 0.4 59 0.24 55 0.22 29 0.12 
E. coli UMN026 259 3.05 100 0.39 64 0.25 54 0.21 30 0.12 
E. coli W [iECW_1372] 259 3.03 100 0.39 61 0.24 56 0.22 29 0.11 
E. coli KO11FL 258 3.09 98 0.38 61 0.24 54 0.21 29 0.11 
E. coli ETEC H10407 257 3.01 100 0.39 60 0.23 55 0.21 29 0.11 
E. coli O55:H7 str. CB9615 247 3.02 100 0.4 61 0.25 54 0.22 28 0.11 
E. coli K-12 MG1655 [iJO1366] 262 3.12 115 0.44 75 0.29 68 0.26 41 0.16 
E. coli K-12 MG1655 [iJR904] 181 2.87 81 0.45 58 0.32 35 0.19 21 0.12 
E. coli LF82 246 3.02 98 0.4 60 0.24 53 0.22 28 0.11 
Mycobacterium tuberculosis H37Rv 122 2.82 55 0.45 30 0.25 55 0.45 30 0.25 
E. coli O83:H1 str. NRG 857C 248 3.03 99 0.4 61 0.25 53 0.21 29 0.12 
Shigella flexneri 2a str. 2457T 218 2.93 90 0.41 55 0.25 57 0.26 31 0.14 
Shigella flexneri 5 str. 8401 218 2.94 86 0.39 52 0.24 54 0.25 30 0.14 
E. coli UM146 249 3 99 0.4 61 0.24 51 0.2 29 0.12 
E. coli UMNK88 259 3.03 98 0.38 60 0.23 55 0.21 29 0.11 
E. coli UTI89 259 2.95 101 0.39 60 0.23 53 0.2 29 0.11 
Klebsiella pneumoniae  MGH78578 227 3 70 0.31 44 0.19 24 0.11 10 0.04 
Bacillus subtilis str. 168 161 3.24 76 0.47 52 0.32 33 0.2 25 0.16 
E. coli O157:H7 str. EDL933 253 3.02 98 0.39 59 0.23 54 0.21 28 0.11 
Salmonella Typhimurium str. LT2 247 2.95 82 0.33 48 0.19 43 0.17 23 0.09 
 
Table S9: Metabolic genes in Operons. Each row corresponds to a given species (strain). Columns, from left to right, show species or strain names, the total number of 
operons in the genome, the average number of genes per operon, the number of operons with at least one conditionally essential gene, the fraction of operons with at least one 
conditionally essential gene, the number of operons with more than one conditionally essential metabolic gene, the fraction of operons with more than one conditionally 
essential metabolic gene, the number of operons with at least one strictly essential gene, the fraction of operons with at least one strictly essential gene, the number of operons 
with more than one strictly essential metabolic gene, and the fraction of operons with more than one strictly essential metabolic gene.  
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Species (strain) (--) (-+) (+-) (++) P-value Odds ratio 
Hypothesis 
rejected 
E. coli K-12 MG1655 [iAF1260] 470 647 51 93 1.50E-01 1.3247 0 
Methanosarcina barkeri str. Fusaro 348 211 94 39 7.15E-02 0.6843 0 
Geobacter metallireducens GS-15 271 459 83 174 1.74E-01 1.2377 0 
E. coli APEC O1 528 627 60 98 7.33E-02 1.3754 0 
E. coli BL21(DE3) [iB21 1397] 415 760 39 123 4.54E-03 1.7222 1 
E. coli BW2952 490 630 63 145 3.05E-04 1.7901 1 
E. coli CFT073 498 616 80 113 4.33E-01 1.1419 0 
E. coli O127:H6 497 629 52 106 7.74E-03 1.6107 1 
E. coli 042 488 669 52 105 3.09E-02 1.4729 1 
E. coli 55989 497 676 49 108 7.43E-03 1.6205 1 
E. coli ABU 83972 508 654 53 105 1.63E-02 1.5389 1 
E. coli B str. REL606 511 661 49 108 3.35E-03 1.7039 1 
E. coli BL21-Gold(DE3)pLysS AG 525 667 49 113 9.11E-04 1.8152 1 
E. coli BL21(DE3) [iECD1391] 518 653 50 112 1.25E-03 1.7769 1 
E. coli DH1 [iEcDH1 1363] 511 695 49 108 7.50E-03 1.6206 1 
E. coli DH1 [iECDH1ME8569 1439] 602 681 46 110 3.81E-05 2.1139 1 
E. coli E24377A 516 668 50 107 5.80E-03 1.6531 1 
E. coli ED1a 499 621 55 104 2.07E-02 1.5194 1 
E. coli O157:H7 502 603 51 106 2.54E-03 1.7303 1 
E. coli HS 498 666 49 108 5.72E-03 1.6481 1 
E. coli NA114 504 641 54 102 3.09E-02 1.4852 1 
E. coli O103:H2 str. 12009 512 658 50 107 4.51E-03 1.6652 1 
E. coli O111:H- str. 11128 513 658 49 108 2.59E-03 1.7184 1 
E. coli O26:H11 str. 11368 512 686 49 108 5.80E-03 1.645 1 
E. coli IHE3034 521 625 54 104 7.97E-03 1.6055 1 
E. coli ATCC 8739 517 694 50 107 9.75E-03 1.5942 1 
E. coli 536 518 633 54 104 1.03E-02 1.576 1 
E. coli O157:H7 str. Sakai 509 635 51 106 4.51E-03 1.666 1 
E. coli S88 506 641 53 105 1.28E-02 1.5639 1 
E. coli SE11 502 689 49 108 9.46E-03 1.6059 1 
E. coli SE15 492 627 64 144 4.14E-04 1.7656 1 
E. coli SMS-3-5 497 693 48 109 7.29E-03 1.6286 1 
E. coli O157:H7 str. TW14359 513 629 52 105 5.89E-03 1.6468 1 
E. coli UMN026 491 683 50 108 1.56E-02 1.5528 1 
E. coli W [iECW_1372] 539 677 47 109 7.64E-04 1.8464 1 
E. coli KO11FL 509 689 49 107 9.32E-03 1.6132 1 
E. coli ETEC H10407 511 665 49 108 3.41E-03 1.6937 1 
E. coli O55:H7 str. CB9615 485 641 51 106 1.22E-02 1.5726 1 
E. coli K-12 MG1655 [iJO1366] 487 673 62 145 1.19E-03 1.6924 1 
E. coli K-12 MG1655 [iJR904] 329 443 55 77 8.50E-01 1.0397 0 
E. coli LF82 507 637 53 105 1.02E-02 1.5768 1 
Mycobacterium tuberculosis H37Rv 233 231 84 113 8.86E-02 1.3569 0 
E. coli O83:H1 str. NRG 857C 507 646 52 106 9.91E-03 1.5998 1 
Shigella flexneri 2a str. 2457T 495 530 54 109 3.60E-04 1.8852 1 
Shigella flexneri 5 str. 8401 490 532 54 108 4.97E-04 1.8421 1 
E. coli UM146 519 643 52 105 6.05E-03 1.6298 1 
E. coli UMNK88 518 678 49 108 4.41E-03 1.6839 1 
E. coli UTI89 494 658 53 105 2.56E-02 1.4874 1 
Klebsiella pneumoniae  MGH78578 514 633 35 47 7.32E-01 1.0904 0 
Bacillus subtilis str. 168 285 441 37 81 1.03E-01 1.4148 0 
E. coli O157:H7 str. EDL933 494 657 51 106 1.55E-02 1.5628 1 
Salmonella Typhimurium str. LT2 483 650 59 79 1.00E+00 0.995 0 
 
Table S10: Operons and the strictly essential genes. Each row corresponds to a given species or 
strain. Columns, from left to right, show species (strain) names, the number of metabolic genes that are 
neither strictly essential nor belong to an operon (− −), the number of metabolic genes that are not 
strictly essential but do belong to an operon (− +), the number of metabolic genes that are strictly 
essential, but do not belong to an operon (+ −), the number of metabolic genes that are both strictly 
essential and belong to an operon (+ +), the P value of a Fisher’s exact test on this data, the odds ratio 
(defined as the odds of being strictly essential for operonic metabolic genes divided by the odds of 
being strictly essential for non-operonic metabolic genes), and whether the null hypothesis of a lack of 
association between a gene’s strict essentiality and being part of an operon is rejected (1) or not (0). In 
42 of the 52 species (80.76%) the null hypothesis is rejected. Note that we consider a metabolic gene 
strictly essential, if its deletion abolishes viability on all carbon sources on which the wild-type 
metabolism is viable. 
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Strain (species) (--) (-+) (+-) (++) P-value Odds ratio 
Hypothesis 
rejected 
E. coli K-12 MG1655 [iAF1260] 411 533 110 207 5.67E-03 1.4511 1 
Methanosarcina barkeri str. Fusaro 348 211 94 39 7.15E-02 0.6843 0 
Geobacter metallireducens GS-15 271 459 83 174 1.74E-01 1.2377 0 
E. coli APEC O1 474 530 114 195 1.66E-03 1.5298 1 
E. coli BL21(DE3) [iB21 1397] 377 644 77 239 3.23E-05 1.817 1 
E. coli BW2952 437 536 116 239 5.68E-05 1.6798 1 
E. coli CFT073 498 616 80 113 4.33E-01 1.1419 0 
E. coli O127:H6 447 535 102 200 3.22E-04 1.6383 1 
E. coli 042 439 558 101 216 1.39E-04 1.6825 1 
E. coli 55989 442 571 104 213 6.59E-04 1.5854 1 
E. coli ABU 83972 459 552 102 207 1.32E-04 1.6875 1 
E. coli B str. REL606 456 557 104 212 1.50E-04 1.6688 1 
E. coli BL21-Gold(DE3)pLysS AG 471 567 103 213 5.43E-05 1.7178 1 
E. coli BL21(DE3) [iECD1391] 465 551 103 214 3.01E-05 1.7534 1 
E. coli DH1 [iEcDH1 1363] 456 594 104 209 1.33E-03 1.5427 1 
E. coli DH1 [iECDH1ME8569 1439] 548 580 100 211 2.34E-07 1.9936 1 
E. coli E24377A 464 566 102 209 1.40E-04 1.6798 1 
E. coli ED1a 453 516 101 209 1.31E-05 1.8167 1 
E. coli O157:H7 449 500 104 209 1.38E-05 1.8046 1 
E. coli HS 445 559 102 215 1.44E-04 1.678 1 
E. coli NA114 451 540 107 203 6.28E-04 1.5845 1 
E. coli O103:H2 str. 12009 461 559 101 206 1.30E-04 1.682 1 
E. coli O111:H- str. 11128 461 560 101 206 1.31E-04 1.679 1 
E. coli O26:H11 str. 11368 456 586 105 208 1.33E-03 1.5415 1 
E. coli IHE3034 468 527 107 202 1.38E-04 1.6765 1 
E. coli ATCC 8739 463 592 104 209 8.47E-04 1.5717 1 
E. coli 536 469 531 103 206 2.58E-05 1.7665 1 
E. coli O157:H7 str. Sakai 456 538 104 203 2.17E-04 1.6544 1 
E. coli S88 456 541 103 205 1.32E-04 1.6776 1 
E. coli SE11 450 586 101 211 4.92E-04 1.6043 1 
E. coli SE15 442 520 114 251 1.11E-06 1.8715 1 
E. coli SMS-3-5 449 580 96 222 2.04E-05 1.7902 1 
E. coli O157:H7 str. TW14359 459 531 106 203 1.79E-04 1.6554 1 
E. coli UMN026 438 573 103 218 3.33E-04 1.6179 1 
E. coli W [iECW_1372] 487 575 99 211 1.18E-05 1.8051 1 
E. coli KO11FL 456 586 102 210 5.03E-04 1.6021 1 
E. coli ETEC H10407 462 562 98 211 2.53E-05 1.77 1 
E. coli O55:H7 str. CB9615 435 527 101 220 1.53E-05 1.798 1 
E. coli K-12 MG1655 [iJO1366] 434 562 115 256 2.38E-05 1.7191 1 
E. coli K-12 MG1655 [iJR904] 262 331 122 189 1.57E-01 1.2262 0 
E. coli LF82 459 537 101 205 5.45E-05 1.7349 1 
Mycobacterium tuberculosis H37Rv 233 231 84 113 8.86E-02 1.3569 0 
E. coli O83:H1 str. NRG 857C 458 547 101 205 9.63E-05 1.6995 1 
Shigella flexneri 2a str. 2457T 441 454 108 185 2.59E-04 1.6639 1 
Shigella flexneri 5 str. 8401 437 462 107 178 1.07E-03 1.5735 1 
E. coli UM146 469 542 102 206 3.47E-05 1.7476 1 
E. coli UMNK88 466 579 101 207 2.29E-04 1.6495 1 
E. coli UTI89 442 559 105 204 1.53E-03 1.5362 1 
Klebsiella pneumoniae  MGH78578 452 528 97 152 4.57E-02 1.3415 1 
Bacillus subtilis str. 168 246 336 76 186 2.35E-04 1.7918 1 
E. coli O157:H7 str. EDL933 443 558 102 205 5.80E-04 1.5956 1 
Salmonella Typhimurium str. LT2 432 575 110 154 7.27E-01 1.0518 0 
 
Table S11: Operons and the conditionally essential genes. Each row corresponds to a given species 
or strain. Columns, from left to right, show species (strain) names, the number of metabolic genes that 
are neither conditionally essential nor belong to an operon (− −), the number of metabolic genes that 
are not conditionally essential but do belong to an operon (− +), the number of metabolic genes that 
are conditionally essential, but do not belong to an operon (+ −), the number of metabolic genes that 
are both conditionally essential and belong to an operon (+ +), the P value of a Fisher exact test on this 
data, the odds ratio (defined as the odds of being conditionally essential for operonic metabolic genes 
divided by the odds of being conditionally essential for non-operonic metabolic genes), and whether 
the null hypothesis of a lack of association between a gene’s conditional essentiality and being on an 
operon is rejected (1) or not (0). In 46 of the 52 species (88.46%) the null hypothesis is rejected. Note 
that we consider a metabolic gene conditionally essential, if its deletion abolishes viability on at least 
one carbon source.  
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Essential genes belonging to an operon 
 
Essential genes not belonging to an operon All essential genes 
 
Species(strains) 
Hypothesis 
rejected P-value 
Kuiper 
test 
statistic 
Critical 
value 
Hypothesis 
rejected P-value 
Kuiper 
test 
statistic 
Critical 
value 
Hypothesis 
rejected P-value 
Kuiper 
test 
statistic 
Critical 
value 
E. coli K-12 MG1655 [iAF1260] 1 1.22E-03 0.232 0.1777 0 1.38E-01 0.2121 0.2385 1 5.48E-03 0.1713 0.1435 
Methanosarcina barkeri str. Fusaro 1 3.65E-02 0.2797 0.271 0 3.93E-01 0.1316 0.1769 0 2.53E-01 0.1211 0.1492 
Geobacter metallireducens GS-15 1 2.08E-06 0.22 0.1307 1 9.90E-04 0.248 0.1876 1 1.84E-05 0.1688 0.1078 
E. coli APEC O1 1 5.75E-07 0.303 0.1736 0 5.79E-01 0.1476 0.22 1 4.16E-05 0.2082 0.1371 
E. coli BL21(DE3) [iB21 1397] 1 2.56E-02 0.165 0.1551 0 2.08E-01 0.2274 0.271 1 3.76E-03 0.1656 0.1354 
E. coli BW2952 1 3.63E-05 0.2183 0.143 0 5.78E-01 0.1442 0.2147 1 2.31E-04 0.1694 0.1197 
E. coli CFT073 1 4.38E-04 0.222 0.1617 0 2.76E-01 0.1529 0.191 1 5.52E-04 0.1687 0.1242 
E. coli O127:H6 1 2.06E-03 0.2113 0.1668 0 6.16E-02 0.2311 0.2362 1 2.15E-03 0.1733 0.1371 
E. coli 042 1 1.24E-03 0.2184 0.1676 1 4.61E-02 0.238 0.2362 1 7.55E-04 0.1839 0.1375 
E. coli 55989 1 2.65E-04 0.2324 0.1653 0 8.06E-02 0.231 0.2432 1 6.16E-04 0.1858 0.1375 
E. coli ABU 83972 1 1.42E-03 0.2168 0.1676 1 4.25E-02 0.2377 0.2339 1 1.17E-03 0.1792 0.1371 
E. coli B str. REL606 1 1.31E-03 0.2148 0.1653 0 1.27E-01 0.2186 0.2432 1 3.72E-03 0.1682 0.1375 
E. coli BL21-Gold(DE3)pLysS AG 1 2.19E-02 0.1742 0.1617 0 9.21E-02 0.2275 0.2432 1 6.43E-03 0.1599 0.1354 
E. coli BL21(DE3) [iECD1391] 1 1.11E-02 0.1846 0.1624 0 1.07E-01 0.2214 0.241 1 2.63E-03 0.1692 0.1354 
E. coli DH1 [iEcDH1 1363] 1 1.18E-03 0.216 0.1653 1 4.60E-02 0.2451 0.2432 1 6.30E-04 0.1856 0.1375 
E. coli DH1 [iECDH1ME8569 1439] 1 8.90E-03 0.1892 0.1638 0 2.47E-01 0.2041 0.2504 1 2.42E-02 0.1474 0.138 
E. coli E24377A 1 3.74E-04 0.2298 0.1661 0 5.76E-02 0.2373 0.241 1 6.38E-04 0.1855 0.1375 
E. coli ED1a 1 2.19E-03 0.2126 0.1684 0 1.42E-01 0.2036 0.2295 1 5.07E-03 0.164 0.1367 
E. coli O157:H7 1 1.08E-03 0.219 0.1668 1 4.48E-02 0.2409 0.2385 1 9.67E-04 0.1816 0.1375 
E. coli HS 1 7.29E-04 0.2214 0.1653 0 1.06E-01 0.2237 0.2432 1 1.74E-03 0.1759 0.1375 
E. coli NA114 1 8.48E-06 0.2734 0.17 0 8.60E-02 0.2188 0.2317 1 2.84E-03 0.1716 0.138 
E. coli O103:H2 str. 12009 1 3.74E-04 0.2298 0.1661 0 1.79E-01 0.2065 0.241 1 1.37E-03 0.1782 0.1375 
E. coli O111:H- str. 11128 1 5.64E-04 0.2243 0.1653 0 5.81E-02 0.2394 0.2432 1 8.53E-04 0.1828 0.1375 
E. coli O26:H11 str. 11368 1 3.58E-04 0.2292 0.1653 0 1.00E-01 0.2252 0.2432 1 8.09E-04 0.1833 0.1375 
E. coli IHE3034 1 2.16E-03 0.2128 0.1684 0 7.99E-02 0.2206 0.2317 1 2.31E-03 0.1726 0.1371 
E. coli ATCC 8739 1 7.05E-04 0.2228 0.1661 0 8.84E-02 0.2264 0.241 1 1.15E-03 0.18 0.1375 
E. coli 536 1 1.90E-03 0.2143 0.1684 1 4.43E-02 0.2346 0.2317 1 1.31E-03 0.1782 0.1371 
E. coli O157:H7 str. Sakai 1 1.09E-03 0.2189 0.1668 0 6.49E-02 0.232 0.2385 1 1.00E-03 0.1812 0.1375 
E. coli S88 1 1.34E-03 0.2175 0.1676 0 1.02E-01 0.2164 0.2339 1 2.07E-03 0.1737 0.1371 
E. coli SE11 1 2.85E-04 0.2316 0.1653 0 1.02E-01 0.2247 0.2432 1 6.58E-04 0.1852 0.1375 
E. coli SE15 1 4.79E-05 0.2168 0.1435 0 6.35E-01 0.1385 0.213 1 1.51E-03 0.1543 0.1197 
E. coli SMS-3-5 1 1.45E-04 0.2376 0.1646 0 7.84E-02 0.2341 0.2455 1 7.94E-04 0.1835 0.1375 
E. coli O157:H7 str. TW14359 1 1.82E-03 0.2138 0.1676 0 5.25E-02 0.235 0.2362 1 1.15E-03 0.1799 0.1375 
E. coli UMN026 1 4.11E-04 0.2277 0.1653 0 1.89E-01 0.2047 0.241 1 1.27E-03 0.1785 0.1371 
E. coli W [iECW_1372] 1 2.31E-04 0.2328 0.1646 0 6.55E-02 0.2412 0.2479 1 2.09E-04 0.196 0.138 
E. coli KO11FL 1 3.82E-04 0.2296 0.1661 0 5.48E-02 0.2408 0.2432 1 5.37E-04 0.1876 0.138 
E. coli ETEC H10407 1 3.24E-04 0.2303 0.1653 0 1.02E-01 0.2247 0.2432 1 7.23E-04 0.1843 0.1375 
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E. coli O55:H7 str. CB9615 1 4.30E-04 0.2293 0.1668 1 4.48E-02 0.2409 0.2385 1 3.12E-04 0.192 0.1375 
E. coli K-12 MG1655 [iJO1366] 1 3.03E-05 0.2198 0.143 0 6.38E-01 0.1404 0.2164 1 8.37E-04 0.1596 0.12 
E. coli K-12 MG1655 [iJR904] 1 4.14E-03 0.237 0.1945 0 9.51E-01 0.113 0.2295 1 3.15E-02 0.1565 0.1498 
E. coli LF82 1 3.71E-09 0.332 0.1676 1 4.64E-02 0.2357 0.2339 1 2.06E-09 0.275 0.1371 
Mycobacterium tuberculosis H37Rv 1 1.79E-02 0.1772 0.1617 0 8.87E-01 0.1007 0.1865 0 2.95E-01 0.097 0.123 
E. coli O83:H1 str. NRG 857C 1 1.61E-03 0.2143 0.1668 1 4.73E-02 0.2375 0.2362 1 1.59E-03 0.1763 0.1371 
Shigella flexneri 2a str. 2457T 1 3.69E-03 0.2014 0.1646 0 1.80E-01 0.1987 0.2317 1 1.13E-02 0.1533 0.135 
Shigella flexneri 5 str. 8401 1 3.16E-03 0.2042 0.1653 1 4.79E-02 0.2328 0.2317 1 9.77E-03 0.1554 0.1354 
E. coli UM146 1 1.20E-03 0.2187 0.1676 1 1.07E-02 0.269 0.2362 1 7.51E-04 0.184 0.1375 
E. coli UMNK88 1 1.21E-02 0.1867 0.1653 0 4.01E-01 0.1799 0.2432 0 1.73E-01 0.1185 0.1375 
E. coli UTI89 1 9.01E-04 0.2221 0.1676 0 7.54E-02 0.2241 0.2339 1 1.30E-03 0.1782 0.1371 
Klebsiella pneumoniae  MGH78578 1 1.23E-02 0.2798 0.2479 0 7.29E-01 0.1751 0.2847 1 4.24E-02 0.1922 0.1887 
Bacillus subtilis str. 168 1 4.03E-04 0.2624 0.1898 0 5.51E-01 0.1895 0.2775 1 4.12E-04 0.218 0.1583 
E. coli O157:H7 str. EDL933 1 3.98E-04 0.2302 0.1668 1 4.33E-02 0.2418 0.2385 1 3.00E-04 0.1923 0.1375 
Salmonella Typhimurium str. LT2 1 2.37E-05 0.2988 0.1922 0 8.02E-02 0.2112 0.2218 1 3.02E-04 0.2048 0.1465 
 
Table S12: Operons may play an important role in the clustering of strictly essential genes. In this analysis we divided the set of strictly non-essential genes into two 
groups: i) those belonging to an operon, and ii) those not belonging to an operon. Using Kuiper’s test, we examined the clustering of i) the first group of strictly essential 
genes alone (columns 2-5; labeled as red in the first row), ii) the second group of strictly essential genes alone (columns 6-9; labeled as blue in the first row), and iii) all 
strictly essential genes together (columns 10-13; labeled as red in the first row). Each row corresponds to a bacterial species or strain. The first column is the species (strain) 
name, and in each of the three set of four columns, from left to right, columns show whether the null hypothesis of a uniform distribution of strictly essential genes is rejected 
by Kuiper’s test (1) or not (0), the P-value of the test, Kuiper’s test statistics, and the critical value of this statistic above which the null hypothesis is rejected. In 51 among 
the 55 species the null hypothesis is rejected, i.e., essential genes are significantly clustered. We consider a metabolic gene strictly essential, if its deletion abolishes viability 
on all carbon sources on which the wild-type metabolism is viable. In 40 out of the 52 genomes (76.92%, colored blue) used in this analysis, the strictly essential genes 
acquired by horizontal gene transfer were significantly clustered (first group), but strictly essential genes not acquired by horizontal gene transfer (second group) were not 
significantly clustered. In the remaining 12 genomes (23.07%, colored black) strictly essential genes of both groups were significantly clustered. 
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Species (strain) 
Number of synthetic 
lethal gene pairs 
Minimum genomic 
distance between 
synthetic lethal genes 
Number of synthetic 
lethal pairs with 
genomic distance <50 
E. coli K-12 MG1655 [iAF1260] 35 51 0 
Methanosarcina barkeri str. Fusaro 71 0 14 
Geobacter metallireducens GS-15 89 0 18 
E. coli APEC O1 59 69 0 
E. coli BL21(DE3) [iB21 1397] 40 51 0 
E. coli BW2952 68 65 0 
E. coli CFT073 191 0 3 
E. coli O127:H6 59 69 0 
E. coli 042 60 51 0 
E. coli 55989 60 51 0 
E. coli ABU 83972 59 69 0 
E. coli B str. REL606 60 51 0 
E. coli BL21-Gold(DE3)pLysS AG 40 50 0 
E. coli BL21(DE3) [iECD1391] 40 51 0 
E. coli DH1 [iEcDH1 1363] 60 53 0 
E. coli DH1 [iECDH1ME8569 1439] 61 54 0 
E. coli E24377A 59 51 0 
E. coli ED1a 59 64 0 
E. coli O157:H7 60 51 0 
E. coli HS 60 51 0 
E. coli NA114 59 0 2 
E. coli O103:H2 str. 12009 61 0 3 
E. coli O111:H- str. 11128 60 52 0 
E. coli O26:H11 str. 11368 60 52 0 
E. coli IHE3034 59 67 0 
E. coli ATCC 8739 60 52 0 
E. coli 536 59 55 0 
E. coli O157:H7 str. Sakai 60 51 0 
E. coli S88 59 68 0 
E. coli SE11 60 51 0 
E. coli SE15 67 67 0 
E. coli SMS-3-5 60 52 0 
E. coli O157:H7 str. TW14359 60 51 0 
E. coli UMN026 56 51 0 
E. coli W [iECW_1372] 61 0 2 
E. coli KO11FL 61 52 0 
E. coli ETEC H10407 60 51 0 
E. coli O55:H7 str. CB9615 60 51 0 
E. coli K-12 MG1655 [iJO1366] 70 54 0 
E. coli K-12 MG1655 [iJR904] 20 4 4 
E. coli LF82 59 0 19 
Mycobacterium tuberculosis H37Rv 41 1 9 
E. coli O83:H1 str. NRG 857C 59 68 0 
Shigella flexneri 2a str. 2457T 62 63 0 
Staphylococcus aureus N315 21 0 5 
Shigella flexneri 5 str. 8401 60 67 0 
E. coli UM146 60 57 0 
E. coli UMNK88 60 0 2 
E. coli UTI89 59 57 0 
E. coli W [iWFL 1372] 61 0 2 
E. coli str. K-12 W3110 60 54 0 
Klebsiella pneumoniae  MGH78578 37 0 9 
Bacillus subtilis str. 168 40 0 8 
E. coli O157:H7 str. EDL933 60 51 0 
Salmonella Typhimurium str. LT2 30 0 9 
 
Table S13: Strictly synthetic lethal gene pairs. Each row corresponds to one of the 55 bacterial 
species or strains. Columns, from left to right, show the species name, the number of strictly synthetic 
lethal gene pairs, the distance between the synthetic lethal pairs with the shortest distance (smallest 
number of intervening genes) in the genome, and the number of strictly synthetic lethal gene pairs with 
distance below 50 intervening genes. In 41 of the genomes (82%), there are no strictly synthetic lethal 
gene pairs with distance below 50. We consider a pair of non-essential genes as strictly synthetic lethal 
if their simultaneous deletion abolishes viability on all carbon sources on which the wild-type 
metabolism is viable.  
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Species (strain) (--) (-+) (+-) (++) P-value 
Odds 
ratio 
Hypothesis 
rejected 
E. coli K-12 MG1655 [iAF1260] 574538 48713 35 0 1.10E-01 0 0 
Methanosarcina barkeri str. Fusaro 130875 21682 57 14 1.76E-01 1.4826 0 
Geobacter metallireducens GS-15 232023 26009 71 18 3.96E-03 2.2616 1 
E. coli APEC O1 614115 49954 59 0 2.20E-02 0 1 
E. coli BL21(DE3) [iB21 1397] 636626 50712 40 0 1.18E-01 0 0 
E. coli BW2952 577882 46453 68 0 9.34E-03 0 1 
E. coli CFT073 561681 45881 188 3 4.91E-04 0.1954 1 
E. coli O127:H6 582591 48476 59 0 2.28E-02 0 1 
E. coli 042 616382 49993 60 0 2.26E-02 0 1 
E. coli 55989 634193 50782 60 0 2.21E-02 0 1 
E. coli ABU 83972 621948 50213 59 0 2.18E-02 0 1 
E. coli B str. REL606 633074 50731 60 0 2.21E-02 0 1 
E. coli BL21-Gold(DE3)pLysS AG 655898 51517 40 0 1.16E-01 0 0 
E. coli BL21(DE3) [iECD1391] 632135 50521 40 0 1.18E-01 0 0 
E. coli DH1 [iEcDH1 1363] 671776 52370 60 0 2.15E-02 0 1 
E. coli DH1 [iECDH1ME8569 1439] 763580 56199 61 0 2.13E-02 0 1 
E. coli E24377A 648766 51511 59 0 2.14E-02 0 1 
E. coli ED1a 576221 48123 59 0 1.38E-02 0 1 
E. coli O157:H7 560227 47466 60 0 1.39E-02 0 1 
E. coli HS 624135 50346 60 0 2.24E-02 0 1 
E. coli NA114 603008 49586 57 2 3.23E-01 0.4267 0 
E. coli O103:H2 str. 12009 630872 50595 58 3 6.26E-01 0.645 0 
E. coli O111:H- str. 11128 631969 50667 60 0 2.22E-02 0 1 
E. coli O26:H11 str. 11368 662610 51940 60 0 2.16E-02 0 1 
E. coli IHE3034 604285 49452 59 0 2.21E-02 0 1 
E. coli ATCC 8739 677564 52612 60 0 2.14E-02 0 1 
E. coli 536 609776 49691 59 0 2.20E-02 0 1 
E. coli O157:H7 str. Sakai 602108 49343 60 0 1.39E-02 0 1 
E. coli S88 605384 49497 59 0 2.21E-02 0 1 
E. coli SE11 654561 51645 60 0 2.17E-02 0 1 
E. coli SE15 576901 46318 67 0 9.27E-03 0 1 
E. coli SMS-3-5 653452 51566 60 0 2.17E-02 0 1 
E. coli O157:H7 str. TW14359 599925 49245 60 0 1.39E-02 0 1 
E. coli UMN026 637525 50970 56 0 2.10E-02 0 1 
E. coli W [iECW_1372] 683337 52893 59 2 3.23E-01 0.4379 0 
E. coli KO11FL 662537 52012 61 0 2.22E-02 0 1 
E. coli ETEC H10407 637566 50925 60 0 2.21E-02 0 1 
E. coli O55:H7 str. CB9615 582568 48498 60 0 1.38E-02 0 1 
E. coli K-12 MG1655 [iJO1366] 623648 48502 70 0 9.41E-03 0 1 
E. coli K-12 MG1655 [iJR904] 263757 32288 16 4 2.67E-01 2.0422 0 
E. coli LF82 579179 47402 40 19 3.58E-08 5.8038 1 
Mycobacterium tuberculosis H37Rv 91476 15899 32 9 1.89E-01 1.6182 0 
E. coli O83:H1 str. NRG 857C 611979 49787 59 0 2.20E-02 0 1 
Shigella flexneri 2a str. 2457T 477361 43292 57 0 1.38E-2 0 1 
Staphylococcus aureus N315 130683 24699 16 5 3.64E-01 1.6534 0 
Shigella flexneri 5 str. 8401 476324 43306 60 0 8.96E-03 0 1 
E. coli UM146 621883 50277 60 0 2.24E-02 0 1 
E. coli UMNK88 660439 51722 58 2 3.23E-01 0.4403 0 
E. coli UTI89 610793 49823 59 0 2.20E-02 0 1 
E. coli W [iWFL 1372] 683337 52893 59 2 3.23E-01 0.4379 0 
E. coli str. K-12 W3110 665915 52226 60 0 2.16E-02 0 1 
Klebsiella pneumoniae  MGH78578 597269 51924 28 9 2.11E-03 3.6973 1 
Bacillus subtilis str. 168 231107 30579 32 8 1.32E-01 1.8894 0 
E. coli O157:H7 str. EDL933 609796 49670 60 0 2.27E-02 0 1 
Salmonella Typhimurium str. LT2 589406 49579 21 9 3.23E-04 5.095 1 
 
 
Table S14: Repulsion of the strictly synthetic lethal gene pairs. Each row corresponds to one of the 
55 bacterial species or strains. Columns, from left to right, show the species (strain) name, the number 
of non-essential metabolic gene pairs that are neither (strictly) synthetic lethal nor less than 50 
metabolic genes apart (− −), the number of non-essential metabolic gene pairs that are not (strictly) 
synthetic lethal but less than 50 metabolic genes apart (+ −), the number of non-essential metabolic 
gene pairs that are (strictly) synthetic lethal and less than 50 metabolic genes apart (−+), the number of 
non-essential metabolic gene pairs that are both (strictly) synthetic lethal and less than 50 metabolic 
genes apart (+ +), the P value of Fisher’s exact test, the odds ratio (the odds of being synthetic lethal 
for pairs of non-essential metabolic genes with distance below 50, divided by the odds of being 
synthetic lethal for pairs of non-essential metabolic genes with distance below 50), and whether 
(strictly) synthetic lethal gene pairs are in significant repulsion. We consider a pair of non-essential 
genes as strictly synthetic lethal if their simultaneous deletion abolishes viability on all carbon sources 
on which the wild-type metabolism is viable.  
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Species (strain) 
Number of synthetic 
lethal gene pairs 
Minimum genomic 
distance between 
synthetic lethal genes 
Number of synthetic 
lethal pairs with 
genomic distance <50 
E. coli K-12 MG1655 [iAF1260] 696 0 46 
Methanosarcina barkeri str. Fusaro 71 0 14 
Geobacter metallireducens GS-15 89 0 18 
E. coli APEC O1 640 0 39 
E. coli BL21(DE3) [iB21 1397] 614 0 41 
E. coli BW2952 652 0 51 
E. coli CFT073 191 0 3 
E. coli O127:H6 720 0 52 
E. coli 042 684 0 45 
E. coli 55989 666 0 46 
E. coli ABU 83972 660 0 38 
E. coli B str. REL606 633 0 43 
E. coli BL21-Gold(DE3)pLysS AG 614 0 41 
E. coli BL21(DE3) [iECD1391] 624 0 53 
E. coli DH1 [iEcDH1 1363] 626 0 40 
E. coli DH1 [iECDH1ME8569 1439] 625 0 39 
E. coli E24377A 640 0 55 
E. coli ED1a 636 0 39 
E. coli O157:H7 699 0 45 
E. coli HS 697 0 44 
E. coli NA114 647 0 34 
E. coli O103:H2 str. 12009 633 0 53 
E. coli O111:H- str. 11128 689 0 49 
E. coli O26:H11 str. 11368 658 0 48 
E. coli IHE3034 640 0 32 
E. coli ATCC 8739 620 0 52 
E. coli 536 658 0 40 
E. coli O157:H7 str. Sakai 652 0 49 
E. coli S88 657 0 33 
E. coli SE11 642 0 49 
E. coli SE15 662 0 39 
E. coli SMS-3-5 650 0 47 
E. coli O157:H7 str. TW14359 651 0 47 
E. coli UMN026 686 0 47 
E. coli W [iECW_1372] 644 0 49 
E. coli KO11FL 652 0 51 
E. coli ETEC H10407 632 0 44 
E. coli O55:H7 str. CB9615 741 0 51 
E. coli K-12 MG1655 [iJO1366] 642 0 47 
E. coli K-12 MG1655 [iJR904] 348 0 23 
E. coli LF82 671 0 78 
Mycobacterium tuberculosis H37Rv 41 1 9 
E. coli O83:H1 str. NRG 857C 670 0 39 
Shigella flexneri 2a str. 2457T 713 0 58 
Staphylococcus aureus N315 322 0 45 
Shigella flexneri 5 str. 8401 626 0 44 
E. coli UM146 633 0 32 
E. coli UMNK88 622 0 37 
E. coli UTI89 660 0 37 
E. coli W [iWFL 1372] 644 0 49 
E. coli str. K-12 W3110 641 0 43 
Klebsiella pneumoniae  MGH78578 576 0 37 
Bacillus subtilis str. 168 552 0 51 
E. coli O157:H7 str. EDL933 653 0 50 
Salmonella Typhimurium str. LT2 226 0 42 
 
Table S15: Conditionally synthetic lethal gene pairs. Each row corresponds to one of the 55 
bacterial species or strains. Columns, from left to right, show the species (strain) name, the number of 
conditionally synthetic lethal gene pairs, the distance between the synthetic lethal pairs with the 
shortest distance (smallest number of intervening genes) in the genome, and the number of 
conditionally synthetic lethal gene pairs with distance below 50. In 54 genomes, conditionally 
synthetic lethal gene pairs exist whose member genes are adjacent in the genome. We consider a pair 
of non-essential genes as conditionally synthetic lethal if their simultaneous deletion abolishes 
viability on some but not all carbon sources. 
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Species (strain) (--) (-+) (+-) (++) P-value 
Odds 
ratio 
Hypothesis 
rejected 
E. coli K-12 MG1655 [iAF1260] 573923 48667 650 46 2.58E-01 0.8346 0 
Methanosarcina barkeri str. Fusaro 130875 21682 57 14 1.76E-01 1.4826 0 
Geobacter metallireducens GS-15 232023 26009 71 18 3.96E-03 2.2616 1 
E. coli APEC O1 613572 49916 601 39 2.02E-01 0.7977 0 
E. coli BL21(DE3) [iB21 1397] 636092 50672 573 41 5.88E-01 0.8982 0 
E. coli BW2952 577348 46403 601 51 7.09E-01 1.0558 0 
E. coli CFT073 561681 45881 188 3 4.91E-04 0.1954 1 
E. coli O127:H6 581981 48425 668 52 7.26E-01 0.9355 0 
E. coli 042 615802 49949 639 45 4.24E-01 0.8682 0 
E. coli 55989 633632 50737 620 46 7.11E-01 0.9266 0 
E. coli ABU 83972 621384 50176 622 38 1.03E-01 0.7566 0 
E. coli B str. REL606 632543 50689 590 43 5.96E-01 0.9095 0 
E. coli BL21-Gold(DE3)pLysS AG 655364 51477 573 41 6.41E-01 0.911 0 
E. coli BL21(DE3) [iECD1391] 631603 50469 571 53 2.84E-01 1.1616 0 
E. coli DH1 [iEcDH1 1363] 671249 52331 586 40 4.87E-01 0.8756 0 
E. coli DH1 [iECDH1ME8569 1439] 763054 56161 586 39 6.34E-01 0.9042 0 
E. coli E24377A 648240 51456 585 55 2.25E-01 1.1844 0 
E. coli ED1a 575682 48085 597 39 1.57E-01 0.7821 0 
E. coli O157:H7 559632 47422 654 45 2.04E-01 0.812 0 
E. coli HS 623541 50303 653 44 2.79E-01 0.8352 0 
E. coli NA114 602452 49554 613 34 2.55E-02 0.6743 1 
E. coli O103:H2 str. 12009 630350 50545 580 53 3.62E-01 1.1396 0 
E. coli O111:H- str. 11128 631388 50619 640 49 8.27E-01 0.955 0 
E. coli O26:H11 str. 11368 662059 51893 610 48 9.40E-01 1.0039 0 
E. coli IHE3034 603735 49421 608 32 1.33E-02 0.643 1 
E. coli ATCC 8739 677055 52561 568 52 2.44E-01 1.1793 0 
E. coli 536 609216 49652 618 40 1.83E-01 0.7942 0 
E. coli O157:H7 str. Sakai 601564 49295 603 49 1.00E+00 0.9916 0 
E. coli S88 604818 49465 624 33 1.19E-02 0.6466 1 
E. coli SE11 654027 51597 593 49 7.61E-01 1.0474 0 
E. coli SE15 576344 46280 623 39 1.38E-01 0.7796 0 
E. coli SMS-3-5 652908 51520 603 47 1.00E+00 0.9878 0 
E. coli O157:H7 str. TW14359 599380 49199 604 47 8.24E-01 0.948 0 
E. coli UMN026 636942 50923 639 47 6.61E-01 0.92 0 
E. coli W [iECW_1372] 682801 52846 595 49 6.47E-01 1.064 0 
E. coli KO11FL 661996 51962 601 51 5.97E-01 1.0811 0 
E. coli ETEC H10407 637037 50882 588 44 7.61E-01 0.9369 0 
E. coli O55:H7 str. CB9615 581937 48448 690 51 4.48E-01 0.8878 0 
E. coli K-12 MG1655 [iJO1366] 623123 48455 595 47 8.79E-01 1.0158 0 
E. coli K-12 MG1655 [iJR904] 263448 32269 325 23 9.52E-03 0.5778 1 
E. coli LF82 578626 47343 593 78 1.83E-04 1.6076 1 
Mycobacterium tuberculosis H37Rv 91476 15899 32 9 1.89E-01 1.6182 0 
E. coli O83:H1 str. NRG 857C 611406 49749 631 39 1.06E-01 0.7596 0 
Shigella flexneri 2a str. 2457T 476763 43234 655 58 9.46E-01 0.9765 0 
Staphylococcus aureus N315 130422 24659 277 45 4.01E-01 0.8592 0 
Shigella flexneri 5 str. 8401 475801 43263 582 44 2.77E-01 0.8315 0 
E. coli UM146 621341 50246 601 32 1.89E-02 0.6584 1 
E. coli UMNK88 659912 51687 585 37 2.46E-01 0.8075 0 
E. coli UTI89 610228 49787 623 37 6.47E-02 0.7279 0 
E. coli W [iWFL 1372] 682801 52846 595 49 6.47E-01 1.064 0 
E. coli str. K-12 W3110 665376 52184 598 43 6.48E-01 0.9168 0 
Klebsiella pneumoniae  MGH78578 596758 51896 539 37 1.91E-01 0.7894 0 
Bacillus subtilis str. 168 230638 30536 501 51 7.35E-02 0.7689 0 
E. coli O157:H7 str. EDL933 609252 49621 603 50 8.82E-01 1.0181 0 
Salmonella Typhimurium str. LT2 589243 49546 184 42 1.28E-07 2.7147 1 
 
Table S16: Repulsion of conditionally synthetic lethal gene pairs. Each row corresponds to one of 
the 55 bacterial species or strains. Columns, from left to right, show the species (strain) name, the 
number of non-essential metabolic gene pairs that are neither (conditionally) synthetic lethal nor less 
than 50 metabolic genes apart (− −), the number of non-essential metabolic gene pairs that are not 
(conditionally) synthetic lethal but less than 50 metabolic genes apart (+ −), the number of non-
essential metabolic gene pairs that are (conditionally) synthetic lethal and less than 50 metabolic genes 
apart (−+), the number of non-essential metabolic gene pairs that are both (conditionally) synthetic 
lethal and less than 50 metabolic genes apart (+ +), the P value of Fisher’s exact test, the odds ratio 
(the odds of being (conditionally) synthetic lethal among the pairs of non-essential metabolic genes 
with less than 50 metabolic genes apart divided by the odds of being (conditionally) synthetic lethal 
among the pairs of non-essential metabolic genes with more than or equal to 50 metabolic genes 
apart), and whether (conditionally) synthetic lethal gene pairs are in significant repulsion. We consider 
a pair of non-essential genes as conditionally synthetic lethal if their simultaneous deletion abolishes 
viability on some but not all carbon sources. 
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Species (strain) 
Number 
of 
clusters 
Average 
length 
Max 
length 
No. Strictly 
non-essential 
 Fraction 
strictly non-
essential 
No. 
Conditionally 
non-essential 
 Fraction 
conditionally 
non-essential 
E. coli K-12 MG1655 [iAF1260] 148 6.38 48 147 0.99 148 1 
Methanosarcina barkeri str. Fusaro 81 6.89 33 78 0.96 78 0.96 
Geobacter metallireducens GS-15 103 7.09 92 98 0.95 98 0.95 
E. coli APEC O1 166 6.04 47 163 0.98 165 0.99 
E. coli BL21(DE3) [iB21 1397] 154 6.62 47 151 0.98 153 0.99 
E. coli BW2952 170 5.72 30 167 0.98 169 0.99 
E. coli CFT073 107 10.4 70 104 0.97 104 0.97 
E. coli O127:H6 153 6.41 45 150 0.98 152 0.99 
E. coli 042 153 6.51 45 150 0.98 152 0.99 
E. coli 55989 157 6.45 66 155 0.99 156 0.99 
E. coli ABU 83972 155 6.52 47 152 0.98 154 0.99 
E. coli B str. REL606 154 6.57 47 151 0.98 153 0.99 
E. coli BL21-Gold(DE3)pLysS AG 154 6.73 47 150 0.97 152 0.99 
E. coli BL21(DE3) [iECD1391] 155 6.55 47 152 0.98 154 0.99 
E. coli DH1 [iEcDH1 1363] 151 6.95 47 147 0.97 149 0.99 
E. coli DH1 [iECDH1ME8569 1439] 150 7.52 97 147 0.98 149 0.99 
E. coli E24377A 154 6.68 66 150 0.97 154 1 
E. coli ED1a 156 6.21 47 153 0.98 155 0.99 
E. coli O157:H7 152 6.24 44 151 0.99 151 0.99 
E. coli HS 154 6.51 47 152 0.99 153 0.99 
E. coli NA114 155 6.39 47 152 0.98 154 0.99 
E. coli O103:H2 str. 12009 154 6.62 66 152 0.99 153 0.99 
E. coli O111:H- str. 11128 154 6.62 65 150 0.97 153 0.99 
E. coli O26:H11 str. 11368 156 6.67 66 154 0.99 155 0.99 
E. coli IHE3034 157 6.33 47 154 0.98 156 0.99 
E. coli ATCC 8739 151 6.98 47 147 0.97 149 0.99 
E. coli 536 158 6.32 47 155 0.98 157 0.99 
E. coli O157:H7 str. Sakai 154 6.45 66 152 0.99 153 0.99 
E. coli S88 154 6.47 46 151 0.98 153 0.99 
E. coli SE11 153 6.76 67 150 0.98 152 0.99 
E. coli SE15 178 5.4 36 175 0.98 177 0.99 
E. coli SMS-3-5 154 6.68 47 151 0.98 153 0.99 
E. coli O157:H7 str. TW14359 154 6.42 66 153 0.99 153 0.99 
E. coli UMN026 156 6.47 47 153 0.98 156 1 
E. coli W [iECW_1372] 152 6.98 62 150 0.99 151 0.99 
E. coli KO11FL 153 6.81 66 150 0.98 151 0.99 
E. coli ETEC H10407 152 6.73 47 149 0.98 151 0.99 
E. coli O55:H7 str. CB9615 154 6.24 44 152 0.99 153 0.99 
E. coli K-12 MG1655 [iJO1366] 175 5.69 32 174 0.99 175 1 
E. coli K-12 MG1655 [iJR904] 135 4.39 29 134 0.99 135 1 
E. coli LF82 129 7.71 60 111 0.86 121 0.94 
Mycobacterium tuberculosis H37Rv 104 4.46 22 104 1 104 1 
E. coli O83:H1 str. NRG 857C 152 6.61 47 149 0.98 151 0.99 
Shigella flexneri 2a str. 2457T 148 6.04 29 145 0.98 146 0.99 
Staphylococcus aureus N315 82 5.59 21 80 0.98 81 0.99 
Shigella flexneri 5 str. 8401 149 6.03 40 147 0.99 148 0.99 
E. coli UM146 155 6.52 47 152 0.98 154 0.99 
E. coli UMNK88 168 6.21 47 165 0.98 167 0.99 
E. coli UTI89 157 6.37 47 154 0.98 156 0.99 
E. coli W [iWFL 1372] 152 6.98 62 150 0.99 151 0.99 
E. coli str. K-12 W3110 155 6.73 47 153 0.99 154 0.99 
Klebsiella pneumoniae  MGH78578 121 8.1 39 116 0.96 118 0.98 
Bacillus subtilis str. 168 108 5.38 34 104 0.96 107 0.99 
E. coli O157:H7 str. EDL933 151 6.62 67 149 0.99 150 0.99 
Salmonella Typhimurium str. LT2 139 7.24 61 135 0.97 138 0.99 
 
Table S17: Non-essential clusters of strictly non-essential genes. Each row corresponds to one of the 55 
bacterial species or strains. Columns, show the species (strain) name (first column), the number of the clusters 
of strictly non-essential genes (second column), the average length of the clusters of strictly non-essential genes 
(third column), the length of the largest cluster of non-essential genes (fourth column), the number (fifth column) 
and fraction (sixth column) of strictly non-essential clusters of strictly non-essential genes, and the number 
(seventh column) and fraction (eighth column) of conditionally non-essential clusters of strictly non-essential 
genes. We consider a metabolic gene as conditionally non-essential if its deletion does not abolish viability on at 
least one carbon source, and consider a metabolic gene as strictly non-essential if its deletion does not abolish 
viability on any carbon source. A cluster of conditionally non-essential metabolic genes is a set of consecutive 
non-essential metabolic genes that lies between two nearest non-adjacent strictly essential metabolic genes. 
Likewise, a cluster of strictly non-essential metabolic genes is a set of consecutive non-essential metabolic genes 
that lies between two nearest non-adjacent conditionally essential metabolic genes. Finally, we consider a cluster 
of strictly non-essential genes as a strictly non-essential cluster of strictly non-essential genes if simultaneous 
deletion of all the genes in the cluster does not abolish viability on any carbon source, and we consider a cluster of 
strictly non-essential genes as  aconditionally non-essential cluster of strictly non-essential genes if simultaneous 
deletion of all the genes in the cluster does not abolish viability on at least one carbon source.  
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Species (strain) 
Number 
of 
clusters 
Average 
length 
Max 
length 
No. Strictly 
non-essential 
 Fraction 
strictly non-
essential 
No. 
Conditionally 
non-essential 
 Fraction 
conditionally 
non-essential 
E. coli K-12 MG1655 [iAF1260] 81 13.79 91 39 0.48 76 0.94 
Methanosarcina barkeri str. Fusaro 81 6.89 33 78 0.96 78 0.96 
Geobacter metallireducens GS-15 103 7.09 92 98 0.95 98 0.95 
E. coli APEC O1 94 12.28 73 48 0.51 88 0.94 
E. coli BL21(DE3) [iB21 1397] 87 13.49 74 47 0.54 81 0.93 
E. coli BW2952 109 10.28 63 67 0.61 103 0.94 
E. coli CFT073 107 10.4 70 104 0.97 104 0.97 
E. coli O127:H6 86 13.08 76 47 0.55 78 0.91 
E. coli 042 86 13.44 71 46 0.53 79 0.92 
E. coli 55989 86 13.63 70 46 0.53 79 0.92 
E. coli ABU 83972 86 13.5 72 46 0.53 78 0.91 
E. coli B str. REL606 86 13.62 71 45 0.52 79 0.92 
E. coli BL21-Gold(DE3)pLysS AG 87 13.69 73 47 0.54 81 0.93 
E. coli BL21(DE3) [iECD1391] 87 13.45 73 47 0.54 81 0.93 
E. coli DH1 [iEcDH1 1363] 85 14.18 80 44 0.52 79 0.93 
E. coli DH1 [iECDH1ME8569 1439] 84 15.27 98 43 0.51 78 0.93 
E. coli E24377A 86 13.76 74 46 0.53 80 0.93 
E. coli ED1a 87 12.86 70 47 0.54 80 0.92 
E. coli O157:H7 86 12.84 67 45 0.52 80 0.93 
E. coli HS 86 13.52 74 46 0.53 79 0.92 
E. coli NA114 85 13.46 86 48 0.56 77 0.91 
E. coli O103:H2 str. 12009 86 13.59 66 48 0.56 79 0.92 
E. coli O111:H- str. 11128 86 13.6 91 48 0.56 79 0.92 
E. coli O26:H11 str. 11368 86 13.92 66 46 0.53 80 0.93 
E. coli IHE3034 86 13.31 73 46 0.53 78 0.91 
E. coli ATCC 8739 85 14.24 75 44 0.52 79 0.93 
E. coli 536 87 13.22 72 47 0.54 79 0.91 
E. coli O157:H7 str. Sakai 87 13.14 66 46 0.53 81 0.93 
E. coli S88 86 13.33 72 46 0.53 78 0.91 
E. coli SE11 85 14 70 45 0.53 78 0.92 
E. coli SE15 109 10.26 63 67 0.61 102 0.94 
E. coli SMS-3-5 86 13.83 74 45 0.52 79 0.92 
E. coli O157:H7 str. TW14359 87 13.11 66 46 0.53 81 0.93 
E. coli UMN026 87 13.48 71 45 0.52 82 0.94 
E. coli W [iECW_1372] 85 14.29 73 46 0.54 79 0.93 
E. coli KO11FL 86 13.92 74 46 0.53 79 0.92 
E. coli ETEC H10407 86 13.66 72 46 0.53 79 0.92 
E. coli O55:H7 str. CB9615 86 13.08 67 44 0.51 79 0.92 
E. coli K-12 MG1655 [iJO1366] 110 10.55 65 65 0.59 106 0.96 
E. coli K-12 MG1655 [iJR904] 71 10.86 52 28 0.39 68 0.96 
E. coli LF82 70 16.33 86 33 0.47 57 0.81 
Mycobacterium tuberculosis H37Rv 104 4.46 22 104 1 104 1 
E. coli O83:H1 str. NRG 857C 86 13.4 72 46 0.53 78 0.91 
Shigella flexneri 2a str. 2457T 89 11.51 70 50 0.56 83 0.93 
Staphylococcus aureus N315 36 15.58 64 15 0.42 29 0.81 
Shigella flexneri 5 str. 8401 88 11.6 68 51 0.58 82 0.93 
E. coli UM146 86 13.5 71 47 0.55 78 0.91 
E. coli UMNK88 105 11.38 76 64 0.61 98 0.93 
E. coli UTI89 87 13.23 74 47 0.54 79 0.91 
E. coli W [iWFL 1372] 85 14.29 73 46 0.54 79 0.93 
E. coli str. K-12 W3110 86 13.95 77 45 0.52 79 0.92 
Klebsiella pneumoniae  MGH78578 54 21.24 127 21 0.39 48 0.89 
Bacillus subtilis str. 168 52 13.94 72 25 0.48 46 0.88 
E. coli O157:H7 str. EDL933 86 13.37 67 46 0.53 80 0.93 
Salmonella Typhimurium str. LT2 77 14.71 99 41 0.53 71 0.92 
 
Table S18: Non-essential clusters of conditionally non-essential genes. Each row corresponds to one of the 55 
bacterial species or strains. Columns, show the species (strain) name (first column), the number of the clusters 
of conditionally non-essential genes (second column), the average length of the clusters of conditionally non-
essential genes (third column), the length of the largest cluster of non-essential genes (fourth column), the number 
(fifth column) and fraction (sixth column) of strictly non-essential clusters of conditionally non-essential genes, 
and the number (seventh column) and fraction (eighth column) of conditionally non-essential clusters of 
conditionally non-essential genes. We consider a metabolic gene as conditionally non-essential if its deletion does 
not abolish viability on at least one carbon source, and consider a metabolic gene as strictly non-essential if its 
deletion does not abolish viability on any carbon source. A cluster of conditionally non-essential metabolic genes 
is a set of consecutive non-essential metabolic genes that lies between two nearest non-adjacent strictly essential 
metabolic genes. Likewise, a cluster of strictly non-essential metabolic genes is a set of consecutive non-essential 
metabolic genes that lies between two nearest non-adjacent conditionally essential metabolic genes. Finally, we 
consider a cluster of conditionally non-essential genes as strictly non-essential cluster of conditionally non-
essential genes if simultaneous deletion of all the genes in the cluster does not abolish viability on any carbon 
sources, and we consider a cluster of conditionally non-essential genes as conditionally non-essential cluster of 
conditionally non-essential genes if simultaneous deletion of all the genes in the cluster does not abolish viability 
on at least one carbon source. 
	 168	
Chapter 4:  
 
Constraint and contingency pervade the emergence of novel 
phenotypes in complex metabolic systems 
Sayed-Rzgar Hosseini and Andreas Wagner 
 
 
 
 
The content of this chapter has been published as: 
Hosseini, S.-R., and A. Wagner. 2017. Constraint and Contingency Pervade the 
Emergence of Novel Phenotypes in Complex Metabolic Systems. Biophys. J. 113: 
690–701.  
DOI: 10.1016/j.bpj.2017.06.034 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 169	
4.1. Abstract 
An evolutionary constraint is a bias or limitation in phenotypic variation that a 
biological system produces. We know examples of such constraints, but we have no 
systematic understanding about their extent and causes for any one biological system. 
We here study metabolisms, genomically encoded complex networks of enzyme-
catalyzed biochemical reactions, and the constraints they experience in bringing forth 
novel phenotypes that allow survival on novel carbon sources. Our computational 
approach does not limit us to analyzing constrained variation in any one organism, 
but allows us to quantify constraints experienced by any metabolism. Specifically, we 
study metabolisms that are viable on one of 50 different carbon sources, and quantify 
how readily alterations of their chemical reactions create the ability to survive on a 
novel carbon source. We find that some metabolic phenotypes are much less likely to 
originate than others. For example, metabolisms viable on D-glucose are 1,835 times 
more likely to give rise to metabolisms viable on D-fructose than on acetate. 
Likewise, we observe that some novel metabolic phenotypes are more contingent on 
parental phenotypes than others. Biochemical similarities among carbon sources can 
help explain the causes of these constraints.  In addition, we study metabolisms that 
can be produced by recombination among 55 metabolisms of different bacterial 
strains or species, and show that their novel phenotypes are also contingent on and 
constrained by “parental” genotypes. Our analysis is the first to systematically 
quantify the incidence of constrained evolution in a broad class of biological system 
that is central to life and its evolution. 
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4.2. Introduction 
Individual organisms or populations cannot produce every conceivable kind of 
phenotypic variation. In other words, phenotypic evolution is to some extent 
constrained. More precisely, an evolutionary constraint is a bias or limitation in the 
emergence of phenotypic variation in a given biological system (1). Examples of 
constraints on the organismal level include the absence of photosynthesis in higher 
animals, the absence of birds that can give birth to live young instead of to eggs, the 
general lack of teeth in the lower jaw of frogs, and the absence of palm trees in cold 
climates (1, 2). Other examples include constrained variation in segment number, 
orientation and identity in the fruit fly Drosophila melanogaster (3), and correlations 
among different characters, such as in allometric scaling (4). Molecular examples of 
phenotypic constraints include the absence of L-isomers in the 20 amino acids found 
in natural proteins (5), and a limited number of possible protein folds caused by the 
packing requirements of hydrophobic amino-acids (6). It is useful to distinguish 
between absolute constraints, which occur when some phenotype cannot be 
produced, and relative constraints, when some phenotypes are more likely to arise 
than others.  
A closely related concept is that of contingency. We speak of contingency when the 
origin of a novel phenotype depends on the history of a population, and specifically 
on pre-existing genotypes or phenotypes (7, 8). For example, experimental evolution 
of Escherichia coli has shown that the emergence of citrate-utilization as a novel 
metabolic phenotype is contingent on the genetic history of a population (9). 
Analogously to constraints, one can distinguish between phenotypes that are 
absolutely or relatively contingent on evolutionary history. Although many anecdotal 
examples of constraints and contingent evolution exist, such examples do not allow 
one to quantify the potential for either phenomenon in any one class of biological 
system. We here undertake such a quantification using a computational approach 
applied to metabolic systems, which are ideal for this purpose for several reasons. 
First, metabolic systems, and especially those of microbes, are an abundant source of 
new adaptations and innovations – qualitatively new adaptations. Especially 
important innovations are those that allow an organism to extract energy and 
chemical elements from new molecules, which can help it survive in new habitats. 
For instance, microorganisms have acquired the ability to utilize many non-natural 
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substances, such as polychlorinated biphenyls, chlorobenzenes, organic solvents, 
synthetic pesticides, and even antibiotics as food (10–14).   
Second, experimentally-validated computational methods such as flux balance 
analysis (FBA) provide efficient means to systematically predict metabolic 
phenotypes – the ability of an organism to survive on specific nutrients – from 
information about metabolic genotypes (15, 16). A metabolic genotype is the part of a 
genome encoding metabolic enzymes. However, computational analyses of metabolic 
systems, often use a more abstract and compact representation of such a genotype, 
referring to it as the collection of chemical reactions that a metabolic reaction 
network is able to catalyze (17–26).  
Third, in metabolic systems, we are not restricted to studying the metabolism of any 
one organism, together with the constraints and contingencies it may be subject to. 
Instead, we can study the potential for contingency and constraint in entire classes of 
metabolic systems. To do so, we take advantage of Markov Chain Monte Carlo 
algorithms ((21, 23) (see methods)) that allow us to create large numbers of 
metabolisms. Each such metabolism is a complex network of chemical reactions with 
a given phenotype, but its complement of metabolic reactions is otherwise sampled at 
random from a “universe” of metabolic reactions that are known to exist among 
prokaryotes (see Methods). We refer to such metabolisms as random viable metabolic 
networks. The phenotypes we study are viability phenotypes, and specifically a 
metabolism’s ability to synthesize all essential biomass precursors in a minimal 
medium that harbors only a single carbon source. We consider 50 such carbon 
sources, i.e., 50 different metabolic phenotypes.  
When analyzing phenotypic variability, it is important to consider the kinds of 
genotype changes that cause this variability. We focus on recombination-like 
processes as a means for genotypic change, and do so for two reasons. First, 
recombination is a ubiquitous force of genetic change, not only in eukaryotes but also 
in prokaryotes whose genomes are being continually reorganized through horizontal 
gene transfer. Second, in contrast to smaller scale genetic change, such as point 
mutations, recombination causes larger-scale genetic change with greater potential to 
create novel phenotypes (27–32). Thus, if we found that phenotypic evolution was 
constrained when recombination causes genotypic change, it would be even more 
constrained if point mutations caused such change.   
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In our simulations, we generated one thousand parental pairs of random viable 
metabolic networks for each of the 50 carbon utilization phenotypes. For each one of 
these 50,000 parental pairs, using a recombination-like process that mimics horizontal 
gene transfer in bacteria (see methods), we generated 1,000 “offspring” to obtain 50 
million recombinant metabolic networks. We focused on those recombinants that did 
not only retain viability on their parental carbon source, but also gained viability on at 
least one novel carbon source. For brevity, we will also refer to them as “innovative 
offspring”. We analyze their phenotypes and how they depend on parental 
phenotypes. In addition, we also study recombination among metabolic networks of 
55 bacterial species or strains.  
We find little evidence for absolute constraints and contingencies. That is, the 
metabolic phenotypes we consider can be brought forth through recombination 
among some parental metabolic networks. However, relatively constraints and 
contingencies are pervasive. Differences in the biochemical relatedness of carbon 
sources, and the ensuing correlations among different carbon usage phenotypes can 
help explain some of these constraints and contingencies.  
4.3. Results 
All metabolic phenotypes can emerge through recombination. 
Our first analysis focused on the perhaps most fundamental question regarding 
absolute constraints: Do some parental phenotypes not give rise to any offspring with 
novel phenotypes? To find out, we quantified for each carbon source 𝐶! and for each 
of the 1,000 parental pairs viable on 𝐶!, the number 𝑁 !!→ of offspring gaining 
viability on some new carbon source (𝐶!, j ≠ 𝑖), among their 106 recombinant 
offspring (with n = 10 altered reactions relative to the parents). Fig. 1a shows the 
distribution of this number, demonstrating that offspring with metabolic innovations 
can emerge from each of the 50 carbon usage phenotypes we analyzed. However, we 
also note that the number of offspring with a metabolic innovation varies greatly 
among different carbon usage phenotypes, ranging from 1,433 for parents viable on 
adenosine to 61,835 for parents viable on D-galactose (per million offspring). We 
repeated this analysis by varying the number of reactions (n) altered during 
recombination, which shows that the relative abundance and the ranking of carbon 
sources in terms of the frequency of innovation stays almost the same for various n 
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((Figs. S1 and S2); n = 10 and 20, Spearman’s R = 0.9982; P < 10-60; n = 10 and 30, 
Spearman’s R = 0.9750; P < 10-33.) In sum, all parental phenotypes we consider can 
give rise to metabolic innovations.  
 
 
Figure 1: Recombination can create all 50 carbon-use phenotypes considered here. A) The 
horizontal axis shows the number of innovative recombinant offspring (out of one million offspring) 
resulting from recombination between parents viable exclusively on the carbon source specified on the 
vertical axis. B) Number of innovative recombinants (per million offspring) gaining viability on the 
novel carbon source specified on the horizontal axis. C) Number of innovative recombinant (per 
million offspring, coded according to the color legend) resulting from recombination between parents 
viable exclusively on the carbon source specified in panel A, which have gained viability on the novel 
carbon source specified in panel B. In these analyses, parental metabolic networks contain ||G|| = 2,079 
reactions, the same number as the E. coli metabolic network, and they differ in D = 100 reactions. 
Moreover, n = 10 reactions are swapped between parental metabolic networks during recombination.  
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Next, we asked whether different carbon usage phenotypes differ in their propensity 
to be found as novel offspring phenotypes, regardless of the parental phenotype. Fig. 
1b shows that this is indeed the case. But while all 50 carbon-usage phenotypes 
appear in the innovative offspring we analyzed, their prevalence (𝑁 →!!) varies by a 
factor 16 among carbon sources, ranging from 6,783 innovative offspring gaining 
viability on melibiose to 107,784 gaining viability on D-glucose (among 50×10! 
recombinant offspring, and a total of 1,556,237 innovative offspring). This variability 
is similarly great with a number (n) of recombined reactions different from n = 10 
(Figs. S1 and S2).We noted a negative correlation between 𝑁 !!→ and 𝑁 →!! (Fig. S3), 
i.e., carbon-usage phenotypes that give rise to more innovative offspring are found 
less frequently as products of recombinational innovation. 
Finally, Fig. 1c shows the variability among different pairs of carbon sources in terms 
of their propensity for generating innovative offspring. In 2,038 pairs (81.52% among 
the possible 2,500 pairs of carbon sources (𝐶! ,𝐶!), fewer than 1,000 innovative 
recombinant (among one million offspring) gain viability on 𝐶! from recombination 
between parents viable on 𝐶!, and only in 17 pairs (0.68%) more than 5,000 
innovative offspring emerge. The largest number of innovative offspring (7,071) 
emerges when parents viable exclusively on D-galactose give rise to offspring that 
gain viability on D-glucose. 
To find out whether parental genotypic distance and the number of reactions in a 
metabolic network might affect our observations, we repeated our analyses with more 
divergent parents (D = 1,000) and smaller metabolic networks (1,800 and 1,600 
reactions, as opposed to the 2,079 reactions identical to the number in E. coli, which 
we had used so far). Although recombination gives rise to fewer innovative offspring 
at higher D and for smaller networks (Fig. S4), the general patterns (Figs. S5, S6, and 
S7) remain similar to that of Fig. 1.   
Also, we had so far recombined parents that were viable on the same carbon source. 
To find out whether this could affect our observations, we generated recombinational 
offspring where one parent is viable on glucose, and the other is viable on a different 
carbon source. We found that recombination again results in fewer innovative 
offspring (Fig. S8), but leaves the patterns observed in Fig. 1 intact (Figs. S9, and 
S10).       
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In sum, each of the 50 carbon usage phenotypes we consider can give rise to 
metabolic innovations. Conversely, recombinants can acquire viability on each of 50 
carbon sources. Thus, at least from this analysis, there is no evidence for absolute 
constraints on carbon usage phenotypes. However, different carbon usage phenotypes 
differ greatly in their propensity to arise as metabolic innovations, providing a first 
line of evidence for relative constraints on metabolic innovation by parental 
phenotypes.  
Novel metabolic phenotypes are relatively constrained by parental phenotypes 
Our next analysis goes to the heart of the question we pose. For each of the 50 focal 
carbon sources 𝐶!, we examined all innovative offspring originating from parents 
viable on 𝐶! to find out whether gaining viability on each of the other 49 carbon 
sources (𝐶!, j ≠ 𝑖) is possible. For 43 of the 50 carbon sources 𝐶!, this is the case (Fig. 
2a). That is, for such a parental carbon source 𝐶!, at least one innovative offspring 
exists that gains viability on some new carbon source (𝐶!, j ≠ 𝑖). Even for the 
remaining seven carbon sources 𝐶!, this holds for the majority of the carbon sources 𝐶!. That is, starting from viability on five of the seven carbon sources 𝐶!, 
recombination can produce viability on more than 40 of the 49 carbon sources 𝐶!. The 
remaining carbon sources 𝐶! are deoxyadenosine and adenosine, where 
recombination can produce metabolisms viable on 30 and 26 other carbon sources, 
respectively. Similar observations emerge when we repeat this analysis by increasing 
the number of reactions exchanged during recombination (Figs. S11a and S12a). In 
sum, for a majority (43 of 50) of parental phenotypes, there are no absolute 
constraints on metabolic innovation, i.e., all novel metabolic phenotypes considered 
here can arise through recombination.  
Our next analysis (Fig. 2b) provides evidence for abundant relative constraints, that 
is, some carbon use phenotypes 𝐶! are more likely to emerge as metabolic innovations 
than others from parents viable on a given carbon source 𝐶! . For example, 65.13% of 
the innovative offspring emerging from parents viable on glucose, gain viability on 
only 4 other carbon sources: 16.37% on D-fructose 6-phosphate, 17.72% on D-
glucose 6-phosphate, 15.15% on D-fructose, and 15.89% on D-gluconate. The other 
34.87% of metabolic innovations are distributed among 45 other carbon sources (on 
average each receiving 0.77% of the innovative offspring). As another example, for 
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parents viable on D-serine, 46% of the innovative offspring gain viability on glycine 
(9.71%), L-aspartate (11.4%), L-alanine (16.73%) or D-alanine (8.16%) and the rest 
of 54% innovations is distributed among the other 45 carbon sources (each on 
average 1.2%).  
 
Figure 2: Emergence of innovative offspring can be constrained by parental phenotypes. A) The 
horizontal axis shows the carbon source on which parental metabolisms are viable, and the vertical 
axis shows the number of novel carbon sources (among the remaining 49 carbon sources) on which at 
least one innovative offspring recombination between parental metabolic networks is viable. B) 
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Fraction of innovative recombinants (coded according to the color legend) resulting from 
recombination between parents viable exclusively on the carbon source specified on the vertical axis, 
which have gained viability on the novel carbon source specified on the horizontal axis. C) 
Dendrogram of carbon sources clustered based on their “innovation distance” defined by the data in 
panel B. We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic carbon 
sources, respectively (except D-galacturonate, L-galactonate, and D-glucoronate (cyan circles), which 
are the gluconeogenic carbon sources.). In these analyses, parental metabolic networks contain ||G|| = 
2,079 reactions, the same number as the E. coli metabolic network, and they differ in D = 100 
reactions. Moreover, n = 10 reactions are swapped between parental metabolic networks during 
recombination. 
We then clustered the 50 carbon sources based on their relative “innovation distance” 
in Fig. 2b, where two carbon sources (𝐶! ,𝐶!) are more distant if parents viable on 𝐶! 
give rise to fewer offspring viable on 𝐶!. Fig. 2c shows that all glycolytic carbon 
sources (see S3 text) form one major branch of the resulting tree (colored red), and 17 
of the 20 gluconeogenic carbon sources (except D-galacturonate, L-galactonate, D-
glucoronate) form another major branch (colored cyan). Hence, the propensity for 
innovation between carbon sources belonging to the same class is higher than those 
belonging to different classes. This observation hints at a cause of the relative 
constraints we observe, which we discuss in more detail in section 3.4. 
We observe qualitatively identical patterns when we repeat this analysis with altered 
numbers of reactions exchanged during recombination (Figs. S11 and S12), with 
altered genotypic distances among metabolic networks (Fig. S13), with smaller 
metabolic networks (Figs. S14 and S15) and with heterogeneous parental phenotypes 
(Figs. S16 and S17). However, in smaller metabolic networks, perhaps due to a 
substantially lower incidence of phenotypic innovation (Fig. S4), emergence of novel 
phenotypes is more constrained by parental phenotypes (Figs. S14 and S15). 
Moreover, for heterogeneous parental phenotypes where all the recipients are viable 
only on glucose and donors are viable on other carbon sources, carbon sources do not 
cluster according to innovation distance. The likely reason is that the recipient 
parental phenotype is constant in this analysis (Fig. S17). 
In sum, different novel phenotypes are constrained in their evolution, because they 
originate with different probabilities from a given parental carbon-usage phenotype. 
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Emergence of innovative offspring is not absolutely but relatively contingent on 
parental phenotypes 
To complement our above analyses, we also studied whether some novel metabolic 
phenotypes are absolutely contingent on a specific parental phenotype. That is, can 
they only emerge from parents with this phenotype? To find out, we studied the 
parental phenotypes of all innovative offspring that have gained viability on a given 
carbon source 𝐶!, and did so for all carbon sources 𝐶!. Fig. S18a shows that for all 
novel carbon-usage phenotypes 𝐶!, innovative offspring can emerge from parents 
with at least 40 different phenotypes. Similar observations emerge when 
recombination alters a different number of reactions (Figs. S19a and S20a).  
While absolute contingency does therefore not exist in our study system, we observe 
relative contingency: Different parental phenotypes 𝐶! have a greater or lesser 
propensity to give rise to a given carbon-usage phenotype 𝐶! (Fig. S18b). 
For example, 42.15% innovative offspring gaining viability on D-galactarate 
originate from parents viable only on 4 different carbon sources, namely D-malate 
(12.86%), D-galacturonate (11.99%), pyruvate (8.70%), and glycolate (8.61%). The 
other 57.85% originate from parents viable on the other 45 carbon sources (where 
each accounts for 1.28% of the innovative offspring on average). Another example 
regards viability on succinate, 20.8% of which originates from parents viable on 
acetate and the rest is distributed among other parental phenotypes (each contributing 
1.65% on average).  
And once again, classification of carbon sources based on their distance (Fig. S18b) 
results in separation of glycolytic and gluconeogenic carbon sources (Fig. S18c). We 
observe similar patterns when we repeat this analysis with a different number of 
reactions altered during recombination (Figs. S19 and S20), with higher genotypic 
distances among parental metabolisms (Fig. S21), with smaller metabolic networks 
(Figs. S22 and S23), and with heterogeneous parental phenotypes (Figs. S24 and 
S25). In smaller metabolic networks, perhaps due to the lower incidence of 
innovation (Fig. S8), relative contingency is most pronounced (Figs. S22 and S23).  
In sum, while we do not observe absolute contingency, some parental phenotypes are 
much more likely than others to give rise to specific new metabolic phenotypes, 
which show relative contingency.   
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On the underlying causes of constraints and contingencies 
As we observed in Figs. 2c and S18c, one specific measure of biochemical similarity 
among carbon sources can help explain the patterns of constraints and contingencies 
that we observed. That is, carbon sources can be broadly partitioned into glycolytic 
and gluconeogenic classes, where parents viable on a carbon source in one class are 
most likely to produce innovative offspring viable on a new carbon source in the 
same class. To provide complementary evidence that constraints increase with 
biochemical distance among carbon sources, we used two other biochemical 
similarity measures, and determined whether they are associated with the innovation 
distance between carbon sources.  
The first defines the metabolic distance between a given pair of carbon sources 
(𝐶! ,𝐶!) as the average shortest path between 𝐶! and 𝐶! in the substrate graph of 1,000 
metabolic networks viable on 𝐶! (see supplementary text S7). This network-based 
biochemical distance is significantly associated with the number of recombinants that 
are generated from parents viable on 𝐶!, and that gain viability on carbon source 𝐶!  (Fig. S26, Pearson r = -0.2722, and P < 10-41). A second quantifier of distance 
relies on the superessentiality index, the proportion of random viable networks in 
which a given reaction is essential for viability on a given carbon source (see 
supplementary texts S7 and S8). Here also, innovation declines with increasing 
biochemical distance among carbon sources (Pearson r = -0.3935, and P < 10-83, 
supplementary text S8, Fig. S27a). 
Another complementary analysis involving biochemical distance focuses on the 
individual reactions that can be transferred from donor to recipient, and that can lead 
to metabolic innovation. For this analysis, it is relevant that the majority of metabolic 
innovations is caused by the transfer of a single key reaction (32). We analyzed 
transferable reactions in greater depth, focusing on all 1,000 parental donor metabolic 
networks viable on a given carbon source 𝐶! , and on the (𝐷/2 = 50) reactions that 
are present in the donor metabolic network, but are absent in the recipient, and so can 
potentially be transferred from the donor to the recipient. Specifically, we quantified 
the fraction of the 1,000 parental donor metabolic networks viable on 𝐶!  in which at 
least one reaction among the (𝐷/2 = 50) transferrable reactions can have 𝐶!  as a 
product or substrate, reasoning that such reactions may be especially prevalent among 
	 180	
reactions causing viability on 𝐶!. The number of innovative offspring that gain 
viability on 𝐶!   by recombining parents viable on 𝐶!, increases significantly with the 
fraction of transferable reactions that involves 𝐶!   (Pearson r = 0.163, and P < 10-15, 
Fig. S27b). It is not difficult to see that this association can also be a consequence of 
the relatedness of two carbon sources. The reason is that metabolic networks viable 
on a given carbon source 𝐶!  are likely to already have some reactions involving 
metabolically related carbon sources 𝐶!. In this case, it is more likely that addition of 
a single novel reaction leads to the completion of a pathway in the recipient that is 
needed to metabolize 𝐶! . We note that these correlation coefficients, albeit statistically 
significant, are low in magnitude, implying that these properties cannot fully explain 
the mechanism underlying phenotypic constraint. A more detailed analysis of each 
pathway connecting different carbon sources may be required to fully understand the 
causes of constraints and contingencies. We leave such an analysis for future work. 
Emergence of innovative offspring is constrained by and contingent on parental 
genotypes of both donors and recipients  
Our analyses thus far were focused on parental metabolic networks with given 
phenotypes, which allowed us to analyze constraints and contingencies emerging 
from such phenotypes. However, the emergence of novel phenotypes may also 
depend on parental genotypes, and we next analyzed such constraints. Random viable 
metabolisms are less than ideal for such an analysis for two reasons. First, they do not 
derive from any one organism with its specific gene-reaction association, and they do 
therefore not allow us to define genotypes on the level of genes. Second, our simple 
model of recombination for such metabolisms neglects the linkage of metabolic genes 
on chromosomes.  
To overcome these limitations, we focused our next analysis on curated metabolic 
networks of 55 distinct bacterial strains or species. Their metabolic genes, reactions, 
gene-reaction association rules, metabolic gene locations, and biomass reactions are 
well-studied and available from the BiGG database (54). We used 30 carbon sources 
on which none of the 55 metabolisms are viable to study the emergence of novel 
phenotypes (supplementary text S3). We examined all 2970 (=55×54) distinct pairs 
of donor-recipient species or strains, and subjected them to recombination events that 
take into account metabolic gene linkage (see methods section 2.4). From each donor-
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recipient pair, we generated millions of recombinant offspring to identify innovative 
offspring, that is, offspring gaining viability on at least one of the 30 novel carbon 
sources.  
 
Figure 3: Emergence of innovative offspring is contingent on and constrained by parental 
genotypes. A) Number of innovative recombinant offspring resulting from linkage-based 
recombination between bacterial DNA donors specified on the vertical axis of panel B, and the 
corresponding recipients specified on the horizontal axis of panel C (number of recombinants encoded 
according to the color legend). B) Total number of innovative recombinant offspring involving the 
donor genotype specified on the vertical axis. C) Total number of innovative recombinant offspring 
involving the recipient genotype specified on the horizontal axis.  
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We observed that the emergence of novel phenotypes is strongly contingent on the 
recombining parental genotypes. Among the 2970 pairs of recombining parental 
genotypes, only 347 pairs (11.68%) brought forth at least one innovative offspring 
(Fig. 3a). In addition, these 347 pairs vary greatly in the number of innovative 
offspring that they can generate. The highest number of innovative offspring (56,461, 
or 1.17% of recombination events) emerges when the donor is Staphylococcus aureus 
N315 and the recipient genotype is E. coli DH1, and the lowest number ((904), or 
0.02% of recombination events) emerges when the donor is E. coli BL21 and the 
recipient genotype is Bacillus subtilis.  
The emergence of innovative offspring was also strongly constrained by the donor 
genotype (Fig. 3b). 97.84% of all innovative offspring identified in this analysis were 
generated from only six donor genotypes. The other 49 donors together were 
responsible only for 2.16% of all innovative offspring. Recombination involving 
Staphylococcus aureus N315 donors caused an exceptionally large fraction of 45.97% 
of innovative offspring. Despite this strong relative constraint on donor genotypes, 
we did not observe any absolute constraints, because all 55 prokaryotic metabolisms 
generated at least one innovative offspring as donor genotypes, even though the 
contributions of 49 metabolisms were so small that they are not visible in Fig. 3b.  
In contrast, the emergence of innovative offspring was not strongly constrained by the 
parental recipient genotype. That is, the majority of recipient metabolisms (48 out of 
55) can generate approximately the same number of innovative offspring (Fig. 3c). 
Only four of them generated considerably fewer innovative offspring, and three of 
them did not generate any innovative offspring as recipients (Fig. 3c). Importantly, 
the potential of metabolic genotypes in generating innovative offspring when used as 
donors or recipients was highly asymmetric. For example, although Staphylococcus 
aureus and Mycobacterium tuberclosis accounted for most innovative offspring as 
donor genotypes, they did not generate any innovative offspring as recipient 
genotype. Similarly asymmetric biases emerged when we repeated the analysis with a 
recombination approach that does not take into account metabolic gene linkage, 
suggesting that such asymmetry is not caused by gene linkage but by the metabolic 
gene content of genomes (Fig. S28). In sum, the emergence of innovative offspring is 
strongly contingent on the genotypes of parental donor-recipient pairs, and especially 
on donor genotypes.  
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4.4. Discussion 
In this study we systematically analyzed the prevalence of constraint and contingency 
for emerging novel phenotypes in complex metabolic systems. We did so by 
computationally emulating recombination among thousands of parental metabolic 
network pairs with specific phenotypes, and created millions of recombinant 
metabolic networks.  
Overall, we observed little evidence for absolute constraints in the origin of novel 
phenotypes, i.e., metabolic networks with most carbon usage phenotypes can give 
rise to all 50 novel carbon usage phenotypes we consider here. However, there is 
ample evidence for relative constraints, that is, some carbon usage phenotypes are 
much more likely to arise relative to others from any one parental carbon usage 
phenotype. 
Similarly, we observed no absolute contingency in the origin of novel phenotypes, 
i.e., recombinant metabolic networks with a given novel carbon usage phenotype can 
originate from all 50 parental phenotypes. In contrast, relative contingency is 
pervasive. That is, a given novel carbon usage phenotype is much more likely to 
originate from some parental phenotypes than others. Importantly, our observations 
remain qualitatively unchanged when we alter various properties of parental 
genotypes, such as their genotypic distance, which suggests that the different extents 
of constraints we observe may be an inherent property of metabolic systems.   
We also analyzed the causes of constraints and contingencies, where several 
complementary analyses point to the importance of biochemical similarities among 
carbon source pairs (𝐶! ,𝐶!), where parents are viable on 𝐶!, and recombinant 
offspring gain viability on 𝐶!. First, if parents are viable on a carbon source that 
belongs to one of two major biochemical classes (glycolytic or gluconeogenic), then 
recombinant offspring tend to gain viability on a carbon source within the same class 
(Figs. 2c and S18c). Second, the smaller the number of reactions is that separate 𝐶!  and 𝐶! in a metabolic network, the greater is the likelihood that offspring gain 
viability on 𝐶!. Third, offspring gain viability on 𝐶!  most often if a reaction 
transferred between donor and recipient involves 𝐶! . This, in turn is most likely if the 
recipient already harbors some reactions necessary to metabolize 𝐶!, and thus if 
catabolizing 𝐶! and 𝐶! involves similar reactions. Our analysis used carbon sources 
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that are not very heterogenous. Many of them, for example, are sugars that play 
important roles in central carbon metabolism. This biochemical similarity among 
carbon sources reduces constraints, and it may be responsible for the paucity of 
evidence for absolute constraints.  
One strength of our approach is that it can address contingency and constraint in an 
entire class of system, and not just a single organism. However, the approach also has 
several limitations. First, any study relying on sampling is sensitive to sample size. 
For example, if we had analyzed only 100 parental metabolic networks and 100 
recombinants per pair, we would not have observed any innovative offspring for most 
parental carbon usage phenotypes. Thus, we would have misleadingly concluded that 
absolute constraints are frequent in our study system. And even though we had 
generated a (computationally expensive) sample of one million offspring for each 
parental phenotype, we did see a small number of carbon sources showing evidence 
for absolute constraints. Such apparent absolute constraints may disappear at even 
higher sample sizes (Fig. S29a). In contrast, our assertion that relative constraints 
exist is less sensitive to sample sizes (Fig. S29b).  Our current analysis generated 
fewer than 1,000 innovative metabolisms for most (𝐶! ,𝐶!) pairs, and larger sample 
sizes may help find out why some pairs (𝐶! ,𝐶!) are more or less involved in metabolic 
innovation. 
Second, our work is based on flux balance analysis (15, 16), which neglects the 
influence of gene and enzyme regulation. However, because regulatory changes 
towards optimal expression of enzymes readily occur, even on the short time scales of 
laboratory evolution, this limitation may not affect our main observations 
(supplementary text S4).  
Third, a recent study showed that the genome-scale metabolic networks are likely to 
include thermodynamically impossible energy-generating cycles (EGCs), which are 
capable of charging energy metabolites without nutrient consumption (56). These 
EGCs can artificially inflate biomass flux and so may mislead evolutionary 
simulations. Most of our randomly sampled viable metabolisms indeed harbor EGCs 
(97.3% and 97.8% of sampled metabolisms viable on glucose and acetate, 
respectively; Supplementary text S9). However, these EGCs do not strongly affect the 
emergence of novel phenotypes, nor do they substantially distort the patterns of 
relative constraint we observed (see supplementary text S9 and Figs. S30, S31, and 
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S32).  
Finally, in our simulations using random metabolic networks, following common 
practice in the field (17–26), we define metabolic genotypes on the level of 
biochemical reactions rather than on that of genes or DNA. This representation 
neglects potentially important information, and especially the linkage of related 
metabolic genes on chromosomes, which may affect the outcome of recombination. 
To address this limitation, we also modeled recombination among metabolisms of 55 
prokaryotic species or strains in a way that includes gene linkage information. This 
analysis also demonstrates strong constraints and contingencies in the emergence of 
novel metabolic phenotypes.  
A previous experimental evolution study suggested a strong relative constraint in the 
emergence of a novel citrate utilization phenotype, which required thousands of 
generations of laboratory evolution subject to mutation and selection to emerge (9). 
Although our simulations are not strictly commensurate with any experimental study, 
for example because we do not consider DNA changes explicitly, we speculate that 
such relative constraints would be less pronounced in any system where 
recombination is abundant, because recombination can cause larger scale changes 
than mere point mutations that would alter individual reactions or transport processes 
(9).  
This was one motivation to choose recombination as an agent of genetic change in the 
first place, reasoning that any constraints visible in the presence of recombination 
might be even stronger in the presence of less dramatic genetic changes.    
Metabolic systems are one of the three classes of biological systems in which 
phenotypic variation is crucial for evolutionary adaptation and innovation (57). The 
other two are macromolecules (protein and RNA) and regulatory systems. Predicting 
phenotypes in these systems is less straightforward than for metabolic systems (58–
60). In proteins, for example, phenotypes form through a complex and incompletely 
understood three-dimensional folding process (58), and in regulatory systems, gene 
expression phenotypes emerge from complex interactions among regulatory 
molecules (59, 60). Our understanding of inherent biases in phenotypic variability 
will not be complete until we understand contingencies and constraints in these 
classes of systems as well, which remains an important task for future work.   
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4.5. Methods 
Genotype-phenotype representation in metabolic networks 
The set of enzyme-catalyzed biochemical reactions that take place in an organism 
constitutes the organism’s metabolic reaction network, i.e., its metabolism. Each such 
metabolism contains a subset of the “reaction universe” of all biochemical reactions 
that are known to occur in some organism within the biosphere. We have manually 
curated a representation of the prokaryotic reaction universe, which comprises 5,906 
reactions known to occur in prokaryotes (see supplementary texts S1 and S2 for 
details). In this framework, we represent an organism’s metabolic genotype as a 
binary vector of length 5,906, each entry of which corresponds to a given reaction in 
the universe, and is equal to one if the corresponding reaction is present in the 
network, and zero otherwise. Hence, each genotype can be envisioned as a single 
member of a vast space of all possible metabolic networks, which contains 25906 
distinct genotypes. We determine the phenotype of a given metabolic genotype based 
on its ability to sustain life in one or more of 50 distinct minimal environments that 
differ only in the sole carbon source they contain (supplementary text S3). We 
consider a genotype viable on a given carbon source, if Flux Balance Analysis (FBA, 
See supplementary text S4) predicts that it can produce all essential biomass 
precursors using this carbon source as its only carbon source (15). We used the 
biomass composition of the E. coli metabolic model iAF1260, because the sampling 
approach described in the next section starts from the E. coli metabolism 
(supplementary text S5). Our C++ implementation of FBA and the code necessary for 
the analyses in this paper are available through this public github repository: 
https://github.com/rzgar/EMETNET.  
Random sampling of parental metabolic network pairs from metabolic genotype 
space 
We here employ a previously described in silico process that relies on Markov Chain 
Monte Carlo (MCMC) random walks to generate randomly sampled viable metabolic 
networks, i.e., networks that are viable on a given carbon source, but that otherwise 
contain a random subset of reactions in the reaction universe (supplementary text S5) 
(21, 23). This procedure ensures uniform sampling from the set of all metabolic 
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networks viable on a given carbon source. Our analyses required us to recombine 
pairs of “parental” metabolic networks (i.e., donor-recipient pairs) with particular 
features, such as a given genotypic distance (D), defined as the number of reactions 
differing between the parents. We used simultaneous genotype-converging MCMC 
random walks to generate pairs of metabolic networks with a given D (See 
supplementary text S6). We required parental metabolisms to be exclusively viable 
on a particular carbon source, i.e., to be inviable on all 49 other carbon sources we 
considered. In most of our analyses, we kept the number of reactions present in the 
metabolic networks constant and equal to that of E. coli with 2,079 reactions. 
Modeling a recombination-like process in metabolic networks 
As in a previous contribution (32), we use a coarse-grained model of prokaryotic 
recombination that mimics the effects of horizontal gene transfer events between 
bacteria on metabolism (33–36). This model is motivated by the importance of 
horizontal gene transfer as a means of genetic change. Through its high incidence, 
horizontal gene transfer can change the gene content of genomes on short 
evolutionary time scales (33, 37, 38). It can also occur between very distantly related 
organisms (39, 40). For several reasons, our recombination model also takes DNA 
deletions into consideration. The first is that during horizontal gene transfer, 
incorporating genes from a donor into a recipient genome relies on DNA 
rearrangements that can also delete resident genes (41). Second, the majority of 
newly acquired genes obtained via horizontal gene transfer reside in the genome only 
for short amounts of time (42). Third, the evolution of prokaryotic genomes is biased 
towards DNA deletions (43). Motivated by these observations, we here model 
prokaryotic recombination as a process where the transfer of biochemical reactions 
from a donor to a recipient is accompanied by concurrent deletion of reactions from 
the recipient metabolic network. 
Specifically, to model recombination for each parental metabolic network pair, we 
generated 1,000 recombinant offspring by (i) adding to the recipient metabolic 
network a given number n/2 of randomly chosen reactions that were present in the 
donor and absent from the recipient, followed by (ii) deleting n/2 reactions randomly 
chosen from the recipient. Thus, the total number of reactions changed by a 
recombination event in the recipient is equal to n. In this present contribution, we 
repeated most of our analyses by using three different values of n; namely n = 10, 20, 
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and 30. Empirical observations also suggest that altering up to n = 60 reactions in a 
recombination event is biologically realistic, because horizontal gene transfer can 
affect long DNA regions (44). Importantly, the transferred material that is integrated 
into the host genome by recombination can constitute stretches of non-coding DNA, 
fragments of genes (45, 46), entire genes (47), multiple adjacent genes (48, 49), 
operons, transposable chromosomal elements, plasmids, as well as other naturally 
occurring extrachromosomal elements (50). The length of contiguously transferred 
stretches may range from a few nucleotides (51) to more than 3 Mbp (44), i.e., some 
two thirds of the length of the E. coli genome, which encodes more than 1300 
reactions. In addition, some megabase-scale horizontally transferred DNA segments 
can become incorporated into a chromosome in the form of hundreds of smaller 
fragments (52). As we have discussed in a previous contribution ((32), electronic 
supplementary text S3), the probability that a recombination event preserves viability 
exceeds 10-3 for values up to n = 60.   
Modeling recombination in curated bacterial metabolic networks from the 
BiGG database 
We used the R-package Sybil (53) to collect 55 well-annotated bacterial genome-
scale metabolic networks available in the BiGG database (54). Each of these species 
or strains has its own biomass growth function, its own complement of reactions, and 
well defined gene-reaction association rules that allowed us to model recombination 
on the level of genes instead of reactions. We used the genomic location of metabolic 
genes in these bacterial species or strains (55) to take gene linkage into account when 
modeling recombination. 
To generate a recombinant metabolic network from a donor and a recipient organism, 
first a given stretch of DNA from the donor genome that contains a given number of 
metabolic genes is translated into reactions based on the gene-reaction association 
rules of the donor organism, and then the resulting reactions are added to the recipient 
metabolic network. Second, a given stretch of DNA from the recipient genome that 
contains a given number of metabolic genes is translated into reactions based on the 
gene-reaction association rules of the recipient organism, and then the resulting 
reactions are deleted from the recipient metabolic network.  
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In a recombination event between a pair of organisms, we set the number of genes in 
a given donor DNA stretch such that on average a given number of n=5 reactions are 
added to the recipient metabolic network, and on average an equal number n=5 of 
reactions are deleted from it. Because gene-reaction associations are not generally 
one-to-one and can be very complicated, and because most of the reactions that are 
encoded in a given stretch of DNA may already be present in the recipient metabolic 
network, the number of metabolic genes that needs to be added from donor to 
recipient genome, such that exactly n reactions are added to the recipient, will often 
be higher than n. In contrast, we found that the number of metabolic genes in a DNA 
stretch to be deleted from the recipient genome in order to eliminate n reactions from 
the recipient metabolic network is lower than n, because deletion of a single 
metabolic gene often causes elimination of multiple reactions. 
More specifically, we modeled recombination among all distinct pairs of donor-
recipient bacterial species or strains in our analysis ((55×54) pairs). From each given 
pair we generated a recombinant offspring by adding a given (𝑝) number of 
consecutive metabolic genes from the donor genome, followed by deleting a given 
(𝑞) number of consecutive metabolic genes from the recipient genome. Importantly, 
we examined all possible combinations of (𝑝) consecutive genes from the donor and 
(𝑞) consecutive genes from the recipient. Thus, for a donor genome with 𝑛 metabolic 
genes, and a recipient genome with 𝑚 metabolic genes, we generated all (𝑛 − 𝑝 +1)×(𝑚 − 𝑞 + 1) recombinant offspring, a number that exceeded one million 
offspring for most pairs.  Note that (𝑝) and (𝑞) are selected based on the gene-
reaction association rules of the donor and recipient species or strains to ensure that 
any one recombination event adds on average 5 new reactions and deletes 5 reactions 
from the recipient metabolic network.  
To study the effect of linkage on the emergence of novel phenotypes, we followed a 
second recombination procedure that neglects linkage between metabolic genes. That 
is, we added or deleted reactions randomly, just as we had done for randomly 
sampled metabolic networks, irrespective of the genomic position of the metabolic 
genes encoding these reactions. To do so, we examined all distinct donor-recipient 
pairs, and from each pair we generated the same number ((𝑛 − 𝑝 + 1)×(𝑚 − 𝑞 + 1)) 
of recombinant offspring as in the linkage-based approach, ensuring that on average 5 
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randomly chosen reactions are added from the donor and deleted from the recipient 
metabolic network.  
To identify innovative offspring among all the generated recombinants, we used 30 
carbon-containing metabolites on which none of the 55 bacterial species or strains are 
predicted to be viable (listed in supplementary text S3). To predict viability of a 
recombinant metabolic network using FBA, we used the objective function of the 
recipient, because recombinants are much more similar to the recipient than to the 
donor.  
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4.7. Supplementary Information 
S1: Genome-scale metabolic networks and their phenotypic representations 
Similar to our previous work describing the procedures used here (1), and following 
common practice in metabolic systems biology (2–4), we represent an organism’s 
metabolic genotype as the set of genomically encoded (enzyme-catalyzed) 
biochemical reactions proceeding inside the organism. This metabolic genotype 
specifies a metabolism or metabolic network, a network of chemical reactions 
encoded by the genotype. A metabolic reaction network enables an organism to 
extract energy and produce small biomass building blocks, such as amino acids, from 
extracellular nutrients. Inference of this genotype from genomic and biochemical 
information has been successful for multiple organisms (5, 6).  
Any one metabolic reaction network contains a subset of the “reaction universe” of all 
biochemical reactions that take place in prokaryotes (See text S2). We have curated a 
representation of this universe, which comprises 5,906 reactions and is based on 
current metabolic knowledge (7–10). We represent an organism’s metabolic genotype 
as a binary vector of length 5,906. Each entry of this vector corresponds to a given 
reaction in the reaction universe, and is equal to one if the corresponding reaction is 
present in the metabolic network, and zero otherwise. Thus, each genotype can be 
thought of as a single member of a vast space of all possible metabolic networks, 
which contains 25906 distinct genotypes.  
We define the phenotype of a given metabolic genotype based on its viability in 50 
distinct minimal environments that differ only in the carbon source they harbor (See 
Text S3). We consider that a genotype is viable on a given carbon source, if it can 
produce all essential biomass precursor molecules from the given carbon source, and 
we use Flux Balance Analysis (FBA, See text S4) to determine viability (11). We 
represent the phenotype of a given metabolic genotype as a binary vector of length 50. 
Each entry of this vector corresponds to a given carbon source, and it is equal to one if 
the genotype is viable on this carbon source, and zero otherwise.  
S2: Reaction universe  
The reaction universe we curated is a set of metabolic reactions in which each reaction 
is known to occur in some prokaryotic organisms. For the curation of this universe, 
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we used data from the LIGAND database (7, 8) of the Kyoto Encyclopedia of Genes 
and Genomes (9). Briefly, the LIGAND database, which is comprised of the 
REACTION and the COMPOUND databases, provides information on reactions, 
associated stoichiometric information, chemical compounds involved in a reaction, 
and the Enzyme Classification (E.C.) identifier of each reaction. From the 
REACTION and the COMPOUND databases we excluded (i) all reactions involving 
polymer metabolites of unspecified numbers of monomers, or general polymerization 
reactions with uncertain stoichiometry, (ii) reactions involving glycans, due to their 
complex structure, (iii) reactions with unbalanced stoichiometry, and, (iv) reactions 
involving complex metabolites without chemical information about their structure 
(10). Moreover, we do not consider unknown reactions, and we also do not take into 
account spontaneous reactions, or reactions that depend on external stimuli. The 
published E. coli metabolic model (iAF1260) consists of 1397 non-transport reactions 
(12). We merged all reactions in the E. coli model with the reactions in the KEGG 
dataset, and retained only the unique (non-duplicate) reactions. This resulted in a 
universe of reactions consisting of 682 transport, 5,906 non-transport reactions and 
5030 metabolites. The reaction universe is available online 
(https://github.com/rzgar/EMETNET/tree/master/UNIVERSE). 
S3: Chemical environments 
We consider 50 minimal growth environments, each of which includes oxygen, 
ammonium, inorganic phosphate, sulfate, sodium, potassium, cobalt, iron (Fe2+ and 
Fe3+), protons, water, molybdate, copper, calcium, chloride, magnesium, manganese, 
zinc, and a specific carbon source. Importantly, to represent different chemical 
environments, we vary the carbon source while keeping all other nutrients constant. 
We consider a metabolic network viable on a given carbon source, if it can synthesize 
all essential biochemical precursors when this carbon source is provided as the sole 
carbon source in the minimal medium just described.  
We used 50 carbon sources for our analysis of randomly sampled metabolic networks, 
including the following 27 glycolytic carbon sources: D-glucose, D-glucose 6-
phosphate, trehalose, maltose, lactose, D-fructose 6-phosphate, D-fructose, D-
mannose, D-mannitol, D-glucose 1-phosphate, D-sorbitol, maltotriose, D-allose, D-
ribose, D-xylose, D-gluconate, 5-dehydro-D-gluconate, L-rhamnose, L-fucose, L-
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arabinose, L-lyxose, D-galactose, melibiose, D-galactonate, N-acetyl-D-glucosamine, 
N-acetyl-D-mannosamine, N-acetylneuraminate.  
In addition, we used the following 20 gluconeogenic carbon sources: pyruvate, L-
alanine, L-lactate, D-alanine, D-malate, acetate, L-serine, L-malate, D-serine, glycine, 
glycolate, L-aspartate, succinate, fumarate, 2-oxoglutarate, D-galacturonate, D-
galactarate, D-glucarate, L-galactonate, D-glucoronate. And we used the following 
three nucleosides as carbon sources: adenosine, deoxyadenosine, inosine. 
To study the emergence of novel phenotypes in 55 prokaryotic metabolic networks 
from the BiGG database (13) (see methods section 2.4 in the main text), we used the 
following 30 carbon sources on which none of the 55 metabolic networks are 
predicted to be viable: Biotin, riboflavin, folate, pimelate, urea, carbonic acid, 
bicarbonate, methanol, trimethylamine, D-methionine, glycine betaine, gamma-
butyrobetaine, choline, L-phenylalanine, L-leucine, L-tyrosine, L-methionine, 
thiamin, 6-diaminoheptanedioate, (R)-pantothenate, spermidine, taurine, isocytosine, 
protoheme, nicotinamide adenine dinucleotide, L-fucose 1-phosphate, dimethyl-
sulfide, L-carnitine, dimethyl sulfoxide, and 1,5-diaminopentane.   
S4: Flux balance analysis  
Flux balance analysis (FBA) is a computational method that is widely used for the 
quantitative analysis and modeling of metabolic networks (11). Based on the 
stoichiometric coefficients of the metabolites participating in the reactions of a given 
metabolic network, FBA predicts the metabolic flux through each reaction. 
Stoichiometric coefficients are stored in a stoichiometric matrix S, which is of 
dimension m×n, where m and n, denote the number of metabolites and the number of 
reactions in a metabolic network. FBA constrains the flux through each reaction based 
on the assumption that a metabolic network is in a steady state where metabolite 
concentrations do not change, i.e., 𝑆𝑣 = 0, where v is the vector of metabolic fluxes vi 
through reaction i. The solutions of the equation 𝑆𝑣 = 0, that is, the null space of 
matrix S, comprises all flux vectors that are allowable in steady state. The null space 
is further constrained by physicochemical information regarding the maximum and 
minimum possible fluxes through each reaction. FBA relies on an optimization 
procedure called linear programming to identify those among the allowable flux 
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vector(s) that maximize an objective function Z. This task can be formulated as 
finding a flux vector v* with the property 
v* = maxv Z(v) = maxv { cTv | Sv = 0, a ≤ v ≤ 𝑏}, 
where the vector c contains a set of scalar coefficients representing the maximization 
criterion, and each entry ai and bi of vectors 𝑎 and 𝑏, indicates the minimally and 
maximally possible flux through reaction i. The vector c represents the proportions of 
each small biomass molecule in a cell’s biomass. Therefore v* maximizes the biomass 
growth flux, that is, the rate at which a metabolic network can produce biomass (11). 
Here we use FBA to predict qualitatively whether a given metabolic network is viable 
in a given environment, and we consider a metabolic network viable if it can produce 
all essential biomass precursors. More precisely, FBA predicts a metabolic network as 
viable on a given environment, if its biomass flux rate exceeds 0.001 1/ℎ. In a free-
living bacterium like E. coli, there are approximately 60 such molecules including 20 
amino acids, DNA, and RNA precursors, lipids and cofactors. We used the biomass 
composition of the E. coli metabolic model iAF1260 to define the vector c (12). 
Moreover, we used the packages CPLEX (11.0, ILOG; http://www.ilog.com/) and 
CLP (1.4, Coin-OR; https://projects/coin-or.org/Clp) to solve the linear programming 
problem of FBA.  
The major limitation of FBA is that it neglects regulatory constraints that can arise 
through suboptimal expression or regulation of enzymes. Newly horizontally 
transferred genes cannot easily establish regulatory interactions with their host genes, 
and it may thus take considerable adaptive evolution until they become expressed at a 
maximal or optimal level (14). Such regulatory constraints would be especially 
important if we focused on quantitative predictions of biomass growth (15). However, 
we use FBA solely for qualitative prediction of viability. This focus on qualitative 
phenotypes is biologically sensible. The reason is that many organisms grow slowly in 
their native environment (16, 17), implying that regulation for maximal biomass 
production is far from universal. Moreover, we note that regulatory constraints can 
easily be broken in evolution, even on the short time scales of laboratory evolution 
experiments (15, 18, 19).  
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S5: Generation of random metabolic networks 
We here employ a previously described in silico process which relies on Markov 
Chain Monte Carlo (MCMC) random walks to generate metabolic networks that 
comprise random sets of metabolic reactions that are viable on a given carbon source 
(10, 20). This procedure can produce metabolic networks that are sampled uniformly 
from the set of all metabolic networks viable on a given carbon source (10, 20). 
Briefly, in each step of such a random walk we perform a reaction swap, defined as 
altering a metabolic network by adding a randomly chosen reaction from the reaction 
universe, and then deleting a reaction randomly chosen from the set of reactions 
present in the metabolic network. If the reaction swap disrupts the metabolic 
network’s viability on the given carbon source (as determined by FBA) we reject it, 
and perform another reaction swap until we find a swap that does not disrupt viability. 
This procedure also ensures that the total number of reactions remains constant. For 
the MCMC method to produce random samples of metabolic networks, it is essential 
to carry out enough reaction swaps to “erase” the random walker’s similarity to the 
initial metabolic network. Previously, it has been shown that 3 × 103 reaction swaps 
are sufficient for this purpose (10, 20). Each of our random walks starts from E. coli’s 
metabolic network and performs 104 reaction swaps before storing the final metabolic 
network for further analysis. We used 104 independent random walks conducted in 
this way to create 104 random metabolic networks viable on each of the 50 carbon 
sources.  
S6: Generation of parental metabolic network pairs 
Some of our analyses required us to recombine pairs of “parental” metabolic networks 
with particular features, such as being viable on a specific carbon source (and only on 
that carbon source), or having a given genotypic distance (D), defined as the number 
of reactions differing between the parents. Generating parents with a given genotypic 
distance (D) is not straightforward, because the random metabolic networks generated 
by MCMC sampling generally have genotypic distances sufficiently large (D ≈ 2,000) 
to be biologically unrealistic for modeling frequently recombining prokaryotic 
genomes. To create less distant metabolic network pairs, we took an MCMC random 
walk approach. It revolves around a reaction-swapping random walk starting with a 
pair of randomly chosen metabolic networks from our sample of 104 sampled 
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metabolic networks that are exclusively viable on a given carbon source. In each step 
of this random walk, we subjected each parental metabolic network to a reaction 
swap, and we accepted each reaction swap if it (i) preserved the original phenotype, 
and (ii) did not increase the genotypic distance of the two metabolic networks after the 
swap, otherwise we rejected the reaction swap. We continued this procedure until the 
genotypic distance between the metabolic networks became equal to a desired 
distance D. We note that this procedure is very time-consuming when applied to the 
thousands of parents we study here.  
Finally, to generate parental metabolic networks with a given number of reactions, we 
started from a random viable metabolic network generated by MCMC sampling, as 
described in the text S5. All such metabolic networks have the same number of 
reactions as E. coli (2,079). We then applied a sequence of individual and random 
reaction deletions, where we required that each deletion preserve viability, until the 
network had reached the desired size.  
S7. Estimation of the metabolic distance between carbon sources 
For each pair of carbon sources (𝐶! ,𝐶!), we calculated metabolic distance with two 
different approaches, a direct approach that is based on the shortest path between 
carbon sources in substrate graph (21), and an indirect approach that is based on 
carbon source-dependent superessentiality of metabolic reactions in metabolic 
networks (22).  
The first approach relies on the substrate graph of a metabolic network, in which 
vertices correspond to metabolites. Two metabolites are linked via an edge, if the 
metabolites participate in the same metabolic reactions as either a substrate or a 
product. From this substrate graph we excluded currency metabolites, which are 
metabolites that transfer small chemical groups, and are involved in many reactions 
(23). Specifically, we excluded protons, H2O, ATP (adenosine triphosphate), ADP 
(adenosine diphosphate), AMP (adenosine monophosphate), NADP(H) (nicotinamide 
adenosine dinucleotide diphosphate), NAD(H) (nicotinamide adenosine 
dinucleotide), and Pi (inorganic phosphate), CoA (coenzyme A), hydrogen peroxide, 
ammonia, ammonium, bicarbonate, GTP (guanosine triphosphate), GDP (guanosine 
diphosphate), and PPi (inorganic diphosphate) that occurred in both the cytoplasmic 
and periplasmic compartments. In addition, we excluded oxidized and reduced forms 
of cofactors such as quinone, ubiquinone, glutathione, thioredoxin, flavodoxin and 
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flavin mononucleotide. For all metabolic networks viable on 𝐶! , we measured the 
shortest path in the substrate graph between 𝐶! and any other 𝐶! , 𝑗 ≠ 𝑖 using Dijkstra’s 
algorithm (24). Then, we considered the average shortest path between 𝐶! and 𝐶! 
among metabolic networks viable on 𝐶! as the metabolic distance between 𝐶! and 𝐶!.  
In the second approach, we take advantage of the fact that metabolic reactions show 
varying degrees of essentiality among different metabolic networks that are viable on 
the same carbon sources. Any one reaction can be essential in one such network and 
inessential in another, depending on which reactions and pathways are present in the 
network. One can quantify a reaction’s degree of essentiality in randomly sampled 
viable networks via a “superessentiality index”, defined as the fraction of metabolic 
networks in which the reaction is essential for viability on a given carbon source (22). 
Highly superessential reactions are essential in most random viable networks, and 
cannot be by-passed easily by alternative metabolic pathways. We first computed the 
superessentiality index of each reaction on each carbon source 𝐶!, and assembled this 
information into a superessentiality vector.  Each element of this vector corresponds 
to one of the 5,906 reactions in the reaction universe, and contains the fraction of 
random viable metabolic networks in which the reaction is essential for viability on 𝐶!. We then computed the Euclidian distance between the superessentiality vectors 
for all pairs of carbon sources 𝐶! and 𝐶! as a proxy for metabolic distance between the 
two carbon sources.  
S8: Distance measure between carbon sources based on superessential reactions  
In the second approach, we take advantage of the fact that metabolic reactions show 
varying degrees of essentiality among different metabolic networks that are viable on 
the same carbon sources. Any one reaction can be essential in one such network and 
inessential in another, depending on which reactions and pathways are present in the 
network. One can quantify a reaction’s degree of essentiality in randomly sampled 
viable networks via a “superessentiality index”, defined as the fraction of metabolic 
networks in which the reaction is essential for viability on a given carbon source (22). 
Highly superessential reactions are essential in most random viable networks, and 
cannot be by-passed easily by alternative metabolic pathways. We first computed the 
superessentiality index of each reaction on each carbon source 𝐶!, and assembled this 
information into a superessentiality vector.  Each element of this vector corresponds 
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to one of the 5,906 reactions in the reaction universe, and contains the fraction of 
random viable metabolic networks in which the reaction is essential for viability on 𝐶!. We then computed the Euclidian distance between the superessentiality vectors 
for all pairs of carbon sources 𝐶! and 𝐶! as a proxy for metabolic distance between the 
two carbon sources.  
Previous work showed that highly superessential reactions are more likely to be 
involved in metabolic innovation (1). We thus also wanted to compute a biochemical 
distance measure of carbon sources based on this index. To this end, we computed, for 
each carbon source, the superessentiality index of all reactions belonging to the 
reaction universe, which yields a superessentiality vector of length 5,906. We then 
computed the Euclidian distance between the superessentiality vectors for all pairs of 
carbon sources 𝐶! and 𝐶! as a proxy for the biochemical distance between the two 
carbon sources. Fig. S27a shows that the number of innovative offspring, which are 
generated by recombination between parents viable on 𝐶!, and gain viability on a 
given carbon source 𝐶!  is significantly correlated with the Euclidian distance between 
the superessentiality vectors for (𝐶! ,𝐶!) (Pearson r = -0.3935, and P < 10-83). 
S9: Random metabolic networks and erroneous energy generating cycles  
A recent study by Fritzemeier et al. showed that most of the published genome-scale 
metabolic networks include thermodynamically impossible energy-generating cycles 
(EGCs), which are capable of charging energy metabolites without nutrient 
consumption (25). It showed that these EGCs can artificially inflate biomass flux by 
25% and could be particularly problematic in evolutionary simulations, which 
involves incorporation of foreign metabolic reactions from other species.  
We applied the approach of Fritzemeier et al., to identify EGCs in metabolic networks 
(25), using 15 different energy dissipation reactions (EDRs) for each of the 15 
different types of energy metabolites in the cell.  (See 
https://doi.org/10.1371/journal.pcbi.1005494.s002 for complete information on these 
reactions). We maximized one energy dissipation reaction flux 𝑣! at a time, while 
preventing all influx of external nutrients into the model. The problem can be 
mathematically expressed as follows:  max 𝑣! subject to: 𝑆𝑣 = 0 ∀𝑖 ∉ 𝐸: 𝑣!!!" ≤ 𝑣! ≤ 𝑣!!"# ∀𝑖 ∈ 𝐸: 𝑣! = 0 
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where 𝑆 is the stoichiometric matrix describing a metabolic system, 𝑣 is the vector of 
all metabolic fluxes, 𝑑 is the index of one of the energy dissipation reactions, 𝑣!"# 
and 𝑣!"# are vectors of lower and upper reaction bounds, and 𝐸 is the set of indices 
of all exchange reactions. An optimal value 𝑣!∗  for this optimization with 𝑣!∗ > 0 for 
at least one of the energy dissipation reactions demonstrates the existence of at least 
one EGC in the corresponding metabolic network. 
Using this approach, we first determined that the initial E. coli metabolic network 
with 2079 reactions (12) from which we started most of our MCMC sampling had no 
EGCs. However, we found that 97.3% and 97.8% of our randomly sampled metabolic 
networks viable on glucose and acetate, respectively, harbored at least one EGC.  
To determine whether these EGCs artificially inflated the number of innovative 
offspring, we sampled EGC-free parental metabolic networks. To do so, we modified 
our MCMC approach such that each sampled metabolic network not only retained 
viability in a given environment, but was also EGC-free. To fulfill these goals, we 
required that each step (reaction swap) in our MCMC sampling preserved viability on 
a given carbon source, and did not introduce an EGC (checked by the EGCs 
identification approach described above). Using this approach, we generated 1,000 
pairs of EGC-free metabolic networks viable exclusively on glucose, and 1,000 pairs 
of EGC-free networks viable only on acetate. We then generated 1,000 recombinant 
offspring from each pair. Recombination between EGC-free metabolisms viable 
exclusively on glucose resulted in 29,941 innovative offspring, only 7.41% fewer 
than the corresponding number for EGC-containing metabolisms (32,338). Likewise, 
we observed 46,941 innovative offspring emerging from EGC-free parental 
metabolisms viable exclusively on acetate, 5.57% fewer than the corresponding 
number for EGC-containing metabolisms (49,708). Thus, removing EGCs slightly 
reduces the incidence of innovation (figure S30). Importantly, the patterns of relative 
constraints remain almost exactly unchanged (figure S31). 
 Fritzemeier et al. showed that EGCs could artificially increase the biomass rate of 
metabolic networks by 25% (25). However, figure S32 indicates that the majority of 
viable networks we study already have a biomass flux considerably larger than our 
threshold of viability, so reducing their biomass production rate by 25% will not result 
in a viability loss for most metabolisms, which is why excluding EGCs does not 
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substantially reduce the emergence of novel phenotypes.  
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Supplementary Figures 
 
 
 
Figure S1: Recombination can create all 50 carbon-use phenotypes considered here (n = 
20). A) The horizontal axis shows the number of innovative recombinant offspring (out of one 
million offspring) resulting from recombination between parents viable exclusively on the 
carbon source specified on the vertical axis. This number varies by a factor 37, ranging from 
977 on Adenosine to 356,378 on D-galactose. B) Number of innovative recombinants (per 
million offspring) gaining viability on the novel carbon source specified on the x-axis. This 
number varies by a factor 15, ranging from 4,042 on melibiose to 63,634 on D-glucose. C) 
Number of innovative recombinants (per million offspring, color-coded according to the 
legend) resulting from recombination between parents viable exclusively on the carbon source 
specified in panel A, which have gained viability on the novel carbon source specified in 
panel B In these analyses, parental metabolic networks contain ||G|| = 2,079 reactions, the 
same as in the E. coli metabolic network, and they differ in D = 100 reactions. Moreover, n = 
20 reactions are swapped between parental metabolic networks in a recombination event.  
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Figure S2: Recombination can create all 50 carbon-use phenotypes considered here (n = 
30). A) The horizontal axis shows the number of innovative recombinant offspring (out of one 
million offspring) resulting from recombination between parents viable exclusively on the 
carbon source specified on the vertical axis. This number varies by a factor 32, ranging from 
299 on adenosine to 9,503 on acetate. B) Number of innovative recombinants (per million 
offspring) gaining viability on the novel carbon source specified on the x-axis. This number 
varies by a factor 16, ranging from 923 on melibiose to 14,452 on D-glucose. C) Number of 
innovative recombinants (per million offspring, color-coded according to the legend) resulting 
from recombination between parents viable exclusively on the carbon source specified in 
panel A, which have gained viability on the novel carbon source specified in panel B. In these 
analyses, parental metabolic networks contain ||G|| = 2,079 reactions, the same as in the E. coli 
metabolic network, and they differ in D = 100 reactions. Moreover, n = 30 reactions are 
swapped between parental metabolic networks in a recombination event.  
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Figure S3: Negative correlation between (𝑁 !!→ ) and (𝑁 →!!). Each circle corresponds to a 
given carbon source 𝐶!. The vertical axis shows (𝑁 !!→ ), the number of metabolic innovations 
emerging from parents viable on carbon source 𝐶!. The horizontal axis shows (𝑁 →!!), the 
number of innovations leading to viability on 𝐶!. There is a negative correlation between (𝑁 !!→ ) and (𝑁 →!!), regardless of the number (n) of reactions exchanged: A) (n = 10, 
Pearson r = -0.239, P < 0.093), B) (n = 20, Pearson r = -0.248, P < 0.082), C) (n = 30, 
Pearson r = -0.256, P < 0.073). For all analyses the genotypic distance between parents is D = 
100. 
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Figure S4: Fewer innovative offspring at higher genotypic distance (D) and smaller 
metabolic network size ||G||. Each circle corresponds to a pair of carbon sources (𝐶! ,𝐶!) and 
shows the number of innovative offspring gaining viability on 𝐶!, which are generated by 
recombination between parents viable on carbon source 𝐶!. The horizontal axis specifies the 
number of innovative offspring where parents have genetic distance D = 100, and metabolic 
network size ||G|| = 2,079. The vertical axes provide the same information, but for parents 
with A) genotypic distance D = 1,000, and metabolic network size ||G|| = 2,079 reactions, B) 
genotypic distance D = 100, and metabolic network size ||G|| = 1,800 reactions, and C) 
genotypic distance D = 100, and metabolic network size ||G|| = 1,600 reactions. The dashed 
diagonal lines correspond to the identity line (y = x). Note that in all three panels, most or all 
data lie below this line, indicating that higher parental genotypic distance and lower metabolic 
network size lead to fewer innovative offspring for almost all carbon source pair. 
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Figure S5: Recombination can create all 50 carbon-use phenotypes considered here (D = 
1,000). A) The horizontal axis shows the number of innovative recombinant offspring (out of 
one million offspring) resulting from recombination between parents viable exclusively on the 
carbon source specified on the vertical axis. This number varies by a factor 25, ranging from 
662 on adenosine to 17,132 on L-lactate. B) Number of innovative recombinants (per million 
offspring) gaining viability on the novel carbon source specified on the x-axis. This number 
varies by a factor 33, ranging from 1081 on L-galactonate to 36,051 on D-glucose. C) 
Number of innovative recombinants (per million offspring, color-coded according to the 
legend) resulting from recombination between parents viable exclusively on the carbon source 
specified in panel A, which have gained viability on the novel carbon source specified in 
panel B. In these analyses, parental metabolic networks contain ||G|| = 2,079 reactions, the 
same number as the E. coli metabolic network, and they differ in D = 1,000 reactions. 
Moreover, n = 10 reactions are swapped between parental metabolic networks in a 
recombination event.  
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Figure S6: Recombination can create all 50 carbon-use phenotypes considered here (||G|| 
= 1800). A) The horizontal axis shows the number of innovative recombinant offspring (out of 
one million offspring) resulting from recombination between parents viable exclusively on the 
carbon source specified on the vertical axis. This number varies by a factor 38, ranging from 
120 on adenosine to 4,616 on L-lactate. B) Number of innovative recombinants (per million 
offspring) gaining viability on the novel carbon source specified on the x-axis. This number 
varies by a factor 79, ranging from 122 on L-lyxose to 9,657 on D-glucose. C) Number of 
innovative recombinants (per million offspring, color-coded according to the legend) resulting 
from recombination between parents viable exclusively on the carbon source specified in 
panel A, which have gained viability on the novel carbon source specified in panel B. In these 
analyses, parental metabolic networks contain ||G|| = 1,800 reactions and differ in D = 100 
reactions. Moreover, n = 10 reactions are swapped between parental metabolic networks in a 
recombination event.  
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Figure S7: Recombination can create all 50 carbon-use phenotypes considered here (||G|| 
= 1,600). A) The horizontal axis shows the number of innovative recombinant offspring (out 
of one million offspring) resulting from recombination between parents viable exclusively on 
the carbon source specified on the vertical axis. This number varies by a factor 58, ranging 
from 28 on deoxyadenosine to 1,623 on acetate. B) Number of innovative recombinants (per 
million offspring) gaining viability on the novel carbon source specified on the x-axis. This 
number varies by a factor 176, ranging from 19 on D-glucuronate to 3,344 on D-glucose. C) 
Number of innovative recombinants (per million offspring, color-coded according to the 
legend) resulting from recombination between parents viable exclusively on the carbon source 
specified in panel A, which have gained viability on the novel carbon source specified in 
panel B. In these analyses, parental metabolic networks contain ||G|| = 1,600 reactions and 
differ in D = 100 reactions. Moreover, n = 10 reactions are swapped between parental 
metabolic networks in a recombination event.  
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Figure S8: Fewer innovative offspring from phenotypically heterogeneous parents than 
from phenotypically homogenous parents. Each circle corresponds to a given pair of carbon 
sources (𝐶! ,𝐶!) and shows the number of innovative offspring gaining viability on 𝐶!, that are 
generated by recombination between parents viable on carbon source 𝐶!. The horizontal axis 
specifies the number of innovative offspring for parents that are viable on the same carbon 
sources (phenotypically homogeneous parents). The vertical axes show the number of 
innovative offspring for A) parental donors viable on D-glucose and parental recipients viable 
on 𝐶!, and B) parental recipients are viable on D-glucose, and parental donors viable on 𝐶!. In 
these analyses, all parents have ||G|| = 2,079 reactions, the same as the E. coli metabolic 
network, and their genotypic distance (D) is constant and equals 100. Note that in both panels, 
the majority of circles (with few exceptions) are placed below the identity (y = x) line, 
indicating that it is more likely for phenotypically homogenous parents to generate innovative 
offspring than for phenotypically heterogeneous parents. 
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Figure S9: Recombination can create all 50 carbon-use phenotypes considered here 
(Parents with heterogeneous phenotypes, donors viable only on glucose). A) The 
horizontal axis shows the number of innovative recombinant offspring (out of one million 
offspring) resulting from recombination between donor parents viable on glucose and 
recipient parents that are viable exclusively on the carbon source specified on the vertical axis. 
This number varies by a factor 32, ranging from 1,371 on deoxyadenosine to 43,615 on 
acetate. B) Number of innovative recombinants (per million offspring) gaining viability on the 
novel carbon source specified on the x-axis. This number varies by a factor 44, ranging from 
729 on N-acetylneuraminate to 32,378 on D-fructose. C) Number of innovative recombinants 
(per million offspring, color-coded according to the legend) resulting from recombination 
between donor parents viable on glucose, and recipient parents viable exclusively on the 
carbon source specified in panel A, which have gained viability on the novel carbon source 
specified in panel B. In these analyses, parental metabolic networks contain ||G|| = 2,079 
reactions, the same number as in the E. coli metabolic network, and they differ in D = 100 
reactions. Moreover, n = 10 reactions are swapped between parental metabolic networks in a 
recombination event.  
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Figure S10: Recombination can create all 50 carbon-use phenotypes considered here 
(Parents with heterogeneous phenotypes, recipients viable only on glucose). A) The 
horizontal axis shows the number of innovative recombinant offspring (out of one million 
offspring) resulting from recombination between recipient parents viable on glucose and 
donor parents viable exclusively on the carbon source specified on the vertical axis. This 
number varies by a factor 5, ranging from 3,511 on D-malate to 18,856 on D-glucose. B) 
Number of innovative recombinants (per million offspring) gaining viability on the novel 
carbon source specified on the x-axis. This number varies by a factor 204, ranging from 343 
on acetate to 70,292 on D-gluconate. C) Number of innovative recombinants (per million 
offspring, color-coded according to the legend) resulting from recombination between 
recipient parents viable on glucose, and donor parents viable exclusively on the carbon source 
specified in panel A, which have gained viability on the novel carbon source specified in 
panel B. In these analyses, parental metabolic networks contain ||G|| = 2,079 reactions, the 
same as in the E. coli metabolic network, and they differ in D = 100 reactions. Moreover, n = 
10 reactions are swapped between parental metabolic networks in a recombination event.  
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Figure S11: Emergence of innovative offspring can be constrained by parental 
phenotypes (n = 20). A) The horizontal axis shows the carbon source on which parental 
metabolisms are viable, and the vertical axis shows the number of novel carbon sources 
(among the remaining 49 carbon sources) on which at least one innovative offspring results 
from recombination between parental metabolic networks. B) Fraction of innovative 
recombinants (color-coded according to the legend) resulting from recombination between 
parents viable exclusively on the carbon source specified on the vertical axis, which have 
gained viability on the novel carbon source specified on the horizontal axis. C) Dendrogram 
of carbon sources clustered based on their “innovation distance” defined by the data in panel 
B. We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic 
carbon sources, (except D-galacturonate, L-galactonate, and D-glucoronate, (shown by cyan 
circles), which are gluconeogenic carbon sources.). In these analyses, parental metabolic 
networks contain ||G|| = 2,079 reactions, the same number as in the E. coli metabolic network, 
and they differ in D = 100 reactions. Moreover, n = 20 reactions are swapped between 
parental metabolic networks in a recombination event.  
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Figure S12: Emergence of innovative offspring can be constrained by parental 
phenotypes (n = 30). A) The horizontal axis shows the carbon source on which parental 
metabolisms are viable, and the vertical axis shows the number of novel carbon sources 
(among the remaining 49 carbon sources) on which at least one innovative offspring results 
from recombination between parental metabolic networks. B) Fraction of innovative 
recombinants (color-coded according to the legend) resulting from recombination between 
parents viable exclusively on the carbon source specified on the vertical axis, which have 
gained viability on the novel carbon source specified on the horizontal axis. C) Dendrogram 
of carbon sources clustered based on their “innovation distance” defined by the data in panel 
B. We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic 
carbon sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan 
circles), which are gluconeogenic carbon sources.). In these analyses, parental metabolic 
networks contain ||G|| = 2,079 reactions, the same number as in the E. coli metabolic network, 
and they differ in D = 100 reactions. Moreover, n = 30 reactions are swapped between 
parental metabolic networks in a recombination event.  
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Figure S13: Emergence of innovative offspring can be constrained by parental 
phenotypes (D = 1,000). A) The horizontal axis shows the carbon source on which parental 
metabolisms are viable, and the vertical axis shows the number of novel carbon sources 
(among the remaining 49 carbon sources) on which at least one innovative offspring results 
from recombination between parental metabolic networks. B) Fraction of innovative 
recombinants (color-coded according to the legend) resulting from recombination between 
parents viable exclusively on the carbon source specified on the vertical axis, which have 
gained viability on the novel carbon source specified on the horizontal axis. C) Dendrogram 
of carbon sources clustered based on their “innovation distance” defined by the data in panel 
B. We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic 
carbon sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan 
circles), which are gluconeogenic carbon sources.). In these analyses, parental metabolic 
networks contain ||G|| = 2,079 reactions, the same number as in the E. coli metabolic network, 
and they differ in D = 1,000 reactions. Moreover, n = 10 reactions are swapped between 
parental metabolic networks in a recombination event.  
 
 
 
 
 
 
	 222	
 
 
 
 
 
 
 
 
 
A)
B)
C)
0
10
20
30
40
50
Nu
mb
er 
of 
ca
rbo
n s
ou
rce
s
Ad
en
os
ine
De
ox
ya
de
no
sin
e
N-
Ac
ety
l-D
-gl
uc
os
am
ine
Ino
sin
e
N-
Ac
ety
l-D
-m
an
no
sam
ine
D-
Gl
uc
os
e
N-
Ac
ety
lne
ura
mi
na
te
Py
ruv
ate
2-O
xo
glu
tar
ate
Ac
eta
te
Gl
yc
ine
L-
Al
an
ine
Su
cc
ina
te
L-
As
pa
rta
te
L-
Se
rin
e
D-
Fr
uc
tos
e 6
-ph
os
ph
ate
D-
Gl
uc
os
e 6
-ph
os
ph
ate
D-
Fr
uc
tos
e
D-
Gl
uc
os
e 1
-ph
os
ph
ate
D-
Ri
bo
se
Fu
ma
rat
e
D-
Ga
lac
tos
e
D-
Al
an
ine
L-
M
ala
te
D-
M
an
no
se
Gl
yc
ola
te
D-
Xy
los
e
L-
La
cta
te
D-
Gl
uc
uro
na
te
M
alt
os
e
La
cto
se
D-
Gl
uc
on
ate
L-
Ar
ab
ino
se
D-
Ga
lac
tur
on
ate
D-
M
an
nit
ol
D-
M
ala
te
L-
Rh
am
no
se
D-
Se
rin
e
D-
So
rbi
tol
D-
Gl
uc
ara
te
D-
Ga
lac
tar
ate
D-
Ga
lac
ton
ate
L-
Fu
co
se
5-D
eh
yd
ro-
D-
glu
co
na
te
Tr
eh
alo
se
D-
Al
los
e
L-
Ly
xo
se
M
alt
otr
ios
e
M
eli
bio
se
L-
Ga
lac
ton
ate
L-
Rh
am
no
se
L-
Fu
co
se
D-
Ri
bo
se
D-
Xy
los
e
D-
Ga
lac
ton
ate
D-
Gl
uc
uro
na
te
L-
Ar
ab
ino
se
5-D
eh
yd
ro-
D-
glu
co
na
te
L-
Ly
xo
se
D-
Gl
uc
on
ate
D-
Ga
lac
tur
on
ate
D-
M
an
nit
ol
D-
So
rbi
tol
M
alt
os
e
M
alt
otr
ios
e
M
eli
bio
se
D-
Ga
lac
tos
e
D-
Gl
uc
os
e 1
-ph
os
ph
ate
L-
Ga
lac
ton
ate
D-
Fr
uc
tos
e 6
-ph
os
ph
ate
D-
Al
los
e
D-
Gl
uc
os
e 6
-ph
os
ph
ate
D-
Fr
uc
tos
e
D-
M
an
no
se
Tr
eh
alo
se
La
cto
se
D-
Gl
uc
os
e
N-
Ac
ety
l-D
-gl
uc
os
am
ine
N-
Ac
ety
l-D
-m
an
no
sam
ine
N-
Ac
ety
lne
ura
mi
na
te
De
ox
ya
de
no
sin
e
Py
ruv
ate
Ac
eta
te
Gl
yc
ine
Su
cc
ina
te
Gl
yc
ola
te
D-
Gl
uc
ara
te
D-
Ga
lac
tar
ate
D-
M
ala
te
L-
La
cta
te
Fu
ma
rat
e
L-
M
ala
te
D-
Al
an
ine
L-
Se
rin
e
D-
Se
rin
e
2-O
xo
glu
tar
ate
L-
Al
an
ine
L-
As
pa
rta
te
Ino
sin
e
Ad
en
os
ine
0.1
0.2
0.3
0.4
0.5
0.6
0.7
L-RhamnoseL-FucoseD-RiboseD-XyloseD-GalactonateD-GlucuronateL-Arabinose5-Dehydro-D-gluconateL-LyxoseD-GluconateD-GalacturonateD-MannitolD-SorbitolMaltoseMaltotrioseMelibioseD-GalactoseD-Glucose 1-phosphateL-GalactonateD-Fructose 6-phosphateD-AlloseD-Glucose 6-phosphateD-FructoseD-MannoseTrehaloseLactoseD-GlucoseN-Acetyl-D-glucosamineN-Acetyl-D-mannosamineN-AcetylneuraminateDeoxyadenosinePyruvateAcetateGlycineSuccinateGlycolateD-GlucarateD-GalactarateD-MalateL-LactateFumarateL-MalateD-AlanineL-SerineD-Serine2-OxoglutarateL-AlanineL-AspartateInosineAdenosine 0
0.05
0.1
0.15
0.2
0.25
	 223	
Figure S14: Emergence of innovative offspring can be constrained by parental 
phenotypes (||G|| = 1,800). A) The horizontal axis shows the carbon source on which parental 
metabolisms are viable, and the vertical axis shows the number of novel carbon sources 
(among the remaining 49 carbon sources) on which at least one innovative offspring results 
from recombination between parental metabolic networks. B) Fraction of innovative 
recombinants (color-coded according to the legend) resulting from recombination between 
parents viable exclusively on the carbon source specified on the vertical axis, which have 
gained viability on the novel carbon source specified on the horizontal axis. C) Dendrogram 
of carbon sources clustered based on their “innovation distance” defined by the data in panel 
B. We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic 
carbon sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan 
circles), which are gluconeogenic carbon sources.). In these analyses, parental metabolic 
networks contain ||G|| = 1,800 reactions, and they differ in D = 100 reactions. Moreover, n = 
10 reactions are swapped between parental metabolic networks in a recombination event.  
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Figure S15: Emergence of innovative offspring can be constrained by parental 
phenotypes (||G|| = 1,600). A) The horizontal axis shows the carbon source on which parental 
metabolisms are viable, and the vertical axis shows the number of novel carbon sources 
(among the remaining 49 carbon sources) on which at least one innovative offspring results 
from recombination between parental metabolic networks. B) Fraction of innovative 
recombinants (color-coded according to the legend) resulting from recombination between 
parents viable exclusively on the carbon source specified on the vertical axis, which have 
gained viability on the novel carbon source specified on the horizontal axis. C) Dendrogram 
of carbon sources clustered based on their “innovation distance” defined by the data in panel 
B. We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic 
carbon sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan 
circles), which are gluconeogenic carbon sources, and L-rhamnose, and L-fucose (shown by 
red circles), which are glycolytic carbon sources). In these analyses, parental metabolic 
networks contain ||G|| = 1,600 reactions, and they differ in D = 100 reactions. Moreover, n = 
10 reactions are swapped between parental metabolic networks in a recombination event.  
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Figure S16: Emergence of innovative offspring can be constrained by parental 
phenotypes (Parents with heterogeneous phenotypes, donors viable only on glucose ). A) 
The horizontal axis shows the carbon source on which parental metabolisms are viable, and 
the vertical axis shows the number of novel carbon sources (among the remaining 49 carbon 
sources) on which at least one innovative offspring results from recombination between 
parental metabolic networks. B) Fraction of innovative recombinants (color-coded according 
to the legend) resulting from recombination between donor parents viable on glucose and the 
recipient parents viable exclusively on the carbon source specified on the vertical axis., which 
have gained viability on the novel carbon source specified on the horizontal axis. C) 
Dendrogram of carbon sources clustered based on their “innovation distance” defined by the 
data in panel B. We used UPGMA (unweighted pair group method with arithmetic means) for 
clustering carbon sources. Branches colored in red (cyan) correspond to glycolytic and 
gluconeogenic carbon sources, (except D-galacturonate, L-galactonate, and D-glucoronate 
(shown by cyan circles), which are gluconeogenic carbon sources.). In these analyses, parental 
metabolic networks contain ||G|| = 2,079 reactions, the same number as in the E. coli 
metabolic network, and they differ in D = 100 reactions. Moreover, n = 10 reactions are 
swapped between parental metabolic networks in a recombination event.  
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Figure S17: Emergence of innovative offspring can be constrained by parental 
phenotypes (Parents with heterogeneous phenotypes, recipients viable only on glucose ). 
A) The horizontal axis shows the carbon source on which parental metabolisms are viable, 
and the vertical axis shows the number of novel carbon sources (among the remaining 49 
carbon sources) on which at least one innovative offspring results from recombination 
between parental metabolic networks. B) Fraction of innovative recombinants (color-coded 
according to the legend) resulting from recombination between recipient parents viable on 
glucose and donor parents viable exclusively on the carbon source specified on the vertical 
axis., which have gained viability on the novel carbon source specified on the horizontal axis. 
C) Dendrogram of carbon sources clustered based on their “innovation distance” defined by 
the data in panel B. We used UPGMA (unweighted pair group method with arithmetic means) 
for clustering carbon sources. In this figure, main branches do not reflect glycolytic and 
gluconeogenic carbon sources as in other figures. In these analyses, parental metabolic 
networks contain ||G|| = 2,079 reactions, the same number as in the E. coli metabolic network, 
and they differ in D = 100 reactions. Moreover, n = 10 reactions are swapped between 
parental metabolic networks in a recombination event.  
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Figure S18: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes. A) The horizontal axis shows the carbon use phenotype 𝐶! of 
recombinant offspring. The vertical axis shows the number of parental carbon use phenotypes 
(among 49 possible such phenotypes), from which at least one innovative offspring gained 
viability on 𝐶!. B) Fraction of innovative recombinants (color-coded according to the legend) 
gaining viability on the novel carbon source specified on the horizontal axis. Recombinants 
are generated between parents viable exclusively on the carbon source specified on the 
vertical axis. C) Dendrogram of carbon sources clustered based on their “innovation distance” 
defined by the data in panel B. We used UPGMA (unweighted pair group method with 
arithmetic means) for clustering carbon sources. Branches colored in red (cyan) correspond to 
glycolytic and gluconeogenic carbon sources, with the exception of the gluconeogenic carbon 
sources D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan circles), and the 
glycolytic carbon sources L-rhamnose, and L-fucose (shown by red circles).  In these 
analyses, parental metabolic networks contain ||G|| = 2,079 reactions, the same number as the 
E. coli metabolic network, and they differ in D = 100 reactions. Moreover, n = 10 reactions 
are swapped between parental metabolic networks during recombination.  
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Figure S19: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes (n = 20). A) The horizontal axis shows the carbon use phenotype 𝐶! 
of recombinant offspring. The vertical axis shows the number of parental carbon use 
phenotypes (among 49 possible such phenotypes), from which at least one innovative 
offspring gained viability on 𝐶!. B) Fraction of innovative recombinants (color-coded 
according to the legend) gaining viability on the novel carbon source specified on the 
horizontal axis, which are generated from recombination between parents viable exclusively 
on the carbon source specified on the vertical axis. C) Dendrogram of carbon sources 
clustered based on their “innovation distance” defined by the data in panel B. We used 
UPGMA (unweighted pair group method with arithmetic means) for clustering carbon 
sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic carbon 
sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan circles), 
which are gluconeogenic carbon sources, and L-rhamnose, and L-fucose (shown by red 
circles), which are glycolytic carbon sources). In these analyses, parental metabolic networks 
contain ||G|| = 2,079 reactions, the same number as in the E. coli metabolic network, and they 
differ in D = 100 reactions. Moreover, n = 20 reactions are swapped between parental 
metabolic networks in a recombination event.  
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Figure S20: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes (n = 30). A) The horizontal axis shows the carbon use phenotype 𝐶! 
of recombinant offspring. The vertical axis shows the number of parental carbon use 
phenotypes (among 49 possible such phenotypes), from which at least one innovative 
offspring gained viability on 𝐶!. B) Fraction of innovative recombinants (color-coded 
according to the legend) gaining viability on the novel carbon source specified on the 
horizontal axis, which are generated from recombination between parents viable exclusively 
on the carbon source specified on the vertical axis. C) Dendrogram of carbon sources 
clustered based on their “innovation distance” defined by the data in panel B. We used 
UPGMA (unweighted pair group method with arithmetic means) for clustering carbon 
sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic carbon 
sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan circles), 
which are gluconeogenic carbon sources.).  In these analyses, parental metabolic networks 
contain ||G|| = 2,079 reactions, the same number as in the E. coli metabolic network, and they 
differ in D = 100 reactions. Moreover, n = 30 reactions are swapped between parental 
metabolic networks in a recombination event.  
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Figure S21: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes (D = 1,000). A) The horizontal axis shows the carbon use phenotype 𝐶! of recombinant offspring. The vertical axis shows the number of parental carbon use 
phenotypes (among 49 possible such phenotypes), from which at least one innovative 
offspring gained viability on 𝐶!. B) Fraction of innovative recombinants (color-coded 
according to the legend) gaining viability on the novel carbon source specified on the 
horizontal axis, which are generated from recombination between parents viable exclusively 
on the carbon source specified on the vertical axis. C) Dendrogram of carbon sources 
clustered based on their “innovation distance” defined by the data in panel B. We used 
UPGMA (unweighted pair group method with arithmetic means) for clustering carbon 
sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic carbon 
sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan circles), 
which are gluconeogenic carbon sources, and D-mannose (shown by red circles), which is a 
glycolytic carbon source). In these analyses, parental metabolic networks contain ||G|| = 2,079 
reactions, the same number as in the E. coli metabolic network, and they differ in D = 1,000 
reactions. Moreover, n = 10 reactions are swapped between parental metabolic networks in a 
recombination event.  
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Figure S22: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes (||G|| = 1,800). A) The horizontal axis shows the carbon use 
phenotype 𝐶! of recombinant offspring. The vertical axis shows the number of parental carbon 
use phenotypes (among 49 possible such phenotypes), from which at least one innovative 
offspring gained viability on 𝐶!. B) Fraction of innovative recombinants (color-coded 
according to the legend) gaining viability on the novel carbon source specified on the 
horizontal axis, which are generated from recombination between parents viable exclusively 
on the carbon source specified on the vertical axis. C) Dendrogram of carbon sources 
clustered based on their “innovation distance” defined by the data in panel B. We used 
UPGMA (unweighted pair group method with arithmetic means) for clustering carbon 
sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic carbon 
sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan circles), 
which are gluconeogenic carbon sources).  In these analyses, parental metabolic networks 
contain ||G|| = 1,800 reactions, and they differ in D = 100 reactions. Moreover, n = 10 
reactions are swapped between parental metabolic networks in a recombination event.  
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Figure S23: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes (||G|| = 1,600). A) The horizontal axis shows the carbon use 
phenotype 𝐶! of recombinant offspring. The vertical axis shows the number of parental carbon 
use phenotypes (among 49 possible such phenotypes), from which at least one innovative 
offspring gained viability on 𝐶!. B) Fraction of innovative recombinants (color-coded 
according to the legend) gaining viability on the novel carbon source specified on the 
horizontal axis, which are generated from recombination between parents viable exclusively 
on the carbon source specified on the vertical axis. C) Dendrogram of carbon sources 
clustered based on their “innovation distance” defined by the data in panel B. We used 
UPGMA (unweighted pair group method with arithmetic means) for clustering carbon 
sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic carbon 
sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan circles), 
which are gluconeogenic carbon sources, and L-rhamnose, and L-fucose (shown by red 
circles), which are glycolytic carbon sources).  . In these analyses, parental metabolic 
networks contain ||G|| = 1,600 reactions, and they differ in D = 100 reactions. Moreover, n = 
10 reactions are swapped between parental metabolic networks in a recombination event.  
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Figure S24: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes (Parents with heterogeneous phenotypes, donors viable only on 
glucose). A) The horizontal axis shows the carbon use phenotype 𝐶! of recombinant offspring. 
The vertical axis shows the number of parental carbon use phenotypes (among 49 possible 
such phenotypes), from which at least one innovative offspring gained viability on 𝐶!. B) 
Fraction of innovative recombinants (color-coded according to the legend) gaining viability 
on the novel carbon source specified on the horizontal axis, which are generated from 
recombination between donor parents viable exclusively on glucose and the recipient parents 
that are exclusively viable on the carbon source specified on the vertical axis. C) Dendrogram 
of carbon sources clustered based on their “innovation distance” defined by the data in panel 
B. We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic 
carbon sources, (except D-galacturonate, L-galactonate, and D-glucoronate (shown by cyan 
circles), which are gluconeogenic carbon sources.). In these analyses, parental metabolic 
networks contain ||G|| = 1,800 reactions, and differ in D = 100 reactions. Moreover, n = 10 
reactions are swapped between parental metabolic networks in a recombination event.  
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Figure S25: Emergence of innovative offspring is relatively but not absolutely contingent 
on parental phenotypes (Parents with heterogeneous phenotypes, recipients viable only 
on glucose). A) The horizontal axis shows the carbon use phenotype 𝐶! of recombinant 
offspring. The vertical axis shows the number of parental carbon use phenotypes (among 49 
possible such phenotypes), from which at least one innovative offspring gained viability on 𝐶!. B) Fraction of innovative recombinants (color-coded according to the legend) gaining 
viability on the novel carbon source specified on the horizontal axis, which are generated from 
recombination between recipient parents viable exclusively on glucose and donor parents that 
are exclusively viable on the carbon source specified on the vertical axis.  C) Dendrogram of 
carbon sources clustered based on their “innovation distance” defined by the data in panel B. 
We used UPGMA (unweighted pair group method with arithmetic means) for clustering 
carbon sources. Branches colored in red (cyan) correspond to glycolytic and gluconeogenic 
carbon sources, (with 12 exceptions; shown by 10 cyan circles, and 2 red circles.).  In these 
analyses, parental metabolic networks contain ||G|| = 1,800 reactions, and differ in D = 100 
reactions. Moreover, n = 10 reactions are swapped between parental metabolic networks in a 
recombination event.  
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Figure S26: Distance between carbon sources in substrate graphs and relative 
constraint in the emergence of innovative offspring. In all 4 panels, the vertical axis shows 
the number of innovative recombinants (per 1 million recombinant offspring) gaining 
viability on some new carbon source 𝐶! resulting from recombination between parental 
metabolic networks viable on carbon source 𝐶!. In panels A and C, the horizontal axes show 
the mean shortest path between carbon source 𝐶!  and 𝐶! in the substrate graph (supplementary 
text S7) of the metabolic networks viable on carbon source 𝐶!. In panel A) each circle 
corresponds to a given pair of carbon sources (𝐶!, 𝐶!), and data on both axes are significantly 
correlated (Pearson r=-0.2722, and P<10-41). In panel B) the carbon source pairs (𝐶!, 𝐶!) are 
divided into three groups based on their mean shortest path (||𝑆𝑃 (𝑖, 𝑗)||) between carbon 
source 𝐶!  and 𝐶! in the substrate graph of metabolic networks viable on carbon source 𝐶!: 
group 1 {𝑖, 𝑗|1 ≤ ||𝑆𝑃 (𝑖, 𝑗)|| ≤ 6}), group 2 {𝑖, 𝑗|6 < ||𝑆𝑃 (𝑖, 𝑗)|| ≤ 1}), and group 3 
{𝑖, 𝑗| | 𝑆𝑃 𝑖, 𝑗 | > 12}. Boxes span the 25-th to 75-th percentile, and whiskers indicate 
maxima and minima.  
In panel A, a non-uniform distribution of mean shortest paths (||𝑆𝑃 (𝑖, 𝑗)||) between carbon 
sources is evident on the horizontal axis. To exclude the possibility that the correlation in 
panel A is significant simply because of a higher number of data points for lower shortest 
path distances, we repeated the analyses shown in panels A and B by resampling from the 
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2500 pairs of carbon sources an equal number of pairs in each distance category, i.e., 284 
pairs (𝐶!, 𝐶!) with {𝑖, 𝑗|1 ≤ ||𝑆𝑃 (𝑖, 𝑗)|| ≤ 6}), 284 pairs (𝐶!, 𝐶!) with {𝑖, 𝑗|6 < ||𝑆𝑃 (𝑖, 𝑗)|| ≤12}), and 284 pairs (𝐶!, 𝐶!) with {𝑖, 𝑗| | 𝑆𝑃 𝑖, 𝑗 | > 12}, to create the subsampled data in 
panels C and D. In panel C) each circle corresponds to a given pair of carbon sources (𝐶!, 𝐶!), 
and data on both axes are significantly correlated (Pearson r=-0.3411, and P<10-24). In panel 
D), analogous to panel B, carbon source pairs (𝐶!, 𝐶!) are divided into three equally-sized 
groups based on their mean shortest path (||𝑆𝑃 (𝑖, 𝑗)||) between carbon source 𝐶!  and 𝐶! in 
the substrate graph of metabolic networks viable on carbon source 𝐶!: group 1 {𝑖, 𝑗|1 ≤||𝑆𝑃 (𝑖, 𝑗)|| ≤ 6}), group 2 {𝑖, 𝑗|6 < ||𝑆𝑃 (𝑖, 𝑗)|| ≤ 1}), and group 3 {𝑖, 𝑗| | 𝑆𝑃 𝑖, 𝑗 | > 12}. 
Boxes span the 25-th to 75-th percentile, and whiskers indicate maxima and minima. In these 
analyses, parental metabolic networks contain ||G||=2079 reactions, the same as the E. coli 
metabolic network, and they differ in D=100 reactions. Moreover, n=10 reactions are 
swapped between parental metabolic networks during recombination.  
 
Figure S27: In both panels, each circle corresponds to a given pair of carbon sources (𝐶!, 𝐶!) 
and the vertical axis shows the number of innovative recombinants (per 1 million 
recombinant offspring) gaining viability on some new carbon source 𝐶! resulting from 
recombination between parental metabolic networks viable on carbon source 𝐶!. The 
horizontal axes show A) the fraction of parental metabolic network pairs viable on carbon 
source 𝐶!, in which a reaction that can enable viability on carbon source 𝐶! can be transferred 
from the donor to the recipient metabolic network, and B) the Euclidian distance between 
superessentiality vectors of the corresponding pair of carbon sources, which we use as 
another proxy for the biochemical distance between carbon sources. In both panels the data 
plotted against one another are significantly correlated: A) Pearson r=0.163, and P<10-15, 
and B) Pearson r=-0.3935, and P<10-83. In these analyses, parental metabolic networks 
contain ||G||=2079 reactions, the same as the E. coli metabolic network, and they differ in 
D=100 reactions. Moreover, n=10 reactions are swapped between parental metabolic 
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networks during recombination. 
 
 
Figure S28: Emergence of innovative offspring is contingent on and constrained by 
parental genotypes. A) Number of innovative offspring resulting from linkage-based 
recombination between bacterial DNA donors specified on the vertical axis of panel B, and 
the corresponding recipient genotypes specified on the horizontal axis of panel C (coded 
according to the color legend). B) Total number of innovative recombinant offspring 
involving the donor genotype specified on the vertical axis. C) Total number of innovative 
recombinant offspring involving the recipient genotype specified on the horizontal axis.  
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Figure S29: Sample size and its effect on absolute and relative constraints. For this 
analysis, we used 1,000 parental metabolic networks that are viable exclusively on glucose, 
and in three different simulations we generated i) 100, ii) 1,000 and iii) 10,000 offspring from 
each parent, which amounts to i) 100,000 ii) 1,000,000 and iii) 10,000,000 total offspring, as 
indicated on the horizontal axes. The vertical axes show A) the number of distinct novel 
phenotypes (among a possible total of 49 phenotypes) that emerged in the offspring, and B) 
the coefficient of variation in the number of innovative offspring for different novel carbon 
usage phenotypes. In these analyses, parental metabolic networks contain ||G||=2079 reactions, 
the same as the E. coli metabolic network, and they differ in D=100 reactions. Moreover, 
n=10 reactions are swapped between parental metabolic networks during recombination.  
 
 
 
Figure S30: Erroneous energy generating cycles (EGCs) and the emergence of 
innovative offspring. The number of innovative offspring (per 1 million recombinants) 
emerging from recombination between parental metabolic networks that contain EGCs (blue) 
or that do not contain EGCs (yellow), and that are viable exclusively on glucose (left) and 
acetate (right). In these analyses, parental metabolic networks contain ||G||=2079 reactions, 
the same as the E. coli metabolic network, and they differ in D=100 reactions. Moreover, 
n=10 reactions are swapped between parental metabolic networks during recombination.  
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Figure S31: Erroneous energy generating cycles (EGCs) and relative constraints. 
Horizontal axes show the number of innovative offspring (per 1 million recombinants) 
emerging from recombination between parental metabolic networks viable exclusively on A) 
glucose and B) acetate, where parental metabolisms contain EGCs (blue) or do not contain 
EGCs (yellow). The ranking of the height of the blue bars and yellow bars in both panels is 
significantly correlated (panel A: Spearman’s 𝜌 = 0.8913, and P < 10-18; panel B: Spearman’s 𝜌 = 0.9197, and P < 10-21). In these analyses, parental metabolic networks contain ||G||=2079 
reactions, the same as the E. coli metabolic network, and they differ in D=100 reactions. 
Moreover, n=10 reactions are swapped between parental metabolic networks during 
recombination.  
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Figure S32: Biomass growth flux of most viable metabolic networks is much greater 
than our cut-off value for viability. The vertical axes show the empirical cumulative 
distribution function of the biomass flux among 10,000 MCMC-sampled metabolic networks 
viable exclusively on A) glucose, and B) acetate. The vertical red and blue lines show the 
cut-off value of 0.01 and 0.1 1/ℎ. We used 0.001 1/ℎ as the cut-off value for viability. 
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Chapter 5:  
 
Historical contingency and the gradual evolution of 
metabolic properties in central carbon and genome-scale 
metabolisms 
Aditya Barve, Sayed-Rzgar Hosseini, Olivier C Martin and Andreas Wagner 
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and the gradual evolution of metabolic properties in central carbon and 
genome-scale metabolisms. BMC Syst. Biol. 8: 48. 
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Note: Although I am not considered as the leading author of this paper, I have made 
substantial contribution on this manuscript. I have performed all the analyses related 
to central carbon metabolism that accounts for more than 75% of the content of this 
paper. I developed an algorithm that efficiently determines the connected components 
of large metabolic genotype networks. Moreover, I suggested the inference of 
connectivity of very large genotype networks based on parent-child relationships of 
genotype networks of consecutive size (see figures 2 and 3 in the manuscript), which 
made the entire analysis possible. However, I did not have a direct role in writing the 
manuscript.   
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5.1. Abstract 
A metabolism can evolve through changes in its biochemical reactions that are caused 
by processes such as horizontal gene transfer and gene deletion. While such changes 
need to preserve an organism’s viability in its environment, they can modify other 
important properties, such as a metabolism’s maximal biomass synthesis rate and its 
robustness to genetic and environmental change. Whether such properties can be 
modulated in evolution depends on whether all or most viable metabolisms – those 
that can synthesize all essential biomass precursors – are connected in a space of all 
possible metabolisms. Connectedness means that any two viable metabolisms can be 
converted into one another through a sequence of single reaction changes that leave 
viability intact. If the set of viable metabolisms is disconnected and highly 
fragmented, then historical contingency becomes important and restricts the alteration 
of metabolic properties, as well as the number of novel metabolic phenotypes 
accessible in evolution. We here computationally explore two vast spaces of possible 
metabolisms to ask whether viable metabolisms are connected. We find that for all 
but the simplest metabolisms, most viable metabolisms can be transformed into one 
another by single viability-preserving reaction changes. Where this is not the case, 
alternative essential metabolic pathways consisting of multiple reactions are 
responsible, but such pathways are not common.  Metabolism is thus highly 
evolvable, in the sense that its properties could be fine-tuned by successively altering 
individual reactions. Historical contingency does not strongly restrict the origin of 
novel metabolic phenotypes. 
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5.2. Introduction 
For biological systems on different levels of organization, the same broadly defined 
phenotype can usually be formed by more than one genotype. Examples include 
RNA, where many genotypes (sequences) share the same secondary structure 
phenotype [1, 2, 3, 4]; proteins, where multiple amino acid sequences form the same 
fold [5, 6]; regulatory circuits, where many genetically encoded circuit topologies can 
form the same expression pattern [7, 8, 9]; and metabolism, where multiple metabolic 
genotypes, encoding different combinations of chemical reactions, can confer 
viability on the same spectrum of nutrients [10, 11, 12, 13]. The number of genotypes 
with the same phenotype is usually astronomical. For example, it can exceed 1020 for 
moderately long RNA molecules of 40 nucleotides with the same secondary structure 
[14]; it has been estimated at 1057 for proteins that adopt a fold characteristic of the 
bacteriophage λ transcriptional repressor [15], and at more than 1040 for model 
regulatory circuits of 10 genes that form a given gene expression pattern [7]. 
The many different genotypes that share one aspect of their phenotype may differ in 
other aspects, such as the thermodynamic stability of a given RNA or protein fold, the 
resilience of a gene expression pattern to stochastic noise, or the robustness of a 
metabolism to deletion of genes that encode metabolic enzymes [1, 7, 16, 17]. 
Because such properties can be important for the biological function of any one 
system, the question whether they can be “fine-tuned” in evolution is important [7, 
18, 19, 20]. Such fine-tuning may depend on whether one can start from any one 
genotype with a given phenotypic property and reach most other such genotypes 
through sequences of small genetic change. 
Whether such fine-tuning is possible can be studied in the framework of a space of 
possible genotypes, where two genotypes are adjacent if they differ by the smallest 
possible genetic change, such as a single amino acid change in two proteins. In this 
framework, the question becomes whether a set of genotypes with the same 
phenotype forms a single connected genotype network (also known as a neutral 
network [1]), or whether this network fragments into multiple isolated subnetworks or 
disconnected components [21]. 
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Whenever such fragmentation occurs, the constraint it imposes on genotypic change 
does not only affect the ability to modulate a phenotype. It also gives an important 
role to historical accidents in the evolutionary process: The genotype with a given 
phenotype that evolution happened to have “discovered” first can determine the 
number and identity of other genotypes reachable through gradual genetic change. 
And by restricting the number of accessible genotypes, fragmentation can also restrict 
the spectrum of novel phenotypes accessible as new adaptations. The reason is that 
this spectrum depends strongly on a genotype’s location in genotype space [22]. The 
further evolution can “walk away” from a given genotype, the more the spectrum of 
accessible phenotypes changes [1, 11, 23, 24, 25, 26]. In sum, fragmentation of a 
genotype network can cause historical contingency and restrict a system’s potential 
for future evolutionary change. 
Existing work, based on computational models of phenotype formation, shows that 
fragmentation is system-dependent. For example, in RNA secondary structure 
phenotypes, genotype networks are typically highly fragmented [18, 27], whereas for 
regulatory circuits, such fragmentation depends on the kind of circuit studied, its size, 
and how one defines its gene expression phenotypes [7, 8, 28]. Because the question 
has thus far not been answered in metabolic systems, we here analyze the 
connectedness of a space of metabolisms. 
A metabolism is a complex network of chemical reactions, catalyzed by enzymes and 
encoded by genes, whose most fundamental task is to synthesize multiple small 
molecule precursors for biomass, such as amino acids, nucleotides, and lipids [29, 
30]. An organism’s metabolic genotype is the part of a genome that encodes 
metabolic genes. It is thus fundamentally a string of DNA, but can be represented 
more compactly as a binary vector of length N, where N is the number of metabolic 
reactions in a known “universe” of metabolic reactions (Additional file 1[10, 11], see 
Methods). This universe comprises all enzyme-catalyzed reactions known to take 
place in some organism. The i-th entry of this vector corresponds to the i-th reaction 
in a list of such reactions, and for any one organism, the value of this entry is one if 
the organism can catalyze the i-th reaction, and zero otherwise. On evolutionary time 
scales, the reaction complement of a metabolism can change through processes such 
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as horizontal transfer of enzyme-coding genes, gene deletions, as well as gene 
duplications followed by sequence divergence. 
The known “universe” of metabolism currently comprises more than N = 5000 
reactions [31, 32]. This means that there are more than 25000 different metabolic 
genotypes, which constitute a vast space of possible metabolisms. For any one 
metabolism in this space and any one chemical environment, one can compute the 
spectrum of biomass precursors that it can synthesize using the constraint-based 
computational method of flux-balance analysis (FBA). We call any one metabolism 
viable in a specific chemical environment, if it can synthesize every single one in a 
spectrum of essential biomass precursors from nutrients in this environment [10, 11, 
13, 33] (see Methods). We will here consider minimal chemical environments that 
contain only one carbon source, such as glucose, as the sole carbon source. 
Because connectedness of a metabolic genotype network may depend on the number 
n of reactions in a metabolism, we distinguish in our analysis metabolisms of 
different sizes. If Ω(n) is the set of all metabolisms with n biochemical reactions 
(n ≤ N) and if V(n) is the subset of all viable metabolisms, we are interested in 
whether V(n) is connected. Because the metabolisms of free-living heterotrophic 
metabolisms may have thousands of reactions, we need to study V(n) for metabolisms 
this large. This is not an easy task, because the set of viable metabolisms is so 
enormous that exhaustive enumeration is impossible [10, 34]. Therefore, to sharpen 
our intuition and to illustrate key concepts, we first analyze a smaller metabolic 
genotype space whose viable metabolisms can be enumerated exhaustively. This is 
the space of metabolisms that can be formed by subsets of N = 51 reactions in central 
carbon metabolism [35] (see Methods). Even though central carbon metabolism is 
highly conserved, its reaction complement varies in nature, for example through 
variants of glycolysis [36, 37, 38, 39, 40] and the tricarboxylic acid cycle, where 
some organisms have an incomplete cycle [41]. We go beyond such naturally 
occurring variation and analyze metabolisms comprised of all possible subsets of all 
51 reactions. Even though this number of metabolisms is astronomical (251 ≈ 1015), 
we were able to determine viability for all of them, and thus analyze the connectivity 
of V(n) for all n ≤ N (N = 51). After that, we turn to larger, genome-scale 
metabolisms, where we study the connectivity of V(n) through a sampling approach. 
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As many of the metabolisms used in our analysis may not be realized in extant 
organisms, we also refer to them as potential metabolisms. 
Our observations show that for all but the simplest metabolisms, those that contain 
close to the minimal number of reactions necessary for viability, most viable potential 
metabolisms V(n) lie on a single connected genotype network. Where fragmentation 
into different components occurs, its biochemical cause are alternative biochemical 
pathways that occur in different components, that are essential for the synthesis of 
specific biomass precursors, that comprise more than one reaction, and that cannot be 
transformed into one another by changes in single reactions without destroying 
viability. Because such pathways only occur in the smallest potential metabolisms, 
fragmentation and thus historical contingency do not strongly constrain the evolution 
of properties such as robustness, biomass synthesis rate, or the accessibility of novel 
metabolic phenotypes. 
5.3. Results 
Study System 1: Central Carbon Metabolism 
Our first analysis focuses on potential metabolic genotypes that can be formed with 
subsets of N = 51 reactions in the central carbon metabolism of E. coli [35] (see 
Methods). This metabolic core of E. coli includes reactions from 
glycolysis/gluconeogenesis, the tricarboxylic acid cycle, oxidative phosphorylation, 
pyruvate metabolism, the pentose phosphate shunt, as well as some reactions from 
glutamate metabolism (Additional file 2). It produces 13 precursor molecules 
(Additional file 2) that are required to synthesize all 63 small biomass molecules of 
E. coli, including nucleotides, amino acids, and lipids [30, 35, 42]. Examples of these 
precursors include oxaloacetate, a metabolite participating in the tricarboxylic acid 
cycle, which is used in the synthesis of amino acids such as asparagine, aspartate, 
lysine, and threonine [29, 42]. Another example is ribose-5-phosphate, which 
participates in the pentose phosphate pathway, and is necessary for the synthesis of 
nucleotides and amino acids, such as histidine, phenylalanine, and tryptophan [29, 
42]. In our analysis, we consider a metabolism viable only if it can synthesize all 13 
of these biomass precursors in a well-defined minimal environment containing a 
specific sole carbon source, such as glucose (see Methods). 
	 258	
The fraction of viable genotypes is extremely small and decreases as metabolism 
size n decreases 
For each n ≤ N = 51, we here explore the space Ω(n) of metabolisms (metabolic 
genotypes) with a given number of n reactions. We represent each such metabolism 
as a binary vector of length N = 51, whose i-th entry is equal to one if the i-th reaction 
is present and zero otherwise. The largest metabolism (n = N) is the one where all 
reactions are present. The space of all possible metabolisms that contain a subset of 
these 51 reactions has 251 (≈1015) member genotypes, while for a given n, Ω(n) 
contains 51𝑛  genotypes. We are especially interested in the subset V(n) of Ω(n) that 
consists only of viable metabolisms. Because, Ω(n) can be very large, determining 
V(n) is no small undertaking. For example, for metabolisms with n = 30, Ω(n) 
contains more than 1.14 × 1014 genotypes, and the viability of each of them cannot be 
determined by brute force. However, one can use some peculiarities of metabolism to 
render this computation feasible (see Methods). For example, consider a metabolism 
(the “parent”) with n reactions and another metabolism (the “child”) derived from it 
by deleting one reaction. If the parent is not viable then the child will not be viable 
either. By analyzing the viability of metabolisms with decreasing numbers of 
reactions n, and taking advantage of this relationship, we were able to reduce the 
computational cost of enumerating viable metabolisms by a factor ≈ 106 to the 
evaluation of viability for only 1.55 × 109 metabolisms [43]. 
Figure 1A shows the number of viable metabolisms V(n) (grey circles), together with 
the number of all metabolisms (black circles, Ω(n) = 51𝑛  as a function of the 
number n of reactions. Note the logarithmic vertical axis. The number of viable 
metabolisms has a maximum at n = 37 with a total of 2.39 x 108 metabolisms, while 
the minimum size of a viable metabolism, i.e., the smallest n such that V(n) > 0 is 23 
(Additional file 3). This means that at least 23 reactions are required to synthesize all 
13 biomass precursors on glucose. There are three such smallest metabolisms, one of 
which is shown in Additional file 4. Figure 1B expresses V(n) as a fraction of the 
number of metabolisms Ω(n) (grey circles), and shows that this fraction decreases 
with decreasing n. This means that random sampling is much less likely to yield a 
viable metabolism for small than for large metabolisms. For the smallest n with 
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viable metabolisms (n = 23), the three viable potential metabolisms correspond to a 
fraction 10-14 of all metabolisms of size 23. The largest viable metabolism contains all 
n = 51 reactions. 
 
 
Figure 1:	The number of viable metabolisms V ( n ) decreases as the number of reactions n 
decreases. (A) The vertical axis (note the logarithmic scale) shows the number of genotypes, and the 
horizontal axis shows the number n of reactions in a potential metabolism. Black circles represent the 
number of genotypes in genotype space Ω(n) (regardless of viability), grey circles show the number of 
potential metabolisms viable on glucose, whereas the blue circles denote the number of potential 
metabolisms viable on all 10 carbon sources. (B) The vertical axis (note the logarithmic scale) shows 
the fraction |V(n)| /|Ω(n)|. The grey circles show the fraction of genotypes viable on glucose relative to 
the number of possible metabolisms, whereas the blue circles denote the fraction of genotypes viable 
on 10 carbon sources relative to the number of possible metabolisms. Note that viable genotypes 
become extremely rare as the number of reactions in a metabolism decreases. Data for both figures is 
based on all viable metabolisms for each n (Additional file 3 and Additional file 8). 
 
Useful principles to determine the connectedness of genotype networks 
The viable genotypes at any one size n can be represented as a genotype network, a 
graph whose nodes are genotypes, and where two genotypes are adjacent (connected 
by an edge), if they share all but one reaction. For example, the two hypothetical 
genotypes G 1 and G 2, where G 1 consists of reactions {R 1, R 2, R 3}, and G 2 consists 
of reactions {R 2, R 3, R 4}, are adjacent. This is because G 1 and G 2 share two out of 
the three reactions (R 2 and R 3). One can reach G 2 from G 1 by adding reaction R 4 
and removing R 1, an event that we refer to as a reaction swap [10, 12, 33]. This 
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definition of neighboring genotypes allows us to keep the number of reactions in a 
genotype network constant. We note that each reaction swap can be decomposed into 
the addition of a reaction followed by the deletion of a reaction, both of which 
preserve viability provided that the reaction swap does. In other words, genotype 
networks that are connected if adjacency is defined under reaction swaps will remain 
connected if adjacency is defined via a sequence of alternating reaction additions and 
reaction deletions. 
Our principal goal is to identify whether genotype networks at any one size n are 
connected. This first requires us to establish the adjacency of 𝑉(𝑛)2  genotype pairs, 
followed by application of standard graph theory algorithms such as breadth-first 
search [21, 44] to compute whether genotypes decompose into two or more 
disconnected components, or whether they form a single connected network, i.e., 
whether a path through V(n) exists connecting any two genotypes [21]. Because V(n) 
exceeds 106 genotypes at intermediate n (Additional file 3), such conventional 
methods lead to large computational cost for all but the largest and smallest 
metabolisms (n = 23–28 and n = 46–50 reactions). For genotype networks comprising 
metabolisms of intermediate size (n = 29–45), we therefore took advantage of another 
relationship between “parent” and “child” metabolisms, namely that the connectivity 
of a genotype network at size n can be understood based on its connectivity at size n-
1. We explain this relationship next. 
Starting from a genotype G(n) with n reactions, one can obtain a parent genotype 
G(n + 1) with (n + 1) reactions by adding to it any one reaction among the N = 51 
reactions that are not already part of G(n). Because addition of a reaction does not 
eliminate viability, G(n + 1) will be viable, and thus be a member of V(n + 1). For any 
one genotype G(n), there exist N-n reactions that are not part of this genotype. 
Therefore, one can obtain exactly N-n genotypes of size n + 1 by adding a single 
reaction to a genotype G(n). And because each pair of these genotypes of size n + 1 
shares all but one reaction (the newly added reaction), every parent genotype in this 
set is adjacent to every other parent genotype. In other words, these genotypes form a 
clique in V(n + 1) [21]. 
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We next point out that if two genotypes of size n are adjacent, then their 
corresponding genotypes of size (n + 1) form two cliques linked by at least one 
genotype of size (n + 1). The hypothetical example in Figure 2 illustrates this fact. 
Consider a “universe” of only N = 6 reactions - {R 1, R 2, R 3, R 4, R 5, R 6}. The upper 
half of Figure 2 shows two hypothetical genotypes (G 1 in blue and G 2 in red) that 
are viable, adjacent, and contain two reactions each (n = 2). Genotype G 1 comprises 
reactions {R 1, R 2}, while the other genotype G 2 comprises reactions {R 2, R 3}. The 
lower part of the figure shows all genotypes containing three reactions each that can 
be obtained from adding one reaction to genotypes G 1 and G 2 . Blue genotypes are 
parents of G 1, whereas red genotypes are parents of G 2. Note that the red and blue 
genotypes form two cliques. Among the 7 genotypes of size n + 1 that are parents of 
either G 1 or G 2, one is special, because the two cliques share it. In our example, this 
is the genotype containing reactions {R 1, R 2, R 3}. More generally, this shared 
genotype is the one genotype obtained from a pair of adjacent genotypes G 1 and G 2 
in V(n) by adding the reaction to G 1 that it does not share with G 2, or vice versa. 
(There is only one such reaction, because G 1 and G 2 are adjacent). We note that 
additional edges connect genotypes in both cliques (Figure 2). Specifically, those 
edges connect the genotypes derived from adding the same reaction to G 1 and G 2. 
There are exactly (N-n-1) such edges. 
 
 
 
 
 
 
 
Figure 2: Connectivity of potential 
metabolisms can be inferred from parent 
and child relationship. The figure uses a 
hypothetical example of two neighboring 
metabolisms with three reactions each (upper 
panel) to illustrate the relationship between the 
connectedness of genotypes with n reactions 
(G(n)) and their “parents” of n + 1 reactions 
that can be obtained from them by adding a 
single reaction (lower panel). Importantly, if 
genotypes G(n) form a connected set, then all 
genotypes G(n + 1) obtained by adding one 
reaction to each of them also form a connected 
set. 
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These observations have the following important corollary: If a genotype network 
containing genotypes of size n is connected, then all genotypes G(n + 1) obtained 
from genotypes of size n are also connected. 
So far, our line of reasoning explains connectedness of genotypes that are parents of 
connected genotypes at a lower size. But some viable genotypes are not parents of 
any other genotype. These are exactly those genotypes in which elimination of any 
one reaction abolishes viability. We have called such genotypes minimal [10, 12], and 
note that they do not necessarily correspond to the smallest metabolisms. For 
example, there are 8 metabolisms that are viable on glucose and that have 24 
reactions, all of which are essential (Table 1), but the smallest viable metabolisms on 
glucose have only 23 reactions. (We explain further below why minimal metabolisms 
may vary in their number of reactions.). As one increases the size of a metabolism, 
such “childless” metabolisms could in principle arise at any n. Since our preceding 
argument about connectedness does not apply to them, they need to be identified, and 
their connectedness to the rest of a genotype network needs to be examined 
separately, as discussed in the next section. 
Number	of	
reactions	in	a	
metabolism	(n) 
Number	of	
components 
Number	of	viable	
metabolisms	V(n)	 
Number	of	
minimal	
metabolisms 
Fraction	of	
minimal	
metabolisms 23 2 3 3 1 24 2 91 8 0.08791 25 2 1333 23 0.01725 26 2 12512 14 0.00111 27 1 84344 27 0.00032 28 2 434238 43 9.9	x	10-5	 29 1 1773969 28 1.57	x	10-5	 30 1 5900578 15 2.54	x	10-5	 
 
Table 1: The number of minimal metabolisms in genotype networks from the central carbon 
metabolism The left-most column shows the number of reactions n in a potential metabolism, the 
second column from the left shows the number of disconnected components into which the genotype 
network of these viable metabolisms fragments, the third column shows the number of viable potential 
metabolisms for each n, and the fourth column shows the number of minimal metabolisms. Note that 
the fraction of minimal metabolisms (column five) decreases as metabolism size n increases. 
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We identified minimal metabolisms at each size n by deleting every single reaction 
from each genotype in V(n), and by examining whether the resulting genotype was 
viable, and thus identifying those genotypes in which no reaction can be deleted. 
Table 1 shows the number of minimal metabolisms at each n, and demonstrates that 
their proportion among all viable metabolisms (V(n)) decreases dramatically with 
increasing metabolism size n. Importantly for the next section, no minimal 
metabolisms viable on glucose exist above n = 30. 
In sum, we here observed that if a genotype network is connected at size n, the 
genotype network formed by the parents of its genotypes is also connected. Because 
minimal metabolisms are not parents of any other metabolisms, they need to be 
analyzed separately. 
Metabolic genotype networks are connected for all but the smallest metabolisms 
To determine connectedness of genotype networks for metabolisms V(n) viable on 
glucose, we began by analyzing the smallest (n = 23–28) and largest (n = 46–50) 
potential metabolisms. We did so by computing, first, edge lists for each genotype 
network, and, second, the connectedness of the genotype network, using the graph 
analysis software igraph [45]. We found that viable metabolisms of size n = 27, as 
well as n = 46 to n = 50 have only one connected component. In contrast, viable 
metabolisms of sizes n = 23, 24, 25, 26, and 28 are fragmented. They form a genotype 
network with two components (Table 2). 
 
Number of reactions 
in a metabolism ( n) 
Number of viable 
potential metabolisms 
V(n)  
Number of 
components 
Fraction of viable 
metabolisms in the 
largest connected 
component 
23 3 2 0.667 
24 91 2 0.637 
25 1333 2 0.997 
26 12512 2 0.992 
27 84344 1 1 
28 434238 2 0.977 
 
Table 2: Fragmentation occurs in central carbon metabolisms close to minimal number of 
reactions . For each metabolism size, the table shows the number of viable potential metabolisms, the 
	 264	
number of components, and the fraction of genotypes in the largest component. The genotype network 
comprising metabolisms of size 23 contains three metabolisms, of which two form one component and 
the other is isolated from them. For metabolisms of size 24, the two components are almost of the 
same size, and the larger component contains 63.74 percent of the viable genotypes. For larger 
metabolisms, the genotype network is largely connected, with more than 97 percent of genotypes 
belonging to the largest component. 
Fragmented genotype networks may decompose into components with different sizes, 
such that the majority of genotypes belong to the largest component. In this case, 
most viable genotypes can be reached from each other through a series of small 
genotypic changes that affect only single reactions each and that leave the phenotype 
constant. Alternatively, fragmentation of a genotype network may result in 
components with similar size, which can impede accessibility of many genotypes. 
Table 2 shows that this is not generally the case. The vertical axis denotes the fraction 
of genotypes belonging to the largest component of a genotype network, and it shows 
that the largest components of the genotype networks at size n = 25–28 encompass 
almost all (i.e., more than 99 percent) of the viable genotypes. At n = 23, the genotype 
network has two components that consist of one and two metabolisms. At size n = 24 
there are 91 viable genotypes, 58 (64 percent) of which belong to the largest 
component. 
We next turn to a more detailed analysis of genotype network fragmentation at the 
smallest sizes. Figure 3 shows graph representations of genotype networks whose 
metabolisms have sizes n = 23, 24 and 25. Filled circles represent genotypes. 
Adjacent genotypes are connected by an edge. The size of a circle corresponds to the 
number of neighbors of the corresponding genotype. Minimal potential metabolisms 
are shown in red in all three panels. All three potential metabolisms of size 23 are 
minimal (Figure 3A). Two of them are adjacent metabolisms and form component A 
(left), whereas the remaining isolated metabolism forms component B (right). The 
green and orange circles of Figure 3B show the result of adding one reaction from the 
remaining pool of 28 reactions (N-n = 51–23 = 28) to each of the two genotypes in 
component A. Such addition yields a connected component A’ of 55 metabolisms 
with 24 reactions (green, Figure 3B). The component consists of two cliques 
connected to each other by a single connected genotype. Analogous addition of 
reactions to the single genotype in component B of Figure 3A yields a connected 
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component B’ with 28 potential metabolisms (orange) of size 24. The total number of 
genotypes in component A’ and B’ is 83. However, there are 91 viable metabolisms 
with size 24 (Table 1). It turns out that the missing eight metabolisms are minimal 
(red) and cannot be derived using reaction addition to metabolisms at size 23. Three 
of them are connected to component A’ and five of them to component B’ 
(Figure 3B). Overall, the number of components at size 24 reflects the number of 
components at size 23, because these components are derived from the smaller 
components at size 23. This, however, is no longer true for the genotype network of 
metabolisms with 25 reactions in Figure 3C. In this panel, genotypes shown in green 
(components A”) and orange (components B”) are parents of the green and orange 
genotypes in components A’ and B’ respectively. Notice that these components are 
now connected, in contrast to their disconnectedness at size 24. What connects them 
are some of the minimal metabolisms that arose anew at size 24 and 25. There are 23 
such child-less minimal genotypes at size 25 (Figure 3C and Table 1). Four of them 
form a new component labeled C (center bottom of Figure 3C). 
An analogous analysis of metabolisms up to size 30 can help understand why all 
larger metabolisms must be connected (Additional files 5 and 6). There are two 
germane observations. First, at size n = 30, there are approximately 5.9 × 106 
metabolisms and all of them fall into a single connected component (Table 1). 
Second, no minimal metabolisms exist at size 31 and beyond (Table 1). This means 
that all parent metabolisms at size (n + 1) are derived from child metabolisms at sizes 
beyond n = 30. By our argument in the preceding section, they must therefore form a 
single connected component (Figure 2). 
In sum, we showed that genotype networks formed by different central carbon 
metabolism variants are connected in metabolic genotype space for all but the 
smallest viable metabolisms. With few exceptions, wherever fragmentation occurs, 
more than 99 percent of genotypes belong to the largest component. This high 
connectivity arises from the parent–child relationships we discussed, as well as from 
the relatively small number of minimal metabolisms that arise at each n (Figure 2 and 
Table 1). 
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Figure 3 Organization of metabolic genotype space. The figure shows the genotype networks of 
potential metabolisms containing 23, 24 and 25 reactions. Each filled circle corresponds to a genotype. 
Two genotypes are connected by an edge (curved line) if they are neighbors. Red circles correspond to 
minimal metabolisms of a given number of reactions n. (A) The genotype network of size 23 is 
fragmented, with component A containing two adjacent genotypes, while component B contains one 
genotype. (B) Structure of the genotype network at size n = 24 reactions. Addition of one reaction to 
the two genotypes in component A results in genotypes of size 24 which belong to component A’ 
(green), and addition of one reaction to the genotype in component B yields genotypes of size 24 
which belong to component B’ (orange). At size n = 24 reactions, eight minimal metabolisms (red 
circles) also arise, of which three genotypes belong to component A’, and five to component B’. Note 
that genotypes in components A’ and B’ remain disconnected. (C) Structure of the genotype network at 
size n = 25 reactions. Adding one reaction to all genotypes in component A’ yields genotypes (green) 
in subgraph A”, while adding one reaction to all genotypes in component B’ yields the genotypes 
(orange) of subgraph B”. There are 23 minimal metabolisms of size 25 (red), of which 4 genotypes 
form a disconnected component C (blue, bottom center). Note that genotypes of size 25 in subgraphs 
A” and B” are connected either directly or through minimal metabolisms. The size of each circle 
corresponds to its number of neighboring genotypes, which increases as metabolism size increases. 
Graphs were drawn using the graph visualization software Gephi [46]. 
	 267	
Essential pathways cause genotype network fragmentation 
Thus far, our analysis focused on broad patterns of genotype network fragmentation. 
We next discuss the possible mechanistic reasons for such fragmentation. They 
revolve around different biochemical pathways that are essential for viability among 
metabolisms in different components. Essential reactions are those whose removal 
results in a loss of viability (see Methods), and a reaction’s essentiality may depend 
on other reactions present in a metabolism. That is, a reaction can be essential in one 
potential metabolism, but nonessential in another potential metabolism, because of 
the presence of alternative metabolic routes [13]. The fraction of metabolisms of a 
given size in which a reaction is essential is a useful quantifier of the reaction’s 
essentiality, which we have called the reaction’s superessentiality index [13]. The 
concept of (super)essentiality can be extended to entire metabolic pathways, groups 
of essential reactions that share substrates/products with each other and cannot be 
replaced without a loss of viability. 
We next illustrate with an example how pathway (super) essentiality causes 
fragmentation of genotype networks, by demonstrating the existence of alternative 
essential pathways in different network components for metabolisms with 23 and 24 
reactions. To identify such pathways, we first computed the superessentiality index of 
reactions in potential metabolisms of size 23 and 24 each, and did so for all genotypes 
in each of the two genotype network components (Figure 3A and B) separately (see 
Methods). We then examined which reactions differ in their superessentiality index 
between the two components. We found five such reactions, which can be subdivided 
into groups of two and three reactions, respectively. The first group comprises the 
reactions catalyzed by transketolase 1 (TKT1) and transaldolase (TALA). They are 
essential in all metabolisms from network component A’ (Figure 3), but inessential in 
all metabolisms belonging to component B’ . The second group comprises the 
reactions catalyzed by the enzymes glucose-6-phosphate dehydrogenase (G6PDH), 6-
phosphogluconolactonase (PGL), and phosphogluconate dehydrogenase (GND). 
They are essential in all metabolisms of component B’, but inessential in any of the 
genotypes in component A’ (Figure 3). Taken together, this means that TKT1 and 
TALA form a small but essential pathway in the genotypes belonging to component 
A’, while G6PDH, PGL and GND form another essential pathway in genotypes 
belonging to component B’. 
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These five reactions are part of the pentose phosphate pathway, as shown in Figure 4. 
The pentose phosphate pathway is required for the synthesis of two biomass 
precursors, ribose-5-phosphate (r5p) and erythrose-4-phosphate (e4p) (solid squares 
in Figure 4). The reactions shown in black are essential in potential metabolisms 
belonging to both genotype network components (Figure 3A and B). In contrast, the 
essentiality of reactions participating in the two alternative essential pathways (green 
and orange), which contain the reactions discussed in the preceding paragraph, 
depends on which of the two components a potential metabolism belongs to. To 
understand why, we first note that the metabolites glucose-6-phosphate (g6p), 
fructose-6-phosphate (f6p), and glyceraldehyde-3-phosphate (g3p) are also 
synthesized by reactions in glycolysis, and thus constitute metabolic inputs to the 
pentose phosphate pathway for the synthesis of e4p and r5p. Flux balance analysis 
can be used to show that reactions catalyzed by transketolase 1 (TKT1) and 
transaldolase (TALA) are required to synthesize sufficient r5p for viability (Table S1 
- biomass reaction) upon removal of any one reaction from the orange pathway 
(G6PDH, PGL, GND), thus rendering the reactions catalyzed by TKT1 and TALA 
essential. Conversely, removal of any one reaction from the green pathway (TKT1, 
TALA) leads to a requirement for all reactions in the orange pathway to produce the 
pathway output. In sum, the genotypes of size 23 and 24 are disconnected because 
alternative essential pathways exist in them that consist of more than one essential 
reaction, and because no one reaction in one pathway can replace a reaction in the 
other pathway. Put differently, loss of any one reaction in one pathway can only be 
compensated by addition of all reactions of the other pathway. Because metabolisms 
at size 23 are separated by three swaps, genotype space can be connected at size 25 
(subgraphs A” and B”), that is, after successive addition of two reactions. 
In Additional files 5 and 7 (section - Essential pathways cause genotype network 
fragmentation) we discuss another example, which illustrates that essential and 
alternative metabolic routes need not contribute to biosynthesis of the same 
precursors, and may arise in functionally different and unrelated parts of metabolism. 
These differences notwithstanding, the examples illustrate the mechanistic reason for 
genotype network fragmentation: It is not possible to interconvert two genotypes in 
different components by one reaction swap because such interconversion will 
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inevitably create unviable genotypes in which two alternative essential pathways are 
incomplete. 
As a corollary, the longer such essential alternative pathways are, the greater the 
number of reactions m that need to be added to non-adjacent viable genotypes G(n), 
such that viable genotypes G(n + m) become connected. 
 
Figure 4 Essential pathways in pentose phosphate metabolism. The figure shows the two essential 
pathways (orange and green) in pentose phosphate metabolism that are necessary for the synthesis of 
biomass precursors e4p and r5p (in square boxes). Reactions in black are essential regardless of the 
metabolism in which they occur. Reactions catalyzed by G6PDH, PGL and GND form an essential 
pathway (orange), while reactions catalyzed by TALA and TKT1 (green) form another essential 
pathway. If the reactions in orange are absent, the reactions in green become essential and vice versa. 
This is because removal of TALA and TKT1 requires the synthesis of r5p through the reactions 
catalyzed by G6PDH, PGL and GND, while removal of these reactions forces the synthesis of r5p 
through TAL and TKT1. Note that metabolites g6p, f6p and g3p also participate in glycolysis and 
therefore can be produced there and supplied to the pentose phosphate pathway. Enzymes catalyzing 
each of the reactions are shown in uppercase italic typeface. Abbreviations - g6p, D-glucose-6-
phosphate; r5p, D-ribose-5-phosphate; e4p, D-erythrose-4-phosphate; f6p, D-fructose-6-phosphate; 
fdp, fructose-diphosphate; g3p, glyceraldehyde-3-phosphate; G6PDH, glucose-6-phosphate 
dehydrogenase; PGL, 6-phosphogluconolactonase; GND, 6-phosphogluconate dehydrogenase; RPI, 
ribose-5-phosphate isomerase; RPE, ribose-5-phosphate 3-epimerase; TKT1, transketolase 1; TALA, 
transaldolase; TKT2, transketolase 2. 
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Metabolisms viable on multiple carbon sources are also mostly connected 
Many organisms are viable on multiple carbon sources, which may impose additional 
constraints on a metabolism. We wished to find out how severely these constraints 
affect genotype network connectivity in our analysis of central carbon metabolism. 
To this end, we analyzed metabolisms that are a subset of our N = 51 reactions and 
that are viable on a total of 10 common carbon sources when each of them is 
provided as the sole carbon source (see Methods for all these carbon sources). 
Because glucose is among these 10 carbon sources, metabolisms viable on all 10 
carbon sources are also viable on glucose. In other words, the genotype network they 
form at any specific metabolism size n is a subset of the genotype network of 
metabolisms viable on glucose. We note that the metabolism comprising all N = 51 
reactions is viable on all 10 different carbon sources. 
We used an approach identical to that described above for glucose to identify 
potential metabolisms viable on all 10 carbon sources. Their numbers are shown in 
Figure 1A (blue circles), which shows that, first, no metabolism with fewer than 
n = 34 reactions is viable on all 10 carbon sources, whereas the minimal size is much 
smaller (n = 23) for metabolisms viable on glucose alone (Additional file 3, 
Additional file 8, Table 1). Second, the number of metabolisms viable on 10 carbon 
sources is much smaller than the number of metabolisms viable on glucose. It reaches 
a maximum at n = 42 with 2.1 × 105 metabolisms (Additional file 8), many fewer than 
for viability on glucose (2.39 × 108 metabolisms at n = 37). This difference is also 
highlighted in Figure 1B whose vertical axis represents genotypes viable on glucose 
(grey) and on all ten different carbon sources (blue) as a fraction of all genotypes. At 
the minimal size of n = 34 reactions, genotypes viable on all 10 different carbon 
sources comprise approximately one 10-8th of those genotypes viable on glucose of 
the same size. 
This strong constraint on metabolisms viable on multiple carbon sources raises the 
possibility of genotype network fragmentation. However, we found no evidence for 
such fragmentation. Because the number of genotypes viable on 10 carbon sources is 
relatively small, we were able to use standard algorithms to determine their 
connectedness, which show that genotype networks of all sizes except for n = 35 and 
36 reactions consist of only one connected component. At size n = 35 the genotype 
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network fragments into three components. The largest of them contains 91.13 percent 
of viable genotypes. At size n = 36, the network fragments into two components, with 
the larger containing 99.6 percent of genotypes. This implies that one can access any 
metabolic genotype viable on 10 carbon sources, regardless of its size, from most 
other viable genotypes through a series of individual reaction changes. 
Study system 2: Genome-scale metabolisms 
We have thus far studied connectedness for potential metabolisms drawn from the 
reduced reaction set of central carbon metabolism, which comprises a small subset of 
the more than 1000 reactions in the typical metabolism of a free-living organism. In 
this section, we focus on the connectedness of larger, genome-scale potential 
metabolisms. Their reactions come from the known “universe” of possible 
biochemical reactions, which comprises, at our present state of partial knowledge, 
already more than 5000 reactions [31, 32]. For any one such metabolism to be viable, 
we require that it is able to synthesize all 63 essential biomass precursors of E. 
coli[30] – most of which are molecules central to all life, such as nucleotides and 
amino acids (see Methods) – in a minimal environment containing glucose as the sole 
carbon source. 
Using our binary representation of a metabolic genotype (Additional file 1), the 
number of possible genome-scale metabolisms is greater than 25000, which renders 
exhaustive analysis of connectivity infeasible. Random sampling of the space using 
Markov Chain Monte Carlo (MCMC) methods can be very useful [10, 11, 13, 33], 
but it is not suitable for our purpose, because the MCMC approach samples 
genotypes from the same component of a genotype network. 
We thus use a different sampling approach [10, 12, 33, 47], which starts from a 
“global” metabolism that comprises all reactions in the known universe (and is viable 
on glucose). This metabolism has 5906 reactions. Its viable children would form a 
single connected component, but as one reduces their number of reactions further, the 
set of viable genotypes V(n) might become disconnected. Figure 5A illustrates this 
possibility schematically. It shows a funnel-like landscape whose width at a given 
number of reactions n (vertical axis) indicates the number of viable metabolisms at 
this n. The number of viable metabolisms approaches zero as n approaches the 
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smallest possible size at which a metabolism can be viable. Starting from the global 
metabolism, one can randomly select a sequence of reactions for deletion while 
requiring that each deletion retain viability. Parts of three hypothetical deletion 
sequences are shown as three trajectories in the panel. Two of them (solid) lead into 
deep depressions in the funnel, which correspond to disconnected components of a 
genotype network. More precisely, a metabolism that resides in one such depression 
cannot be converted into another viable metabolism without changing its number of 
reactions (the altitude in the landscape), as doing so would require it to traverse the 
exterior of the funnel. The third trajectory (dotted line) enters such a depression only 
at a much lower number of reactions. We wanted to know whether such funnels 
appear in the landscape at moderate n (Figure 5A) or only at values of n close to the 
smallest number of reactions permitting viability (Figure 5B). 
 
 
Figure 5  
A spatial schematic of genotype network connectivity at different metabolism sizes n . Each panel 
shows a funnel-like landscape, where the funnel’s width reflects the number of potential metabolisms 
that are viable at any given number n of reactions (altitude in the landscape). The lowest points of the 
landscape correspond to potential metabolisms whose size are close to the smallest possible n needed 
for viability. Solid and dotted lines denote random sequences of reaction removal from some viable 
starting metabolism (not shown) that terminate at a particular size n and result in some viable 
metabolism denoted by circles. Depressions in the funnel correspond to disconnected components of 
the genotype network. Disconnected components in (A) arise at higher metabolism sizes than in (B). 
Two of the trajectories in A (solid lines) terminate in such depressions, that is, in potential 
metabolisms that are part of a disconnected component. These metabolisms are not interconvertible 
through viability preserving reaction swaps. The same trajectories in B terminate at a part of the funnel 
where all viable metabolisms are still connected. The figure was generated using a script from 
(http://www.oaslab.com/Drawing_funnels.html) 
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To find out, we derived multiple viable metabolisms with a given size n as follows. 
Starting from the global metabolism, we repeatedly deleted randomly chosen 
reactions from it, such that each deletion preserved viability, until we had arrived at a 
minimum metabolism, that is, a metabolism whose number of reactions cannot be 
reduced further. In doing so, we kept track of the deleted reactions, and the sequence 
in which they were deleted. Each minimum metabolism created in this way had fewer 
than 400 reactions (see also below). We used these minimal metabolisms, as well as 
information about the sequence in which reactions were deleted, to create larger 
potential metabolisms of varying sizes n, each of which corresponds to a specific 
point in the deletion sequence. We repeated this procedure 500 times, which allowed 
us to create 500 minimal metabolisms, as well as 500 potential metabolisms of 
various intermediate sizes. 
Most viable genome-scale metabolisms reside in the same connected component 
If genotype networks were highly fragmented at a given size n, then different random 
deletion sequences would yield potential metabolisms that reside in different 
components of a genotype network. In this case, it would not be possible to connect 
two metabolisms that reside in different components of a genotype network through a 
sequence of reaction swaps, each of which preserves viability. With these 
observations in mind, we attempted to connect metabolisms in our samples of viable 
metabolisms of a given size (see Methods). Specifically, for any sample of 
metabolisms [G 1, G 2, G 3, … , G 500], we attempted to connect G i and G i+1 
(1 ≤ i < 500) through viability-preserving reaction swaps. We did this for 500 
potential metabolisms of size 1400 (similar to that of E. coli), 1000, 500, and 400 
(above the size of minimal metabolisms, see below). In this way, we were able to 
show that all 500 potential metabolisms are connected at each of these sizes. Thus, 
down to a size of n = 400 reactions, the genotype network of metabolisms viable on 
glucose is not highly fragmented, and one component comprises the vast majority or 
all metabolisms. 
Because many free-living microorganisms are viable on multiple carbon sources, we 
generated 500 additional potential metabolisms through the reaction deletion process 
just described, but with the additional constraint that they remain viable on ten sole 
carbon sources (the same ten as used in our analysis of central carbon metabolism). 
	 274	
Specifically, we created again potential metabolisms of size 1400, 1000, 500, 450 and 
425 (slightly above the size of minimal metabolisms for viability on 10 carbon 
sources). We then repeated the procedure that attempts to connect genotypes G i and 
G i+1 through viability-preserving reaction swaps. In this way, we were able to show 
that all 500 potential metabolisms are connected at each of these sizes. Thus, down to 
a size of n = 425 reactions, the genotype network of most metabolisms viable on all 
10 carbon sources consists of one connected component. 
It is possible to make this point more quantitatively and establish a statistical bound 
on the fraction of potential metabolisms contained in the largest connected 
component of V(n). Specifically, let us consider the null hypothesis that more than 
one percent of V(n) resides outside this largest component. If this null hypothesis is 
correct, then the probability p that a randomly drawn viable genotype is not on this 
largest component is greater then p = 0.01. Moreover, the probability that some 
number M of genotypes drawn at random from V(n) all fall on the largest connected 
component would be smaller than (1-p) M . In our case, M = 500 and (1-p) M 
 < 0.99500 = 0.0066. In other words, the results of our sampling allow us to reject the 
above null hypothesis at a significance level smaller than 1 percent. 
Minimal metabolism size can help explain connectedness 
In the sections on central carbon metabolism we showed that new components 
disconnected from the remainder of a genotype network can arise as one increases 
metabolism size, and that they originate from “childless” minimal metabolisms which 
appear at a given size n that is small compared to the total number of possible 
reactions. To examine their size for larger metabolic system, we studied the 500 
minimal metabolisms that we derived from the sequential random deletion strategy 
described in the previous section (Figure 6A). Their size ranges from 324 to 391 
reactions, with a mean of 352 reactions (standard error = 11.44 reactions) 
(Figure 6A). Although we cannot absolutely exclude the possibility that minimal 
metabolisms exist with more than 400 reactions, the fact that all of the minimal 
metabolisms we found have fewer reactions suggests that the emergence of new 
genotype network components will be rare above 400 reactions. This observation 
further supports our assertion that most metabolisms with more than 400 reactions 
will be part of a single genotype network. It also means that essential alternative 
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metabolic pathways of more than one reaction that are characteristic for a given 
connected component exist only for small metabolisms. Alternative pathways for the 
synthesis of most biomass molecules undoubtedly exist, but most of them can be 
converted into one another through sequences of single reaction changes that preserve 
viability. 
 
 
Figure 6 Minimal metabolisms from the 
complete universe can have many viable 
neighbors. (A) The horizontal axis denotes the 
size of minimal metabolisms and the vertical 
axis denotes their frequency. The average 
minimal metabolism comprises 352 reactions, 
while the largest minimal metabolism we find 
has 391 reactions. (B) The vertical axis shows 
the frequency of potential metabolisms with a 
given number of neighbors (horizontal axis). A 
minimal metabolism has 372.8 viable 
neighbors on average. Data in (C) show that 
the number of viable neighbors (vertical axis) 
is positively correlated with the number of 
reactions present in a minimal metabolism 
(horizontal axis). Data in (A), (B) and (C) are 
based on 500 minimal metabolisms generated 
through the random reaction deletion process 
described in the text. 
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In a final analysis, we asked whether the minimal networks that our approach 
identified are isolated in metabolic genotype space Ω(n), or whether they might 
themselves form large components. To this end, we simply asked whether these 
networks have any viable neighbors in Ω(n), metabolisms that differ by a single 
reaction swap, which are also viable. The result (Figure 6B) shows that even minimal 
metabolisms have typically hundreds of neighbors. Specifically, an average minimal 
metabolism has 372.8 viable neighbors (standard deviation: 79 neighbors). The 
maximum number of neighbors for a minimal metabolism is 685. Figure 6C shows 
that larger minimal metabolisms tend to have more neighbors than smaller ones 
(Spearman’s ρ = 0.43, p-value < 10-22). Taken together, this means that minimal 
metabolisms themselves must form large components and are certainly not isolated. It 
mirrors the situation in central carbon metabolism, where newly emerging minimal 
metabolisms at a given size n also form connected components, albeit small ones 
(Figure 3). 
 
5.4. Discussion 
To our knowledge, our analysis of all possible ≈ 1015 metabolisms comprising subsets 
of reactions in central carbon metabolism is the first exhaustive analysis of a 
metabolic space this large, even though smaller-scale analyses were carried out 
before with different goals [48, 49, 50]. Our analysis focused on metabolisms viable 
on glucose, which are required to synthesize 13 products of central carbon 
metabolism that are biomass precursors. We found that viable metabolisms could 
have fewer than half (23) of the maximal number of 51 reactions in central carbon 
metabolism. Moreover, for metabolisms covering 77 percent of the size of the viable 
range (n = 23–51), all (n = 29–51) or the vast majority of metabolisms of size n form 
a single connected component (network) in the space of metabolisms. 
In genome-scale metabolisms, where exhaustive enumeration is no longer possible, 
and where we required the synthesis of 63 common biomass molecules for viability, 
we found viable potential metabolisms with as few as 324 reactions, and for 93.23 
percent of the size range of viable metabolisms (n = 400–5906) the vast majority of 
potential metabolisms form a single connected component of a genotype network. 
More specifically, with a probability of greater than 0.99, more than 99 percent of all 
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viable metabolisms exceeding 400 reactions are part of the same component. We note 
that it would have been sufficient to perform the sequential reaction deletion 
procedure needed to arrive at this conclusion for metabolisms of size n = 400, and not 
also for metabolisms of size n = 400–1400, as we did. The reason is an elementary 
observation we made about metabolic genotype space: If a set of viable metabolisms 
V(n) is connected for some number of reactions n, then V(m) must be connected for 
all m > n, provided that no new minimal metabolisms appear at any value of m. The 
largest minimal metabolism we found has n = 391 reactions, and while we cannot 
exclude the existence of minimal metabolisms above n = 400 with certainty, such 
potential metabolisms would be increasingly rare at large n. They would create new 
genotype network components that would comprise a vanishing fraction of the rest of 
the connected genotype network (even though they might contain many potential 
metabolisms in absolute numbers). 
Figure 5B illustrates schematically the dependence of fragmentation on metabolism 
size n that we observed. Depressions in the funnel-like landscape whose width 
reflects the number of viable potential metabolisms correspond to disconnected 
metabolic networks and appear only at small altitudes (metabolism sizes). That is, the 
hypothetical landscape of Figure 5B reflects our observations, whereas that of 
Figure 5A, where disconnected metabolisms appear at much higher reaction numbers 
does not. 
While we study only viability on a carbon source, other metabolic properties such as 
mutational robustness and access to novel phenotypes are also important [10, 11] and 
may differ in different components. In such cases, historical contingency may indeed 
play a role towards the fine-tuning of metabolic properties and would be relevant in a 
scenario depicted by Figure 5A. However, as fragmentation occurs only at lower 
metabolism sizes, historical contingency may not constrain the overall evolution of 
metabolic systems sharply. 
With possible exceptions in some marine bacteria [51, 52] metabolisms with sizes as 
small as n = 400 are not usually found in free-living organisms. They occur in 
(endo)symbionts [53, 54] and (endo)parasites [55, 56], which live in close association 
with a host organism and are provided nutrients and a constant environment which 
allows them to shed many enzyme-coding genes [47, 57, 58, 59, 60]. Organisms that 
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have lived inside a host for a long time experience less of the kinds of evolutionary 
change – especially horizontal gene transfer – that is powerful in endowing the 
genomes of free-living organisms with new evolutionary adaptations [57, 59]. In 
other words, the fragmentation of genotype networks that we see for very small 
potential metabolisms, and that can constrain their evolution, is of little relevance for 
the evolution of free-living organisms. Those organisms whose evolution it could 
constrain the most are already subject to little evolutionary change for ecological 
reasons. 
Our analysis of genotype network fragmentation provides a coarse, statistical view on 
the organization of genotype space. This view needs to be complemented by a 
mechanistic perspective that asks what distinguishes the metabolisms that exist in 
different components of a genotype network? What could prevent evolution from 
converting them into each other through a series of single viability-preserving 
reaction changes? The answer lies in alternative metabolic pathways that are essential 
for the biosynthesis of one or more biomass molecules. Potential metabolisms in one 
genotype network component have one such pathway, and potential metabolisms in 
the other component have another such pathway. (In addition, these potential 
metabolisms may differ in other essential pathways.) At least one of these pathways 
must comprise more than one reaction, otherwise the two metabolisms could be 
converted into one another through a single reaction swap. We have provided two 
examples, one involving the biosynthesis of erythrose-4-phosphate and ribose-5-
phosphate through variants of the pentose phosphate pathway, the other concerning 
the biosynthesis of phosphoenolpyruvate. 
For two reasons, such alternative essential pathways are not likely to hamper the 
evolution of most metabolic systems. First, we observed fragmentation only for 
relatively small metabolisms, which means that in larger metabolisms, alternative 
essential pathways with more than one reaction do not exist. They can usually be 
converted into each other by single reaction changes that do not cause a loss of 
viability. Second, our analysis required that we impose change through reaction 
swaps – a reaction addition paired with a deletion – that leave reaction numbers 
constant. However, this is not usually how evolutionary change in a metabolism’s 
reactions occurs. For example, horizontal gene transfer frequently adds more than one 
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gene and thus more than one reaction to a metabolism [61, 62, 63]. In a metabolism 
that harbors one of two alternatives for an essential pathway, a horizontal gene 
transfer event may introduce the genes of the other pathway. After that, the two 
pathways may coexist, and the first pathway is free to deteriorate through loss of 
function mutations in its genes. A potential example of co-existing alternative 
pathways involves the two pathways responsible for synthesizing isopentenyl 
diphosphate (the 1-deoxy-D-xylulose 5-phosphate pathway and the mevalonate 
pathway), a molecule that is required for the synthesis of isoprenoids. Some 
actinomycetes that harbor both pathways in their complete forms may have obtained 
the responsible genes through horizontal gene transfer [64]. In sum, common forms 
of genetic change can help bridge different components of a genotype network where 
such components exist. 
The main limitation of our work comes from the enormous computational cost 
associated with evaluating the viability of many metabolisms. While our sampling 
approach for genome-scale metabolisms allowed us to circumvent this problem for 
any one carbon source, it is possible that viability on a broader range of carbon 
sources (or sources of other chemical elements) might have led to greater genotype 
network fragmentation. This possibility is suggested by our analysis of central carbon 
metabolism, where metabolisms viable on 10 carbon sources must have at least 34 
reactions, and fragmentation of genotype networks stops at 37 reactions. However, 
for genome-scale metabolisms, the metabolism sizes at which fragmentation would 
cease would increase only modestly with each additional carbon source on which 
viability is required. This is because previous work has shown that viability on every 
additional carbon source requires on average the addition of only two reactions to a 
metabolism [65]. For example, viability on ten additional carbon sources would 
increase the size of minimal metabolisms by only 20 reactions. Because the number 
of minimal metabolisms that arise de novo with increasing metabolic complexity n is 
closely linked to the metabolism size at which fragmentation occurs, viable genotype 
networks V(n) would still remain connected over the vast majority of the range of n. 
Indeed, we found that genome-scale metabolisms viable on 10 carbon sources and 
comprising 425 reactions are connected in genotype space and belong to the same 
component. Possible exceptions might involve metabolisms viable on hundreds of 
different carbon sources, but even environmental generalists are typically not viable 
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on that many. (The generalist E. coli is viable on some 50 alternative carbon sources 
[30]). 
Another limitation of our work is that we only considered viability on carbon sources. 
We cannot exclude the possibility that viability on sources of different chemical 
elements may lead to different fragmentation patterns. However, it is unlikely that 
carbon sources are exceptional in this regard. For example, the minimal size of 
metabolisms viable on different sulfur sources comprises only 90 reactions, and is 
thus even smaller than that of metabolisms viable on carbon [12]. The reason is that 
fewer biomass molecules contain sulfur, an observation that also holds for the two 
other key elements nitrogen and phosphorus. 
A further limitation is that we focus on evolutionary constraints caused by the 
presence or absence of biochemical reactions, rather than on differences in the 
regulation of existing enzymes or their encoding genes. Such regulatory constraints 
can influence important metabolic properties such as biomass growth rate [20]. 
However, they can also be easily broken through regulatory evolution, even on the 
short time scales of laboratory evolution experiments [19, 20, 66]. Reaction absence 
is thus a more fundamental constraint, but we note that the exploration of regulatory 
constraints remains an important task for future work. Moreover, to understand 
connectedness as a function of reaction numbers, we had to preserve reaction 
numbers and analyze connectedness through reaction swaps. We note that a reaction 
swap can be considered as an addition of a reaction, which does not change viability 
and a reaction deletion that preserves viability. That is, every reaction swap can be 
broken down into two biologically relevant changes, and thus genotype network 
connectivity resulting from reaction swaps also holds for single reaction additions 
and deletions. 
Finally, we do not consider one potential cause of genotype network fragmentation: If 
one required for viability that biomass precursors need to be synthesized at a high 
rate, then genotype networks may fragment more often than we observe. However, 
fast biomass synthesis and its main consequence, rapid cell division, are not 
universally important outside the laboratory environment. For example, a survey of 
microbial growth rates shows that many microbes have very long generation times in 
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the wild [67]. Rapid growth thus may not be a biological sensible requirement for 
viability in many wild organisms. 
5.5. Methods 
Flux balance analysis 
Flux balance analysis (FBA) is a constraint-based computational method [34, 70] that 
can predict synthetic abilities and other properties of metabolisms – complex 
networks of enzyme-catalyzed biochemical reactions. Any one such network can 
comprise anything from a few dozen reactions, such as central carbon metabolism 
[70], to the thousands of reactions in a complex genome-scale metabolism. FBA uses 
information about the stoichiometry of each reaction to predict steady state fluxes for 
all reactions in a metabolic network. The necessary stoichiometric information is 
represented as a stoichiometric matrix, S, of dimensions m × n, where m denotes the 
number of metabolites, and n denotes the number of reactions in a metabolism [34, 
70]. FBA assumes that the concentrations of intracellular metabolites are in a steady 
state, which allows one to impose the constraint of mass conservation on them. This 
constraint can be written as Sv = 0, where v denotes a vector of metabolic fluxes 
through each reaction in a metabolism. The above equation has a large space of 
possible solutions, but not all of these solutions may be of biological interest. To 
restrict this space to fluxes of interest, FBA uses linear programming to maximize a 
biologically relevant quantity in the form of a linear objective function Z[70]. 
Specifically, the linear programming formulation of an FBA problem can be 
expressed as 
maxZ=max{cTv∣∣Sv=0,a≤v≤b} 
The vector c contains the set of scalar coefficients that represent the maximization 
criterion. The individual entries of vectors a and b, respectively, contain the minimal 
and maximally possible fluxes for each reaction in v. Irreversible reactions can only 
have fluxes with positive signs, whereas irreversible reactions can have fluxes of both 
signs. 
We are here interested in predicting whether a metabolism can sustain life in a given 
spectrum of environments, that is, whether it can synthesize all necessary small 
biomass molecules (biomass precursors) required for survival and growth. For our 
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analysis of central carbon metabolism, there are 13 such essential precursors 
(Additional file 2 and [35]). For our analysis of genome scale metabolisms, we use all 
63 [30] biomass precursors of E. coli, because most of them would be required in any 
free-living organism. They include 20 proteinaceous amino acids, DNA and RNA 
nucleotide precursors, lipids and cofactors. We use these biomass precursors to define 
the objective function and the vector c. We employed the package CLP (1.4, Coin-
OR; https://projects.coin-or.org/Clp) to solve linear programming problems. The 
computer program required for FBA is available in Additional file 9. 
Growth environments 
Along with the biomass composition and stoichiometric information about a 
metabolic network, computational predictions of viability require information about 
the chemical environments that contain the nutrients needed to synthesize biomass 
precursors. In our analysis of central carbon metabolism, we consider a minimal 
aerobic growth environment composed of a sole carbon source, along with 
ammonium as a nitrogen source, inorganic phosphate as a source of phosphorus, as 
well as oxygen, protons, and water. When studying the viability of metabolisms on 
different carbon sources, we vary the carbon source while keeping all the other 
nutrients constant. When we say a particular metabolism is viable on 10 carbon 
sources, we mean that it can synthesize all biomass precursors when each of these 
carbon sources is provided as the sole carbon source in a minimal medium. The ten 
carbon sources we consider are D-glucose, acetate, pyruvate, D-lactate, D-fructose, 
alpha-ketoglutarate, fumarate, malate, succinate and glutamate. 
Our analysis of genome-scale metabolisms requires a minimal environment with 
more nutrients, i.e., a sole carbon source, ammonium, inorganic phosphate, sulphate, 
sodium, potassium, cobalt, iron (Fe2+ and Fe3+), protons, water, molybdate, copper, 
calcium, chloride, magnesium, manganese and zinc [30]. For our analysis of genome-
scale metabolisms viable on 10 carbon sources, we used the 10 carbon sources from 
the preceding paragraph. 
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The reactions used in the analysis of central carbon metabolism 
We use a global set of reactions in central carbon metabolism, which is based on a 
published reconstruction of E. coli central carbon metabolism [35]. From the 
published reconstruction [35], we deleted four reactions involved in ethanol 
synthesis, metabolism and transport. We also grouped the reactions catalyzed by 
aconitase A and aconitase B into one reaction. We did this mainly to reduce the size 
of the set of reactions, in order to render the exploration of all variant metabolisms 
derived from it feasible. The final reaction set consists of N = 51 intracellular 
reactions, and we analyzed the viability of metabolisms comprising all possible 251 
subsets of this set. The reconstruction in [35] also involves 20 transport reactions, 
which are necessary to import nutrients or excrete waste products, and which we 
assume to be present in all metabolisms we studied. 
The known reaction “universe” and the global metabolism 
We refer to the known universe of biochemical reactions as the set of reactions 
known to occur in some organism based on currently available biochemical 
knowledge. To arrive at this set, we curated data from the LIGAND database [31, 32] 
of the Kyoto Encyclopedia of Genes and Genomes [71], which is divided into two 
smaller databases, the REACTION database and the COMPOUND database. These 
two databases together provide information about metabolic reactions, participating 
chemical compounds, and associated stoichiometric information. As described 
previously [10, 11, 13, 33], we curated reactions from these databases by excluding 
reactions involving polymer metabolites of unspecified numbers of monomers; 
general polymerization reactions with uncertain stoichiometry; reactions involving 
glycans, owing to their complex structure; reactions with unbalanced stoichiometry; 
and reactions involving complex metabolites without detailed structural information 
[71]. After curation of these reactions, we added to them all non-redundant reactions 
from the published E. coli metabolic model (i AF1260), which comprises 1,397 non-
transport reactions [30]. At the end of this procedure, we had arrived at a set of 5,906 
non-transport reactions and 5,030 metabolites. We converted this set into what we 
call a global metabolism by including all E. coli transport reactions in this set [30]. 
Unsurprisingly, the global metabolism can synthesize all biomass precursors of E. 
coli from any of the carbon sources we consider here. We note that this metabolism 
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may not be biologically realizable, for example, because it may contain 
thermodynamically infeasible pathways. However, we merely use it as a starting 
point to create smaller and ultimately minimal metabolisms through the sequential 
reaction deletion process described below. 
Genotypes, phenotypes and viability 
The genes encoding the enzymes that catalyze a metabolism’s reactions constitute the 
metabolic genotype of an organism. For our purpose, a more compact representation 
of a metabolic genotype is useful, which represents this genotype as a binary vector 
whose i-th entry corresponds to the i-th reaction in some global set or universe of 
biochemical reactions. This entry will be equal to one if an organism’s genome 
encodes an enzyme capable of catalyzing this reaction, and zero otherwise 
(Additional file 1). The genotype space of all possible metabolisms comprises 2 N 
metabolisms, where N is the total number of known or considered chemical reactions 
(N = 51 for our analysis of central carbon metabolism, and N = 5906 for our analysis 
of genome-scale metabolisms). Any one organism's metabolic genotype can be 
thought of as a point in this space. Genotypes (metabolisms) viable in a given 
chemical environment are those that can synthesize all biomass precursors from 
nutrients in this environment. Specifically, a metabolism is considered viable on a 
carbon source if its biomass synthesis rate is more than one percent of the biomass 
synthesis rate of the central carbon metabolism (N = 51) on that carbon source. We 
note that many of the metabolisms we study here, may not be realized in extant 
organisms. We thus refer to these metabolisms as potential metabolisms. 
Essential and nonessential reactions 
We define a reaction as essential for viability if its elimination abolishes viability in a 
given chemical environment. To identify all such essential reactions in a given 
metabolism, we eliminated each reaction and used FBA to assess whether non-zero 
biomass growth flux was still achievable. For our analysis of viability on 10 different 
(sole) carbon sources, we defined a reaction as essential if its elimination abolishes 
viability on at least one of the 10 carbon sources. The computer program required for 
computing essential and non-essential reactions is available in Additional file 9. 
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Identification of viable central carbon metabolisms 
To identify all viable metabolisms by exhaustive enumeration of viability for all 251 
(1015) possible metabolisms in central carbon metabolism would be infeasible. 
Fortunately, such brute-force enumeration is also not necessary, for two reasons. The 
first originates from the notion of “environment-general superessential reactions” 
[13]. These are reactions whose elimination abolishes viability in each of the 10 
carbon sources used here. To find such reactions, we converted the universe of 
central carbon metabolism into a format amenable to FBA analysis, as described 
earlier in this section. We then deleted each reaction and determined viability on each 
of the 10 carbon sources. We found six reactions (Additional file 2, in red) that were 
necessary for biomass synthesis on each source. Any viable central carbon 
metabolism would require all six reactions, which reduces the number of metabolisms 
whose viability needs to be evaluated from 251 to 2(51–6) = 245(≈1013). 
The second reason derives from a simple observation that reduces the number of 
genotypes whose viability needs to be determined even more dramatically: Removal 
of a reaction from an unviable metabolism cannot result in a viable metabolism. This 
means that among all metabolisms with n-1 reactions, we need to evaluate only the 
viability of those that are derived from viable potential metabolisms with n reactions 
through removal of one reaction. We incorporated this idea into an algorithm that 
allowed us to enumerate all viable genotypes [43]. 
Sampling of viable genome-scale metabolisms 
To sample large (genome-scale) metabolisms, we started from the global metabolism 
of 5,906 reactions and deleted (eliminated) from it a sequence of randomly chosen 
reactions, while requiring that each such deletion preserves viability. Specifically, we 
chose a metabolic reaction at random and equiprobably among all reactions, deleted 
it, and used FBA to determine viability of the resulting metabolism. If the metabolism 
was viable, we accepted the deletion. Otherwise we randomly choose another 
reaction for deletion, and so on, until we found one whose deletion left the resulting 
metabolism viable. We also kept a count of the number of successive attempted 
deletions that resulted in a non-viable metabolism. This count was reset to zero if the 
deletion of a randomly chosen reaction was successful. Once that count reached 1000, 
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that is 1000 successive attempts at reaction deletion abolished viability, we 
considered the metabolism a good candidate for a minimal metabolism. To confirm 
minimality, we deleted each reaction in this metabolism, and if every such deletion 
resulted in non-viability, we declared the metabolism to be minimal. The computer 
program required for generating viable potential metabolisms by random reaction 
deletion is available in Additional file 9. 
Identification of viability-preserving paths connecting viable genotypes G1 and 
G2 at arbitrary size n 
To find out whether two genotypes G 1 and G 2 can be connected to one another 
through viability-preserving reaction swaps, we used the following heuristic 
approach. It does not rely on reaction swaps of arbitrary reactions, which we found to 
be too inefficient, but takes advantage of existing reactions in the two genotypes to 
accelerate the process. It defines a “walker” genotype G 1 and alters it through 
multiple random steps (reaction swaps) that approach the other, “target” genotype G 
2. Before starting this walk, we established two lists of reactions L 1 and L 2 . L 1 
contained all reactions in G 1 that were not contained in G 2 . In this list we placed 
reactions non-essential in G 1 first (and in random order), followed by reactions 
essential in G 1 (also in random order). Conversely, L 2 consisted of arbitrarily ordered 
essential reactions in G 2 , followed by arbitrarily ordered reactions nonessential in G 
2 . 
Each step in the random walk consisted of two parts, i.e., (i) adding to G 1 a reaction 
from L 2 (i.e., a reaction essential in G 2), and (ii) deleting from G 1 a reaction listed in 
L 1 . Subsequent steps used subsequent reactions in each list for addition and deletion. 
As this walk through genotype space progressed, we continued adding reactions to G 
1 until all essential reactions from G 2 in list L 2 had been added to G 1, and continued 
from there on to adding nonessential reactions from L 2 . During part (ii) of any given 
step, if none of the remaining reactions in the list could be deleted from walker G 1 
without losing viability, we reverted the last reaction addition, and chose instead a 
reaction at random from the universe as a candidate for addition. Before adding it, we 
ensured that the chosen reaction shared all of its substrates and products with other 
reactions in the random walker. If the product of the reaction was not shared with 
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another reaction, we checked if it could be secreted by a transport reaction. A 
candidate reaction that did not fulfill both criteria would be disconnected from the 
rest of metabolism, could therefore not possibly contribute to viability [33], and we 
discarded it, choosing another candidate, and so on, until we had found one that 
fulfilled both criteria. We then determined if, after the addition of this reaction, some 
reaction in the list could be deleted from the random walker. If so, we accepted the 
resulting swap, otherwise we tried another addition, and so on, until we had found an 
acceptable swap. 
The two parts of each step ensure, first, that essential reactions from the target are 
preferentially added to the walker, thus increasing the likelihood of adding “useful” 
reactions to G 1, perhaps from one of several alternative metabolic pathways. Second, 
they reduce the chances of yielding an unviable genotype after a reaction deletion. 
However, the probability that the deletion of a reaction from walker G 1 can render it 
unviable increases with the number of reaction swaps, because past steps may have 
rendered previously nonessential reactions essential. We therefore also needed to use 
FBA after each deletion to ensure that G 1 retained viability after a reaction deletion. 
We continued this guided random walk for as many swaps as needed to reach the 
target G 2, or until we had performed 5000 attempted swaps. In the latter case, we 
declared G 1 and G 2 disconnected. We note that this is no proof of disconnectedness, 
as some path may exist that this procedure cannot find. However, in practice, all our 
attempts to connect genotype pairs in this way were successful. 
The computer program required for checking connectedness between a pair of 
metabolic genotypes using the above procedure is available as Additional file 9. 
Identification of a metabolism’s viable neighbors 
Two metabolisms are adjacent or neighbors of each other with respect to a reaction 
swap if they differ by one such swap. If the focal metabolism contains n reactions, 
then there are N-n reactions that are not part of the focal metabolism, where N is the 
total number of reactions a metabolism could possibly have. One can thus obtain a 
neighbor of the focal metabolism by deleting one of its n reactions and 
simultaneously adding one of the N-n reaction from the universe of reactions. Any 
metabolism therefore has n × (N-n) possible neighbors. To identify the viable 
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neighbors of a minimal metabolism, we generated all possible n × (N-n) neighbors, 
and used FBA to determine their viability on glucose. (We also note that any minimal 
metabolism trivially has zero viable neighbors with respect to reaction deletion, and 
N-n viable neighbors with respect to reaction additions). 
The computer program required for computing the viable neighbors of a metabolic 
genotype is available as Additional file 9. We used MATLAB (Mathworks Inc.) for 
all numerical analysis. Genotype space visualization was generated using the script 
available at (http://www.oaslab.com/Drawing_funnels.html). 
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5.7. Supplementary Information 
 
 
 
Additional file 1: Representation of a genotype vector. Any genotype encoding n 
reactions (n ≤ N) can be represented as a binary vector of length N, with n entries 
equal to one and all others equal to zero. The reactions that are present in the above 
hypothetical genotype are shown in black and the reactions that are absent are shown 
in grey. (PDF 10 KB) 
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Abbreviation  Metabolite full name 
13dpg  3-Phospho-D-glyceroyl phosphate 
2pg  D-Glycerate 2-phosphate 
3pg  3-Phospho-D-glycerate 
6pgc  6-Phospho-D-gluconate 
6pgl  6-phospho-D-glucono-1,5-lactone 
ac  Acetate 
ac[e]  Acetate (extracellular) 
acald  Acetaldehyde 
acald[e]  Acetaldehyde (extracellular) 
accoa  Acetyl-CoA 
actp  Acetyl phosphate 
adp  ADP 
akg  2-Oxoglutarate 
akg[e]  2-Oxoglutarate (extracellular) 
amp  AMP 
atp  ATP 
cit  Citrate 
co2  CO2 
co2[e]  CO2 (extracellular) 
coa  Coenzyme A 
dhap  Dihydroxyacetone phosphate 
e4p  D-Erythrose 4-phosphate 
f6p  D-Fructose 6-phosphate 
fdp  D-Fructose 1,6-bisphosphate 
for  Formate 
for[e]  Formate (extracellular) 
fru[e]  D-Fructose (extracellular) 
fum  Fumarate 
fum[e]  Fumarate (extracellular) 
g3p  Glyceraldehyde 3-phosphate 
g6p  D-Glucose 6-phosphate 
glc-D[e]  D-Glucose (extracellular) 
gln-L  L-Glutamine 
gln-L[e]  L-Glutamine (extracellular) 
glu-L  L-Glutamate 
glu-L[e]  L-Glutamate (extracellular) 
glu-L[e]  L-Glutamate (extracellular) 
glx  Glyoxylate 
h  H+ 
h[e]  H+ (extracellular) 
h2o  H2O 
h2o[e]  H2O (extracellular) 
icit  Isocitrate 
lac-D  D-Lactate 
lac-D[e]  D-Lactate (extracellular) 
mal-L  L-Malate 
mal-L[e]  L-Malate (extracellular) 
nad  Nicotinamide adenine dinucleotide 
nadh  Nicotinamide adenine dinucleotide (reduced) 
nadp  Nicotinamide adenine dinucleotide phosphate 
nadph 
 Nicotinamide adenine dinucleotide phosphate 
(reduced) 
nh4  Ammonium 
nh4[e]  Ammonium (extracellular) 
o2  O2 
o2[e]  O2 (extracellular) 
oaa  Oxaloacetate 
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pep  Phosphoenolpyruvate 
pi  Phosphate 
pi[e]  Phosphate (extracellular) 
pyr  Pyruvate 
pyr[e]  Pyruvate (extracellular) 
q8  Ubiquinone-8 
q8h2  Ubiquinol-8 
r5p  alpha-D-Ribose 5-phosphate 
ru5p-D  D-Ribulose 5-phosphate 
s7p  Sedoheptulose 7-phosphate 
succ  Succinate 
succ[e]  Succinate (extracellular) 
succoa  Succinyl-CoA 
xu5p-D  D-Xylulose 5-phosphate 
 
Additional file 2: Metabolites in central carbon metabolism. Metabolites 
abbreviations (left columns) and their full names (right columns) are shown. Note 
Rows in red correspond to biomass precursors in the central carbon metabolism. atp, 
nadph and nad are also biomass precursors, but we wish to emphasize on metabolites 
that are act as biochemical precursors to the actual biomass precursors of E. coli (See 
main text). atp, nadph and nad are also biomass precursors for E. coli. 
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Metabolism size n 
Number of 
metabolisms Ω(n) 
Number of viable 
potential metabolisms 
V(n) on glucose 
Fraction of viable 
potential metabolisms 
on gluose 
23 1.9679E+14 3 1.52444E-14 
24 2.2959E+14 91 3.96355E-13 
25 2.4796E+14 1333 5.37588E-12 
26 2.4796E+14 1.2512E+04 5.04599E-11 
27 2.2959E+14 8.4344E+04 3.67365E-10 
28 1.9679E+14 4.3424E+05 2.20657E-09 
29 1.5608E+14 1.7740E+06 1.1366E-08 
30 1.1446E+14 5.9006E+06 5.15529E-08 
31 7.7535E+13 1.6274E+07 2.09889E-07 
32 4.8459E+13 3.7712E+07 7.78212E-07 
33 2.7901E+13 7.4145E+07 2.65744E-06 
34 1.4771E+13 1.2456E+08 8.43246E-06 
35 7.1745E+12 1.7967E+08 2.50429E-05 
36 3.1887E+12 2.2325E+08 7.0013E-05 
37 1.2927E+12 2.3933E+08 0.000185138 
38 4.7626E+11 2.2138E+08 0.00046484 
39 1.5875E+11 1.7647E+08 0.0011116 
40 4.7626E+10 1.2087E+08 0.002537936 
41 1.2778E+10 7.0817E+07 0.005542198 
42 3.0423E+09 3.5259E+07 0.01158958 
43 6.3676E+08 1.4786E+07 0.023220727 
44 1.1578E+08 5.1600E+06 0.044569549 
45 1.8009E+07 1.4745E+06 0.081871194 
46 2.3491E+06 3.3744E+05 0.143647672 
47 2.4990E+05 5.9966E+04 0.239959984 
48 2.0825E+04 7909 0.379783914 
49 1275 721 0.565490196 
50 51 40 0.784313725 
51 1 1 1 	
Additional File 3: Number of potential metabolisms viable on all ten carbon 
sources as a function of metabolism size. 
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Additional file 4: An example of a minimal metabolism viable on glucose. The 
figure shows an example of a minimal metabolism of size 23, which is also one of the 
smallest metabolisms viable on glucose. All 13 biomass precursors are framed with 
solid rectangles. Only important transport reactions and cofactors are shown. 
Enzymes catalyzing each of the reactions are shown in uppercase italic typeface. 
Abbreviations are spelled out in Additional file 2. 
 
Additional file 5: Supplementary results. Downloadable at https://static-
content.springer.com/esm/art%3A10.1186%2F1752-0509-8-
48/MediaObjects/12918_2014_1319_MOESM5_ESM.pdf 
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Additional file 6: Connectedness of genotype networks containing viable 
genotypes of n  = 28, 29, and 30 reactions. The figure shows the connectivity of 
genotype networks for reactions in central carbon metabolisms, as a function of size 
n. Each circle corresponds to a connected component, and the number in each circle 
corresponds to the number of genotypes in this component. The components at size 
28 were obtained by full enumeration, but for larger sizes such an approach is not 
feasible. Instead one has to use a form of recursive evaluation that we illustrate here 
for two larger sizes. Panel (A) shows the two disconnected components in the 
network corresponding to size 28, one containing 434234 genotypes, and the other 
component containing just 4 genotypes. The addition of one reaction to these 4 
genotypes results in 88 genotypes of size 29, which must be connected (see main 
text). (B) Aside from these 88 connected genotypes, there are also 28 minimal 
genotypes of size 29 (red circles). We verified computationally that both groups of 
genotypes (88 and 29) were connected using breadth-first search and found that they 
form a single component of 116 genotypes. We were also able to demonstrate that 
this component is connected to the 1773853 connected genotypes that are parents of 
the large component at size n = 28 (panel A). The two thus form a connected 
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genotype network of 1773969 metabolisms of size 29. Panel (C) shows that adding 
one reaction to these genotypes results in 5900563 connected genotypes at size 30. In 
addition, 15 new minimal metabolisms (red circles) come into being at size 30. We 
found that they were connected to the remaining 5900563 genotypes, thus forming a 
single connected network comprising 5900578 genotypes. (PDF 12 KB) 
 
 
Additional file 7: An example of essential pathways that result in fragmentation 
of genotype space. The figure shows the two essential pathways (green and blue) in a 
pair of genotypes belonging to the two disconnected components in the genotype 
network of potential metabolisms with n = 25 reactions (Figure 3C). The reactions in 
green, catalyzed by enzymes PFK, FBAl and TPI are essential in all genotypes 
belonging to the largest component (subgraphs A” and B”) in Figure 3C, while the 
reactions in blue are essential to all four genotypes in component C in Figure 3C. The 
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13 biomass precursors are surrounded by black rectangles. Only important transport 
reactions and cofactors have been shown. Enzymes catalyzing each of the reactions 
are shown in uppercase italic typeface. Information on abbreviations is provided in 
Additional file 2. 
 
Metabolism size n Number of metabolisms Ω(n) 
Number of potential 
metabolisms viable on 
all carbon sources 
Fraction of  potential 
metabolisms viable on 
all carbon sources 
34 1.4771E+13 4 2.708E-13 
35 7.1745E+12 79 1.10112E-11 
36 3.1887E+12 736 2.30817E-10 
37 1.2927E+12 4249 3.2869E-09 
38 4.7626E+11 1.6869E+04 3.54197E-08 
39 1.5875E+11 4.8507E+04 3.05549E-07 
40 4.7626E+10 1.0399E+05 2.18349E-06 
41 1.2778E+10 1.6902E+05 1.32277E-05 
42 3.0423E+09 2.1017E+05 6.90827E-05 
43 6.3676E+08 2.0060E+05 0.000315025 
44 1.1578E+08 1.4667E+05 0.001266835 
45 1.8009E+07 8.1539E+04 0.004527565 
46 2.3491E+06 3.3985E+04 0.014467489 
47 2.4990E+05 1.0377E+04 0.04152461 
48 2.0825E+04 2237 0.107418968 
49 1275 320 0.250980392 
50 51 27 0.529411765 
51 1 1 1 
Additional file 8: Number of metabolisms viable on all ten carbon sources as a 
function of metabolism size. 
 
Additional file 9: The essential computer programs used in this analysis. 
Downloadable at https://static-content.springer.com/esm/art%3A10.1186%2F1752-
0509-8-48/MediaObjects/12918_2014_1319_MOESM9_ESM.zip 
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Chapter 6:  
 
Exhaustive analysis of a genotype space comprising 1015 
central carbon metabolisms reveals an organization 
conducive to metabolic innovation 
Sayed-Rzgar Hosseini, Aditya Barve and Andreas Wagner  
 
 
 
 
The content of this chapter has been published as: 
 
Hosseini, S.-R., A. Barve, and A. Wagner. 2015. Exhaustive analysis of a genotype 
space comprising 1015 central carbon metabolisms reveals an organization 
conducive to metabolic innovation. PLoS Comput. Biol. 11: e1004329. 
https://doi.org/10.1371/journal.pcbi.1004329  
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6.1. Abstract 
All biological evolution takes place in a space of possible genotypes and their 
phenotypes. The structure of this space defines the evolutionary potential and 
limitations of an evolving system. Metabolism is one of the most ancient and 
fundamental evolving systems, sustaining life by extracting energy from extracellular 
nutrients. Here we study metabolism’s potential for innovation by analyzing an 
exhaustive genotype-phenotype map for a space of 1015 metabolisms that encodes all 
possible subsets of 51 reactions in central carbon metabolism. Using flux balance 
analysis, we predict the viability of these metabolisms on 10 different carbon sources 
which give rise to 1024 potential metabolic phenotypes. Although viable metabolisms 
with any one phenotype comprise a tiny fraction of genotype space, their absolute 
numbers exceed 109 for some phenotypes. Metabolisms with any one phenotype 
typically form a single network of genotypes that extends far or all the way through 
metabolic genotype space, where any two genotypes can be reached from each other 
through a series of single reaction changes. The minimal distance of genotype 
networks associated with different phenotypes is small, such that one can reach 
metabolisms with novel phenotypes – viable on new carbon sources – through one or 
few genotypic changes. Exceptions to these principles exist for those metabolisms 
whose complexity (number of reactions) is close to the minimum needed for viability. 
Increasing metabolic complexity enhances the potential for both evolutionary 
conservation and evolutionary innovation. 
Author Summary: 
Genotype-phenotype mapping provides an unprecedented opportunity to gain new 
insights into the function of biological systems and their evolution. We present a 
comprehensive genotype-phenotype map for a genotype space comprising more than 
1015 central carbon metabolisms.  The subsets of viable metabolisms form a 
connected genotype network that extends far through genotype space, and that 
renders multiple novel phenotypes in the immediate neighborhood of viable 
metabolisms accessible.  The map we describe reveals an organization of core 
metabolism that simultaneously facilitates evolutionary conservation of existing 
metabolic phenotypes and the origination of novel metabolic traits that allow viability 
on novel carbon sources. 
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6.2. Introduction 
Attempts to understand the relationship between genotype and phenotype have played 
a pivotal role in the history of genetics and evolutionary biology, beginning with the 
rediscoveries of Mendel’s laws, which revealed genotypes as distinct from 
phenotypes and responsible for the inheritance of phenotypic traits [1]. Subsequent 
efforts to map individual genes encoding such traits onto chromosomes helped 
develop classical and molecular genetic mapping methods [2]. Decades later, genome 
sequencing facilitated more systematic studies of the relationship between genotypes 
and complex traits, and resulted in the emergence of functional genomics and systems 
biology.  Today, a central goal of systems biology is to uncover and predict the 
relationship between genotypes and complex phenotypes, which include the structure 
and dynamics of complex intracellular networks like gene regulatory, signaling, and 
metabolic networks [3,4]. 
Computational methods to predict phenotype from genotype are increasingly 
powerful and they can help establish genotype-phenotype maps at unprecedented 
resolution [5–7]. An ideal such map would cover all possible genotypes, but 
unfortunately, the entire space of a system’s genotypes is usually too vast to study. 
For instance, the space of all RNA sequences of length 100 comprises 4100= 1060 
different RNA sequences, and the space of all protein sequences of length 100 
comprises 20100=10130 different protein sequences. Exhaustive genotype-phenotype 
mapping using computational approaches is possible only in small systems. They 
include short hydrophobic polar (HP) model proteins folding on square and cubic 
lattices [8], short RNA sequences folding into planar secondary structures [9], and 
small gene regulatory networks [10]. Similar exhaustive approaches have not been 
taken yet in metabolic systems, and our understanding of metabolic systems is thus 
far limited to sampling of metabolic genotype space [11–18]. Here, we build on our 
previous work studying the connectivity of the space of central carbon metabolisms 
[19] and present an exhaustive genotype-phenotype map of this space.  
In evolution, phenotypic change is caused by genotypic change. Thus, the structure of 
a genotype-phenotype map contains information about the evolutionary potential and 
limitations of an evolving system. Metabolisms are important classes of evolving 
systems, because they are a source of many evolutionary adaptions and innovations, 
especially in microorganisms. For instance, microorganisms have acquired the ability 
	 304	
to utilize many non-natural substances like polychlorinated biphenyls, chlorobenzens, 
organic solvents and synthetic pesticides as food [20–23]. Microbial isolates from 
pristine soils can survive on several antibiotics like ciprofloxacin by using them as 
sole carbon sources [24], and halophilic bacteria can tolerate high salt concentration 
by synthesizing novel molecules like ectoine or glycine betaine [25,26].  
An organism’s metabolism is a biochemical reaction network that comprises a set of 
reactions that are catalyzed by enzymes encoded by genes. Following common 
practice in the computational analysis of metabolism [4], we here represent a 
metabolic genotype as a binary presence-absence pattern of a set of biochemical 
reactions, i.e., as a binary string whose entries indicate presence (1) or absence (0) of 
a reaction among some set of N possible reactions. In our analysis (see also [19]), this 
global reaction set comprises 51 reactions from central carbon metabolism (see 
Methods, and table S9). Any one metabolism can be viewed as a point in metabolic 
genotype space whose size is equal to 251=2.25 x 1015 metabolisms. In this 
framework, a metabolism’s genotype can evolve by either losing one or more 
reactions, for example through a loss of function mutation, or by gaining one or more 
reactions, for example through horizontal gene transfer or gain of function mutations 
[27–29]. 
We focus on central carbon metabolism because of its pivotal role in extracting 
energy from extracellular carbon sources. It comprises the interconnected 
biochemical pathways of glycolysis, gluconeogenesis, the pentose-phosphate 
pathway (PP), and the tricarboxylic acid cycle (TCA). These are supplemented by 
anaplerotic reactions and the glyoxylate shunt [30]. Glycolysis converts glucose into 
pyruvate and produces high-energy compounds like ATP and NADH. In parallel, the 
pentose-phosphate pathway generates NADPH and pentose sugars required for 
anabolic reactions. The glycolytic end product pyruvate is oxidized to acetyl-CoA, 
which enters the tri-carboxylic acid cycle (TCA), a cyclical series of reactions that 
generate ATP, NADH, and amino acid precursors. Pyruvate and 
phosphoenolpyruvate (PEP) can also enter the TCA cycle directly through anaplerotic 
reactions that replenish TCA cycle intermediates consumed in biosynthetic processes. 
Conversely, under gluconeogenic conditions, the TCA cycle intermediates 
oxaloacetate or malate are converted to pyruvate and PEP to provide the precursors 
for gluconeogenesis. Acetyl-CoA can also participate in the glyoxylate shunt to 
	 305	
generate succinate for carbohydrate synthesis. Finally, reactions of the oxidative 
phosphorylation pathway participate in production of ATP from NADH (Figure S1).  
Not all organisms contain all reactions associated with central carbon metabolism. 
For example, although the Embden–Meyerhoff–Parnass (EMP) glycolytic pathway 
(figure S1) is nearly ubiquitous among eukaryotes, prokaryotes can use diverse 
natural glycolytic alternatives [31–33]. Archaebacteria like Sulfolobus solfataricus 
[34] and Thermoplasma acidophilum [35], metabolize glucose through the Entner-
Doudoroff (ED) pathway and heterolactic fermentative bacteria use phosphoketolase 
pathway instead of the canonical glycolytic pathway [32]. Natural glycolytic 
pathways vary in their reaction content and in how much ATP they produce per 
glucose [33,36]. Furthermore, genome analysis of 19 species including 4 archaea, 14 
bacteria and 1 eukaryote has revealed that in the majority of species the citric acid 
cycle is incomplete or absent [37]. Also, in vivo quantification of intracellular carbon 
fluxes from C13 tracer experiments has shown that relative activities of individual 
reactions of central carbon metabolism vary widely among different species [38]. 
Such variation calls for an examination of how genotypic variation maps into 
variation in metabolic phenotypes. 
For our analysis, we define a metabolic phenotype based on a metabolism’s viability, 
its ability to sustain life in a given set of environments. We call a metabolism viable 
in any one environment if it can synthesize 13 key precursors (Figure S1) that are 
produced by central carbon metabolism and that are necessary for the synthesis of 
amino acids and other essential biomass molecules [39]. We here consider 10 
environments that vary in their carbon source and contain an otherwise minimal 
complement of nutrients (see Methods). We represent the phenotype of a given 
metabolism as a binary string of length 10 whose entries indicate viability (1) or 
inviability (0) of the metabolism on a given carbon source. In this framework, a 
change in metabolic genotype is a metabolic innovation if it leads to viability on new 
combinations of carbon sources. To compute the phenotype of a given metabolic 
genotype, we use the constraint-based method of flux balance analysis (FBA, see 
Methods) [7,40–42] whose qualitative predictions of viability are in good agreement 
with experimental data [43–49]. FBA takes advantage of constraints imposed by the 
stoichiometry of all metabolic reactions and maximal nutrient uptake rates in a given 
environment. Subject to the law of mass conservation in a metabolic steady state, it 
	 306	
can predict the rate at which each reaction can proceed under conditions of maximal 
production of biomass precursors [7,40,44,47,50–52]. Although FBA is 
computationally efficient [7,40–42], determining the phenotypes of more than 1015 
metabolic genotypes in each of 10 possible environments is challenging and required 
us to develop techniques that simplify this task (see Methods). 
We use the resulting genotype-phenotype map to analyze a set of viable metabolisms 
with a given phenotype as a graph, where two nodes (metabolisms) are neighbors if 
they can be connected by a single reaction change. We study the organization of these 
graphs in metabolic genotype space, and find that they typically extend far through 
this space. To study a metabolism’s potential for metabolic innovation, that is, how 
changes in metabolic reactions can lead to new metabolic phenotypes (viability in 
new environments) we explore the metabolism’s neighborhood in genotype space and 
this neighborhood’s phenotypic diversity. We find that the neighborhoods of 
metabolisms with the same phenotype but different genotype often contain 
metabolisms with different novel metabolic phenotypes. Also, the genotype networks 
of different metabolic phenotypes abut each other in genotype space. Together, these 
observations suggest that the organization of metabolic genotype space is conducive 
to metabolic innovation.  
 
6.3. Results 
The number of viable metabolisms depends on carbon source and reaction 
numbers 
We first enumerated the number of central carbon metabolisms (CCM) on a given 
carbon source. Figure 1a shows this number as a function of metabolism size, that is, 
the number n of reactions in a metabolism, for various carbon sources. Note the 
logarithmic vertical axis. Black data points indicate the total number of metabolisms 
of a given size n, regardless of their viability. This number is given by the binomial 
coefficient . The following observations emerge from this figure. First, the 
minimum number of reactions  in a viable metabolism is not the same for all 
carbon sources. For example, it varies from nmin=23 for glucose and fructose to 
nmin=30 for acetate (Figure S2, See the Supplementary Text S1 for an explanation of 
this difference).  
( )Nn
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Figure 1: Metabolisms viable on different carbon sources and genotypic differences among them. 
a) Number of viable metabolisms. Black circles (vertical axis) indicate the total possible numbers  
of metabolisms of a given size n (horizontal axis, N=51, 0≤n≤51). Colored data points indicate the 
number of metabolisms viable on the single carbon sources indicated in the legend. b) Fraction of 
metabolisms viable on different carbon sources. Note the logarithmic vertical scale. Data on glucose in 
a) and b) has been previously published [19].  c) Genotype network diameter. Black circles indicate the 
diameter of genotype space for metabolisms of a given size, which is an upper bound to the diameter 
of any one genotype network. Colored data points indicate genotype network diameter for metabolisms 
viable on a single carbon source. Where sets of viable metabolisms comprised more than one 
connected component, the diameter of the giant component was chosen. At n≥40, all genotype 
networks have the maximally possible diameter. d). Fraction of metabolisms that contain no 
disconnected reactions.  Colored circles correspond to metabolisms viable on the carbon source 
specified in the legend and black circles correspond to inviable metabolisms.  Data on inviable 
metabolisms is based on 10000 randomly sampled inviable metabolisms. Interpolation between data 
points (circles) is linear and displayed as a visual guide.  
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Second, the maximum number of viable metabolisms also varies by more than two 
orders of magnitude, from approximately 1.9×106 for acetate to 2.4×108 for glucose 
(see Table S1).  
Third, the number of viable metabolisms shows a unimodal distribution whose 
qualitative shape is predicted by binomial coefficients that are shifted by , i.e., 
, for any one carbon source (See figure S3a and S3b for examples). This is a 
result of the fact that adding any number of reactions to a viable metabolism of 
minimal size creates another viable metabolism, and there are ways of 
adding reactions. We note that this qualitative relationship is not 
quantitatively accurate, for reasons explained in the supplementary Text S2. 
Figure 1b shows the same information as figure 1a, but expresses the number of 
viable metabolisms as a fraction of all metabolisms  at a given size N. Note the 
logarithmic scale and that the fraction of viable metabolisms declines faster than 
exponentially with decreasing n. It is easy to understand this pattern if one considers 
a metabolism (“the child”) that is derived from another (“the parent”) by eliminating 
a single reaction. First, some fraction of the children of viable parent metabolisms is 
inviable; second, this fraction increases as n decreases; third, all children of inviable 
metabolisms are themselves inviable. Together, these observations can account for 
the rapid decrease of the fraction of viable metabolisms.  
Except for the smallest metabolisms, most viable metabolisms form a genotype 
network with a large diameter. 
Viable genotypes of all but the smallest sizes n form a single connected network of 
genotypes, where any two genotypes can be reached from one another through 
changes in individual reactions. In a previous contribution, we have demonstrated this 
connectivity for metabolisms viable on glucose and on all ten carbon sources we 
consider here taken together [19]. Table S2 shows that it also holds for metabolisms 
viable on the nine other carbon sources. Even where the set of viable metabolisms is 
partitioned into more than one component (nC>1; table S2), i.e., more than one 
genotype network, this number of components is usually small, and the largest of 
them harbors a large fraction rG of genotypes (rG>0.95 in 23 out of 29 cases where 
rG<1; table S2).  
minn
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Starting from these observations, we asked how different the reaction content of 
metabolisms viable on the same carbon source could be. In graph theoretic terms, this 
is a question about the diameter of the set of viable genotypes at any one size n. 
Figure 1c shows this diameter as a function of metabolism size n for all 10 carbon 
sources. For most metabolism sizes, the diameter lies between 5 and 15, indicating 
that metabolisms of the same size and viable on the same carbon sources can have 
very different reaction complements. Moreover, for any one carbon source, and for 
metabolisms of most sizes above nmin, the diameter as a fraction of the diameter of the 
genotype space (i.e. the maximum possible diameter (See methods)) is equal to one 
or very close to one (figure 1c). This implies that the set of viable metabolisms is not 
highly localized within a small region of genotype space. Rather, its members occur 
throughout the space and the set comprising them often spans this space. Since the 
fraction of viable metabolisms increases with n, the fractional diameter increases with 
increasing n (until n=40, where it reaches one for all carbon sources).  
Figure 2: Example of two maximally different metabolisms. Each arrow in each panel corresponds 
to one of the 51 internal reactions we consider. Black arrows and gray arrows correspond to reactions 
that are present or absent, respectively, in the metabolism shown. Metabolites are indicated by their 
acronyms (see Table S9). Boxed metabolites correspond to 13 essential biomass precursors. Note that 
4 metabolites (accoa, g3p, f6p and e4p) are shown more than once for visual clarity. a) A metabolism 
with 33 reactions that is viable on fructose and that differs from another metabolism of size 33 viable 
on fructose shown in b) by 16 reactions. The two metabolisms share 17 reactions.  
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As an example of two viable networks comprising maximally different reaction sets, 
figure 2 shows two maximally different metabolisms viable on fructose. Each 
metabolism contains 33 reactions. The two metabolisms share 17 reactions, and differ 
in 16 reactions. The products of the 17 shared reactions are the essential biomass 
precursors (boxed molecules in figure 2), meaning that the respective reactions 
cannot be bypassed via alternative reactions or pathways. In contrast, the 16 differing 
reactions are either non-essential reactions that do not directly contribute to the 
production of small biomass molecules, or they are reactions essential only in one of 
the metabolisms but not in both. Such non-shared but essential reactions exist, 
because a necessary biomass molecule may be synthesized by one or more alternative 
reactions or pathway in two metabolism. An example is the reaction catalyzed by 
glutaminase, which is essential for the synthesis of glutamate (glu-L) from glutamine 
(gln-L) and 𝛼-ketoglutarate (akg) in the metabolism of figure 2b, but is substituted 
for by the reaction catalyzed by glutamate dehydrogenase, which is essential for 
production of glutamate from 𝛼-ketoglutarate (akg) and ammonium (not shown) in 
the metabolism of figure 2a.  
Central carbon metabolism contains pairs of reactions that differ only in the co-factor 
they use. Three such pairs are relevant for our analysis. The first comprises two 
reactions catalyzed by malic enzyme that use NAD and NADP as co-factors. The 
second comprises two reactions catalyzed by different transhydrogenases, and the 
third includes the reactions catalyzed by ATPase and ATP synthase (Table S9). We 
wanted to examine whether such pairs of reactions trivially increase the genotypic 
distance among metabolism pairs and thus artificially inflate genotype network 
diameter. For any given genotype network, this could only be the case if the two 
members of all metabolism pairs with the highest genotypic distance use different 
reactions from at least one of these two pairs. To find out, we first enumerated all 
metabolism pairs with genotypic distance equal to the diameter of the given genotype 
network, and noted that there are up to millions of such pairs.  Next, we examined for 
each such pair of metabolisms whether (i) one member used the NAD isoform of 
malic enzyme while the other one used the NADP isoform, or (ii) one member used 
one transhydrogenase while the other member used the other transhydrogenase or (iii) 
one member used ATPase and the other one ATP synthase. If so, we eliminated the 
pair from the set of pairs with largest distance. Table S3 shows the percentage of 
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metabolism pairs that remained in the set based on this criterion. It exceeds 30% for 
most genotype networks and is greater than zero for every genotype network. This 
observation implies that in every genotype network at least one metabolism pair does 
not have artificially large genotypic distance due to co-factor dependency. Hence, co-
factor dependency does not artificially inflate genotype network diameter. 
Reactions that are blocked – they must have zero flux for stoichiometric reasons [11, 
53] – could also contribute to large genotype network diameter. To find out whether 
this is the case, we calculated the total number of blocked reactions for each 
metabolism pair that is viable on the same carbon source and whose genotypic 
distance is equal to the diameter of its genotype network. Table S4 shows, for each 
carbon source, the minimum number of blocked reactions among such metabolism 
pairs. For most genotype networks (71.6% percent, 189 of 253) this minimum is zero. 
This means that at least one pair of metabolisms without any blocked reaction exists 
among the metabolism pairs with the largest genotypic distance. The exceptions are 
some genotype networks of metabolisms with intermediate sizes, where some contain 
no metabolism pairs without blocked reactions. Even in these genotype networks, 
however, only one or at most two reactions are blocked, meaning that the genotype 
network diameter would decrease only by this number if one were to disregard 
blocked reactions.   
The majority of reactions are connected to one another in most viable 
metabolisms.  
In a horizontal gene transfer event, enzyme-coding genes can be imported into a 
genome whose products catalyze reactions that may be connected to or disconnected 
from the resident metabolism. We define a reaction as disconnected from a 
metabolism if (i) its products are neither biomass precursors nor substrates of any 
other reaction in the resident metabolism, or (ii) at least one of its substrates is neither 
a product of other reactions nor a nutrient taken up from the environment. For 
example, among the 16 reactions that differ between the metabolisms in figure 2, one 
reaction in each of the two metabolisms is disconnected from the rest, that is, its 
substrates are neither products of other reactions nor are they nutrients provided by 
the environment in which fructose is the sole carbon source. Specifically, in figure 2a, 
the reaction that is catalyzed by malate synthase and produces L-malate (mal-L) from 
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glyoxylate (glx) and acetyl-coenzyme A (accoa) is a disconnected reaction, because 
glyoxylate is neither available in the environment, nor is it produced by other 
reactions in the metabolism. Similarly, in figure 2b the reaction that is catalyzed by 
fructose-bisphosphatase and produces fructose 6-phosphate (f6p) from fructose 1,6-
bisphosphate (fdp) is disconnected.  
To find out whether such disconnected metabolisms could strongly influence our 
analysis of metabolic genotype space, we determined how abundant they are. 
Specifically, we first computed the fraction fd of all viable metabolisms that contained 
at least one such disconnected reaction. The value of fd ranged from 0.517 for 
metabolisms viable on pyruvate to 0.307 for those viable on acetate. Figure 1d shows 
1- fd, i.e., the fraction of viable metabolisms containing only connected reactions as a 
function of metabolism size. We note that for any one carbon source, the smallest 
viable metabolisms contain only connected reactions. It is easy to see why this must 
be the case: if a minimal metabolism contained a disconnected reaction, then this 
reaction would by definition be dispensable, and its elimination could not abolish 
viability, which means that the metabolism could not possibly be minimal. 
Conversely, the largest viable metabolism contains all reactions we consider, which 
are also connected. Only at intermediate sizes do metabolisms with disconnected 
reactions occur. However, we also found that at most sizes, most viable  metabolisms 
contain only connected reactions, regardless of the carbon source considered (Figure 
1d). This stands in contrast to the fraction of inviable metabolisms lacking 
disconnected reactions (i.e. 1-fd )n (black circles in Figure 1d), which is much smaller 
for metabolisms  up to about 42 reactions, where it approaches that of viable 
metabolisms.  
Given these observation, it is thus of little surprise that the patterns we reported above 
extend to metabolisms where all reactions are connected. Specifically, the quasi-
binomial dependence of the number of viable genotypes on n, and the greater than 
exponential reduction in the fraction of viable genotypes with decreasing n, are 
preserved (Figures S4a and S4b). Moreover, such metabolisms can also be quite 
different from one another (Figure S4c) and at most sizes n, most or all such 
metabolisms reside in a single connected genotype network (Table S5).  
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Metabolisms viable on multiple carbon sources show similar organization 
In a next analysis, we asked how the observations we made so far translate into 
metabolisms that are viable on some number k>1 of carbon sources. This analysis is 
more challenging, because at each k there are  possible k-tuples of carbon 
sources. We exhaustively enumerated, for each possible k-tuple of carbon sources, the 
number of metabolisms of a given size that are viable on that k-tuple. Then, we 
calculated the average number of metabolisms viable on a given k-tuple. Figure 3a 
and 3b show the number and fraction of viable metabolisms as a function of 
metabolism size n, and for different values of k. Several observations are germane. 
First, the unimodal relationship between the number of viable genotypes and 
metabolism size still holds for metabolisms viable on multiple carbon sources. 
Second, the smallest number of reactions in a viable metabolism increases from 23 
for metabolisms viable on a single carbon source to 34 for metabolisms viable on 10 
carbon sources. Third, the fraction of viable metabolisms declines at a greater than 
exponential rate as the number of reactions decreases (Figure 3b). Fourth, the rate of 
this decline becomes steeper as the number of carbon sources increases on which a 
metabolism is viable (Figure 3b).  
Tables S6, S7, and S8, respectively, show the median, maximum, and minimum of 
the number nC of connected components, and the fraction of metabolisms in the 
largest (“giant”) component for metabolisms of size n required to be viable on k 
carbon sources. The results show that for metabolisms above n=36 reactions, all 
metabolisms viable on a given number of carbon sources are connected. Wherever 
the set of viable metabolisms are disconnected, they are partitioned into few 
connected components (with a median of 2-3 and a maximum of 7), and with few 
exceptions most metabolisms reside in the largest of these components. 
Figure 3c shows the median diameter of the set of genotypes viable on k carbon 
sources as a function of n (see figure S5a, and S5b, for the minimum and maximum 
diameters for each k). This median diameter is not substantially lower than for 
metabolisms viable on single carbon sources. Specifically, for metabolisms of most 
sizes, the diameter of the set of viable metabolisms lies between 5 and 15, indicating 
that metabolisms of the same size and viable on the same number of carbon sources 
can differ substantially in their reaction complement. Moreover, the median diameter 
( )10k
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as a fraction of the maximally possible diameter, i.e., the diameter of genotype space, 
is one or close to one for most sizes above nmin. In other words, the set of viable 
metabolisms viable on any set of carbon sources is not localized to a small region of 
genotype space. It often spans the entire space.  
Figure 3d shows not only that the majority of metabolisms considered lack 
disconnected reactions, but also that the fraction of metabolisms without any 
disconnected reactions increases with the number k of carbon sources on which 
viability is required. The patterns of organization from figure 3a to 3c also hold for 
viable metabolisms where all reactions are biochemically connected to one another, 
as shown in figures S6 and S7.  
 
Figure 3: Metabolisms viable on multiple carbon sources and genotypic differences among them. 
a) Average number of metabolisms per genotype network that are viable on k carbon sources for 1 ≤ 𝑘 ≤ 10. Each curve corresponds to one value of k and is colored as indicated in the legend. b) 
Fraction of metabolisms viable on k carbon sources. Note the logarithmic scale. Data on ten carbon 
sources in a) and b) has been previously published [19].  c) Genotype network diameter. Black circles 
indicate the diameter of genotype space for metabolisms of a given size, which is an upper bound to 
the diameter of any one genotype network. Colored data points indicate the median of the diameter of 
the genotype networks of metabolisms viable on k carbon sources. At n≥40, almost all genotype 
networks have the maximally possible diameter. d) Fraction of metabolisms that are viable on k carbon 
sources and contain no disconnected reactions.  
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Local neighborhoods of viable metabolisms are phenotypically diverse  
We refer to the neighborhood of a metabolism M as the set of metabolisms differing 
in one reaction from M. Neighborhoods are important in the evolution of biological 
systems, because they contain those genotypes that are easily reachable through a 
small genotypic change – in our case, change of a single reaction- from a given 
genotype. In our next analysis, we studied the number of novel phenotypes contained 
in such neighborhoods. To this end, we first sampled 1000 metabolisms of a given 
size from each of the distinct genotype networks viable on different carbon sources. 
Representing each phenotype as a binary vector of length 10 whose i-th entry 
indicates viability (1) or inviability (0) on the i-th carbon source, we asked whether 
multiple distinct novel phenotypes in the neighborhood of a given metabolism M 
exist, i.e. phenotypes different from M that indicate growth on at least one additional 
carbon source compared to that of M. The answer is yes. (Figure 4a). Supplementary 
Text S3 explains the single-peaked shape of the distributions in Figure 4a. Figure S8 
shows that the number of these novel accessible phenotypes is greater than expected 
by chance, based on a simple randomization test.  
In a next analysis, we asked whether the neighborhoods of different metabolisms 
viable on the same carbon source contain different novel phenotypes. If so, which 
novel phenotypes are accessible may depend on where in metabolic genotype space a 
viable metabolism is located. To find out, we randomly and uniformly sampled 1000 
pairs of metabolisms with n reactions and viable on a given carbon source, where 
each pair differed in D reactions. Then, we determined the set of new phenotypes 
accessible in the local neighborhood of metabolisms M1 and M2, which we denote by 
P1 and P2, respectively. We then computed the fraction u (for unique) phenotypes, 
which appear in P1 or P2 but not in both, i.e.,             u=1-|P1∩ P2|/(|P1|+|P2|-
|P1∩P2|). We first studied the average of u (regardless of D and n) for all pairs of 
viable metabolisms sampled, and did so for each of the 10 carbon sources.  Figure S9 
shows that u ranges from 0.65 to 0.85, indicating that the majority of novel 
phenotypes accessible to a local neighborhood is unique to that neighborhood, 
regardless of the carbon source considered. The average u for pairs of metabolisms 
where all reactions are connected to one another is very similar (Figure S9). 
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Figure 4: Neighborhood analysis. a) 
Average number of distinct novel 
metabolic phenotypes in a 
neighborhood as a function of 
metabolism size (n) and b) average 
local neighborhood diversity (u) as a 
function of genotypic distance (D) 
(horizontal axes), for metabolisms of 
size 40 that are viable on different 
single carbon sources, as indicated in 
the legend, c) Average local 
neighborhood diversity u (see color 
legend) for metabolism pairs of a 
given genotype distance (D, y-axis) 
and size (n, x-axis), that are viable on 
glucose, Data are based on 1000 
randomly sampled networks for each 
metabolism size (n), genotypic 
distance (D), and carbon source. 
 
Subsequently, we investigated how genotypic distance (D), and reaction numbers (n) 
influence phenotypic diversity u. We define the genotype distance as the number of 
reaction changes required to convert one genotype to the other. It is equal to half the 
Hamming distance of two genotype vectors.  Figure 4b illustrates how u increases 
with increasing genotype distance D, for metabolisms with n=40 reactions required to 
be viable on each of the 10 carbon sources. The figure illustrates that u increases 
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rapidly until it reaches close to its maximal value at D≥4. The dependency of u on D 
is qualitatively identical for different metabolism sizes (Figure S10) and a similar 
trend is apparent for pairs of metabolisms viable on any one of the 10 carbon sources 
(Figure S10). Figure 4c shows how u depends on both D and n for metabolisms 
viable on glucose as the sole carbon source. The figure indicates that regardless of n, 
the fraction of unique phenotypes u increases rapidly with increasing D and reaches a 
value close to its maximum of u=1 at modest D. While this qualitative pattern is 
similar for different carbon sources and reaction numbers (Figure S10), the 
quantitative relationship between u, D, and n depends on the carbon source (compare 
figure 4c based on metabolisms viable on glucose with figure S11 for metabolisms 
viable on fumarate). Despite such quantitative differences, however, a simple general 
pattern emerges: except for small metabolisms that are very similar to one another, 
the majority of phenotypes accessible from any one neighborhood are unique 
(u>0.5). Accessible new phenotypes strongly depend on a metabolism’s location in 
genotype space. Figure S12 shows that for every carbon source, local neighborhood 
diversity u is greater than expected by chance based on a simple randomization test.  
Genotype networks of different phenotypes are close together in genotype space 
A complementary perspective on the accessibility of novel phenotypes regards the 
minimal distance of the genotype networks GN1 and GN2 of different phenotypes P1 
and P2, i.e., Dmin=min{D(G1,G2)|G1∈GN1∧ G2∈GN2} where D(G1,G2) indicates the 
genotype distance of two metabolic genotypes G1 and G2. This distance is equivalent 
to the minimal number of reaction changes that are necessary to convert metabolisms 
with one phenotype into metabolisms with the other phenotype. We analyzed the 
distribution of this distance for genotype networks of different phenotypes, focusing 
our analysis on the giant component for the minority of phenotypes whose viable set 
of genotypes had more than one connected component (Tables S2, S5, S6, S7 and 
S8). In analogy to neighboring genotypes, we call two genotype networks neighbors 
if their minimal distance is Dmin=1. Before embarking on the analysis, we note that 
only 84 of the 210=1024 possible phenotypes for our 10 carbon sources have a 
genotype associated with it (Figure S13). To see why, consider that all metabolisms 
viable on fructose are also viable on glucose, because glucose and fructose are 
biochemically similar and enter central carbon metabolism near one another. 
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Therefore, there exists no metabolism viable on any combination of carbon sources 
that contain fructose and lack glucose (28=256 such “forbidden” phenotypes). 
Analogous dependencies among other combinations of carbon sources shrink the total 
number of allowed phenotypes from 1024 to 84.  
 
Figure 5: Minimal distance between genotype networks. Each rectangular colored area shows the 
color-coded minimal genotype distance Dmin between genotype networks comprised of metabolisms 
that are viable only on carbon sources indicated on the corresponding (x, y) positions where (n=35). b) 
Average minimal distance among all pairs of genotype networks (red curve, inner vertical axis) and 
fraction of pairs of genotype networks that are neighbors (blue curve, outer vertical axis) as a function 
of metabolism size (n). c) Each rectangular area shows the color-coded average of the minimal 
distance Dmin (see color legend) between pairs of genotype networks with phenotypic complexity (k, x-
axis) and (k’, y-axis) for metabolisms of size n=35. At this size, the highest average minimal distances 
exists for metabolisms of complexity (k, k’)=(10, 7), which show Dmin=2.6. d) Data points of a given 
shading indicate the distribution of genotypic distance DG (x-axis) among pairs of metabolisms with a 
given phenotypic distance DP, as indicated in the color legend for metabolisms of size n=30.  
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We first analyzed minimal genotype distances for metabolisms viable on only a 
single carbon source. (Instead of ten carbon sources, there are only eight to consider 
in this analysis, because all metabolisms viable on fructose are also viable on glucose, 
and the same holds for malate and fumarate.) Figure 5a shows the minimal distance 
between such genotype networks at intermediate reaction numbers n=35. All except 
4 pairs of genotype networks have a minimal distance of one. As n approaches the 
minimally admissible size for viability, this minimal distance gets modestly larger. 
However, even at the lowest size (n=30) where viable metabolisms exist for all 
carbon sources, genotype networks are immediately adjacent to one another for 19 
out of the 28 possible pairs (Figure S14). Only for a single pair of carbon sources 
(lactate and acetate) does the minimal distance have the largest value of Dmin=6 (See 
figure S14, as well as figure S15 for two representative examples of how minimal 
genotype distances change with increasing metabolism size.) 
Figure 5b (red curve) shows the average Dmin between genotype networks as a 
function of metabolism size n, where the average is over all pairs of carbon sources.  
This average Dmin decreases rapidly as n increases. Figure 5b (blue curve) shows the 
fraction of genotype network pairs for which Dmin=1 increases rapidly with increasing 
n. In sum, except for the smallest metabolisms, most genotype networks associated 
with viability on single carbon sources are neighbors and are thus easily reached from 
one another through single reaction changes.  
Next, we extended this analysis to genotype networks for metabolisms viable on k>1 
carbon sources. For brevity, we refer to k as the phenotypic complexity of a 
metabolism. Figure 5c shows the average minimal distance, i.e., the average number 
of reaction changes minimally needed to reach a genotype network with phenotypic 
complexity k from a network with complexity k’, where k and k’ range between 1 and 
10 and where n=35. The figure demonstrates that Dmin generally increases with either 
k or k’, and that it is most difficult to reach metabolisms of intermediate phenotypic 
complexity (k=7) from metabolisms with the highest complexity (k=10), where Dmin 
≈2.60. At the same time, Dmin decreases with increasing metabolism size (compare 
figures S16a, 5c, and S16b). A complementary analysis in figure S17, which focuses 
on the fraction of neighboring genotype networks (Dmin=1) as a function of 
phenotypic complexity, shows a similar pattern: At any one metabolism size, the 
fraction of neighboring genotype networks decreases with phenotypic complexity. 
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Figures S18 and S19 show that these patterns also hold if we consider only those 
metabolisms where all reactions are connected to one another. Finally, figures S20 
and S21 show that except in the smallest metabolisms, the average of the minimal 
distance among all pairs of genotype networks is close to 1 (See supplementary Text 
S4) indicating that most genotype networks abut each other in the genotype space. 
Genotypic similarity versus phenotypic similarity 
In our last analysis, we asked how many reaction changes are required to change a 
metabolism with a given genotype G1 and phenotype P1 into a metabolism G2 with an 
arbitrary new phenotype P2. More specifically, we were interested in how the 
(Hamming) distance between the two genotypes DG depends on the (Hamming) 
distance DP between the phenotypes P1 and P2. DP is based on the representation of 
phenotypes as ten-dimensional binary vectors indicating viability on each of our ten 
carbon sources. The answer can indicate how difficult it is to reach a distant 
phenotype from any one viable genotype. To compute this distance, we first sampled 
1000 metabolisms with a given size (n=35) among all viable metabolisms, regardless 
of the number of carbon sources that they are viable on. Next, for each sampled 
metabolism, we exhaustively calculated its genotype distance and its phenotype 
distance against all viable metabolisms of the same size.  
The results are shown in figure 5d. The left-most distribution shows the genotype 
distances of those genotypes that have identical phenotypes (DP=0), for comparison 
against those genotypes that have different phenotypes (DP>0). The figure shows that 
the distributions of genotypic distance of phenotypes with varying phenotypic 
distance are very similar. Moreover, the mean distance is shifted only slightly to the 
right (by one reaction change) relative to the mean distance of genotypes with 
identical phenotypes. Similar patterns exist for metabolisms of different sizes (Figure 
S22) and for metabolisms consisting only of connected reactions (Figure S23). Taken 
together, these patterns imply that reaching a genotype with an arbitrarily distant 
phenotype from any one point in genotype space does not require many more reaction 
changes than traversing a genotype network.  
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6.4. Discussion 
Any population of organisms evolves in a space of possible genotypes and their 
phenotypes. Such a “space of the possible” may harbor new and useful phenotypes, 
but it may also constrain a population’s potential for innovation. To understand both 
innovation opportunities and constraints, it is necessary to understand the 
organization of such spaces. For a population of organisms whose metabolic reaction 
network changes through addition and elimination of individual reactions, the 
relevant space is a space of metabolic genotypes – each genotype represents a 
specific set of reactions – and the phenotypes they encode. If one considers all known 
biochemical reactions, this space is vast, around 102000 genotypes [54–56]. Past 
analyses thus relied on sampling [11–18]. We here complement sampling-based 
analyses through an exhaustive enumeration of all 2.25 x 1015 genotypes in the 
subspace whose reactions are involved in central carbon metabolism.  
Our most basic observation regards the fraction of viable metabolisms, which is tiny, 
ranging from 10-8 (for acetate) to 10-6  (for glucose) for metabolisms viable on at least 
one carbon source, and becomes substantially smaller for metabolisms viable on all 
10 carbon sources (10-10). However, because the entire space is large, these tiny 
fractions translate into sizable numbers of 10,850,304 and 1,549,771,520 viable 
metabolisms on acetate and glucose respectively and 1,029,375 metabolisms on all 10 
carbon sources. Because we observe that most viable metabolisms do not contain any 
reactions disconnected from the rest of the reaction network, most of these variant 
metabolisms are not trivially obtainable by addition of disconnected reactions to a 
functional metabolic core. Thus, even in the modest genotype space created by all 
subsets of 51 biochemical reactions, there are myriad alternative metabolic 
organizations that achieve viability through different means.  
The fraction of viable metabolisms is not uniformly distributed among metabolisms 
with different complexity, i.e., number n of reactions. Regardless of the specific 
phenotype one considers, the fraction has a minimum at the minimal complexity 
needed for viability (the smallest nmin=23 exists for viability on glucose, and the 
largest nmin=30 for metabolisms viable on acetate) and increases rapidly towards a 
fraction of one for the largest metabolisms. In addition, metabolisms with the same 
phenotype form large connected networks. These networks may contain more than 
one connected components at the smallest complexity but they congeal to a single 
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component at intermediate complexity. Moreover, this “giant” component [55,58] 
extends increasingly far through genotype space until its diameter becomes equal to 
the entire space at intermediate reaction numbers. Taken together, this means that 
central carbon metabolism shows substantial internal flexibility in its organization. It 
can be altered one reaction at a time to create different metabolic architectures with 
the same phenotype, exemplified by metabolisms like those shown in figure 2 that 
differ in about half of their reactions. The exceptions to this rule can be found among 
the smallest, least complex metabolisms. Evolutionary change that alters metabolic 
genotypes without altering phenotypes is easier in complex metabolisms with many 
reactions.  
A metabolism’s complexity is also relevant for its potential to encounter novel 
metabolic phenotypes in its immediate neighborhood, i.e., through single reaction 
changes. The number of different novel phenotypes that are encountered in a 
metabolism’s neighborhood exceeds one for all but the smallest metabolisms, and it 
rises to a maximum of 8-11 at intermediate metabolic complexity. That it does not 
increase further for larger n is the result of a model limitation, namely that we 
consider only ten carbon sources. Large metabolisms are already viable on most of 
these carbon sources, such that further addition of reactions can no longer create 
novel phenotypes that are viable on additional carbon sources (Figure S24). These 
observations suggest that the number of novel phenotypes accessible through single 
reaction changes increases with metabolic complexity.    
While the neighborhoods of most metabolisms contain multiple novel phenotypes, 
the identity of these phenotypes depends strongly on a metabolism’s location in 
genotype space. That is, the majority of novel phenotypes contained in the 
neighborhoods of two closely related metabolisms are not shared between these 
neighborhoods. In other words, any one novel phenotype tends to occur either in one 
or the other neighborhoods, but not in both. This means that the evolutionary 
potential of any one metabolism with a given phenotype is contingent upon its 
genotype. This contingency is alleviated by the connectedness of different 
metabolisms with the same phenotype. Because their genotype can be altered without 
phenotypic change, phenotype-preserving evolutionary change in genotypes can 
make different neighborhoods and their novel phenotypes accessible. In this regard, it 
is also relevant that the minimal distance of most genotype networks is small, such 
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that one can reach novel phenotypes through one or few genotypic changes from any 
one genotype network. The exceptions to this rule come again from the smallest 
metabolisms, suggesting that metabolic complexity also facilitates this aspect of 
phenotypic evolution. 
One major obstacle to genotype-phenotype mapping comes from the vast size of 
genotype spaces. We could overcome this obstacle here by considering a modestly 
sized genotype space of 1015 carbon metabolism variants. Carbon metabolism is an 
attractive small study system, because it plays a key role in extracting energy from 
extracellular carbon sources. In addition, we limited ourselves to viability on 10 
different carbon sources, and thus to potentially 210=1024 viability phenotypes. This 
number is sufficiently small to be computationally tractable, yet large enough to 
allow quantitative analyses, for example about the phenotypic diversity of different 
neighborhoods. Even so, we could enumerate the phenotype of all 1015 metabolisms 
only after taking advantage of certain relationships among metabolisms, such as that 
the children of inviable metabolisms are also inviable.   
A limitation of analyzing central carbon metabolism is that it is not suited to study 
metabolic innovation in essential nutrients like nitrogen or sulfur. It thus remains to 
be seen whether similar principles hold for these nutrients and their metabolism. 
Sampling studies of larger genotype spaces suggest that this is indeed the case 
[14,59].  
Another limitation of our analysis is its focus on evolutionary constraints that are 
imposed only by the presence or absence of reactions. In other words, we have 
neglected regulatory constraints that can arise through suboptimal expression or 
regulation of an enzyme. In this regard, we note that such constraints are most 
important if one focuses on the quantitative predictions of biomass growth via flux 
balance analysis [60]. In contrast, we here focus on the purely qualitative prediction 
of viability, i.e., whether biomass can be produced at all. This qualitative phenotype 
is biologically relevant if one considers that many organisms grow slowly in their 
native environment [61–63]. In addition, we note that regulatory constraints can 
easily be broken in evolution, even on the short time scales of laboratory evolution 
experiments [60,64,65].  
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A third limitation comes from the fact that the exhaustive enumeration we pursue 
requires us to start from a limited “universe” of chemical reactions. The choice of 
reactions in this universe may introduce some biases into our analysis. For example, 
it is not clear whether the small number of metabolisms viable on acetate is a result of 
this choice, or whether it would also persist in an unbiased analysis of larger, genome 
scale metabolisms. However, we note that our core results agree well with previous 
studies based on sampling of genome-scale metabolisms that comprise more than a 
thousand reactions. For instance, genome-scale metabolisms with the same phenotype 
can be Genotypically very different [12] and usually form single connected genotype 
networks [19], which is in line with our present observation that genotype networks 
have large diameter. Moreover, genome-scale metabolisms can encounter many new 
phenotypes in their immediate neighborhood, and the neighborhood of different 
genome-scale metabolisms contains different novel phenotypes [12,14,59], which is 
consistent with our neighborhood analysis. Finally, genome-scale metabolisms with 
different phenotypes can be found close together in genotype space [12,59]. 
A final limitation comes from our definition of a metabolic genotype centered on 
individual metabolic reactions. Although widely used in the field [44, 66-70] this 
notion of a genotype does not take into account that some reactions are catalyzed by 
multiple enzymes [71], and conversely, that some enzymes catalyze multiple 
reactions [72-74]. Our focus on the metabolic reaction as the most elementary unit of 
evolutionary change should not distract from the fact that actual change in metabolic 
systems may be more complex. 
In sum, our exhaustive analysis of central carbon metabolism’s genotype space 
reveals an organization that is conducive to both the preservation of phenotypes in the 
face of genotypic change, and the exploration of new phenotypes. Because 
metabolisms with the same phenotype can be connected to one another through single 
reaction changes, viability phenotypes can be preserved through substantial genotypic 
change. Because connected sets of genotypes associated with different phenotypes 
are close to each other in genotype space, novel phenotypes can often be reached with 
few or no transitions through intermediate phenotypes. These principles only break 
down in metabolisms with low complexity, close to the minimal number of reactions 
needed for viability. Thus, increasing metabolic complexity enhances both the 
potential for evolutionary conservation and innovation. 
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6.5. Methods 
Flux balance analysis 
Flux balance analysis (FBA) is a constraint-based computational modeling approach 
that is widely used for quantitative analysis and modeling of metabolism. FBA 
predicts the metabolic flux through every reaction in a metabolism, based on 
information about the metabolism’s reactions, as well as about the stoichiometric 
coefficients of the reactants in each reaction. These coefficients are contained in the 
stoichiometric matrix S, which is of dimension m×n, where m and n, respectively, 
denote the number of metabolites and the number of reactions in the metabolism. An 
important assumption behind FBA is that the concentration of metabolites does not 
change, that is, the metabolism is in a steady state. This assumption imposes mass 
conservation constraints on the metabolites in the network, which can be 
mathematically expressed as 𝑆𝑣 = 0, where v is the vector of metabolic fluxes vi 
through reaction i. The possible solutions of the above equation are the allowable flux 
vectors, which form the null space of the stoichiometric matrix S. This space is 
further constrained by the fact that each reaction has a maximally and minimally 
possible flux through it. FBA uses an optimization technique called linear 
programming to identify among the allowed flux vectors those vectors that maximize 
an objective function Z. This task can be formulated as finding a flux vector v* with 
the property 
v*=maxv Z(v)={cTv|S.v=0, a≤v≤ 𝑏} 
where the vector c is a set of scalar coefficients representing the maximization 
criterion, and each entry ai and bi of vectors 𝑎 and 𝑏, respectively, indicates the 
minimally and maximally possible flux through reaction i.  
We are interested in knowing whether a metabolic reaction network can sustain life in 
a given environment, that is, whether it can synthesize all essential small biomass 
molecules required for survival and growth. In this work, we used 13 well-known 
precursor substances from central carbon metabolism as the set of required biomass 
molecules (table S9). As is common in FBA applications [75–79], the objective 
function that we use for the linear programming of FBA is a biomass reaction that 
transforms 13 precursors into biomass (table S9). We used the package CLP (1.4, 
Coin-OR; https://projects.coin-or.org/Clp) to solve linear programming problems.   
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Chemical environments 
In addition to a stoichiometric matrix and an objective function (biomass growth), it 
is necessary to define the chemical composition of an environment that contains 
different nutrients required for the synthesis of biomass precursors. We consider 
minimal growth environments composed of a sole carbon source, along with oxygen, 
ammonium, inorganic phosphate, sulfate, sodium, potassium, cobalt, iron (Fe2+ and 
Fe3+), protons, water, molybdate, copper, calcium, chloride, magnesium, manganese 
and zinc. All these nutrients except the carbon source are shared between different 
minimal environments. Each minimal environment contains a different one of the 10 
carbon sources acetate, 𝛼-ketoglutarate, fumarate, fructose, glucose, glutamate, 
lactate, malate, pyruvate, and succinate in our analysis. 
 
Reaction universe  
The “universe” of reactions in our metabolic genotype space is based on E. coli 
central carbon metabolism [80], from which we deleted four reactions involved in 
ethanol synthesis, metabolism, and transport. We also grouped the reactions catalyzed 
by aconitase A and aconitase B into one reaction, to render exploration of all 
metabolisms that consist of different combinations of these reactions feasible. The 
final reaction set consists of N = 51 intracellular reactions that can be present or 
absent in different metabolisms (table S9). Twenty different transport reactions, 
which are necessary to import nutrients or excrete waste products, are present in all 
metabolisms we study, i.e., we do not vary their presence among metabolisms. 
 
Metabolic genotypes, metabolic phenotypes and genotype networks 
The nucleotide sequence of the genes encoding the enzymes catalyzing a 
metabolism’s reactions constitutes the metabolic genotype of an organism. However, 
for our purpose, we use a more compact representation of a metabolic genotype, in 
which we represent this genotype as a binary vector whose i-th entry corresponds to 
the i-th reaction in our reaction universe. The i-th entry is equal to one if an 
organism’s genome encodes an enzyme capable of catalyzing this reaction, and zero 
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otherwise. The genotype space of all possible metabolisms comprises 2N metabolisms 
(N=51). Each metabolism can be thought of as a point in this space. We call 
metabolisms that are able to synthesize all 13 biomass precursors from nutrients in 
this environment viable. More precisely, we consider a metabolism viable on a 
carbon source if its biomass synthesis rate is greater than one percent of the biomass 
synthesis rate of the network formed by all N = 51 reactions on that carbon source 
[19]. Our definition of a carbon utilization phenotype for any one genotype is based 
on its viability on different carbon sources. Specifically, we assign to each genotype a 
phenotype vector of length 10, equal to the number of distinct carbon sources we 
consider. The i-th entry of the phenotype vector corresponds to the minimal 
environment containing the i-th sole carbon source. This entry equals 1 if the 
metabolism is viable on that minimal environment and zero otherwise. In other 
words, we consider 210=1024 distinct metabolic phenotypes. We partition metabolic 
genotype space into distinct sets of genotypes, each with a different phenotype. Each 
such genotype set can be further partitioned into subsets of metabolisms with 
different sizes, that is, different numbers n of chemical reactions. If a subset of 
metabolisms (genotypes) forms a connected graph [57,58] in genotype space, we call 
that graph a genotype network. For some analyses, it is useful to consider a modified 
definition of a phenotype that just specifies whether a metabolism is viable on at least 
a specific set of carbon sources – it may be viable on other carbon sources as well. 
With this phenotype definition, different genotype sets and genotype networks can 
overlap.  
 
 Exhaustive enumeration of viable metabolisms 
To exhaustively characterize the phenotype of every single one among 251 (1015) 
metabolic genotypes one would need to use FBA 1015 times. Given that a typical 
FBA computation takes of the order of 10-2 seconds of CPU time, exhaustive 
computational phenotyping would require 105 years and would thus be prohibitive. 
However, one can take advantage of two simple facts to render this computation 
feasible in approximately 10 days [19,81]. First, six among the 51 internal reactions 
of central carbon metabolism are essential for viability on every carbon source we 
consider [15]. The corresponding entries of the genotype vector need to be set to one, 
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which reduces the number of required FBA computations by a factor 26 from 251 
(1015) to 245 (1013).  
Second, all metabolisms (“children”) that contain a subset of the reactions of an 
inviable metabolism (“parent”) will also be inviable, because deleting one or more 
reactions from an inviable metabolism cannot result in a viable metabolism. In an 
earlier work, one of us designed an algorithm to take advantage of this observation 
[81]. It divides genotype vectors of length 45 into 5 distinct sub-vectors of length 9, 
determines all viable genotypes originating from each binary sub-vector of length 9 
(29=512 subvectors), and merges the sub-vectors of viable genotypes in a five-step 
procedure to determine all the viable genotypes on a given carbon source. At each 
step, only sub-vectors that preserve viability are merged, which dramatically 
decreases the number of required FBA tests to approximately109 total tests. 
Once the set GN(Ci) of metabolisms viable on each of the 10 carbon sources Ci has 
been determined, one can easily identify the set of metabolisms that are viable on a 
given subset S of the 10 carbon sources. Specifically, V(S)={G∈Ω, ∀ 
Ci∈S|G∈GN(Ci)} where G denotes a given genotype belonging to the genotype space Ω. Similarly, one can define the set of genotypes that are exclusively viable on carbon 
sources in S as: V(S)={G∈Ω, ∀ Ci∈S, ∀ Cj∈S′ |G∈GN(Ci), G∉GN(Cj)} , where S’ 
denotes the complement of S.  
 
Connectedness of metabolic genotype networks 
We can represent each set of metabolisms (genotypes) of a given size n that is viable 
on a subset S of carbon sources as a graph. The nodes of this graph are metabolisms. 
Two viable metabolisms A and B are connected by an edge if metabolism A is 
convertible to B via a reaction swap, that is, by deleting a reaction that A possesses 
but B lacks, followed by adding a reaction that B possesses but A lacks. We note that 
such a swap leaves the number of reactions constant, as is required for metabolisms 
that have the same size. However, any one reaction swap can be decomposed into an 
addition of a reaction followed by a deletion of a reaction. In other words, viable 
metabolisms that are neighbors based on reaction swaps are also connected through 
single reaction changes.  
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If this graph of metabolisms is connected, then every single metabolism in it can be 
reached from any other metabolism via a sequence of single reaction changes. 
Otherwise, the graph fragments into several disconnected components, one of which 
may be much larger than the others, and is therefore often also called the “giant” 
component [57,58]. The connected components of a graph can be computed with the 
aid of algorithms like Breadth-First Search (BFS) [82]. BFS requires a graph’s 
adjacency list, which contains the neighbors of each node in the graph. To generate 
this list for a genotype network, one needs to compare V2 pair of metabolisms to 
ascertain whether they are neighbors. Because the genotype networks we consider 
may comprise many thousands to millions of metabolisms, doing so would be 
computationally prohibitive. Moreover, storing an entire adjacency list causes 
memory problems in large genotype networks. Therefore, we developed an algorithm 
to examine connectedness of genotype networks [81], which differs from 
conventional BFS in that (i) it does not need to fill the adjacency matrix in advance, 
and (ii) it can avoid comparing genotypes that could not possibly be neighbors. In 
doing so, it reduces the number of genotype comparisons from V2 to mV where m is 
the average number of a genotype’s neighbors. Using this algorithm, we could 
determine connectedness of genotype networks comprising as many as 106 
metabolisms. For larger metabolisms, where the requirements for storing all 
metabolisms becomes prohibitive, we could determine genotype network 
connectivity by taking advantage of the following simple principle: If a genotype 
network of metabolisms of size n is connected, then the genotype network of 
metabolisms of size n+1, each genotype of which is constructed by adding an 
additional reaction to each genotype belonging to the genotype networks of size n, is 
also connected [19]. In other words, we could infer the connectedness of larger 
genotype networks from the connectedness of smaller ones.  
 
Diameter of metabolic genotype networks 
The diameter of a graph (genotype network) is the maximum length of all shortest 
paths between any pair of nodes that reside in the same connected component. In a 
connected genotype network, the shortest path between any pair of genotypes is the 
minimal number of reaction changes required to convert the two genotypes into each 
other. This number is equivalent to half of the Hamming distance between the binary 
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vectors representing the genotypes. To determine the diameter of a genotype network, 
we needed to identify those genotypes whose Hamming distance is maximal. We 
were able to do this through exhaustive enumeration for genotype networks with 
fewer than 105 metabolisms. For larger genotype networks, we could only determine 
a lower bound on the diameter, and we did so by sampling 105 genotypes from a 
given genotype network and determining the two genotypes with the largest distance 
among them. We note that maximum diameter of genotype space as a function of 
metabolism size (n) is Min {(51-n), n}, and in most of the large genotype networks, 
the sampling based diameter estimate was equal to the maximum diameter of the 
genotype space. This confirms that the sample size was big enough to accurately 
estimate the diameter of the genotype networks. 
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6.7. Supplementary Information 
Text S1: Size differences between minimal metabolisms viable on acetate and 
glucose 
As we mentioned in the main text, the minimal number of reactions in a viable 
metabolism (i.e. minimal metabolism) is not the same for different carbon sources. 
For example, it varies from nmin=23 for glucose and fructose to nmin=30 for acetate 
(Figure S2).The reason why a minimal metabolism using acetate needs more 
reactions is that it uses reactions from gluconeogenesis (Figure S2b) whereas glucose 
metabolism relies on glycolysis (Figure S2a). More specifically, the acetate (ac) to be 
metabolized is converted to acetyl-coenzyme A (accoa, Figure S2b) through two 
consecutive reactions, catalyzed respectively by acetate kinase and 
phosphotransacetylase. Acetyl-coenzyme A is then used in the glyoxylate cycle in 
order to produce malate and oxaloacetate. The latter is subsequently converted to 
phosphoenolpyruvate by phosphoenolpyruvate carboxylase. The gluconeogenic 
pathway that ensures production of the remaining essential biomass molecules is 
initiated from phosphoenolpyruvate. Thus, the two reactions in the production of 
acetyl-coenzyme A, plus the five reactions needed to produce phosphoenolpyruvate 
through the glyoxylate cycle (i.e. isocitrate lyase, malate synthase, succinate 
dehydrogenase, fumarase, and malate dehydrogenase) account for the seven 
additional reactions that are required for viability of a minimal metabolism on 
acetate. In contrast, glucose neither needs the reactions of the glyoxylate shunt nor 
those of acetate metabolism, and can thus be metabolized with fewer reactions.   
Text S2: Prediction of the number of viable metabolisms based on binomial 
coefficients 
Figures S3a and S3b illustrate that a shifted binomial coefficient (i.e., ) 
qualitatively predicts the relationship between reaction number and the number of 
metabolisms viable on a carbon source. However, it overestimates this number, 
especially for metabolisms at low- and intermediate sizes. The reason for the 
qualitative agreement stems from the fact that adding reactions to a viable 
metabolism will not render this metabolism inviable. Assume that only a single viable 
( )minminN nn n−−
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metabolism with a set of reactions exists for a given carbon source. Adding any 
subset of the remaining reactions to this metabolism will not render it 
inviable. To obtain a viable metabolism with size n that lies reactions above 
the minimum, one has  possible choices of  reactions, which explains 
the qualitative binomial relationship. 
The discrepancies between the binomial relationship and the data stem from 
violations of this assumption. In previous contributions [1,2] we showed that there 
are usually multiple minimal viable metabolisms . For instance, there are 3 and 4 
minimal viable metabolisms on glucose and acetate, respectively (Table S1). If one 
extends the above line of reasoning to incorporate this observation, one arrives at the 
relationship  as a predictor for the number of viable metabolisms, which 
is shown in dashed lines in figures S3a an S3b. This predictor is clearly superior to 
the shifted binomial coefficient, but a slight discrepancy persists. 
This discrepancy has two causes, one a source of underestimating, the other a source 
of overestimating numbers of viable metabolisms. To explain them, we briefly review 
some previous observations on minimal metabolisms [1,3,4]. By definition, a 
minimal metabolism is one from which no reaction can be removed without 
eliminating viability. Importantly, a minimal metabolism is not necessarily the 
smallest possible viable metabolism, because there may be metabolisms with more 
than reactions, from which no reactions can be removed. On glucose, for 
example, the smallest viable metabolisms with reactions is also a minimal 
metabolism, but there also exist other metabolisms, at sizes n=24 (8 metabolisms), at 
n=25 (23 metabolisms), up through n=30, from which no reaction can be removed. 
To each of these metabolisms, any number of reactions can be added without 
abolishing viability, and each of them can thus contribute to the number of viable 
metabolisms at larger sizes. Not taking them into account is a reason why the 
predictor  underestimates the total number of viable metabolisms at these 
sizes. 
minn
minN n−
minn n−
( )minminN nn n−− minn n−
minv
( )minminmin N nn nv −−
minn
min 23n =
( )minminmin N nn nv −−
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To understand how the binomial predictor can also overestimate the number of viable 
metabolisms, consider two minimal metabolisms A and B of the same size, and the 
metabolism AB consisting of the union of their constituent reactions. Because AB 
can be viewed as resulting from adding sets of reactions to A or to B, it should be 
viable (𝐴𝐵 = 𝐴 ∪ 𝐴𝐵\𝐵  or 𝐴𝐵 = 𝐵 ∪ 𝐴𝐵\𝐴 ). The above binomial expression 𝑉!"# 𝑁 − 𝑛!"#𝑛 − 𝑛!"#  implicitly counts the metabolism AB twice in computing the 
number of viable metabolisms, whereas AB should only be counted once. This cause 
is responsible for the overestimation of total metabolism sizes at large n, for example 
at n=49 to n=51 for glucose.  
Text S3: The unimodal distribution of the number of novel phenotypes in the 
neighborhood of viable metabolisms 
To explain the unimodal distribution from figure 4a, consider first metabolisms M 
whose size n is below this peak. As we mentioned in the text, the fraction of viable 
metabolisms increases faster than exponentially with increasing reaction numbers 
(Figure 1b). At larger sizes, more metabolisms in any one metabolism’s 
neighborhood are thus viable, which also increases the number of novel phenotypes 
that these metabolisms can have. This observation can explain that the number of 
accessible novel phenotypes increases with n, at least up to intermediate n. The 
fraction of all viable metabolisms (Figure 1b) continues to increase above the value 
of n where the number of accessible novel phenotypes is maximal, but a second 
pattern becomes important above this peak n. Specifically, the total number of 
distinct phenotypes that all metabolisms of a given size can have is highest for 
intermediate sizes and decreases at the largest sizes. The reason is that metabolisms 
M containing most reactions also tend to be viable on most carbon sources, such that 
there are fewer possible phenotype vectors with more ones than M (Figure S11). This 
is why the average number of accessible novel phenotypes declines beyond the peak 
n.  
Text S4: Minimal genotype network distance as a function of phenotypic 
complexity and metabolism size 
We determined the average minimal distance (Dmin) between the genotype networks 
of phenotypes with a given complexity (k=k’), as a function of metabolism size n. 
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Except for the smallest metabolisms (n<35), the average minimal distance is close to 
Dmin=1, regardless of phenotypic complexity. Similarly, the fraction of neighboring 
genotype networks is only low in small metabolisms (n<35), and this fraction 
increases until it reaches a maximum at intermediate metabolism sizes (Figure S18). 
At these sizes, the fraction of neighboring genotype networks depends on the 
phenotypic complexity, decreasing from lowest to highest complexity. Genotype 
networks of phenotypes with lower phenotypic complexity tend to be closest. Figure 
S19 indicates that the same patterns obtain when we consider only those metabolisms 
where all reactions are connected to one another.  
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E. Accessed 14 November 2013.      
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Supplementary Figures 
 
S1 Fig. Central carbon metabolism. Each arrow in each panel corresponds to one of the 51 internal 
reactions we consider. Metabolites are indicated by their acronyms (see S9 Table). Boxed metabolites 
correspond to 13 essential biomass precursors. Note that 4 metabolites (accoa, g3p, f6p and e4p) are 
shown more than once for visual clarity. Metabolic pathways, including glycolysis/gluconeogenesis, 
pentose-phosphate pathway, citric-acid cycle, oxidative phosphorylation, pyruvate and glutamate 
metabolism are distinguished by the colored and dashed rectangles. Anaplerotic reactions and 
glyoxylate shunt are highlighted using the purple and green arrows respectively. 
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S2 Fig. Example minimal metabolisms. Each arrow in each panel corresponds to one of the 51 
internal reactions we consider. Black arrows and gray arrows correspond to reactions that are present 
or absent, respectively, in the metabolism shown. Metabolites are indicated by their acronyms (see S9 
Table). Boxed metabolites correspond to 13 essential biomass precursors. Note that 4 metabolites 
(accoa, g3p, f6p and e4p) are shown more than once for visual clarity. (A) Minimal metabolism with 
30 reactions viable on acetate. (B) Minimal metabolism with 23 reactions viable on glucose. 
 
S3 Fig. Binomial distribution of the number of viable metabolisms. The number of metabolisms 
viable on (A) glucose (red circles) and (B) acetate (cyan circles) for metabolisms of a given size (x-
axis). Note the logarithmic vertical axis. The black curve corresponds to the predicted number of 
viable metabolisms based on the shifted binomial coefficients 
n-k'k-k'  where n = 51 and k’ = 23	for 
glucose and k’ = 30	for acetate. The dashed curve is the result of the multiplication of the black curve 
by a factor three in Fig (A) and by a factor four in Fig (B). 
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S4 Fig. Viability of metabolisms that contain no disconnected reactions on different carbon 
sources and the genotypic differences among them. 
(A) Number of viable metabolisms lacking disconnected reactions. Black circles (vertical axis) 
indicate the total possible numbers of metabolisms of a given size n (horizontal axis, N = 51, 0 ≤ n ≤ 51). Colored data points indicate the number of metabolisms without disconnected reactions 
that are viable on the single carbon sources indicated in the legend. (B) Fraction of metabolisms viable 
on different carbon sources. Note the logarithmic scale. (C) Genotype network diameter. Black circles 
indicate the diameter of genotype space for metabolisms of a given size, which is an upper bound for 
the diameter of any genotype network. Colored data points indicate genotype network for metabolisms 
without disconnected reactions that are viable on a single carbon source. At n ≥ 44 all genotype 
networks have the maximally possible diameter. 
 
 
 
 
 
S5 Fig. Genotype network diameter for metabolisms viable on multiple carbon sources. Black 
circles indicate the diameter of genotype space for metabolisms of a given size, which is an upper 
bound for the diameter of any genotype network. Color-coded data points indicate in (A) the minimum 
and in (B) the maximum of the diameter of genotype networks for metabolisms viable on k carbon 
sources. At n ≥ 40, almost all genotype networks have the maximally possible diameter. 
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S6 Fig. Viability of metabolisms that contain no disconnected reactions on multiple carbon 
sources. (A) Average number of metabolisms that contain no disconnected reactions and are viable on k carbon sources (1 ≤  10, see legend). (B) Fraction of metabolisms without disconnected reactions 
that are viable on k carbon sources. Note the logarithmic vertical scale. 
 
 
S7 Fig. Diameter of genotype networks of metabolisms that contain no disconnected reactions 
and that are viable on multiple carbon sources. Black circles indicate the diameter of genotype 
space for metabolisms of a given size, which is an upper bound to the diameter of any genotype 
network. Color-coded data points indicate (A) the median, (B) the maximum, and (C) the minimum of 
genotype network diameter for metabolisms without disconnected reactions that are viable on k carbon 
sources. At n ≥ 40, almost all genotype networks have the maximally possible diameter. 
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S8 Fig. Comparison of the number of novel phenotypes in a neighborhood between actual 
genotype networks and randomized (null) networks. We generated null networks for each genotype 
network by randomly permuting the phenotypes among all members of the genotype network, and did 
so for all genotype networks. The height of each bar (blue: actual genotype network; red: randomized 
network) corresponds to the average number of novel phenotypes in a neighborhood, where the 
average is taken over all metabolisms viable on the carbon source indicated along the horizontal axis. 
Error bars indicate one standard deviation. 
 
 
S9 Fig. Average local neighborhood diversity. The height of the bars corresponds to the average 
local neighborhood diversity (u) among all pairs of metabolisms viable on the carbon source indicated 
along the horizontal axis. Blue bars are based on all viable metabolisms, and brown bars are based on 
viable metabolisms lacking any disconnected reactions. 
0
2
4
6
8
10
12
A
ve
ra
ge
 n
um
be
r o
f n
ov
el
 p
he
no
ty
pe
s i
n 
ne
ig
hb
or
ho
od
Gl
uc
os
e
Fr
uc
tos
e
α−
ke
tog
lut
ara
te
Gl
uta
ma
te
Py
ru
va
te
M
ala
te
Fu
ma
rat
e
Ac
eta
te
La
cta
te
Su
cc
ina
te
Genotype networks
Null networks
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Ac
eta
te
Fr
uc
tos
e
Fu
ma
rat
e
Gl
uc
os
e
Gl
uta
ma
te
La
cta
te
M
ala
te
Py
ru
va
te
Su
cc
ina
te
A
ve
ra
ge
 lo
ca
l n
ei
gh
bo
rh
oo
d 
di
ve
rs
ity
 (u
)
all metabolisms
connected metabolisms
α−
ke
tog
lut
ara
te
	 345	
 
S10 Fig. Local neighbor diversity as a function of genotypic distance. Local neighborhood 
diversity (u) as a function of genotypic distance (D) is shown for metabolisms viable on a given 
carbon source (color-coded, see legend). (A) Data for metabolisms with n = 32, (B) n = 36, (C) n = 40, and (D) n = 44 reactions. 
 
 
S11 Fig. Average local neighborhood diversity. For metabolism pairs of a given genotype distance 
(D, y-axis) and size (n, x-axis), that are viable on fumarate, the average local neighborhood diversity 
(u) (see color legend) is shown. Data are based on 1000 randomly sampled networks for each 
metabolism size (n), and genotypic distance (D). 
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S12 Fig. Comparison of the local neighborhood diversity (u) between actual genotype networks 
and randomized (null) networks. 
We generated null networks for each genotype network by randomly permuting the phenotypes among 
all members of the genotype network, and did so for all genotype networks. The height of each bar 
(blue: actual genotype network; brown: randomized network) corresponds to the average local 
neighborhood diversity (u), where the average is taken over all metabolisms viable on the carbon 
source indicated along the horizontal axis. Error bars indicate one standard deviation. 
 
 
S13 Fig. Number of phenotypes as a function of metabolism size (n). Each black circle shows the 
number of phenotypes (out of 2!"  = 1024 possible phenotypes) for which at least one metabolism 
with this phenotype exists (vertical axis), as a function of the size n of the metabolism (horizontal 
axis). 
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S14 Fig. Minimal distance between genotype networks. Each rectangular colored area shows the 
color-coded minimal genotype distance D!"# between genotype networks for phenotypes viable on 
carbon sources indicated on the corresponding (x, y) positions (n = 30). 
 
 
S15 Fig. Minimal distance between genotype networks as a function of metabolism size. Minimal 
distance between pairs of genotype networks for metabolisms (A) viable only on acetate or glucose, 
and (B) viable only on glutamate or malate, as a function of metabolism size (horizontal axes). Note 
that at the largest n where metabolisms exist that are viable on only a single carbon source, D!"# 
increases in some cases from one to two and that is because of the small size of genotype networks at 
the largest metabolism sizes. 
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S16 Fig. Minimal distance between genotype networks as a function of phenotypic complexity. 
Each rectangular area shows the color-coded average of the minimal distance D!"# (see color legend) 
between pairs of genotype networks with phenotypic complexity (k, x-axis) and (k’,	y-axis) for 
metabolisms of size 34 (A) n = 30 and (B) n = 40. At n = 30, no metabolism is viable on more than k = k’ = 7	carbon sources, hence no distances can be calculated for the corresponding values of k. The 
highest average minimal distances exists for metabolisms of complexity (A) (k, k’) = (4, 7),	which 
show D!"# = 3.5 and (B) (k,	k’)=(10,	7), which show D!"# = 1.82. 
 
 
S17 Fig. Fraction of neighboring genotype 
networks as a function of phenotypic 
complexity. Each color-coded rectangular area 
shows the fraction of genotype networks that 
are neighbors (have D!"# = 1) among pairs of 
genotype networks of a given phenotypic 
complexity (k, x-axis) and (k’,	yaxis), for 
metabolisms of size (A) n = 30 (B) n =35 and (C) n = 40. At n = 30, no metabolism 
is viable on more than k = k’ = 7	carbon 
sources, hence no distances can be calculated 
for the corresponding values of k. 
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S18 Fig. Minimal distance between 
genotype networks as a function of 
phenotypic complexity for metabolisms 
without disconnected reactions. Each color-
coded rectangular area shows the average 
minimal distance of pairs of genotype 
networks with phenotypic complexity (k, x-
axis) and (k’,	y-axis), for metabolisms of size 
(A) n = 30 (B) n = 35 and (C) n = 40. Note 
that in this analysis (unlike Figs 5C and S14) 
only genotype networks of metabolisms 
without disconnected reactions are considered. 
At n = 30, no metabolism is viable on more 
than k = k’ = 7	carbon sources, hence no 
distances can be calculated for the 
corresponding values of k. The highest 
average minimal distances exists for 
metabolisms of complexity (A) (k, k’) =(4, 7),	which show D!"# = 3.87, (B) (k, k’) = (10, 6),	which show D!"# = 2.6 and 
(C) (k, k’) = (10, 5), which show D!"# =1.82. 
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S19 Fig. Fraction of neighboring genotype 
networks as a function of phenotypic 
complexity. Each color-coded rectangular area 
shows the fraction of neighboring genotype 
networks among pairs of genotype networks 
with a given phenotypic complexity (k, x-axis) 
and (k’,	y-axis), for metabolisms of size (A) 
n=30 (B) n=35 and (C) n=40. Note that in this 
analysis (unlike S15 Fig) only genotype 
networks of metabolisms without disconnected 
reactions are considered. At n = 30, no 
metabolism is viable on more than k = k’ = 7	
carbon sources, hence no distances can be 
calculated for the corresponding values of k. 
 
 
 
S20 Fig. Average minimal distance and fraction of neighboring genotype networks as a function 
of metabolism size. Each color-coded rectangular area indicates (A) the average minimal distance, 
and (B) the average fraction of neighboring genotype networks, for all pairs of genotype networks of 
metabolisms with a given size (n, x-axis) and with a given phenotypic complexity (y-axis). 
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S21 Fig. Average minimal distance and fraction of neighboring genotype networks as a function 
of metabolism size. Each color-coded rectangular area indicates (A) the average minimal distance, 
and (B) the average fraction of neighboring genotype networks, for all pairs of genotype networks of 
metabolisms with a given size (n, x-axis) and with a given phenotypic complexity (y-axis). Note that 
in this analysis (unlike S18 Fig) only genotype networks of metabolisms without disconnected 
reactions are considered. 
 
 
S22 Fig. Distribution of genotypic distances DG for phenotypes of a given distance DP. Data points 
of given shading indicate the distribution of genotypic distance D! (x-axis) among pairs of 
metabolisms with a given phenotypic distance D!, as indicated in the color legend for metabolisms of 
size (A) n = 30, (B) n = 35, (C) n = 40 and (D) n = 45. 
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S23 Fig. Distribution of genotypic distances DG  for phenotypes of a given distance DP  (only 
connected metabolisms). Data points of a given shading indicate the distribution of genotypic 
distance D! (x-axis) among pairs of metabolisms with a given phenotypic distance D!, as indicated in 
the color for metabolisms of size (A) n = 30, (B) n = 35, (C) n = 40 and (D) n = 45. Note that in 
this analysis (unlike S20 Fig.) only genotype networks of metabolisms without disconnected reactions 
are considered. 
 
 
 
S24 Fig. Normalized number of novel phenotypes in neighborhood. Average number of distinct 
novel metabolic phenotypes in neighborhood of metabolisms of a given size (n) and viable on a given 
carbon source, divided by the number of distinct phenotypes existing in metabolisms of this size. 
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Carbon source nmin number of 
viable 
metabolisms at 
nmin 
total number of 
viable 
metabolisms 
nmax maximum number of 
viable metabolisms at 
nmax  
Acetate 30 4     10850304 40 1922772 
α-ketoglutarate 25 6   928636928 38 153139863 
Fructose 23 3 1473094400 37 227234491 
Fumarate 26 8   412139520 38 68804412 
Glucose 23 3 1549771520 37 239328665 
Glutamate 26 8   342265856 38 56385611 
Lactate 26 2   141944832 39 23190620 
Malate 25 8   781627392 38 126729791 
Pyruvate 26 6   353501184 38 57805322 
Succinate 27 8   217774080 39 36626028 
 
S1 Table. Further information on the number of viable metabolisms and minimal metabolisms. 
Each row contains data for metabolisms viable on one of 10 carbon sources, as indicated in the left-
most column. Columns from left to right indicate the minimum number of reactions required to be 
viable on that carbon source (n!"#), the number of metabolisms with this minimum number of 
reactions, the total number of viable metabolisms, the size n!"# at which the number of viable 
metabolisms is maximal, and the maximum number of viable metabolisms at n!"#. 
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n Acetate Alpha-
ketoglutarate 
Fructose Fumarate Glucose Glutamate Lactate Malate Pyruvate Succinate 
nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG 
23     2 0.6666   2 0.6666           
24     2 0.6373   2 0.6373           
25   1 1 2 0.9969   2 0.9969     1 1     
26   2 0.9672 2 0.9919 1 1 2 0.9920 1 1 2 1 2 0.9642 3 0.3333   
27   2 0.9973 1 1 2 0.9629 1 1 3 0.9425 1 0.9622 1 1 4 0.9617 1 1 
28   3 0.9996 2 0.9999 1 1 2 0.9999 3 0.9977 2 1 1 1 3 0.9964 2 0.9649 
29   2 0.9999 1 1 1 1 1 1 2 0.9999 3 0.9992 1 1 3 0.9974 1 1 
30 1 1 1 1 1 1 1 1 1 1 1 1 2 0.9998 1 1 3 0.9999 1 1 
31 2 0.9545 1 1 1 1 1 1 1 1 1 1 1 0.9999 1 1 1 1 1 1 
 
S2 Table. Number of connected components and the fractional size of the largest component for the metabolisms viable on a given carbon source. Each pair of 
columns shows the number of connected components (n!) as well as the fractional size of the largest component (r!) for metabolism of different sizes n (left-most column) 
that are required to be viable on a given carbon source (first row). For metabolisms with n ≥ 32, for every carbon source, n! and r! both equal to one. Empty fields mean 
that no viable metabolism exists for the corresponding carbon source and metabolism size n. 
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Metabolism size Acetate Alphaketoglutarate Fructose Fumarate Glucose Glutamate Lactate Malate Pyruvate Succinate 
23    100.0000   100.0000      
24      96.0000     96.0000      
25   100.0000  100.0000   100.0000    100.0000   
26     50.0000    96.5600  100.0000    96.1600    75.0000  100.0000  100.0000  100.0000  
27     37.8378  100.0000  100.0000  100.0000    60.7143  100.0000    88.2353    90.8696  100.0000 
28     29.1262    96.6543    87.7551    98.0000    54.2636  100.0000    70.5871    73.3333    50.0000 
29     19.9496    71.9000    50.0000    49.7200    50.0700    99.1667    48.3871    95.4071    75.0000 
30 100.0000    22.9630    68.1300    46.3612    46.8557    42.3800    94.1176    48.2759    66.6667    54.7896 
31    88.8889    04.2300    61.0700    34.9593    40.6250    33.3700    86.2700    37.5465    49.2063    42.6200 
32    84.6154    11.2100    62.2174    25.4144    56.4103    02.8798    68.9446    48.6842    50.0000    35.2000 
33    65.1556    22.2341    58.0000    54.1604    55.6818    10.6900    71.5284    65.1163    56.1538    53.2000 
34    49.7000    44.5946    20.0000    51.0204    58.2800    26.8536    72.9299    90.0000    57.6923    51.8047 
35    36.4300    61.8182    58.8837    59.2857    59.7800    48.2759    52.1739    54.6032    53.4483    30.7692 
36    26.6200    58.7124    61.6600    57.5800    61.2300    63.5406    53.1469    58.8900    60.6626    53.1282 
37    16.4163    65.7900    67.4800    61.0400    65.2400    58.5200    55.4600    61.9700    62.8800    58.9300 
38    80.0000    70.2400    69.5800    66.4600    70.6000    64.5500    60.3300    68.0000    66.8000    64.5100 
39    47.9769    76.0176    49.2200    42.3000    48.4400    45.5100    40.9200    45.3900    45.5400    41.3400 
40    30.6100    57.6500    54.8100    49.9900    55.6100    52.9600    46.9700    52.9700    52.5100    48.7000 
41    39.1100    63.6400    60.8800    59.2200    61.3500    60.7300    54.3000    60.3300    59.1100    56.0800 
42    48.5400    70.2800    67.7500    65.9600    69.5300    67.8000    60.3100    67.5100    65.3300    64.0900 
43    58.3500    75.9000    75.7300    73.4600    76.1000    73.5900    68.5000    74.7200    71.9200    70.7400 
44    67.7000    81.5700    81.3900    79.1900    82.4000    80.4400    75.2100    81.4800    78.7900    78.2900 
45    76.6500    86.7100    87.1000    85.6200    86.8400    84.9200    82.9000    86.0500    85.1000    84.2800 
46    84.2100    93.2300    93.2600    92.3100    91.7900    92.7100    88.2800    92.6300    92.8500    88.9400 
47    90.0700    94.1000    94.5700    93.5600    95.0100    93.9500    93.0300    94.5200    93.9100    93.7000 
48    94.4000    96.8400    97.0200    96.5400    97.0900    96.6400    96.3900    97.0700    97.1500    96.2500 
49    97.8800    98.7600    98.9900    98.7000    98.9000    98.7100    98.5600    98.8500    98.6800    98.3500 
50    99.5074    99.7155    99.7301    99.6825    99.7436    99.6825    99.6639    99.6997    99.7155    99.6639 
S3 Table. Percentage of metabolism pairs with genotypic distance equal to network diameter, where different members of a metabolism pair do not use alternative 
reactions that differ only in a co-factor. Each entry of the table corresponds to the genotype network of metabolisms of a given size (specified by the left-most column) that 
are viable on a given carbon source (specified in the first row). Empty fields mean that no viable metabolism exists for the corresponding carbon source and metabolism size.  
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Metabolism size Acetate Alphaketoglutarate Fructose Fumarate Glucose Glutamate Lactate Malate Pyruvate Succinate 
23   0  0      
24   0  0      
25  0 0  0   0   
26  0 0 0 0 0 0 0 0  
27  0 0 0 0 0 0 0 0 0 
28  0 0 0 0 0 0 0 0 0 
29  0 1 0 1 0 0 0 0 0 
30 0 0 1 0 1 0 0 0 0 0 
31 0 1 1 0 2 0 0 2 2 0 
32 0 1 1 1 1 1 0 2 2 0 
33 0 1 2 1 2 1 1 2 1 1 
34 0 2 2 2 1 0 1 2 2 1 
35 0 2 2 1 1 0 2 2 2 2 
36 0 1 2 1 2 0 2 1 2 1 
37 0 1 1 1 2 0 2 1 2 1 
38 0 0  1 1 1 0  1 1 1 1 
39 0 0 0 0 0 0 0 0 0 0 
40 0 0 0 0 0 0 0 0 0 0 
41 0 0 0 0 0 0 0 0 0 0 
42 0 0 0 0 0 0 0 0 0 0 
43 0 0 0 0 0 0 0 0 0 0 
44 0 0 0 0 0 0 0 0 0 0 
45 0 0 0 0 0 0 0 0 0 0 
46 0 0 0 0 0 0 0 0 0 0 
47 0 0 0 0 0 0 0 0 0 0 
48 0 0 0 0 0 0 0 0 0 0 
49 0 0 0 0 0 0 0 0 0 0 
50 0 0 0 0 0 0 0 0 0 0 
S4 Table. Minimum number of blocked reactions among all pairs of metabolisms with genotypic distance equal to genotype network diameter. Each element of the 
table corresponds to the genotype network of metabolisms of a given size (specified in the left-most column) that are viable on a given source (specified in the first row). 
Empty fields mean that no viable metabolism exists for the corresponding carbon source and metabolism size n. 
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S5 Table. Number of connected components and the fractional size of the largest component for the metabolisms viable on a given carbon source. Each pair of 
columns shows the number of connected components (n!) as well as the fractional size of the largest component (r!) for metabolisms of different size n (left-most column) 
that are viable on a given carbon source (first row). For metabolisms with n ≥ 48 for every carbon source, n! and r! both equal to one. Empty fields mean that no viable 
metabolism exists for the corresponding carbon source and n. The information in this table is restricted to metabolisms without disconnected reactions. 
 
n Acetate Alpha-
ketoglutarate 
Fructose Fumarate Glucose Glutamate Lactate Malate Pyruvate Succinate 
nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG 
23     2 0.6666   2 0.6666           
24     2 0.6190   2 0.6190           
25    1 2 0.9964   2 0.9965     1 1     
26   2 0.9622 2 0.9907 1 1 2 0.9908 1 1 2 1 2 0.96 3 0.3333   
27   2 0.9833 1 1 2 0.9583 1 1 3 0.9322 1 0.9574 1 0.9983 4 0.6564 1 1 
28   3 0.9994 2 0.9999 1 0.9982 2 0.9999 3 0.9869 2 0.9962 1 1 3 0.7072 2 0.9607 
29   2 0.9999 1 1 1 1 1 1 2 0.9998 3 0.9989 1 1 3 0.7352 1 0.9983 
30 1 1 1 1 1 1 1 1 1 1 1 1 2 0.9989 1 1 3 0.7698 1 1 
31 2 0.95 1 1 1 1 1 1 1 1 1 1 1 0.9998 1 1 1 0.8041 1 1 
32 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.8386 1 1 
33 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.8717 1 1 
34 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9016 1 1 
35 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9273 1 1 
36 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9480 1 1 
37 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9640 1 1 
38 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9758 1 1 
39 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9842 1 1 
40 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9901 1 1 
41 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9940 1 1 
42 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9965 1 1 
43 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9981 1 1 
44 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9990 1 1 
45 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9996 1 1 
46 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9998 1 1 
47 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.9999 1 1 
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 Number k of carbon sources 
Number 
n of 
reactions 
k = 1  k = 2 k = 3 k = 4 k = 5 k = 6 k = 7 k = 8 k = 9 k = 10 
nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG 
23 2 0.6666 2 0.6666                 
24 2 0.6373 2 0.6373                 
25 2 0.9969 2 0.9969                 
26 2 0.9672 1 1                 
27 2 0.9629 1 1 1 1               
28 2 0.9996 2 0.9606 2 0.9529               
29 2 0.9995 2 0.9994 2 0.9593 1 1 1 1           
30 3 0.9999 2 0.9929 2 0.9591 1 1 1 1 1 1 1 1       
31 2 0.9772 2 0.9993 2 0.9905 2 0.9221 2 0.9937 1 1 1 1 1 1     
32 1 1 2 0.9999 2 0.9979 3 0.9851 3 0.9811 2 0.9851 1 1 1 1 1 1   
33 1 1 1 1 2 0.9998 3 0.9973 3 0.9925 3 0.991 2 0.9984 1 1 1 1   
34 1 1 1 1 1 1 2 0.9998 3 0.9976 3 0.9966 3 0.9862 3 0.9966 1 1 1 1 
35 1 1 1 1 1 1 1 1 1 1 2 0.9995 2 0.9973 3 0.9963 3 0.9113 3 0.9113 
36 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 0.9959 2 0.9959 
 
S6 Table. Median of the number of connected components and the fractional size of the largest component for metabolisms viable on multiple carbon sources. Each 
pair of columns shows the median number of connected components (n!), as well as the fractional size of the largest component (r!) for metabolisms of different sizes n 
(left-most column) that are required to be viable on k carbon sources (first row). For metabolisms with n ≥ 37, for every k, n! and r! both equal to one. Empty fields mean 
that no viable metabolism exists for the corresponding k and n. 
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 Number k of carbon sources 
Number 
n of 
reactions 
k = 1 k = 2 k = 3 k = 4 k = 5 k = 6 k = 7 k = 8 k = 9 k = 10 
nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG 
23 2 0.6666 2 0.6666                 
24 2 0.6373 2 0.6373                 
25 2 0.9969 2 0.9969                 
26 3 0.992 2 1                 
27 4 1 2 1 1 1               
28 3 1 4 1 4 1 1 1             
29 3 0.9999 4 1 4 1 4 1 1 1           
30 3 0.9999 5 1 5 1 5 1 5 1 1 1 1 1       
31 2 0.9999 5 1 7 1 7 1 7 1 7 1 3 1 1 1     
32 1 1 6 1 7 1 7 1 7 1 7 1 7 1 4 1 1 1   
33 1 1 3 1 7 1 7 1 7 1 7 1 6 1 5 1 4 1   
34 1 1 3 1 5 1 7 1 7 1 6 1 6 1 6 1 5 1 1 1 
35 1 1 1 1 3 1 3 1 3 1 3 1 3 1 3 1 3 0.9995 3 0.9113 
36 1 1 1 1 1 1 2 1 2 1 2 1 2 1 2 1 2 1 2 0.9959 
 
S7 Table. Maximum number of connected components and the fractional size of the largest component for metabolisms viable on multiple carbon sources. Each pair 
of columns shows the maximum number of connected components (n!) as well as the fractional size of the largest component (r!) for metabolism of different sizes n (left-
most column) and required to be viable on k carbon sources (first row). For metabolisms with n ≥ 37, for every k, n! and r! both equal to one. Empty fields mean that no 
viable metabolism exists for the corresponding k and n. 
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Number 
n of 
reactions 
k = 1 k = 2 k = 3 k = 4 k = 5 k = 6 k = 7 k = 8 k = 9 k = 10 
nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG nC rG 
23 2 0.6666 2 0.6666                 
24 2 0.6373 2 0.6373                 
25 2 0.9969 2 0.9969                 
26 2 0.3333 1 0.9919                 
27 1 0.9425 1 0.5 1 1               
28 1 0.9649 1 0.2857 1 0.2857 1 1             
29 2 0.9974 1 0.5049 1 0.2857 1 0.2857 1 1           
30 3 0.9998 1 0.7142 1 0.3809 1 0.3809 1 0.3809 1 1 1 1       
31 2 0.9545 1 0.7377 1 0.4 1 0.3809 1 0.3809 1 0.3809 1 0.6666 1 1     
32 1 1 1 0.9518 1 0.4122 1 0.4122 1 0.4122 1 0.4122 1 0.6666 1 0.8256 1 1   
33 1 1 1 0.9268 1 0.9232 1 0.6043 1 0.6043 1 0.6043 1 0.6043 1 0.8076 1 0.819   
34 1 1 1 0.9975 1 0.9135 1 0.9135 1 0.9135 1 0.9135 1 0.9135 1 0.9135 1 0.9156 1 1 
35 1 1 1 1 1 0.9961 1 0.909 1 0.909 1 0.909 1 0.909 1 0.909 2 0.909 3 0.9113 
36 1 1 1 1 1 1 1 0.9957 1 0.9957 1 0.9957 1 0.9957 1 0.9957 1 0.9957 2 0.9959 
 
S8 Table. Minimum number of connected components and the fractional size of the largest component for metabolisms viable on multiple carbon sources. Each pair 
of columns shows the minimum number of connected components (n!) as well as the fractional size of the largest component (r!) for metabolism of different sizes n (left-
most column) that are viable on k carbon sources (first row). For metabolisms with n ≥ 37, for every k, n! and r! both equal to one. Empty fields mean that no viable 
metabolism exists for the corresponding k and n. 
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Abbreviation  Metabolite full name 
13dpg  3-Phospho-D-glyceroyl phosphate 
2pg  D-Glycerate 2-phosphate 
3pg  3-Phospho-D-glycerate 
6pgc  6-Phospho-D-gluconate 
6pgl  6-phospho-D-glucono-1,5-lactone 
ac  Acetate 
ac[e]  Acetate (extracellular) 
acald  Acetaldehyde 
acald[e]  Acetaldehyde (extracellular) 
accoa  Acetyl-CoA 
actp  Acetyl phosphate 
adp  ADP 
akg  2-Oxoglutarate 
akg[e]  2-Oxoglutarate (extracellular) 
amp  AMP 
atp  ATP 
cit  Citrate 
co2  CO2 
co2[e]  CO2 (extracellular) 
coa  Coenzyme A 
dhap  Dihydroxyacetone phosphate 
e4p  D-Erythrose 4-phosphate 
f6p  D-Fructose 6-phosphate 
fdp  D-Fructose 1,6-bisphosphate 
for  Formate 
for[e]  Formate (extracellular) 
fru[e]  D-Fructose (extracellular) 
fum  Fumarate 
fum[e]  Fumarate (extracellular) 
g3p  Glyceraldehyde 3-phosphate 
g6p  D-Glucose 6-phosphate 
glc-D[e]  D-Glucose (extracellular) 
gln-L  L-Glutamine 
gln-L[e]  L-Glutamine (extracellular) 
glu-L  L-Glutamate 
glu-L[e]  L-Glutamate (extracellular) 
glu-L[e]  L-Glutamate (extracellular) 
glx  Glyoxylate 
h  H+ 
h[e]  H+ (extracellular) 
h2o  H2O 
h2o[e]  H2O (extracellular) 
icit  Isocitrate 
lac-D  D-Lactate 
lac-D[e]  D-Lactate (extracellular) 
mal-L  L-Malate 
mal-L[e]  L-Malate (extracellular) 
nad  Nicotinamide adenine dinucleotide 
nadh  Nicotinamide adenine dinucleotide (reduced) 
nadp  Nicotinamide adenine dinucleotide phosphate 
nadph 
 Nicotinamide adenine dinucleotide phosphate 
(reduced) 
nh4  Ammonium 
nh4[e]  Ammonium (extracellular) 
o2  O2 
o2[e]  O2 (extracellular) 
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oaa  Oxaloacetate 
pep  Phosphoenolpyruvate 
pi  Phosphate 
pi[e]  Phosphate (extracellular) 
pyr  Pyruvate 
pyr[e]  Pyruvate (extracellular) 
q8  Ubiquinone-8 
q8h2  Ubiquinol-8 
r5p  alpha-D-Ribose 5-phosphate 
ru5p-D  D-Ribulose 5-phosphate 
s7p  Sedoheptulose 7-phosphate 
succ  Succinate 
succ[e]  Succinate (extracellular) 
succoa  Succinyl-CoA 
xu5p-D  D-Xylulose 5-phosphate 
 
S9 Table. Metabolites and reactions in central carbon metabolism.  Metabolites in central 
carbon metabolism. Metabolites abbreviations (left columns) and their full names (right columns) are 
shown. Note Rows in red correspond to biomass precursors in the central carbon metabolism. atp, 
nadph and nad are also biomass precursors, but we wish to emphasize on metabolites that are act as 
biochemical precursors to the actual biomass precursors of E. coli (See main text). atp, nadph and nad 
are also biomass precursors for E. coli. 
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7.1. Abstract 
Biological systems are rife with examples of pre-adaptations or exaptations. They 
range from the molecular scale – lens crystallins, which originated from metabolic 
enzymes – to the macroscopic scale, such as feathers used in flying, which originally 
served thermal insulation or waterproofing. An important class of exaptations is novel 
and useful traits with non-adaptive origins. Whether such origins could be frequent 
cannot be answered with individual examples, because it is a question about a 
biological system’s potential for exaptation.  
We here take a step towards answering this question by analyzing central carbon 
metabolism, and novel traits that allow an organism to survive on novel sources of 
carbon and energy.  We have previously applied flux balance analysis to this system 
and predicted the viability of 1015 metabolic genotypes on each of 10 different carbon 
sources. 
We here use this exhaustive genotype-phenotype map to ask whether a central carbon 
metabolism that is viable on a given, focal carbon source C – the equivalent of an 
adaptation in our framework – is usually or rarely viable on one or more other carbon 
sources Cnew – a potential exaptation. We show that most metabolic genotypes harbor 
potential exaptations, that is, they are viable on one or more carbon sources Cnew. The 
nature and number of these carbon sources depends on the focal carbon source C 
itself, and on the biochemical similarity between C and Cnew. Moreover, metabolisms 
that show a higher biomass yield on C, and that are more complex, i.e., they harbor 
more metabolic reactions, are viable on a greater number of carbon sources Cnew.  
A high potential for exaptation results from correlations between the phenotypes of 
different genotypes, and such correlations are frequent in central carbon metabolism. 
If they are similarly abundant in other metabolic or biological systems, innovations 
may frequently have non-adaptive (“exaptive”) origins. 
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7.2. Introduction 
One of the most fundamental questions in evolutionary biology regards the origin of 
qualitatively new and beneficial traits, i.e., evolutionary innovations [1]. On the one 
hand, such traits can originate as adaptations that help an organism survive or 
reproduce. On the other hand, they can also have non-adaptive origins as pre-
adaptations or exaptations [2, 3]. Darwin was the first to pay attention to the 
importance of pre-adaptation when he said that “an organ originally constructed for 
one purpose… may be converted to one for a widely different purpose“ [4]. Later on, 
multiple lines of evidence from the organismal to the molecular scale confirmed the 
importance of exaptations as important sources of evolutionary innovation [5–7]. A 
textbook example involves feathers, which are made of keratins, the same proteins 
that constitute the scales of reptiles. Feathers most likely originally served as 
thermoregulation and waterproofing, and were only later ”exapted“ for flying [2]. 
Many crystallins, light-refracting proteins in eye lenses, originated as metabolic 
enzymes [8]. More generally, many genes have been coopted into various 
developmental and physiological functions by changing their patterns of regulation 
[5]. For example, the Hedgehog signaling protein, responsible for proper limb 
development in mammals, has also been coopted to paint eyespots in butterflies, and 
it helps shape feathers in birds [7]. Exaptations may also have been important in 
human evolution [9]. 
It is easy to find examples of exaptations, but much more difficult to find out how 
frequently any one biological system can bring forth non-adaptive traits that could 
turn into exaptations. This is not a question about natural history, but about a 
biological system’s potential for exaptation. It is the focus of this contribution. The 
question can only be answered in systems where one can study, either experimentally 
or computationally, many genotypes and the phenotypes that they form [10–14]. In 
doing so, one can ask whether a beneficial phenotypic trait frequently entails other 
traits with the potential to become an exaptation. 
Metabolism is a well-suited system for this purpose, and for two main reasons. First, 
metabolism is a source of multiple evolutionary innovations, especially in 
microorganisms. For example, microorganisms have acquired the ability to extract 
energy from non-natural substances, including toxic compounds [15–18]. By 
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producing novel molecules such as ectoine or glycine betaine, halophilic bacteria can 
tolerate high salt concentrations [19]. And microbial isolates from pristine soils show 
not only resistance to a wide range of antibiotics, but many of them are also capable 
of using these molecules as sources of energy and chemical elements [20]. 
Second, one can predict novel metabolic phenotypes using computational tools such 
as flux balance analysis (FBA) for multiple metabolic genotypes [21–26]. The 
metabolic genotype of an organism is a string of DNA encoding the enzymes 
catalyzing metabolic reactions, but for computational expediency, a more compact 
representation of a metabolic genotype based on reactions rather than genes is often 
used [21–24, 27, 28]. Specifically, given a known “universe” of enzyme-catalyzed 
biochemical reactions, one can represent the metabolic genotype of an organism as a 
binary vector whose i-th entry corresponds to the i-th reaction in this reaction 
universe [29]. If an organism’s genome encodes an enzyme capable of catalyzing a 
given reaction, the corresponding entry in the genotype vector will be one and zero 
otherwise. The collection of all such vectors constitutes a metabolic genotype space, 
and any one organism’s metabolic genotype can be thought of as a point in this space.  
FBA can predict metabolic phenotypes, such as viability (the ability of a metabolism 
to sustain life in a given spectrum of chemical environments) for any one metabolic 
genotype. Importantly, FBA-based predictions of viability are in good agreement 
with experimental data [27, 30–35]. 
In previous work, we analyzed potential exaptations in genome-scale metabolisms 
[36]. This work relied on sampling of metabolic genotypes from a vast metabolic 
genotype space [14, 26]. Because any such sample represents a tiny fraction of the 
whole space, we here complement this analysis with a more comprehensive approach 
that examines all members of a genotype space. This is impossible for genome-scale 
metabolisms, because of their astronomical numbers, but it is possible for smaller-
scale metabolic systems, such as a genotype space defined by the 51 biochemical 
reactions of central carbon metabolism [29]. 
Central carbon metabolism is a small but crucial part of metabolism, because it plays 
a pivotal role in life by extracting energy from extracellular carbon sources 
(Additional files 1 and 2). It includes the interrelated biochemical pathways of 
glycolysis, gluconeogenesis, the pentose-phosphate pathway (PP), and the 
tricarboxylic acid cycle (TCA), which are supplemented by anaplerotic reactions and 
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the glyoxylate shunt [37]. Glycolysis creates high-energy compounds like ATP and 
NADH and converts glucose into pyruvate. The tricarboxylic acid cycle (TCA) 
generates ATP, NADH, and amino acid precursors from acetyl-CoA, which results 
from oxidation of the glycolytic end product pyruvate.  The pentose-phosphate 
pathway produces NADPH and pentose sugars for anabolic reactions. Finally, the 
reactions of the oxidative phosphorylation pathway participate in production of ATP 
from NADH. 
We here use the genotype-phenotype map of central carbon metabolism to ask how 
often metabolisms viable on a given carbon source C can survive on one or more 
other carbon sources Cnew. We show that this is the case for most metabolisms, and 
we analyze which properties of a metabolism facilitate its potential for exaptation. 
These properties include the complexity of a metabolism and its efficiency in 
converting nutrients into biomass. We emphasize that we are not focused on the 
evolutionary history of central carbon metabolism, but on the potential for its 
biochemical pathways to bring forth exaptations.  
7.3. Results 
The genotype space of central carbon metabolism 
The genotype space we consider includes all 251≈1015 metabolic genotypes whose 
reactions form a subset of the 51 internal reactions of the central carbon metabolism 
of E. coli [29]. Each genotype specifies a chemical reaction network that we refer to 
as a central carbon metabolism. We call a genotype (metabolism) viable on a given 
carbon source, if it can synthesize each one of 13 biomass precursors from this source 
in an otherwise minimal chemical environment (Additional files 1 and 2) [38]. In 
previous work, we determined the viability of each of the 251 genotypes on 10 
different carbon sources [39–41], and found that only a tiny fraction of genotypes can 
sustain life on any one carbon source. This fraction ranges from 10-8 (on acetate) to 
10-6 (on glucose), corresponding to between  ≈107 and ≈109 genotypes that are viable 
on acetate and glucose, respectively. Genotypes viable on a given carbon source form 
a connected network in genotype space, which implies that different metabolisms can 
be converted into each other in few viability-preserving mutational steps [39]. We use 
E. coli central metabolism as a departure point for our analysis for two reason. First, 
it is small enough to be amenable to exhaustive genotype-phenotype mapping, yet 
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large enough to show multiple different phenotypes. Second, E. coli central carbon 
metabolism is especially well characterized and reasonably complete [38, 42]. Other 
genotypes in the genotype space we examine correspond to incomplete variants, such 
as those lacking a complete citric acid cycle or having incomplete pentose-phosphate 
pathway.  
The fundamental question we ask here is whether a metabolism that is viable on a 
specific focal carbon source C is usually also viable on one or more other carbon 
sources Cnew, which corresponds to a potential exaptation or preadaptation in the 
framework of our computational analysis. In a previous analysis, we had asked this 
question for randomly sampled genome-scale metabolisms required to be viable on a 
specific carbon source C [36], and we here extend this approach to all ≈1015 central 
carbon metabolisms whose phenotypes we have previously exhaustively enumerated 
[39–41]. 
High potential for exaptation in central carbon metabolism 
We first defined an exaptation index I as the number of carbon sources Cnew on which 
a metabolism is viable (in addition to the carbon source C) [36]. We then asked what 
fraction of metabolisms viable on C have I>0, i.e., they are exapted to at least one 
additional carbon source. Figure 1A shows that for all ten focal carbon sources C we 
consider here except one, the majority of metabolisms are viable on at least one 
carbon source Cnew. For example, 95 percent of metabolisms viable on glucose are 
also viable on at least one additional carbon source. The one exception is α-
ketoglutarate for which only 38 percent of viable metabolisms are also viable on 
additional carbon sources (Figure 1A). Another extreme is represented by 
metabolisms viable on fructose and fumarate, all of which are viable on additional 
carbon sources.  The reason is that all metabolisms viable on fructose are also viable 
on glucose, and all metabolisms viable on fumarate are also viable on succinate. In 
sum, central carbon metabolism harbors great potential for exaptation. 
One can partition metabolic genotype space according to the complexity or size of 
genotypes, defined as the number of reactions n in a metabolism [40]. Any one 
metabolism needs to have a minimal size n for viability, which depends on the carbon 
source considered, and ranges from n=23 for glucose to n=30 for acetate. We next 
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asked if the fraction of metabolisms with I >0 depends on this metabolism size. 
Figure 1B shows that it does. For any one carbon source C, more complex 
metabolisms have a higher potential for exaptation. The exceptions are metabolisms 
viable on fumarate and fructose, because all of them have I>0, regardless of size. 
 
Figure 1 High exaptation potential in central carbon metabolisms. (A) Fraction of metabolisms 
with exaptation index I>0 (y-axis) viable on some carbon source C (x-axis); (B) fraction of 
metabolisms (coded by shade of grey, see legend) with exaptation index (I>0) that are viable on some 
carbon source C (x-axis) and have a given size (y-axis),  (C) mean exaptation index of metabolisms 
viable on some carbon source C (x-axis), and (D) mean exaptation index (coded by shade of grey, see 
legend) of metabolisms viable on some carbon source C (x-axis) and with a given size (y-axis). White 
in (B) and (D) corresponds to metabolisms whose size is too small for viability on C. 
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We next determined the average exaptation index among all viable metabolisms, 
which indicates the average number of additional carbon sources Cnew that a 
metabolism viable on some carbon source C is also viable on. This average 
exaptation index exceeds 1 in all of the carbon sources except for α-ketoglutarate, 
where it is 0.88 (Figure 1C). For acetate, this index has the largest value (I=5.27), 
which implies that a metabolism viable on acetate will, on average, be viable on more 
than 5 of the remaining 9 carbon sources. The index also increases with increasing 
metabolism size (Figure 1D), meaning that larger metabolisms are viable on more 
carbon sources Cnew. Furthermore, we observed that the exaptation index varies 
widely among metabolisms of the same size and viable on the same carbon source 
(Additional file 3).  
In a final analysis, we asked whether high exaptation potential might be caused 
preferentially by reactions that are disconnected from the rest of metabolism. Such 
disconnected reactions must fulfill at least one of the following two criteria. First, 
their products are neither biomass precursors nor substrates of any other reaction of a 
given metabolism. Second, at least one of their substrates is neither a product of other 
reactions nor a nutrient taken up from the environment. To find out how disconnected 
reactions affect exaptation potential, we eliminated from our analysis those 
metabolisms harboring such reactions, and observed that the exaptation indices 
remain almost unchanged (Additional file 4). The incidence of disconnected reactions 
does not strongly affect the exaptation potential of central carbon metabolism. 
In sum, viability on a given carbon source generally entails viability on other carbon 
sources, and often on multiple such carbon sources. Thus, central carbon metabolism 
has a high potential for exaptation. This potential increases with metabolic 
complexity, i.e., with the number of reactions in a metabolism. 
Minimal central carbon metabolisms also harbor exaptation potential 
A special role in our analysis is played by metabolisms that are minimal. We define 
them as metabolisms from which not a single reaction can be removed without 
abolishing viability on the focal carbon source. We note that there may be multiple 
such metabolisms, and that they are not necessarily the smallest possible metabolisms 
viable on this carbon sources. They are important, because they harbor only essential 
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reactions. If exaptation potential depends on non-essential reactions, then it is 
possible that such minimal metabolisms harbor no exaptation potential.  
To find out, we first identified all minimal central carbon metabolisms viable on a 
given focal carbon source (table 1). For example, 161 minimal central carbon 
metabolisms are viable on glucose, and their size varies from 23 to 30 reactions [39].  
Focal Carbon 
Source  
Number of  
Minimal 
Metabolisms 
Size 
Range 
Number (percentage) of 
Minimal 
Metabolisms with I>0 
Fructose 146 [23-30] 146  (100.00%) 
Fumarate 456 [26-32] 456  (100.00%) 
Glucose 161 [23-30] 154    (95.65%) 
Succinate 348 [27-32] 304    (87.36%) 
Lactate 180 [26-34] 144    (80.00%) 
Malate 456 [25-32] 176    (38.60%) 
Glutamate 187 [26-32] 72      (38.50%) 
Acetate 76 [30-36] 16      (21.05%) 
Pyruvate 569 [26-34] 96      (16.87%) 
α-ketoglutarate 970 [25-32] 80        (8.25%) 
Table 1: Exaptation potential of minimal metabolisms. Columns, from left to right, indicate the 
focal carbon source, the number of minimal metabolisms that are viable on this carbon source, the size 
range of these metabolisms, and the number (percentage) of minimal metabolisms with exaptation 
index (I>0).  
The ten focal carbon sources in Table 1 can be subdivided into two groups. In the 
first group (fructose, fumarate, glucose, succinate and lactate), the vast majority (80-
100 percent) of minimal central carbon metabolisms have exaptation indices I>0. For 
example, among the 161 minimal metabolisms viable on glucose, 154 (95.7%) can 
survive on at least one additional carbon source (146 on one, and eight on two 
additional carbon sources). Three of these 154 minimal metabolisms have the 
smallest possible size for metabolisms viable on glucose (n=23 reactions), and each 
of these three is viable on one additional carbon source. For the second group of focal 
carbon sources (table 1, malate, glutamate, acetate, pyruvate, and α-ketoglutarate), 
fewer than 50 percent of minimal metabolisms show an exaptation index I>0. For 
example, among the 76 minimal metabolisms viable on acetate, 60 are only viable on 
acetate and only 16 (21%) of them can survive on another carbon source. In sum, 
there are clear differences among carbon sources in the exaptation potential of 
minimal metabolisms. However, on all carbon sources some minimal metabolisms 
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show exaptation potential, and on half of the carbon sources the vast majority of 
minimal metabolisms does. Non-essential reactions are not solely responsible for the 
exaptation potential of central carbon metabolisms.   
That being said, reactions that are non-essential on any one carbon source do play a 
role in increasing a metabolism’s exaptation potential, but the importance of this role 
depends on the carbon source. We demonstrated this with the following approach, 
applied to all carbon sources, all minimal metabolisms for each carbon source, and all 
possible numbers nne of non-essential reactions. We identified all nne -tuples of such 
reactions, i.e., reactions that are not already part of the metabolism, added each nne-
tuple to the minimal metabolism, and determined the exaptation index I of the 
resulting metabolism. Figure 2A shows the number of added non-essential reactions 
together with the fraction of metabolisms with an exaptation index I >0, for two 
representative carbon sources from the two groups, glucose (group 1) and acetate 
(group 2). For glucose, where most minimal metabolisms already have exaptation 
potential,  adding non-essential reactions cannot strongly increase this potential. 
Specifically, the fraction of metabolisms with exaptation index (I>0) grows very 
slowly and it does not reach one even after addition of 20 non-essential reactions to 
some of the minimal metabolisms. Figure 2B shows the exaptation index itself as a 
function of the number nne of added reactions. For glucose, it remains nearly 
unchanged after adding 5 non-essential reactions to minimal networks, and starts to 
increase only thereafter. In contrast, for acetate, where the fraction of metabolisms 
with I>0 is low for nne=0, this fraction rises rapidly, to over 60 percent after adding 5 
reactions, and to 100 percent after adding 17 reactions (Figure 2A). Moreover, the 
exaptation index itself increases rapidly. It surpasses the exaptation index of minimal 
metabolisms viable on glucose after adding merely three non-essential reactions, and 
increases rapidly thereafter as well. In sum, even minimal metabolisms have some 
exaptation potential, and in those with low exaptation potential, the addition of non-
essential reactions increases this potential to the greatest extent. 
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Figure 2 Exaptation potential and non-essential reactions. Vertical axes show (A) the fraction of 
metabolisms with exaptation index (I>0), and (B) the exaptation index itself, among metabolisms 
generated by adding a given number nne of non-essential reactions (x-axis) to the minimal metabolisms 
viable on glucose (open circles/boxes), and acetate (filled circles/boxes). Boxes span the 25-th to 75-th 
percentile, and whiskers indicate maxima and minima. Note that this analysis is exhaustive, meaning 
that (i) all minimal metabolisms viable on glucose (161), and acetate (76) are considered, and (ii) all 
possible nne -tuples of non-essential reactions (x-axis) have been added to each minimal metabolism.  
Metabolisms viable on a given focal carbon source can be pre-adapted to a wide 
variety of other carbon sources 
Our analysis thus far has not addressed the question whether different metabolisms 
viable on some carbon source C show exaptation to different carbon sources Cnew. To 
answer this question, we separated metabolisms according to their focal carbon 
source C and their numbers of reactions, and determined the number of carbon 
sources Cnew on which metabolisms in each of these categories are viable. For all 
except the smallest metabolisms (n<30), at least one metabolism in each category is 
viable on each of the nine possible carbon sources Cnew (Additional file 5). In other 
words, regardless of the focal carbon source C, exaptation is possible on every single 
alternative carbon source. 
For the next step of our analysis, we represented viability on each of the nine carbon 
sources Cnew as a binary phenotype vector. For any one metabolism, this vector 
contains a one for each carbon source Cnew, on which that metabolism is viable, and a 
zero otherwise. We defined the phenotypic distance between a given pair of 
metabolisms as the Hamming distance between these phenotype vectors. The greater 
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this distance is for two metabolisms, the larger is the number of carbon sources Cnew 
on which one metabolism is viable and the other is not.  
 
 
Figure 3 Metabolisms can preadapt to a 
wide variety of carbon sources. Panels (A) 
and (B) show histogram of the phenotype 
distance (x-axis), for metabolisms of size (A) 
30, and (B) 45 viable on glucose as carbon 
source C. (C) Mean phenotypic distance 
(coded by shade of grey, see legend) of 
metabolisms viable on a focal carbon source 
(x-axis) and with a given number of reactions 
n (y-axis
Figures 3A and 3B show examples of the distribution of the phenotype distance for 
metabolisms of n=30 and n=45 reactions viable on the focal carbon source glucose. 
29.28% (n=30) and 92.89% (n=45) of all metabolism pairs have phenotypic distance 
larger than or equal to one, and 32.15% (n=45) of all metabolism pairs have 
phenotypic distance larger than or equal to five. Phenotypic distances can reach 
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values up to eight, meaning that two metabolisms may share viability on only one of 
the nine possible carbon sources Cnew. (See also Additional file 6 for the remaining 
glucose panels and Additional file 7, where C is pyruvate). Figure 3C shows the mean 
phenotypic distances for metabolisms of different sizes n and focal carbon sources C. 
It illustrates that large phenotypic distances are not peculiarities of metabolism pairs 
viable on glucose or pyruvate. Also, for each focal carbon source C, phenotypic 
distance generally increases with metabolism size. The only exception involves the 
largest metabolisms (n>48), where the average phenotypic distance is low and 
decreases with increasing n. The reason is that the largest metabolisms are highly 
likely to be viable on all ten carbon sources, which lowers their phenotypic distance. 
Similar observations hold for metabolisms without disconnected reactions 
(Additional files 8, 9 and 10). 
In sum, different metabolisms viable on a given carbon source are usually exapted to 
different additional carbon sources, and this exaptive diversity increases with a 
metabolism’s size. The exaptation potential of central carbon metabolism can give 
rise to multiple different metabolic innovations. 
The potential for pre-adaptation depends on the biochemical similarity between 
carbon sources 
In a next analysis, we asked whether different carbon sources Cnew are equally likely 
to occur as exaptations. Figure 4A shows, for each of nine carbon sources Cnew, and 
for metabolisms whose focal carbon source C is glucose, the fraction of metabolisms 
that are also viable on Cnew. The figure indicates huge disparities between carbon 
sources, where 97.5% of metabolisms viable on glucose are also viable on fructose, 
but only 11.7% are viable on malate, and fewer than 10% are viable on any of the 
other 7 carbon sources. Figure 4B shows these fractions broken down by metabolism 
size n. Almost all metabolisms viable on glucose are also viable on fructose, 
regardless of n, but the potential for preadaptation to other carbon sources is 
monotonically increasing with increasing n. Note that the only metabolism with the 
maximum of n=51 reactions is viable on all 10 carbon sources, such that at the 
highest n, the potential for preadaptation to any carbon source must reach one. These 
patterns are not a peculiarity of metabolisms viable on glucose, as Additional file 11 
illustrates for metabolisms with lactate as the focal carbon source C. 
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Figure 4 Potential for preadaptation depends on biochemical similarity between carbon sources. 
(A) The histogram shows the fraction of metabolisms viable on glucose as carbon source C that are 
also viable on each of the nine other carbon sources Cnew (x-axis). (B) As in (A), but broken down by 
metabolism size, and fractions of viable metabolisms are represented by different shades of grey (see 
legend). (C) Fraction of metabolisms viable on carbon source C (x-axis), which are also viable on 
carbon source Cnew (y-axis), (coded by shade of grey, see legend). (D) Dendrogram of carbon sources 
clustered based on their pairwise preadaptation propensity. We used UPGMA method (unweighted 
pair group method with arithmetic means), for clustering carbon sources. 
Figure 4C extends this analysis to all carbon sources C. Its x-axis shows the focal 
carbon source C, its y-axis the carbon source Cnew, and the grey shading of each 
matrix entry corresponds to the fraction of metabolisms viable on C and Cnew. 
Importantly, this matrix is not symmetric, showing that the potential of preadaptation 
between a given pair of carbon sources is not necessarily reciprocal. For example, the 
probability of preadaptation to glucose among metabolisms viable on acetate is 0.33 
but the probability of preadaptation to acetate among metabolisms viable on glucose 
is only 0.0023. Moreover, all the metabolisms viable on fumarate are also viable on 
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malate (i.e. preadaptation probability=1), but only 52.73% of metabolisms viable on 
malate are also viable on fumarate (i.e. preadaptation probability =0.5273). This 
asymmetry comes from the relative position of carbon sources in central carbon 
metabolism. For example, fumarate precedes malate in the citric acid cycle 
(Additional files 1 and 2), because malate is synthesized from fumarate. This ordering 
means that metabolisms viable on fumarate will also frequently be viable on malate, 
whereas the opposite is not necessarily true. 
In a final analysis, we also clustered carbon sources according to their mutual 
propensity for preadaptation, using the hierarchical clustering method UPGMA 
(unweighted pair group method with arithmetic means) [43]. Figure 4D shows the 
resulting dendrogram. The carbon sources that cluster together are biochemically 
closely related, which can help explain their mutual propensity for pre-adaptation. 
Specifically,  (i) glucose and fructose are both glycolytic carbon sources, (ii) 
fumarate, succinate and malate occupy consecutive steps in the citric acid cycle, (iii) 
pyruvate and lactate are interconvertible via lactate dehydrogenase, (iii) acetate is 
functionally linked to pyruvate via acetyl-coenzymeA, which is produced from 
pyruvate through a reaction catalyzed by pyruvate dehydrogenase, and (iv) glutamate 
and α-ketoglutarate are interconvertible via glutamate dehydrogenase. An analysis of 
metabolisms without disconnected reactions shows a similar pattern (Additional files 
12 and 13). In sum, metabolisms viable on biochemically similar focal carbon sources 
C also tend to be pre-adapted to biochemically similar carbon sources Cnew. 
 
High biomass yield and low waste production are associated with greater 
potential for pre-adaptation 
Metabolisms of the same size and that are viable on the same carbon source C can 
vary widely in their exaptation index, i.e., the number of additional carbon sources 
Cnew on which they are viable. To understand the causes of this variation, we 
analyzed the average biomass yield per mole of carbon. We found that this yield 
increases with increasing exaptation index, regardless of the focal carbon source C 
(Figure 5A), and regardless of metabolism size (Additional file 14). We also 
examined the number of waste metabolites, molecules that a metabolism synthesizes 
(and excretes) but that are not biomass precursors. This number of molecules can 
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vary widely for metabolisms of the same size that are viable on the same carbon 
source C (Figure 5B, and Additional file 15). Not surprisingly, metabolisms that 
show higher yield also excrete fewer waste molecules, regardless of their size, and 
regardless of their focal carbon source C (Figure 5C and Additional file 16). In 
addition, we observed that metabolisms with more reactions generally produce less 
waste, regardless of their focal carbon source (Figure 5D). 
 
Figure 5 High biomass yield and low waste production are associated with greater potential for 
preadaptation. (A) The x-axis shows the exaptation index, i.e., the number of carbon sources Cnew on 
which metabolisms viable on carbon source C (color legend) are viable. The y-axes show the average 
biomass yield. Data is based on metabolisms of size n=40. (B) Fraction of metabolisms excreting a 
given number of metabolites (x-axis) among metabolisms of size 40 and viable on glucose. (C) Each 
point shows mean number of excreted metabolites (y-axis), and mean biomass (x-axis) among 
metabolisms of a given size viable on a given carbon source colored according to legend in (A). (D) 
Mean of the number of excreted metabolites (coded by shade of grey, see legend) among metabolisms 
of a given size (y-axis), that are viable on a given carbon source (x-axis). White colors correspond to 
metabolisms whose size is too small for viability on C. 
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Taken together, these observations show that metabolisms with higher exaptation 
index are more efficient, converting more of their carbon source C into biomass, and 
excreting fewer waste products.  Larger metabolisms synthesize less waste and show 
higher biomass yield (Additional file 17), which can help explain their greater 
potential for exaptation (Figure 1B and 1D). 
7.4. Discussion 
We systematically analyzed the potential for exaptation or preadaptation in the simple 
but biologically important system of central carbon metabolism. Our analysis 
complements a previous study based on sampling a much larger metabolic genotype 
space [36], because it examines the potential for exaptation in an exhaustively 
enumerable genotype space of 1015 metabolisms. Our observations are consistent 
with that of the previous study, in that we also find a high potential for exaptation in 
this smaller metabolic system. 
Our central observation is that most metabolisms viable on a given carbon source C 
are also viable on one additional carbon source Cnew, and often on multiple such 
carbon sources. In a changing chemical environment, where the focal carbon source 
C has been consumed but where one or more carbon sources Cnew become available, 
this ability can become an important innovation. In other words, potential exaptations 
are highly abundant, even in a simple metabolic system. They occur preferentially for 
carbon sources Cnew that are biochemically similar to C, and are ultimately caused by 
shared biochemical pathways that connect different extracellular carbon sources to 
essential biomass precursors. Such shared pathways result in complex phenotypic 
correlations among different genotypes. 
We also observed that different metabolisms viable on a given carbon source C can 
be preadapted to widely different sets of carbon sources Cnew. This diversity of 
preadaptation can help make populations robust to environmental changes in carbon 
source availability, because a sufficiently large and genotypically diverse population 
may harbor at least one metabolic genotype that is already preadapted to some newly 
available Cnew. 
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One advantage of an exhaustive enumeration approach like ours is that it allows us to 
systematically identify metabolic properties associated with high exaptation potential. 
One such property is metabolic complexity, i.e., the number of reactions in a 
metabolism.  The greater metabolic complexity is, the greater is the number of carbon 
sources Cnew on which a metabolism is viable. Another property is metabolic 
efficiency, the ability to convert carbon into biomass (precursors) with few waste 
products. The more efficient a metabolism is, the greater is its potential for 
exaptation. Complexity and efficiency are linked, because at least in our study 
system, larger metabolisms produce less waste. These associations might be more 
difficult to understand in genome-scale systems with thousands of reactions, but 
studying them in a simpler system leads to a straightforward explanation. 
Specifically, in a larger metabolism it is more likely that most reactions link carbon 
sources and biomass productively, without producing dead-end products that cannot 
be used by other reactions. And this very feature makes it also more likely that a 
reaction path exists from any one carbon source Cnew to each biomass precursor. 
Among the limitations of our study is that we focused on carbon metabolism, and the 
metabolism of other chemical elements, such as nitrogen or sulfur, may differ in its 
exaptation potential. To find out whether this is the case remains a task for future 
work, but we note that sulfur and nitrogen metabolism generally show similar 
properties to carbon metabolism in studies of metabolic genotype spaces [44, 45]. 
A second limitation is that our analysis focuses on the presence or absence of 
reactions, and it neglects regulatory constraints arising through sub-optimal 
expression or regulation of an enzyme. This is consistent with our focus on the 
qualitative feature of viability, for which the presence or absence of reactions 
(enzymes) is more important than their quantitative regulation. We also note that 
regulatory constraints can be readily broken in evolution, even on the short time 
scales of laboratory evolution experiments [46–48]. 
A third limitation comes from our reaction-centered definition of metabolic 
genotypes. This coarse-grained definition of metabolic genotype is widely used [21–
24, 27, 28] , because it is simple, computationally efficient, and yet sufficiently 
informative for many analyses. However, it neglects that there need not be a one-to-
one relationship between metabolic genes and metabolic reactions. Some reactions 
are catalyzed by multiple enzymes [49], and some enzymes catalyze multiple 
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reactions [50–52]. One recent study that speaks to this limitation has focused on 
promiscuous enzymes that catalyze multiple biochemical reactions in genome-scale 
metabolisms. It shows that considering this one-to-many relationship between 
enzymes and reactions leads to an increase in the number of environments in which a 
metabolism is viable [53]. This would also apply to our study system, because adding 
reactions catalyzed by promiscuous enzymes to a metabolism can only increase its 
potential for exaptation. That is, addition of a reaction cannot abolish viability on the 
focal carbon source, but it might convey the ability to survive on further carbon 
sources Cnew  
Fourth, while E. coli central carbon metabolism is more complete than that of other 
species, where, for example, parts of the citric acid cycle are missing [42], we have 
not considered all reactions that could be considered part of a central carbon 
metabolism. For example, we have only considered the canonical Embden-Meyerhof-
Parnas glycolytic pathway, and we have neglected reactions belonging to the Entner-
Doudoroff (ED) and the phosphoketolase pathways [54, 55].  This was necessary, 
because the size of the genotype space we analyze is already large (1015 genotypes), 
and at the limit of feasibility for exhaustive genotype-phenotype mapping [40, 41]. 
Any additional reactions would have made an exhaustive analysis impossible. Just as 
for the preceding limitation, we note that adding these or other reactions to any one 
metabolism could only increase its potential for exaptation. For this reason, 
considering more complex metabolisms would not affect our core observation that 
many variants of central carbon metabolism harbor exaptive potential.  
Finally, we only considered 10 carbon sources, whereas metabolic generalists like E. 
coli can be viable on many more carbon sources [56, 57]. However, even this low 
number of carbon sources was sufficient to detect a high potential for exaptation, and 
once again, considering more carbon sources could only increase the estimated 
exaptive potential.  
One can envision the following evolutionary scenario in which traits with exaptive 
potential facilitate survival in novel environments. Consider a minimal metabolic 
network adapted to a specific carbon source C, i.e., a network from which no reaction 
can be removed without abolishing viability on C. Many such minimal networks are 
also viable on one or more additional carbon sources Cnew. If Cnew becomes available 
and the organism hosting this metabolism (or its competitors) has consumed C, then 
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viability on Cnew becomes an adaptation that helps the organism survive. The 
survivor’s descendants undergo processes such as gene duplication, point mutations, 
and horizontal gene transfer, which may enable some of them to catalyze novel 
reactions that allow it to utilize a carbon source C’ (and as a by-product, perhaps one 
or more additional carbon sources C’new). If none of these carbon sources ever occur 
in the environment, any such genetic change will eventually disappear through 
genetic drift or degenerative mutations. However, if C’ occurs in the environment, a 
new adaptation with exaptive potential on carbon source C’new has arisen. In other 
words, one can envision a step-wise expansion of metabolism that is driven by 
adaptive processes, but in which the exaptive potential of some traits facilitates 
survival in novel environments. That different genotypes viable on C are viable on 
different carbon sources Cnew (figure 3) may further facilitate adaptive evolution. 
The high exaptation potential of central carbon metabolism, and of genome-scale 
metabolisms in general [36] invites speculation that many metabolic innovations 
originate non-adaptively. However, we emphasize that our analysis is not suited to 
identify any one metabolic trait as an exaptation. It can thus also not identify the 
incidence of exaptations in metabolic evolution, which remains a major challenge for 
future work. 
We analyzed central carbon metabolism, a metabolic system small enough to lend 
itself to exhaustive genotype-phenotype mapping, and have systematically quantified 
this system’s potential for preadaptation for viability on novel carbon sources. Our 
results indicate that metabolisms viable on any one carbon source can be preadapted 
to multiple other carbon sources. The potential for such preadaptation rises with the 
complexity of a metabolism, i.e., with its numbers of reactions, and with its 
efficiency. It results from correlations between the phenotypes of different genotypes, 
which are caused by shared pathways that connect different extracellular carbon 
sources to essential biomass precursors 
7.5. Methods 
Flux balance analysis 
Flux Balance Analysis (FBA) is a widely used computational method that predicts 
the metabolic flux through biochemical reactions in metabolic networks [58–61]. 
FBA uses information about the stoichiometric coefficients of the metabolites 
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participating in each reaction, encapsulated in the stoichiometric matrix S, which is of 
dimension m×n, where m and n, respectively, denote the number of metabolites and 
the number of reactions in a metabolism. FBA assumes that a metabolism has reached 
a steady-state, as might be attained by a growing population of bacteria in chemostat 
with constant nutrient supply, where mass conservation constraints apply. These 
constraints are mathematically expressed as 𝑆𝑣 = 0, where v is the vector of fluxes 
(vi) through reaction i. The solution space of this equation is called the null space of 
the stoichiometric matrix (S). This null space is further constrained by upper and 
lower bounds on the fluxes through each reaction. FBA applies linear programming 
to find the optimal flux vector(s) that maximize an objective function Z. This task can 
be mathematically formulated as finding a flux vector (v*) with the property 
v*=maxv Z(v)={cTv|S.v=0, a≤v≤ 𝑏}, 
where the vector c contains scalar coefficients representing a maximization criterion, 
and entries 𝑎! and 𝑏! of vectors 𝑎 and 𝑏, respectively, indicate the minimally and 
maximally possible flux through reaction i. 
We use a set of 13 well-known precursors from central carbon metabolism as 
biomass molecules required for viability (S1 Table). We use the software package 
CLP (1.4, Coin-OR; https://projects.coin-or.org/Clp) to solve all linear programming 
problems. 
Chemical environments and carbon sources 
To computationally predict the viability of a metabolism on a given carbon source, 
information about the chemical environment that contains this and other nutrients 
needed to synthesize biomass precursors is required. In our analysis of central carbon 
metabolism, we consider a minimal aerobic growth environment composed of a sole 
carbon source, along with ammonium as a nitrogen source, inorganic phosphate as a 
source of phosphorus, as well as oxygen, protons, and water. Different environments 
vary in their carbon source but are the same in other nutrients. A metabolism is viable 
on a given carbon source, if it can synthesize all 13 biomass precursors (Additional 
files 1 and 2) from that carbon source. In our study, we used the following carbon 
sources: D-glucose, acetate, pyruvate, D-lactate, D-fructose, alpha-ketoglutarate, 
fumarate, malate, succinate and glutamate. 
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Reaction universe 
As a reaction “universe” we use a global set of reactions in central carbon 
metabolism, which is based on a published reconstruction of E. coli central carbon 
metabolism [29]. From this reconstruction, we deleted four reactions involved in 
ethanol metabolism, because in this study we are not interested in ethanol 
biosynthesis or degradation. We also grouped the reactions catalyzed by aconitase A 
and aconitase B into one reaction. The final reaction set consists of N = 51 
intracellular reactions (Additional files 1 and 2). The reconstruction in [29] also 
involves 20 transport reactions, which are necessary to import nutrients or excrete 
waste products, and which we assume to be present in all metabolisms we study. 
Genotype-phenotype mapping in metabolic genotype space 
For computational expediency, we use a compact representation of a metabolic 
genotype that is based on reactions rather than genes. Specifically, we represent such 
a genotype as a binary vector whose i-th entry corresponds to the i-th reaction in our 
reaction universe. If an organism’s genome encodes an enzyme capable of catalyzing 
a given reaction, the corresponding entry in the genotype vector will be one and zero 
otherwise. The genotype space including all possible metabolisms comprises 
2N metabolisms, where N is the total number of known or considered chemical 
reactions (N = 51 for our analysis). Any metabolic genotype can be thought of as a 
point in this space. We consider a metabolism viable on a carbon source if its biomass 
synthesis rate is more than one percent of the biomass synthesis rate of the network 
formed by all N=51  reactions in central carbon metabolism. Some metabolic 
genotypes correspond to metabolisms in which some reactions are disconnected. 
We call a reaction disconnected if (i) its products are neither biomass precursors nor 
substrates of any other reaction of the metabolism, or (ii) at least one of its substrates 
is neither a product of other reactions nor a nutrient taken up from the environment. 
We performed some analyses separately for metabolisms with and without 
disconnected reactions, to find out whether the presence of such reactions would 
affect our conclusions. 
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Exhaustive enumeration of viable metabolisms 
To exhaustively characterize the phenotypes of all 251 (1015) metabolic genotypes 
would be prohibitive if one had to perform one FBA computation (consuming about 
10-2 seconds) for each genotype. However, this computation becomes feasible when 
two facts are considered [39, 40]. First, six among the 51 internal reactions of central 
carbon metabolism are essential for viability on every carbon source we consider 
[62], which reduces the number of required FBA computations by a factor 26 from 251 
(1015) to 245 (1013). Second, deleting one or more reactions from an inviable 
metabolism cannot result in a viable metabolism, such that all metabolisms 
(“children”) that contain a subset of the reactions of an inviable metabolism 
(“parent”) will also be inviable. An algorithm that takes this observation into account 
decreases the number of required FBA evaluations further to approximately109 [41]. 
The set of metabolisms that are viable on a given subset S of the 10 carbon sources 
can easily be identified after the set 𝐺𝑁(𝐶!) of metabolisms viable on each of the 10 
carbon sources Ci has been determined. Specifically, 𝑉(𝑆) = 𝐺 ∈ Ω,∀ 𝐶! ∈ 𝑆,∀ 𝐶! ∈ 𝑆! 𝐺 ∈ 𝐺𝑁 𝐶! ,𝐺 ∉ 𝐺𝑁 𝐶!  where G denotes a 
genotype from genotype space Ω, and S’ denotes the complement of S. 
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7.7. Supplementary Information 
 
 
Additional file 1: Central carbon metabolism. Each arrow in each panel corresponds to one of the 
51 internal reactions we consider. Metabolites are indicated by their acronyms (see Additional file 2). 
Boxed metabolites correspond to 13 essential biomass precursors. Note that 4 metabolites (accoa, g3p, 
f6p and e4p) are shown more than once for visual clarity. Metabolic pathways, including 
glycolysis/gluconeogenesis, pentose-phosphate pathway, citric-acid cycle, oxidative phosphorylation, 
pyruvate and glutamate metabolism are distinguished by the colored and dashed rectangles. 
Anaplerotic reactions and glyoxylate shunt are highlighted using the purple and green arrows 
respectively. The figure is taken by permission from [40]. 
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Abbreviation  Metabolite full name 
13dpg  3-Phospho-D-glyceroyl phosphate 
2pg  D-Glycerate 2-phosphate 
3pg  3-Phospho-D-glycerate 
6pgc  6-Phospho-D-gluconate 
6pgl  6-phospho-D-glucono-1,5-lactone 
ac  Acetate 
ac[e]  Acetate (extracellular) 
acald  Acetaldehyde 
acald[e]  Acetaldehyde (extracellular) 
accoa  Acetyl-CoA 
actp  Acetyl phosphate 
adp  ADP 
akg  2-Oxoglutarate 
akg[e]  2-Oxoglutarate (extracellular) 
amp  AMP 
atp  ATP 
cit  Citrate 
co2  CO2 
co2[e]  CO2 (extracellular) 
coa  Coenzyme A 
dhap  Dihydroxyacetone phosphate 
e4p  D-Erythrose 4-phosphate 
f6p  D-Fructose 6-phosphate 
fdp  D-Fructose 1,6-bisphosphate 
for  Formate 
for[e]  Formate (extracellular) 
fru[e]  D-Fructose (extracellular) 
fum  Fumarate 
fum[e]  Fumarate (extracellular) 
g3p  Glyceraldehyde 3-phosphate 
g6p  D-Glucose 6-phosphate 
glc-D[e]  D-Glucose (extracellular) 
gln-L  L-Glutamine 
gln-L[e]  L-Glutamine (extracellular) 
glu-L  L-Glutamate 
glu-L[e]  L-Glutamate (extracellular) 
glu-L[e]  L-Glutamate (extracellular) 
glx  Glyoxylate 
h  H+ 
h[e]  H+ (extracellular) 
h2o  H2O 
h2o[e]  H2O (extracellular) 
icit  Isocitrate 
lac-D  D-Lactate 
lac-D[e]  D-Lactate (extracellular) 
mal-L  L-Malate 
mal-L[e]  L-Malate (extracellular) 
nad  Nicotinamide adenine dinucleotide 
nadh  Nicotinamide adenine dinucleotide (reduced) 
nadp  Nicotinamide adenine dinucleotide phosphate 
nadph 
 Nicotinamide adenine dinucleotide phosphate 
(reduced) 
nh4  Ammonium 
nh4[e]  Ammonium (extracellular) 
o2  O2 
o2[e]  O2 (extracellular) 
oaa  Oxaloacetate 
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pep  Phosphoenolpyruvate 
pi  Phosphate 
pi[e]  Phosphate (extracellular) 
pyr  Pyruvate 
pyr[e]  Pyruvate (extracellular) 
q8  Ubiquinone-8 
q8h2  Ubiquinol-8 
r5p  alpha-D-Ribose 5-phosphate 
ru5p-D  D-Ribulose 5-phosphate 
s7p  Sedoheptulose 7-phosphate 
succ  Succinate 
succ[e]  Succinate (extracellular) 
succoa  Succinyl-CoA 
xu5p-D  D-Xylulose 5-phosphate 
 
Additional file 2: Metabolites and reactions in central carbon metabolism. This table lists all the 
reactions (Sheet 1) and metabolites (Sheet 2) of central carbon metabolism, their abbreviations, and 
further associated information. 
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Additional file 3: Metabolisms viable on a given carbon source vary widely in their exaptation 
potential. Histogram of the exaptation index (x-axis), i.e., the number of carbon sources Cnew on which 
a metabolism is viable, for metabolisms viable on lactate as carbon source C with size (A) 35, (B) 40, 
(C) 45, and for metabolisms viable on malate as carbon source C with size (D) 35, (E) 40, (F) 45. 
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Additional file 4: High exaptation potential in central carbon metabolisms (considering only 
metabolisms without disconnected reactions). (A) Fraction of metabolisms with exaptation index 
I>0 (y-axis) viable on some carbon source C (x-axis). Red bars correspond to viable metabolisms 
without disconnected reactions, and blue bars correspond to all viable metabolisms. (B) Fraction of 
metabolisms (coded by shade of grey, see legend) with exaptation index (I>0) that are viable on some 
carbon source C (x-axis) and have a given size (y-axis), . (C) Mean exaptation index of metabolisms 
without disconnected reactions, and viable on a given focal carbon source C (x-axis). Red bars 
correspond to viable metabolisms without disconnected reactions, and blue bars correspond to all 
viable metabolisms. (D) Mean exaptation index (coded by shade of grey, see legend) of metabolisms 
without disconnected reactions, and viable on some carbon source C (x-axis) and with a given size (y-
axis). White colors in (B) and (D) correspond to metabolisms whose size is too small for viability on 
C. 
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Additional file 5: Exaptation diversity. For 
metabolisms whose focal carbon source C is 
shown on the x-axis, and the number of 
reactions (n) is shown on the vertical axis, the 
number of carbon sources Cnew on which at 
least one metabolism is preadapted, is coded 
by shade of grey (see legend). 
 
 
Additional file 6: Metabolisms viable on glucose as the main carbon source C can differ greatly 
in their viability on other carbon sources. The figure shows a histogram of the phenotype distance 
(x-axis), for metabolisms of size (A) 35, and (B) 40, viable on glucose as carbon source C. 
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Additional file 7: Metabolisms viable on pyruvate as the main carbon source C can differ greatly 
in their viability on other carbon sources. The figure shows a histogram of the phenotype distance 
(x-axis), for metabolisms of size (A) 30, (B) 35, (C) 40, and (D) 45, viable on pyruvate as focal carbon 
source C. 
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Additional file 8: Metabolisms can preadapt to a wide variety of carbon sources (considering 
only metabolisms without disconnected reactions). (A) For metabolisms (without disconnected 
reactions) whose focal carbon source C is shown on the x-axis, and the number of reactions (n) is 
shown on the vertical axis, each shade of grey (see legend) shows the number of carbon sources Cnew 
on which at least one metabolism is preadapted. (B) Mean phenotypic distance (see legend) of 
metabolisms (without disconnected reactions) viable on a focal carbon source (x-axis) and with a given 
number of reactions n (y-axis). 
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Additional file 9: Metabolisms viable on glucose as the main carbon source C can differ greatly 
in their viability on other carbon sources (considering only metabolisms without disconnected 
reactions). The figure shows a histogram of the phenotype distance (x-axis), for metabolisms without 
disconnected reactions with size (A) 30, (B) 35, (C) 40, and (D) 45, viable on glucose as carbon source 
C. 
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Additional file 10: Metabolisms viable on pyruvate as the main carbon source C can differ 
greatly in their viability on other carbon sources (considering only metabolisms without 
disconnected reactions). The figure shows a histogram of the phenotype distance (x-axis), for 
metabolisms without disconnected reactions with size (A) 30, (B) 35, (C) 40, and (D) 45, viable on 
pyruvate as carbon source C. 
 
Additional file 11: Metabolisms viable on lactate differ in their propensity for preadaptation to 
other carbon sources Cnew. (A) The histogram shows the fraction of metabolisms viable on lactate as 
carbon source C that are also viable on each of the nine other carbon sources Cnew (x-axis). (B) As in 
(A), but broken down by metabolism size, and fractions of viable metabolisms are coded by shade of 
grey, see legend.  
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Additional file 12: Potential for preadaptation depends on biochemical similarity between 
carbon sources (considering only metabolisms without disconnected reactions). (A) The histogram 
shows the fraction of metabolisms (without disconnected reactions) viable on glucose as carbon source 
C that are also viable on each of the nine other carbon sources Cnew (x-axis). (B) As in (A), but broken 
down by metabolism size, and fractions of viable metabolisms are coded by shade of grey, see legend 
(C) Fraction of metabolisms (without disconnected reactions) viable on carbon source C (x-axis), that 
are also viable on carbon source Cnew (y-axis), are coded by shade of grey, see legend. (D) Dendrogram 
of carbon sources clustered based on their pairwise preadaptation propensity. We used UPGMA 
method (unweighted pair group method with arithmetic means), for clustering carbon sources. 
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Additional file 13: Metabolisms viable on lactate have different potential for preadaptation to 
other carbon sources Cnew (considering only metabolisms without disconnected reactions). (A) 
The histogram shows the fraction of metabolisms (without disconnected reactions) viable on lactate as 
carbon source C that are also viable on each of the nine other carbon sources Cnew (x-axis). (B) As in 
(A), but broken down by metabolism size, and fractions of viable metabolisms are coded by shade of 
grey, see legend. 
 
 
Additional file 14: Association between exaptation potential and biomass yield. The x-axes show 
the exaptation index, i.e., the number of carbon sources Cnew on which metabolisms viable on carbon 
source C (color legend) are viable. The y-axes show the average biomass yield. Data is based on 
metabolisms of size (A) n=35, and (B) n=45. 
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Additional file 15: Distribution of the number of synthesized metabolites among metabolisms 
viable on glucose. Fraction of metabolisms excreting a given number of metabolites (x-axis) among 
metabolisms viable on glucose with size (A) n=35, and (B) n=45. 
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Additional file 16: Association between 
biomass yield and number of excreted waste 
metabolites. The vertical axis shows the 
biomass yield of metabolisms of size (A) 
n=30, (B) n=40, and (C) n=50 viable on 
glucose that excrete a given number of 
metabolites (x-axis). Boxes span the 25-th to 
75-th percentile, and whiskers indicate the 
maximu shows the m and minimum values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Additional file 17:  Larger metabolisms 
have higher biomass yield. Mean of biomass 
yield among metabolisms of a given size (y-
axis), that are viable on a given carbon source 
(x-axis), coded by shade of grey, see legend. 
White colors correspond to metabolisms 
whose size is too small for viability on C.	
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Chapter 8: Conclusion 
In conclusion, in my thesis, I have studied the origins of evolutionary innovations in 
complex metabolic systems. In particular, my studies have identified the prominent 
principles underlying the emergence of novel metabolic phenotypes. First and 
foremost, I have shown that recombination is a powerful mechanism of genetic 
change behind phenotypic innovation. My results revealed that recombination is able 
to dramatically increase the probability of the emergence of phenotypically 
innovative recombinant genotypes. This ability reflects the combinatorial nature of 
innovation in biological systems, that is, novel traits emerge when already-existing 
components come together in a new combination. Moreover, my results identify the 
factors that can enhance phenotypic innovation through recombination. These 
principles can equip us with the capability to manipulate and control biological 
systems towards higher innovation capacity. For example, my results revealed that 
recombination between genotypically more similar but phenotypically more 
dissimilar metabolisms can lead to a higher probability of the emergence of novel 
phenotypes. These observations may find practical value in experimental settings to 
generate pools of recobinant genomes with the capacity to manifest novel 
phenotypes. 
Moreover, my exhaustive analysis of genotype space in central carbon metabolism 
revealed organizational principles facilitating metabolic innovations. In particular, 
metabolic genotypes are organized in genotype space in a non-random way, which 
ensures high probability of the emergence of novel phenotypes. My observations 
indicate that genotypes with the same phenotype form a connected network in 
genotype space. In other words, the members of every pair of viable genotypes are 
accessible from each other through a few viability-preserving mutational steps. This 
property renders the emergence of novel metabolic phenotypes independent of 
historical events, and so historical contingency does not play a strong role in the 
emergenece of metabolic properties. Moreover, all possible metabolic phenotypes are 
accessible in the immediate neighborhood of most viable genotypes. Thus, novel 
phenotypes are accessible in genotype space through a small number of genetic 
changes. 
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Furthermore, I observed that metabolic traits are highly correlated, and this 
correlation stems from overlapping network components, for example shared 
metabolic reactions and pathways that connect biomass components to external 
metabolites. The extent of this correlation raises the possibility that metabolic 
phenotypes might have non-adaptive origins. In other words, the emergence of novel 
phenotypes in metabolic systems may not necessarily have adaptive reasons. Instead, 
it can happen passively due to the inherent correlation between metabolic phenotypes.   
Finally, my results revealed that in metabolic systems, phenotypic robustness helps 
promote phenotypic innovation. Importantly, genomes have evolved an organization 
that ensures substantially higher phenotypic robustness to large-scale gene deletions 
than a random arrangement of metabolic genes. This observation provides evidence 
supporting the claim that randomness is not sufficient to explain complex phenotypes 
in biological systems. An evolved arrangement of metabolic genes provides higher 
phenotypic robustness to the deleterious effects of large-scale gene deletions, and this 
increased robustness can be helpful for the emergence of novel phenotypes. 
In sum, the take home message of my dissertation is that a complex biological 
phenomenon like metabolic innovation can be analyzed rigorously in order to dissect 
underlying evolutionary rules and principles. If we characterize the hidden rules 
behind it, phenotypic innovation will no longer remain a black box. Although 
evolutionary theory is the ultimate explanation for the emergence of complex 
biological traits, we still need to identify the proximate cuases behind phenotypic 
innovation. Importantly, characterizing the proximate causes of innovation can 
mechanistically clarify the underlying processes, and provides us with a more 
accurate and evidence-based interpretation of evolutionary theory in the context of 
complex systems.    
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